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Summary of thesis 
 In both natural and man-made water systems, the gram-negative bacterium 
Legionella pneumophila likely resides within complex biofilm communities.  However, 
when various freshwater protozoa ingest L. pneumophila, the microbes can efficiently 
establish an intracellular niche protected from digestion.  Moreover, if humans inhale 
bacteria-laden aerosols, L. pneumophila can survive and replicate within alveolar 
macrophages to cause the severe pneumonia, Legionnaires’ disease.  To persist within 
these diverse niches, L. pneumophila alternates between at least two distinct phenotypic 
phases:  a non-infectious, replicative form required for intracellular growth and an 
infectious, transmissive form that enhances survival in the extracellular milieu.  In this 
thesis, I identify metabolites that cue L. pneumophila differentiation and analyze several 
proteins that enable the bacterium to initiate its phenotypic switch as appropriate for the 
local environment.   
 My work extends our knowledge of the regulatory elements that govern L. 
pneumophila differentiation.  In particular, previous studies established that the 
LetA/LetS two-component system regulates host transmission through the activity of the 
global regulator CsrA, and the stringent response pathway coordinates transcription 
through the production of the signaling molecule ppGpp (Fettes et al., 2001; Hammer and 
Swanson, 1999; Hammer et al., 2002; Lynch et al., 2003; Molofsky and Swanson, 2003; 
Zusman et al., 2002).  In Chapter Two, I provide evidence that the design of the 
LetA/LetS two-component system enables L. pneumophila to customize its 
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transcriptional and phenotypic profiles.  Moreover, I present data that suggests that the 
model of the flexible LetA/LetS regulon may be applicable to many two-component 
systems, which may equip microbes with a mechanism to fine-tune their traits.  In 
Chapter Three, I identify a new metabolic cue that triggers L. pneumophila 
differentiation.  Specifically, I find (1) excess short chain fatty acids inhibit growth and 
induce all transmission phenotypes, (2) the response of L. pneumophila to the short chain 
fatty acids is dependent on the LetA/LetS system and the stringent response enzyme 
SpoT, and (3) excess short chain fatty acids perturb fatty acid biosynthesis, which is 
likely sensed via an interaction between SpoT and a critical component of the fatty acid 
biosynthetic pathway, acyl carrier protein.  In Chapter Four, I determine the 
transcriptional profiles of replicative and transmissive phase L. pneumophila by 
microarray analysis.  Also, using genotypic and phenotypic approaches, I demonstrate 
that nicotinic acid is an additional trigger of L. pneumophila differentiation.  In Chapter 
Five, I summarize the key findings of my work and discuss both the implications and the 
unsolved questions regarding L. pneumophila virulence regulation, metabolism and 
pathogenesis.   
 
Life cycle of L. pneumophila 
 When planktonic, transmissive L. pneumophila are engulfed by phagocytic cells, 
the bacteria avoid lysosomal degradation and instead establish a vacuole isolated from the 
endocytic network (Fig. 1.1).  To gauge nutrient conditions within its host cell, L. 
pneumophila employs the Pht family of transporters (Sauer et al., 2005).  If vacuolar 
conditions are favorable, the post-transcriptional regulator CsrA, and perhaps the sRNA 
chaperone Hfq, suppresses transmissive traits and promotes intracellular replication 
(Fettes et al., 2001; McNealy et al., 2005; Molofsky and Swanson, 2003).  When 
nutrients are depleted, bacterial replication halts and the enzymes RelA and SpoT 
produce ppGpp (Hammer and Swanson, 1999; Zusman et al., 2002).  The accumulation 
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of ppGpp in the bacterial cytosol stimulates the LetA/LetS two-component system to 
relieve CsrA repression of transmissive traits (Hammer and Swanson, 1999; Hammer et 
al., 2002; Molofsky and Swanson, 2003).  Together, the LetA/LetS system, the enhancer 
protein LetE, and the alternative sigma factors RpoS, RpoN and FliA induce traits 
thought to promote efficient host transmission and survival in the environment, including: 
evasion of phagosome-lysosome fusion, motility, cytotoxicity, sodium sensitivity and 
resistance to environmental stresses (Bachman and Swanson, 2001, 2004a, b; Hammer et 
al., 2002; Jacobi et al., 2004; Lynch et al., 2003).  Under defined conditions, L. 
pneumophila may further develop into the highly resilient and infectious cell type, the 
mature intracellular form (Faulkner and Garduno, 2002; Garduno et al., 2002).  
Eventually, the exhausted host cell lyses, and progeny are released into the environment.  
While L. pneumophila that fail to find a new phagocyte probably establish complex 
biofilms, planktonic bacteria that encounter another suitable host can initiate the 
intracellular life cycle once more.   
 
Broth model of differentiation 
 Broth cultures of L. pneumophila grown to either the exponential or stationary 
phase exhibit traits similar to replicative and transmissive bacteria, respectively, that are 
observed in co-cultures with phagocytic cells (Fig. 1.1).  While many of the different 
stages and regulatory elements of the L. pneumophila life cycle were originally discerned 
by observing synchronous broth cultures, subsequent analysis in eukaryotic cells has 
supported many of these findings.  Likewise, comparison of the transcription profiles of 
L. pneumophila cultured in broth and in Acanthamoeba castellanii has revealed that 84% 
of replicative phase genes and 77% of transmissive phase genes are up-regulated both in 
vitro and in vivo, thereby confirming the utility of broth culture studies (Bruggemann et 
al., 2006).  Several lines of evidence suggest that the replicative and transmissive phases 
observed in both broth and eukaryotic cell cultures are reciprocal.  For example, when 
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stationary phase L. pneumophila are cultured within eukaryotic cells, they suppress their 
transmissive traits of cytotoxicity, sodium sensitivity, and motility, and instead replicate 
profusely (Alli et al., 2000; Byrne and Swanson, 1998).  Following the replicative period, 
transmissive traits are induced, and the host cell lyses (Alli et al., 2000; Byrne and 
Swanson, 1998).  Similarly, FlaA, Mip, DotH and DotO proteins, which are known to 
enhance invasion of eukaryotic cells, are expressed during the entry and exit periods, but 
not during replication (Hammer and Swanson, 1999; Watarai et al., 2001a; Wieland et 
al., 2005).  In contrast, the promoter of CsrA, a repressor of transmission traits, is only 
active during the replicative period, not during invasion or host cell lysis (Molofsky and 
Swanson, 2003).   
 While pure bacterial cultures are advantageous for many molecular and 
biochemical techniques, several characteristics of L. pneumophila have only been 
observed in vivo, emphasizing the simplicity and limitations of the broth model.  For 
instance, the replication vacuole in A/J mouse macrophages acidifies and L. pneumophila 
remain acid tolerant, whereas exponentially growing broth cultures are acid sensitive 
(Sturgill-Koszycki and Swanson, 2000).  Additionally, bacteria harvested from A. 
castellanii are more infectious than agar-grown bacteria, suggesting that the intracellular 
environment of amoebae can affect virulence traits (Cirillo et al., 1999).  Moreover, after 
extended culture in HeLa cells, L. pneumophila differentiates to the cyst-like MIF, a cell 
type also observed in amoebae and clinical samples, but not in broth or macrophage 
cultures (Garduno et al., 2002; Greub and Raoult, 2003).  The substantial differences 
observed between broth and phagocytic cell cultures highlight the impact of experimental 
design and lend caution to making inferences based on any single laboratory model.   
 
Amino acid availability governs differentiation 
 Although the exact nutrient composition of the L. pneumophila replication 
vacuole is unknown, several lines of evidence indicate that amino acids are critical, and 
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differences in these concentrations can affect the differentiation state of the microbe.  
Foremost, broth studies indicate that L. pneumophila depends on amino acids for its sole 
source of carbon and energy (Tesh et al., 1983).  Additionally, the uptake of amino acids 
by its host cell via the human transporter protein SLC1A5 (hATB0,+) is required for L. 
pneumophila to replicate in macrophages (Wieland et al., 2005).  Furthermore, L. 
pneumophila uses amino acid transporters to determine the nutrient availability of the 
environment and trigger its differentiation as deemed appropriate (discussed below) 
(Sauer et al., 2005).  Finally, when amino acids are depleted, L. pneumophila utilizes the 
stringent response to induce a panel of traits that enable escape from its spent host, 
survival in the environment, and the capacity to invade another suitable host (discussed 
below) (Hammer and Swanson, 1999).  The regulatory linkage of nutrient availability to 
differentiation is essential for L. pneumophila pathogenesis, as it determines the 
phenotypic profile of the microbe.   
 
  
Pht family of transporters 
 To sense amino acid availability and determine if differentiation to a replicative 
state is advantageous, transmissive L. pneumophila use a family of phagosomal 
transporters (Phts) (Sauer et al., 2005).  In particular, a L. pneumophila mutant of the 
phtA gene was shown to have a pronounced defect in intracellular growth in murine bone 
marrow-derived macrophages, and it failed to differentiate to the replicative state (Sauer 
et al., 2005).  However, the ability of the phtA mutant to infect macrophages and 
establish a protected ER-derived vacuole was not compromised (Sauer et al., 2005).  
Using sequence analysis, PhtA was predicted to be a transmembrane protein that 
traverses the membrane twelve times and belong to the Major Facilitator Superfamily of 
transporters (Pao et al., 1998; Sauer et al., 2005).  Indeed, the growth defect of the phtA 
mutant in both minimal media and macrophages can be bypassed by supplementing 
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media with free threonine or threonine dipeptides (Sauer et al., 2005).  Taken together 
with the aforementioned data, it is proposed that L. pneumophila uses the PhtA 
transporter as a mechanism to couple nutrient acquisition to differentiation (Fig. 1.3) 
(Sauer et al., 2005).   
 Examination of the L. pneumophila genome reveals that strains Philadelphia 1 and 
Lens have 11 phtA homologues, while the Paris strain has nine (Cazalet et al., 2004; 
Sauer et al., 2005).  Though several of these loci are likely gene duplications, it is 
conceivable that L. pneumophila encodes pht homologues dedicated to transporting each 
of the six essential amino acids, either arginine, cysteine, methionine, serine, threonine or 
valine (Ristroph et al., 1981).  In support of this model, a phtJ (previously milA) mutant 
has a growth defect in macrophages and alveolar epithelial cells (Harb and Abu Kwaik, 
2000), which can be suppressed by valine supplementation (Sauer and Swanson, 
unpublished).  Other intracellular environmental pathogens may also exploit transporters 
to evaluate nutrient availability before undergoing differentiation, since pht homologues 
have been identified in Coxiella burnetti and Francisella tularensis, two closely related 
pathogens that also efficiently parasitize both macrophages and amoebae (Oyston et al., 
2004).  Thus, the Pht family of transporters may equip vacuolar pathogens to assess the 
nutrient composition in their protective vacuole before committing to differentiation.   
 
Stringent response 
 Microbes trigger a global change in their cellular metabolism known as the 
stringent response when confronted with nutritional and metabolic stresses, such as the 
limitation of amino acids, carbon, iron, nitrogen, phosphorous and fatty acids 
(Magnusson et al., 2005).  Numerous physiological processes are coordinately altered, 
including growth inhibition, down-regulation of nucleic acid and protein synthesis, 
enhancement of protein degradation, and up-regulation of amino acid synthesis and 
transport.  The stringent response is triggered when uncharged tRNAs accumulate in the 
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A-site of the 50S ribosome.  Using ATP as a phosphate donor, the ribosome-associated 
enzyme RelA is activated to synthesize the alarmone, ppGpp (guanosine 3', 5'-
bispyrophsophate), and its precursor, pppGpp (guanosine 3'-diphosphate, 5'-triphosphate) 
by phosphorylating GDP and GTP, respectively.  The ppGpp effector molecule then 
binds directly to the β and β' subunits of the RNA polymerase (RNAP) core enzyme.  As 
a result, the transcription of some classes of genes is up-regulated, while the expression 
of other sets of genes is inhibited (Magnusson et al., 2005; Srivatsan and Wang, 2008).   
 There is considerable evidence that ppGpp acts as a global regulator to modulate a 
variety of bacterial cellular and physiological processes.  Furthermore, numerous 
intracellular and extracellular pathogens appear to exploit the stringent response pathway 
to activate virulence genes and persist in the hostile environment of their host; these 
include Mycobacterium tuberculosis, Listeria monocytogenes, Pseudomonas aeruginosa, 
Streptococcus pyogenes, Staphylococcus aureus, Borrelia burgdorferi and Salmonella 
typhimurium (Godfrey et al., 2002; Magnusson et al., 2005).  By monitoring 
environmental conditions and invoking the stringent response, pathogens can elicit swift 
changes in gene expression to adapt to the metabolic stresses encountered in their host, 
thereby promoting self-preservation.   
In broth culture, L. pneumophila accumulate ppGpp upon entry into stationary 
phase, when amino acids are depleted, or when relA is induced (Hammer and Swanson, 
1999).  As a result, the microbe converts from a replicative to transmissive state, as 
characterized by the expression of virulence traits (Hammer and Swanson, 1999).  L. 
pneumophila relA mutants are unable to produce detectable levels of ppGpp and are 
defective for the transmission traits of pigmentation and motility (Zusman et al., 2002).  
However, relA is dispensable for intracellular growth in both human macrophages and 
amoebae, suggesting relA activity contributes exclusively to the transmissive phase, not 
replication (Zusman et al., 2002).  By analogy to other bacteria that use a stringent 
response, it is proposed that ppGpp acts as an alarmone to induce the coordinate 
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expression of traits that equip L. pneumophila to escape its spent host and persist in the 
environment until it encounters another phagocyte.   
 In broth cultures, the L. pneumophila RelA enzyme appears to be the major 
ppGpp synthetase because only minimal levels of the alarmone are detected in relA 
mutants (Zusman et al., 2002).  However, many prokaryotes contain a second enzyme, 
SpoT, which, depending on environmental conditions, exhibits either ppGpp synthatase 
or hydrolase activity (Chatterji and Kumar Ojha, 2001).  When growth conditions are 
favorable, SpoT diminishes ppGpp levels in the cytosol through its hydrolase activity 
(Chatterji and Kumar Ojha, 2001).  But under certain nutrient limitations, such as 
nitrogen, phosphorous and fatty acid starvation, SpoT can synthesize ppGpp to elicit the 
stringent response (Magnusson et al., 2005).  Sequence analysis indicates the L. 
pneumophila genome contains a homologue 52% identical to the Escherichia coli spoT 
gene that appears to be essential for viability, as attempts to delete the locus were 
unsuccessful (Zusman et al., 2002).  Recent work in E. coli indicates that SpoT interacts 
with the functional form of acyl carrier protein to respond to fatty acid starvation (Battesti 
and Bouveret, 2006).  Therefore, we postulated that L. pneumophila might similarly 
employ SpoT to sense fatty acid concentrations.  Indeed, our data suggest that 
perturbations in the fatty acid biosynthetic pathway cue L. pneumophila differentiation 
through an interaction between SpoT and acyl carrier protein (Chapter 3 and Appendix 
A).  We predict that this provides the bacterium with a mechanism to sense local 
conditions and make decisions regarding its fate.   
 
Evidence that other factors trigger differentiation 
 Although the RelA-induced stringent response pathway is the most well 
characterized mechanism by which L. pneumophila controls differentiation, several lines 
of evidence indicate that other signals are likely to be involved.  By phenotypic analysis, 
relA mutants appear less defective for transmissive traits than other known regulators of 
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differentiation, suggesting additional factors act in concert with RelA (Hammer and 
Swanson, 1999; Zusman et al., 2002).  Also, letA mutants (discussed below) do express 
traits that are normally impaired when certain growth conditions are altered, such as 
aeration, temperature or media composition (Fernandez-Moreia and Swanson, 
unpublished).  Furthermore, broth cultures of letA and letS mutants are defective in their 
ability to infect mouse macrophages, but surviving bacteria can initiate secondary and 
tertiary infections as efficiently as wild-type (Hammer et al., 2002).  Additionally, L. 
pneumophila letA mutants are more infectious when harvested from cultures of murine 
bone marrow-derived macrophages (Byrne and Swanson, unpublished).  Taken together, 
these data indicate that additional regulators can bypass RelA and the LetA/LetS two-
component system by receiving signals and initiating differentiation.  Whether the signals 
stem from the unique environment of the L. pneumophila vacuole or are only induced 
when bacterial density within the vacuole reaches a certain threshold remains to be 
determined.   
 
Acetyl-phosphate 
 In addition to ppGpp, acetyl-phosphate can act as a global signal for many cellular 
processes, including chemotaxis, nitrogen and phosphate assimilation, biofilm 
development and the expression of virulence traits (Wolfe, 2005).  Acetyl-phosphate is a 
high energy phosphate compound that can be synthesized by two separate reactions: (1) 
from acetyl-CoA and Pi by phosphotransacetylase, encoded by the pta gene, or (2) from 
ATP and acetate, in a reaction catalyzed by acetyl kinase, the product of ackA (McCleary 
et al., 1993; Wolfe, 2005).  Response regulators of two-component systems can use 
acetyl-phosphate to catalyze their own phosphorylation (Wolfe, 2005).  Accordingly, the 
Bordetella pertussis response regulator, BvgA, can be phosphorylated in the absence of 
its cognate histidine kinase using acetyl-phosphate as a donor (Boucher et al., 1994).  
Likewise, either acetyl phosphate or the histidine kinase BarA can activate the S. 
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typhimurium response regulator SirA to induce the expression of invasion genes (Lawhon 
et al., 2002).  The L. pneumophila genome contains homologues of both pta and ackA of 
E. coli (Gal-Mor and Segal, 2003a), suggesting that acetyl-phosphate may phosphorylate 
one of the two-component systems to induce gene expression.   
 
Transcriptional control of differentiation via sigma factors 
 To regulate gene expression, one mechanism commonly employed by bacteria is 
to modify RNAP activity by altering its sigma factor.  In E. coli, RNAP consists of a core 
enzyme and one of seven potential sigma factors that direct the RNAP to a distinct cohort 
of promoters (Nystrom, 2004).  For growth-related activities and proliferation, E. coli 
require the housekeeping sigma factor, σ70, encoded by rpoD (Nystrom, 2004).  
However, during conditions of growth arrest, starvation, stress or maintenance, the 
bacteria replace σ70 with alternate sigma factors, thereby recruiting RNAP to the 
promoters of a cohort of genes that will confer survival under the deleterious conditions 
(Nystrom, 2004).  Analysis of the L. pneumophila genome has identified six alternative 
sigma factors: RpoD (σD/σ70), RpoE, RpoH, RpoN (σ54), RpoS (σS/σ38) and FliA (σ28), 
as well as the sigma factor-dependent enhancer, FleQ, and the anti-sigma factors, FlgM 
and anti-sigma factor B (Cazalet et al., 2004; Chien et al., 2004).  Several of the L. 
pneumophila sigma factors have been implicated by genetic analysis to regulate subsets 
of transmission traits (Bachman and Swanson, 2001; Molofsky et al., 2005).   
 Recent biochemical and genetic data obtained with E. coli indicate that the 
effector molecule of the stringent response, ppGpp, controls sigma factor competition for 
the RNAP core enzyme (Nystrom, 2004).  In particular, ppGpp regulates the ability of 
different alternative sigma factors to bind RNAP, and ppGpp also controls the production 
and activity of many sigma factors (Magnusson et al., 2005).  Therefore, under nutrient 
limiting conditions, the stringent response governs sigma factor competition and other 
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aspects of gene transcription, thus altering the expression profile and enhancing the 
fitness of the microbe.   
 
RpoS 
 The stationary phase sigma factor, RpoS, is required for L. pneumophila sodium 
sensitivity, maximal expression of flagellin, and lysosomal evasion, but it is dispensable 
for the other known transmissive phase phenotypes (Bachman and Swanson, 2001; Hales 
and Shuman, 1999).  In accordance with the theory of sigma factor competition, over-
expression of rpoS decreases csrA, letE, fliA and flaA transcripts, and inhibits the fliA-
dependent transmission traits of motility, infectivity and cytotoxicity (Bachman and 
Swanson, 2004b).  Also, multiple copies of rpoS inhibit intracellular replication in A. 
castellanii (Hales and Shuman, 1999).  Although the global regulation of gene expression 
by sigma factors in L. pneumophila has not been confirmed biochemically, these data 
support the model that, during stringency, ppGpp alters the competition among sigma 
factors for RNAP, thus allowing recruitment of RNAP to the appropriate set of 
transmission genes (Bachman and Swanson, 2004b; Hales and Shuman, 1999).   
 
RpoN and FleQ 
 Since the assembly of the bacterial flagellum is an energetically taxing process, 
microbes encode a complex regulatory cascade to ensure that the timing and synthesis of 
both structural and accessory proteins of the flagellar regulon are tightly controlled.  In L. 
pneumophila, the alternative sigma factor RpoN and the coactivator FleQ are at the top of 
this transcriptional hierarchy; hence, rpoN and fleQ mutants lack a flagellum and produce 
very little flagellin protein (Jacobi et al., 2004).  Additionally, both RpoN and FleQ 
positively regulate transcription of several genes within the second tier of the regulation 
cascade, including fliM, fleN and fleSR (Jacobi et al., 2004).  In contrast, RpoN and FleQ 
are dispensable for fliA and flaA transcription, suggesting that additional factors may 
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govern genes within the transcriptional cascade of the L. pneumophila flagellar regulon 
(Jacobi et al., 2004).   
 
FliA 
 To induce flaA transcription, assemble a monopolar flagellum, and become 
motile, L. pneumophila require a second sigma factor, FliA (Heuner et al., 1997; Heuner 
et al., 2002).  Besides controlling genes of the flagellar regulon, FliA governs a set of 
motility-independent traits thought to promote host transmission and persistence.  In 
particular, L. pneumophila require FliA to produce a melanin-like pigment, alter its 
surface properties, avoid lysosomes, and replicate within Dictyostelium discoideum 
(Hammer et al., 2002; Heuner et al., 2002; Molofsky et al., 2005).  By coordinating 
motility with other essential virulence traits, L. pneumophila can fine-tune its expression 
profile to enhance its versatility when confronted by a multitude of host defenses and 
environmental stresses.   
 
Post-transcriptional control of differentiation 
 
LetA/LetS two-component system 
 Two-component systems are widely used by prokaryotic organisms to adapt to 
environmental fluctuations.  Typically, these signal transduction systems consist of a 
membrane–bound sensor protein that monitors the environment and a cytoplasmic 
response regulator that binds target DNA sequences (Appleby et al., 1996; Bijlsma and 
Groisman, 2003).  Upon stimulation, the sensor autophosphorylates a conserved histidine 
residue using the γ-phosphoryl group of ATP as a donor (Appleby et al., 1996; Bijlsma 
and Groisman, 2003).  The phosphate is then transferred to an aspartic acid in the 
response regulator, allowing for activation or repression of target genes (Appleby et al., 
1996; Bijlsma and Groisman, 2003).  The specific signal for autophosphorylation may be 
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abiotic or biotic, and be produced by the environment, the host cell, or generated by the 
bacteria themselves via quorum sensing (Heeb and Haas, 2001).  However, for many 
microbial two-component systems, the corresponding signal remains elusive.   
 The LetA/LetS (Legionella transmission activator and sensor, respectively) 
system of L. pneumophila was originally identified by screening for mutants defective for 
flagellin expression (Hammer et al., 2002).  Further analysis demonstrated that, as cells 
exit exponential phase, LetA/LetS induces an array of traits likely to promote 
transmission, including the ability to infect both macrophages and A. castellanii, avoid 
phagosome-lysosome fusion, sodium sensitivity, stress resistance, motility, pigmentation 
and macrophage cytotoxicity (Bachman and Swanson, 2004a; Hammer et al., 2002; 
Lynch et al., 2003).  Accordingly, letA and letS mutants do not express transmissive 
traits, and instead constitutively display phenotypes similar to wild-type replicative 
bacteria (Hammer et al., 2002; Lynch et al., 2003).  Bacteria that lack LetA fail to 
respond to ppGpp (Hammer et al., 2002), but whether LetS is activated directly by the 
alarmone or by another signaling molecule that stimulates its autophosphorylation is 
unknown.  By analogy to other two-component systems, LetS is the proposed membrane-
associated sensor kinase and LetA the cognate response regulator.   
 LetA/LetS belongs to a family of signal-transducing proteins that includes 
BvgA/BvgS of Bordetella, GacA/GacS of Acinetobacter baumannii, PigQ/PigW of 
Serratia marcescens, VarA/VarS of Vibrio cholerae, SirA/BarA of Salmonella, 
GacA/GacS of Pseudomonas and the UvrY/BarA, EvgA/EvgS and TorR/TorS systems of 
E. coli (Heeb and Haas, 2001; Lapouge et al., 2008; Perraud et al., 1999).  The 
BvgA/BvgS system, which established the paradigm for this family of signaling 
molecules, deviates from classic two-component systems by employing a four-step 
phosphorelay in which His-Asp-His-Asp residues are sequentially phosphorylated (Uhl 
and Miller, 1996a).  BvgS is a tripartate, transmembrane sensor whose periplasmic 
domain is linked by a membrane-spanning region to three cytoplasmic signaling 
 14 
domains:  a transmitter, receiver and histidine phosphotransfer domain (Cotter and 
DiRita, 2000).  In response to an unknown signal, BvgS autophosphorylates a histidine in 
the transmitter, and then sequentially transfers the phosphoryl group to aspartic acid and 
histidine residues first in the receiver and then in the histidine phosphotransfer domain, 
respectively (Cotter and DiRita, 2000).  BvgA is the response regulator that, when 
transphosphorylated by BvgS, gains affinity for Bvg-activated promoters (Cotter and 
DiRita, 2000).   
 It has been suggested that the multi-step design of this family of two-component 
systems enables the bacteria to express a spectrum of phenotypes in response to different 
environmental conditions.  In support of this model, Bordetella alternate between several 
distinct phenotypic phases, and it is the BvgA/BvgS system that regulates the phases by 
temporally controlling the expression of different classes of genes (Cotter and Miller, 
1997).  Due to the similarities in domain architecture of the BvgA/BvgS and LetA/LetS 
systems, we predicted that L. pneumophila may use the four-step phosphorelay to fine-
tune its panel of transmission traits.  Indeed, in Chapter 3 I demonstrate that the complex 
design of the LetA/LetS system enables L. pneumophila to customize its transcriptional 
and phenotypic profiles, thereby enhancing its versatility and fitness.   
 All transmission traits activated by LetA/LetS and repressed by CsrA (discussed 
below) are also affected by a mutation in letE, suggesting that LetE either enhances 
LetA/LetS function or inhibits CsrA activity (Bachman and Swanson, 2004a).  LetE 
apparently functions as a small protein, rather than a regulatory RNA, but the mechanism 
by which LetE augments transmission traits has not been elucidated (Bachman and 
Swanson, 2004a).  Homologues of letE have not been identified in other microbial 
genomes, and sequence analysis has provided little insight to its biochemical activity.  
Thus, additional research is necessary to determine how this protein functions and, 
furthermore, how LetE interacts with other regulators to coordinate L. pneumophila 
differentiation (Bachman and Swanson, 2004a).   
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Carbon storage regulatory (Csr) system 
 In a variety of microbes, the global regulatory system CsrA/CsrB functions post-
transcriptionally to control stationary phase gene expression.  Numerous cellular 
processes are regulated by this highly conserved system, including the inhibition of 
biofilm formation, gluconeogenesis, glycogen biosynthesis and catabolism, as well as the 
activation of glycolysis, acetate metabolism, flagellum biosynthesis and motility (Suzuki 
et al., 2002).  CsrA is a small effector protein that binds near the ribosomal binding site, 
and, depending on the target mRNA, either stabilizes the transcript or promotes transcript 
decay (Romeo, 1998).  CsrB is an untranslated RNA that contains imperfect repeats 
located in the predicted loop regions of the RNA molecule (Romeo, 1998).  In E. coli, 
CsrB forms a globular complex with approximately 18 CsrA molecules, likely facilitated 
through binding the repeat elements (Romeo, 1998).  As a result, CsrB antagonizes the 
activity of CsrA by sequestering the molecule away from its target mRNAs, thus 
reducing the concentration of free CsrA (Romeo, 1998).   
 A homologue of the E. coli csrA gene was identified in L. pneumophila and 
shown to be essential for replication in broth culture, macrophages and A. castellanii 
(Fettes et al., 2001; Forsbach-Birk et al., 2004; Molofsky and Swanson, 2003).  Genetic 
data indicate that, in L. pneumophila, every transmission trait induced by the LetA/LetS 
two-component system is repressed by CsrA (Fettes et al., 2001; Molofsky and Swanson, 
2003).  In addition, the loss of CsrA activity bypasses all transmission trait defects 
displayed by a letA mutant, suggesting LetA functions to alleviate CsrA repression 
(Molofsky and Swanson, 2003).  The model predicts that when nutrients are depleted, the 
stringent response produces ppGpp, and LetA/LetS is activated.  The two-component 
system then transcribes the regulatory RNAs, which titrates CsrA away from its mRNA 
targets, allowing transmissive phase traits to be induced (Fig. 1.2).   
 Although only one mRNA target of CsrA has been identified in L. pneumophila 
(C. Buchrieser, personal communication), the CsrA-repressed transmission traits of 
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cytotoxicity, lysosome evasion and motility all depend on the efficient transcription of 
the flagellar sigma factor, FliA (Fettes et al., 2001; Hammer et al., 2002; Molofsky and 
Swanson, 2003).  Furthermore, over-expression of csrA leads to a reduction in fliA and 
flaA transcript levels (Fettes et al., 2001).  By analogy to other prokaryotic Csr regulatory 
systems, it is predicted that L. pneumophila CsrA inhibits the stability or translation of 
fliA mRNA, thus affecting transcription of flaA and the expression of motility and 
transmission phenotypes (Romeo, 1998).  While data suggest that several copies of csrA 
are present in L. pneumophila, the significance of multiple csrA homologues is unclear 
(Brassinga et al., 2003).  Recently, two L. pneumophila small regulatory RNAs were 
identified bioinformatically, designated as RsmY and RsmZ (Kulkarni et al., 2006), 
which were then found to be functionally analogous to CsrB of E. coli (Kulkarni et al., 
2006).  Furthermore, the transcription of rsmY and rsmZ is dependent on LetA, which 
binds to a conserved motif located upstream of the RNAs (Sahr et. al., unpublished1).  
Additional research will provide insight into how the L. pneumophila Csr system 
regulates its mRNA targets to enhance the fitness of L. pneumophila and control its 
differentiation.   
 
Hfq and small RNAs (sRNAs) 
 In addition to the Csr regulatory system, prokaryotes can employ other noncoding 
RNAs to modulate gene expression (Gottesman, 2004; Majdalani et al., 2005).  These 
sRNAs require the Hfq chaperone protein, and, through complementary base pairing with 
mRNAs, can modify either the translation or stability of their mRNA targets (Gottesman, 
2004; Majdalani et al., 2005).  Data indicate that Hfq contributes to virulence in a number 
of bacterial pathogens, presumably by altering the interaction of sRNAs with rpoS, thus 
affecting rpoS translation (McNealy et al., 2005).   
                                                
1 Sahr, T., Brüggemann, H., Jules, M., Albert-Weissenberger, C., Cazalet, C. and Buchrieser, C.  Two non-
coding RNAs govern virulence regulation and transmission in Legionella pneumophila.  In preparation.   
 17 
 Recently, a hfq homologue was identified in L. pneumophila, and the gene 
appears to be temporally regulated by both RpoS and LetA (McNealy et al., 2005).  In 
the replicative phase, RpoS induces the expression of hfq (McNealy et al., 2005).  
Exponential phase transcripts, such as csrA and fur (ferric uptake regulator), are then 
stabilized by Hfq and most likely by sRNAs (McNealy et al., 2005).  Upon entering 
stationary phase, ppGpp accumulates and the LetA/LetS two-component system is 
induced (Hammer and Swanson, 1999; Hammer et al., 2002).  As a result, LetA activates 
transmissive phase traits, while directly or indirectly repressing hfq transcription 
(McNealy et al., 2005).  Although sRNAs other than RsmY and RsmZ have not been 
found in L. pneumophila, they could be identified using Hfq as a tool, and, subsequently, 
their role in post-transcriptional regulation of differentiation examined.   
 
Regulation of the Dot/Icm type IV secretion system 
 To escape the endocytic pathway and establish a replicative vacuole, L. 
pneumophila depends on a group of 26 genes designated dot/icm (defect in organelle 
trafficking/intracellular multiplication) (Sexton and Vogel, 2002).  This family of genes 
has homology to bacterial conjugation systems and mediates the transfer of mobilizable 
plasmids between bacterial strains (Sexton and Vogel, 2002).  In addition, the type IV 
secretion system encoded by the dot/icm genes translocates effector molecules into host 
cells (Sexton and Vogel, 2002).  At present, information regarding factors that regulate 
the timing and expression of genes required for assembling the secretion apparatus and its 
secreted effectors is limited.  A series of nine icm::lacZ translational fusions were 
constructed, and examination of their temporal expression indicated that, in broth culture, 
several icm genes show a modest increase in their expression level upon entering 
stationary phase, including: icmF, icmM, icmP, icmR and icmT (Gal-Mor et al., 2002).  
Subsequent studies demonstrated that LetA moderately regulates the expression of icmP, 
icmR and icmT, while RelA and RpoS have only minor effects on dot/icm expression 
 18 
(Gal-Mor and Segal, 2003b; Zusman et al., 2002).  In contrast, letA mutants show a 
substantial decrease in dotA transcription, indicating that LetA may regulate a subset of 
dot/icm genes (Lynch et al., 2003).   
 While each of the previously described studies have implicated indirect regulators 
of dot/icm genes, the only evidence for direct regulation is by the response regulator 
CpxR (Gal-Mor and Segal, 2003a).  CpxR and its cognate sensor kinase CpxA constitute 
a classic two-component system whose autophosphorylation is stimulated by stress 
signals (Gal-Mor and Segal, 2003a).  Data indicate that CpxR directly regulates icmR 
gene expression, and, while likely indirect, can also moderately induce the icmV-dotA 
and icmW-icmX operons.  Nevertheless, CpxR is dispensable for intracellular growth in 
both human-derived macrophages and A. castellanii, suggesting that dot/icm genes must 
be positively regulated by other factors to enable L. pneumophila to establish a replicative 
vacuole (Gal-Mor and Segal, 2003a).   
 
Genomic methods of studying differentiation 
 When confronted with environmental fluctuations, L. pneumophila must 
coordinately regulate its gene expression profile to enhance its fitness and adaptability.  
Since a large number of genes are dedicated to controlling differentiation, and a diverse 
repertoire of genes are expressed during the different phenotypic states, modern 
techniques have been applied to allow a comprehensive analysis of L. pneumophila 
biology.  Recently, the complete genome sequences of L. pneumophila strains Lens, Paris 
and Philadelphia 1 were published, and many genes predicted to promote microbial 
adaptation were identified, including six sigma factors, 13 histidine kinases, 14 response 
regulators and 23 members of the GGDEF-EAL family of regulators (Cazalet et al., 
2004; Chien et al., 2004).  A comparison of the genome sequences of Lens, Paris and 
Philadelphia 1 revealed a remarkable plasticity and diversity of L. pneumophila, two 
characteristics thought to enhance the versatility of the microbe.  In addition, genome-
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wide promoter trap strategies have been utilized to discern L. pneumophila genes that are 
specifically expressed during intracellular replication; this class of factors includes redox 
proteins, a response regulator and sensor kinase, several heavy metal transporters, and a 
gene homologous to the Pht family of transporters, smlA (Rankin et al., 2002).  
Furthermore, proteomic analysis of L. pneumophila has been used to successfully identify 
130 expressed proteins, including: flagellin, legiolysin, and components and substrates of 
the Dot/Icm type IV secretion system (IcmX, RalF, SdeA and SidC) (Lebeau et al., 
2005).  In the future, research that is directed toward the global analysis of the L. 
pneumophila genome and proteome may identify regulatory factors that promote survival 
under disparate environmental conditions, as well as components essential to its 
pathogenesis.   
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Figure 1.1. 
Figure 1.1.  Life cycle of L. pneumophila.   
(1)  Transmissive L. pneumophila engulfed by phagocytic cells reside in vacuoles and 
avoid lysosomal degradation.  (2)  Under favorable conditions, transmissive bacteria 
begin to replicate.  (3)  When nutrients are depleted, replicating bacteria stop dividing and 
begin to express transmission traits.  (4)  Microbes may develop into a more resilient and 
infectious mature intracellular form (MIF).  (5)  The host cell is lysed and transmissive 
microbes are released into the environment.  (6)  L. pneumophila that do not encounter a 
new host cell probably establish biofilms in water systems and ponds.  (7)  When 
microbes encounter a host cell, the cycle begins anew.  (8)  L. pneumophila cultured in 
broth to either exponential or stationary phase exhibit many of the traits of the replicative 
and transmissive forms, respectively. Modified from Molofsky AB and Swanson MS 







Figure 1.2.  A model for regulation of L. pneumophila differentiation.   
Arrows indicate activation and bars indicate inhibition.  Replicative phase regulatory 
interactions are represented by solid double lines, while transmission phase regulatory 
pathways are indicated by a single solid line.  Speculative interactions are designated by 






Figure 1.3.  Pht transporters couple nutrient acquisition to microbial differentiation.  
Transport of amino acids and other essential metabolites by Pht proteins trigger 
intracellular transmissive L. pneumophila to differentiate to the replicative form.  
Nutrient acquisition via Pht proteins is also essential for L. pneumophila to replicate in 
macrophages.  When replicative bacteria fail to acquire essential amino acids, L. 
pneumophila induce expression of transmission traits.   
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CHAPTER TWO  
THE MULTI-STEP DESIGN OF THE LETA/LETS TWO-COMPONENT 
SYSTEM ENABLES LEGIONELLA PNEUMOPHILA TO CUSTOMIZE ITS 
ARRAY OF VIRULENCE TRAITS 
 
Summary 
 When confronted with environmental stresses, Legionella pneumophila converts 
from a non-infectious, replicative form to an infectious form required for host 
transmission.  This process is mediated by the LetA/LetS two-component system, which 
belongs to a family of signal-transducing proteins that employ a four-step phosphorelay 
to regulate gene expression.  We determined that histidine 307 in LetS is the primary 
histidine required to activate LetA and that other residues in LetS cannot substitute for 
LetA/LetS function.  Additionally, a threonine substitution at position 311 of LetS 
generated a L. pneumophila mutant with an intermediate phenotype.  When compared 
with WT and letS null bacteria, letST311M mutants were intermediate for the transmission 
traits of infectivity, cytotoxicity and lysosome evasion.  In contrast, letST311M mutants 
resemble either WT or letS null bacteria for the other transmissive phase phenotypes.  
After observing that only 30-50% of letST311M mutants were motile, we demonstrated by 
flow cytometry that every cell in the population eventually activates the flagellin 
promoter to a similar level, but the expression is delayed when compared to WT.  
Moreover, transcriptional profile analysis of letST311M mutants indicated that gene 
expression of not only the flagellar regulon but also numerous other loci was delayed 
when compared to WT.  We postulate that, compared to the WT LetS sensor protein, the 
LetST311M mutant relays phosphate either slowly or less efficiently, thereby leading to 
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sluggish gene expression and a unique phenotypic profile.  Accordingly, we propose that 
the multi-step design of this family of two-component systems allows microbes to 
modulate their phenotypic profiles as deemed appropriate for the local environment.   
 
Introduction  
 In aquatic reservoirs, the gram-negative bacterium Legionella pneumophila most 
likely resides within biofilm communities (Fields et al., 2002).  However, when L. 
pneumophila are ingested by various species of amoebae or ciliated protozoa, they avoid 
digestion and instead establish a protective intracellular niche (Fields et al., 2002).  
Consequently, if humans inhale aerosols contaminated with L. pneumophila, the bacteria 
can exploit alveolar macrophages (Horwitz and Silverstein, 1980) to cause an acute 
pneumonia, Legionnaires’ disease (McDade et al., 1977).  Due to the disparate conditions 
under which L. pneumophila persists, the pathogen must employ strategies that enable 
swift adaptations to environmental fluctuations.   
 One mechanism by which L. pneumophila acclimate to their surroundings is by 
altering their cellular physiology in a process known as differentiation (Molofsky and 
Swanson, 2004).  When either protozoa or professional phagocytes engulf transmissive 
phase L. pneumophila, the microbes avoid lysosomal degradation and instead establish 
vacuoles isolated from the endosomal network, a process mediated by a type IV secretion 
system (Berger and Isberg, 1993; Roy et al., 1998; Segal et al., 1998; Vogel, 1998) and 
the shedding of vesicles rich in lipopolysaccharide (Fernandez-Moreira et al., 2006).  If 
conditions in the vacuole are favorable, L. pneumophila represses its transmissive traits 
and instead undergoes robust replication (Fettes et al., 2001; Molofsky and Swanson, 
2003).  Once amino acid supplies and other nutrients are exhausted, bacterial replication 
halts, and the progeny induce traits that promote escape from their spent host, survival in 
the extracellular milieu, and the ability to infect subsequent phagocytic cells (Hammer 
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and Swanson, 1999; Molofsky and Swanson, 2003; Sauer et al., 2005; Zusman et al., 
2002).   
 From studies of synchronous broth cultures, many of the regulatory elements that 
govern the reciprocal phases displayed by L. pneumophila during its life cycle have been 
discerned.  During the exponential (E) phase of growth, the post-transcriptional regulator 
CsrA and the sRNA chaperone Hfq suppress transmissive traits and promote replication 
(Fettes et al., 2001; McNealy et al., 2005; Molofsky and Swanson, 2003).  However, 
once E phase L. pneumophila experience nutrient deprivation, cell division stops, and the 
enzymes RelA and SpoT produce the alarmone ppGpp (Hammer and Swanson, 1999; 
Zusman et al., 2002).  Activation of the stringent response pathway leads to an 
accumulation of ppGpp in the bacterial cytosol (Hammer and Swanson, 1999; Zusman et 
al., 2002).  As a result, the LetA/LetS two-component system (Legionella transmission 
activator and sensor, respectively) transcribes two small regulatory RNAs, RsmY and 
RsmZ, which then bind to CsrA to relieve its repression on the transmission traits 
(Hammer and Swanson, 1999; Hammer et al., 2002; Molofsky and Swanson, 2003).  
Together with alternative sigma factors and other regulatory proteins, the LetA/LetS 
system induces traits that enable efficient host transmission and survival in the 
environment including: sodium sensitivity, infectivity, cytotoxicity, motility, lysosome 
evasion and pigment production (Edwards and Swanson, 2006; Steinert et al., 2007).   
 For most two-component systems, the physiological stimulus that activates the 
signal transduction pathway has remained elusive.  Nevertheless, for the two-component 
systems where the environmental cues or conditions are known, it appears that multiple 
inputs can induce the phosphorelay (Calva and Oropeza, 2006).  In L. pneumophila, the 
precise signal that triggers LetS autophosphorylation has yet to be identified.  However, 
similar to other two-component systems, we predict that various stimuli may induce the 
phosphorelay, and likewise L. pneumophila differentiation.   
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 Originally identified by screening for mutants defective for flagellin production, 
the LetA/LetS two-component system was subsequently shown to regulate all known 
transmissive phase phenotypes (Hammer et al., 2002).  Although conventional two-
component systems require a two-step phosphorelay to induce a response, the L. 
pneumophila LetA/LetS system belongs to a family of signal-transducing proteins whose 
tripartite sensor kinase regulates their response pathways.  The model for this unorthodox 
family of signaling molecules is the Bordetella BvgA/BvgS system, which employs a 
four-step relay involving consecutive phosphorylation of His-Asp-His-Asp residues (Uhl 
and Miller, 1996b, c).  BvgS is the sensor protein whose large periplasmic domain is 
linked by a membrane-spanning region to three cytoplasmic signaling domains (Cotter 
and DiRita, 2000).  BvgA is the cytoplasmically located activator kinase that, upon 
phosphorylation, gains an affinity for Bvg-regulated promoters (Cotter and DiRita, 2000; 
Cotter and Jones, 2003).  Upon receiving an appropriate signal, BvgS autophosphorylates 
on a conserved histidine residue and then sequentially transfers the phosphoryl group 
along the relay, culminating with BvgA activation (Uhl and Miller, 1994).  It has been 
proposed that the complexity of the BvgA/BvgS signaling mechanism enables Bordetella 
to express a spectrum of traits according to local conditions (Cotter and Miller, 1997; 
Cummings et al., 2006; Stockbauer et al., 2001).  In support of this model, Bordetella 
alternates among at least three distinct phenotypic phases in response to various external 
stimuli (Cotter and Miller, 1997; Lacey, 1960).  Work by Cotter and Miller has deduced 
that the multi-step design of the BvgA/BvgS system enables Bordetella to regulate the 
amount of phosphorylated BvgA (BvgA~P) present in the cell.  The level of BvgA~P, 
together with the binding affinities for BvgA that are present in Bvg-regulated promoters, 
enables Bordetella to control the temporal expression of different classes of genes, and 
likewise, its different phenotypic states (Cotter and Jones, 2003).   
 Unlike the well-studied Bordetella system, other members within this family of 
tripartite two-component systems have not been analyzed to discern whether they also 
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employ similar regulatory processes to enhance their spectrum of traits.  Sequence 
analysis indicates that the three predicted signaling domains of LetS are highly 
homologous to the analogous regions of B. bronchiseptica BvgS; the domain architecture 
is also comparable.  Therefore, we postulated that, similar to the Bordetella signal 
transduction system, LetA/LetS equips L. pneumophila to customize its genotypic and 
phenotypic expression profiles.  To test this hypothesis, we constructed single amino acid 
substitutions in LetS and analyzed the mutants via transcriptional and phenotypic 
methods.  Our data suggest that, although their down-stream circuitries differ, the L. 
pneumophila LetA/LetS two-component system resembles Bordetella BvgA/BvgS by 
functioning as a rheostat to fine-tune its virulence traits, thereby augmenting versatility 




Bacterial strains and culture conditions.  L. pneumophila Lp02 (thyA hsdR rpsL; 
MB110), a virulent thymine auxotroph derived from the Philadelphia 1 clinical isolate, 
was the parental strain for all constructed mutants (Berger and Isberg, 1993).  MB355 
contains the pflaG plasmid, which encodes a transcriptional fusion of the flaA promoter 
to green fluorescent protein (Hammer and Swanson, 1999).  MB417 contains letS-36, a 
mariner insertion allele in lpg1912 that confers kanamycin resistance and carries the 
pflaG plasmid for fluorescence quantification (Hammer et al., 2002).  To construct a letS 
insertion mutant that lacks pflaG, the letS locus containing the transposon insertion was 
amplified from MB417 and transferred to Lp02 by natural competence, resulting in strain 
MB416 (Hammer et al., 2002).  Bacteria were cultured at 37°C in 5 ml aliquots of N- (2-
acetamido)-2-aminoethanesulfonic acid (ACES; Sigma)-buffered yeast extract (AYE) 
broth and supplemented with 100 µg/ml thymidine when necessary.  Post-exponential 
(PE) cultures were defined as having an optical density at 600 nm (OD600) of 3.4 to 4.5; 
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within each experiment, similar culture densities were used to analyze strain phenotypes.  
To enumerate colony-forming units (CFU), L. pneumophila were plated on ACES-
buffered charcoal-yeast extract agar supplemented with 100 µg/ml thymidine (CYET) 
and incubated at 37°C.  For constructing amino acid substitutions in letS, the semi-
defined media CAA was prepared as described (Mintz et al., 1988) and thymidine added 
to 100 µg/ml (CAAT media).  For solid CAAT media, agar was added to 15 mg/ml, 
starch to 5 mg/ml, and trimethoprim to 100 µg/ml.   
 
Macrophage culture.  Bone marrow-derived macrophages were isolated from femurs of 
A/J mice (Jackson Laboratory) and cultured in RPMI-1640 containing 10% heat-
inactivated fetal bovine serum (RPMI/FBS; Gibco BRL) as described previously 
(Swanson and Isberg, 1995).  After a 7-day incubation in L-cell supernatant-conditioned 
media, macrophages were plated at 2.5 × 105/well in 24-well plates for infectivity and 
degradation assays and to 5 × 104/well in 96-well plates for cytotoxicity assays.   
 
Construction of chromosomal substitutions.  The 3.1-kb letS locus was amplified from 
Lp02 genomic DNA using primers LetS F and LetS R (Table 2.2), the PCR fragment 
purified and ligated into pGEM-T (Promega), and the resulting plasmid designated as 
pletS (pMB596).  Nucleotide substitutions were introduced into the letS ORF in pletS 
using the QuikChange XL site-directed mutagenesis kit (Stratagene).  A glutamate was 
substituted for the histidine at amino acid 307 by changing CAT to CAA with primers 
LetS Mut His F and LetS Mut His R (Table 2.2), resulting in the plasmid pletSH307Q 
(pMB610).  To substitute methionine for the threonine at residue 311 of letS, ACC was 
changed to ATG using primers LetS Mutagenesis F and LetS Mutagenesis R (Table 2.2), 
resulting in pletST311M (pMB597).  Synthesis of plasmid DNA, template digestion and 
transformations into XL10-gold were performed according to the manufacturer.  
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Mutagenesis was verified by sequencing the letS locus using the primer LetS Mut Seq F 
(Table 2.2).   
 The gene encoding thymidylate synthetase was excised from pMB540 and 
subcloned into the EcoRI site of pletS (MB598).  The interrupted gene was amplified by 
PCR using primers LetS F and LetS R (Table 2.2), transferred to Lp02 by natural 
competence as described (Stone and Abu Kwaik, 1999), and selected for growth in the 
absence of thymidine (MB599).  The point mutants were amplified from their respective 
plasmids, pletSH307Q or pletST311M, using primers LetS F and LetS R (Table 2.2), the PCR 
fragments purified (Qiaquick PCR purification kit; Qiagen), and the PCR products 
transferred to a patch of MB599 on CYET media.  Following a 2-day incubation at 30°C, 
the cells were resuspended in 1 ml CAA and plated onto solid CAAT media with or 
without trimethoprim.  Recombinants were selected for growth on media containing 
trimethoprim and confirmed both by their thymidine requirement and by sequencing the 
letS locus with the LetS Mut Seq F primer (Table 2.2).   
 
Sequence and protein analysis.  The membrane-spanning regions of LetS were predicted 
using Kyte-Doolittle hydropathy plots (Kyte and Doolittle, 1982).  To predict the protein 
domains that are present in LetA and LetS, amino acid sequences were analyzed using 
the Conserved Domain Database (Marchler-Bauer et al., 2005).  For alignments of the 
two-component sensor kinases, amino acid sequences from L. pneumophila LetS; B. 
bronchiseptica BvgS; E. coli ArcB, BarA, EvgS and TorS; Pseudomonas aeruginosa 
GacS; and Salmonella typhimurium BarA were aligned using T-Coffee (Notredame et al., 
2000).  To determine the percent identity and similarity between L. pneumophila LetS 
and B. bronchiseptica BvgS amino acid sequences, the GeneStream align program was 
used (Pearson et al., 1997).   
 
 30 
Infectivity.  To ascertain the degree to which L. pneumophila bind, enter, and survive 
inside macrophages, PE bacteria were co-cultured with macrophages at a 1:1 ratio in 
duplicate (Byrne and Swanson, 1998).  The cells were centrifuged at 400 × g for 10 min 
at 4°C and then incubated an additional 2 h at 37°C (Molofsky et al., 2005).  To remove 
extracellular bacteria, the infected monolayers were washed three times with fresh 
RPMI/FBS.  Macrophages were mechanically lysed in 1 ml of PBS, the lysate plated onto 
CYET, and the intracellular bacteria enumerated.  Infectivity was expressed as (cell-
associated CFU at 2 h/CFU added at 0 h) × 100 (Bachman and Swanson, 2004b; Byrne 
and Swanson, 1998).   
 
Cytotoxicity.  To measure contact-dependent cytotoxicity of L. pneumophila for 
macrophages, PE phase bacteria suspended in RPMI/FBS were added to macrophages at 
various multiplicities of infection (MOIs) in triplicate.  After centrifugation at 400 × g for 
10 min at 4°C (Molofsky et al., 2005), cells were incubated for 1 h at 37ºC.  To assess 
macrophage viability, the infected monolayers were incubated for 6-12 h with RPMI/FBS 
that contained 10% alamarBlue™ (Trek Diagnostic Systems), and then reduction of the 
colorimetric dye was measured spectrophoretically and calculated as described (Byrne 
and Swanson, 1998; Hammer and Swanson, 1999; Molofsky et al., 2005).   
 
Lysosomal degradation.  The percent of microbes that were intact following a 2-h 
incubation in macrophages was determined by fluorescence microscopy.  Briefly, cells 
plated onto coverslips in a 24-well plate were infected with PE L. pneumophila at an MOI 
~1.  Following centrifugation at 400 × g for 10 min at 4°C, the cells were incubated at 
37°C for 2 h.  After removing uninternalized bacteria by washing with RPMI/FBS, the 
macrophages were fixed, permeabilized and stained for L. pneumophila as described, and 
duplicate coverslips were scored for intact rods versus degraded particles (Bachman and 
Swanson, 2001; Molofsky and Swanson, 2003; Swanson and Isberg, 1996).   
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Sodium sensitivity.  Sodium sensitivity was determined by plating 10-fold serial dilutions 
of PE broth cultures in PBS onto CYET agar containing or lacking 100 mM NaCl 
(Molofsky and Swanson, 2003).  Following a 6-day incubation at 37°C, CFUs were 
enumerated, and the percent of sodium sensitive bacteria calculated as described (Byrne 
and Swanson, 1998).   
 
Pigmentation.  To quantify pigment accumulation, 1 ml samples were obtained from 
broth cultures maintained in the PE phase for 5 days at 37°C.  The aliquots were 
centrifuged at 16,000 × g for 10 min and supernatants measured at OD550nm (Molofsky 
and Swanson, 2003; Wiater et al., 1994).   
 
Flow cytometry.  To monitor the promoter activity for an entire letST311M population of 
cells, MB597 was transformed with pflaG, which contains the promoter for the flagellin 
gene, flaA, fused to a GFP reporter (Hammer and Swanson, 1999).  The resulting strain, 
MB605, was cultured in AYE media and monitored for induction of the flaA promoter 
over time.  At the designated optical densities, samples were centrifuged at 5,900 × g, 
washed in PBS to remove impurities and the cells normalized to 5 × 105 in PBS.  Total 
GFP fluorescence was analyzed using a BD FACSAria™ cell sorter.  PE MB355 and 
MB417 were used as positive and negative controls, respectively.   
 
Statistical analyses for phenotypic assays.  To calculate p-values for infectivity, 
lysosomal degradation, sodium sensitivity and pigmentation assays, one-way analysis of 
variance (ANOVA) was used for at least 3 independent samples.   
 
RNA isolation, RNA labeling and microarray hybridization.  WT and letST311M mutants 
were cultured on an orbital shaker at 37ºC to either OD600 = 2 or OD600 = 3 in 500 ml 
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AYE containing 100 µg/ml thymidine.  Upon reaching the appropriate optical density, 10 
ml aliquots were centrifuged at 6,000 × g for 2 min. at 4ºC.  The culture supernatants 
were discarded, and the pellets were flash frozen and stored at -80ºC.  Total RNA was 
extracted using TRIzol (Invitrogen) as described previously (Milohanic et al., 2003).  The 
RNA was reverse-transcribed and labeled with Cy3 or Cy5 according to the 
manufacture’s instructions (Amersham Biosciences).  The microarrays were designed to 
contain gene-specific 70mer oligonucleotides based on all predicted genes within the 
genome of L. pneumophila strain Paris (CR628336) and its plasmid (CR628338) as 
described previously (Bruggemann et al., 2006).  Hybridizations were performed 
following the manufacturers’ recommendations (Corning) using 250 pmol of Cy3 and 
Cy5 labeled cDNA.  Slides were scanned on a GenePix 4000A scanner (Axon 
Instruments) and the laser power and PMT were adjusted to balance the two channels.  
The resulting files were analyzed using Genepix Pro 5.0 software.  Spots were excluded 
from analysis if they contained high background fluorescence, slide abnormalities or 
weak intensity.  To obtain statistical data for the gene expression profiles, all microarrays 
were performed in duplicate with a dye swap.   
 
Data and statistical analysis for microarrays.  Data normalization and differential 
analysis were conducted using the R software (http://www.R-project.org).  No 
background subtraction was performed, but a careful graphical examination of all the 
slides was performed to ensure a homogeneous, low-level background in both channels.  
A loess normalization (Yang et al., 2002) was performed on a slide-by-slide basis 
(BioConductor package marray; 
http://bioconductor.org/packages/2.2/bioc/html/marray.html).  Differential analysis was 
carried out separately for each comparison between the two time points, using the VM 
method (Delmar et al., 2005), together with the Benjamini and Yekutieli p-value 
adjustment method (Reiner et al., 2003).  If not stated otherwise, only differently 
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expressed genes with 1.6-fold-changes were taken into consideration.  Empty and flagged 
spots were excluded from the data set, and only genes without missing values for the 




Architecture of the LetA/LetS signal transduction system 
The L. pneumophila LetA/LetS two-component system belongs to a family of 
signaling molecules that use a multi-step phosphorelay to activate or repress their target 
genes.  LetS is a 103 kDa sensor kinase that is likely localized to the membrane by two 
transmembrane regions (Kyte and Doolittle, 1982).  In addition, LetS is predicted to have 
three cytoplasmic signaling domains, namely a transmitter, receiver and histidine 
phosphotransfer domain (Marchler-Bauer et al., 2005).  The cognate response regulator, 
LetA, is a 43 kDa protein that contains a receiver domain and a helix-turn-helix motif 
(Marchler-Bauer et al., 2005).  By analogy to proteins of similar structure, it is predicted 
that, in response to a signal input, LetS autophosphorylates on a histidine residue and 
then sequentially transfers the phosphoryl group to an aspartic acid in the receiver 
domain, to a second histidine in the histidine phosphotransfer domain, and finally to an 
aspartic acid located in the receiver domain of LetA.  Sequence analysis indicates that, 
overall, LetS is only 18% identical to BvgS at the amino acid level (Pearson et al., 1997).  
However, within each H box region, which contains the primary phosphorylation site, 
LetS is 78% identical and 89% similar to BvgS (Pearson et al., 1997).  Due to the 
similarities displayed between LetS and BvgS in this critical portion of each protein, we 
predicted that L. pneumophila also uses a four-step phosphorelay to customize its traits 
when challenged by local stresses and fluctuations.   
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The H-box regions of many sensor kinases are highly conserved   
Since LetS belongs to a family of tripartite two-component systems, we 
postulated that other sensor kinases within this unorthodox class of signaling molecules 
might have comparable domain architecture, and likewise, might employ similar 
regulatory mechanisms.  Amino acid sequences from L. pneumophila LetS, B. 
bronchiseptica BvgS, Escherichia coli ArcB, BarA, EvgS and TorS, Pseudomonas 
aeruginosa GacS, and Salmonella typhimurium BarA were aligned using T-Coffee 
(Notredame et al., 2000).  Indeed, the H-box regions of all the sensor proteins analyzed 
are remarkably similar.  Moreover, the primary histidine residue, which is the proposed 
site for autophosphorylation, is conserved (Fig. 2.1B).  Importantly, the threonine 
residue, which, when substituted with methionine enables Bordetella to display an 
intermediate class of genes and phenotypes (Cotter and Miller, 1997), is also conserved 
among all family members analyzed (Fig. 2.1B).  Therefore, we sought to test whether 
the rheostat model of the Bordetella BvgA/BvgS system is also applicable to other 
members of this family of signal transducing proteins.   
 
Histidine 307 of LetS is critical for LetA/LetS activity 
In response to a stimulus, the sensor protein of a microbial two-component system 
autophosphorylates on a conserved histidine residue using ATP as a phosphate donor.  In 
Bordetella, a histidine-to-glutamine substitution at amino acid 729 of BvgS abolishes its 
autophosphorylation as well as BvgA activation (Uhl and Miller, 1994).  Sequence 
alignments between the L. pneumophila and Bordetella sensor kinases predict that 
histidine 307 of LetS is the initial site of phosphorylation (Fig. 2.1A).  To test this model, 
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we substituted a glutamine residue for histidine 307 of LetS.  The unmarked, 
chromosomal point mutant, designated as letSH307Q, was verified by amplifying and 
sequencing the letS locus.  Subsequently, letSH307Q was analyzed for its expression of PE 
phenotypes using WT L. pneumophila and a letS transposon insertion mutant (allele letS-
36) as positive and negative controls, respectively.   
Phenotypic analysis of letSH307Q mutants indicated that, after a 2 h incubation with 
macrophages, less than 5% of the L. pneumophila inoculum remains cell-associated (Fig. 
2.2A).  In addition, histidine 307 of LetS is essential for both flagellin- and contact-
dependent cell death of macrophages (Molofsky et al., 2005).  Likewise, phase-contrast 
microscopy indicated that letSH307Q mutants are completely defective for motility (data 
not shown).  Using immunofluorescence microscopy to analyze the morphology of 
intracellular bacteria following a 2 h incubation within macrophages, we determined that, 
similar to the letS insertion mutant, only 40% of letSH307Q mutants resist lysosomal 
degradation (Fig. 2.2C).  Furthermore, histidine 307 of LetS is necessary for salt 
sensitivity, a phenotype that reflects activity of the type IV secretion system (Byrne and 
Swanson, 1998; Sadosky et al., 1993; Vogel et al., 1996), as well as for the production of 
a soluble melanin-like pigment that accumulates in the PE phase (Warren and Miller, 
1979; Wiater et al., 1994; Wintermeyer et al., 1994).  Taken together, these data are 
consistent with the model that histidine 307 is the autophosphorylation site of LetS that is 
critical for LetA/LetS activity, and other residues in LetS cannot substitute to activate 
LetA.   
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An amino acid substitution at position 311 of LetS unveils a hierarchy among PE 
phenotypes 
 The Bordetella BvgA/BvgS paradigm suggests that the design of the two-
component system equips the bacteria with a rheostat to customize their expression 
profile.  In support of this model, seminal work from Cotter and Miller demonstrated that 
a single amino acid substitution at residue 733 of BvgS created a mutant that displayed 
intermediate phenotypes (Cotter and Miller, 1997).  To test this model, a methionine was 
substituted for the corresponding threonine at position 311 in the cytoplasmic transmitter 
domain of LetS, four residues from the proposed autophosphorylation site.  After 
sequence verification, the letST311M mutant was analyzed for each PE phenotype.  The 
letST311M mutants were identical to WT L. pneumophila in the PE phase with regard to 
their sodium sensitivity, as no apparent defect was detected (Fig. 2.3A).  However, 
letST311M mutants resembled letS null bacteria in that neither mutant accumulated 
appreciable levels of the soluble pigment (Fig. 2.3B).  Moreover, when letST311M mutants 
were compared to WT and letS null bacteria, the point mutant was intermediate for 
several PE traits.  For example, letST311M mutants were intermediate for entry and survival 
in macrophages (Fig. 2.4A) and for contact-dependent cytotoxicity (Fig. 2.4B).  
Likewise, only approximately 25-40% of letST311M mutants were motile, as indicated by 
microscopic analysis (data not shown).  By analyzing the number of bacteria that escape 
lysosomal degradation, we also deduced that the letST311M mutant was intermediate when 
compared to WT and letS null bacteria (Fig. 2.4C).  Therefore, these phenotypic data 
support the model that the design of the LetA/LetS system enables the bacteria to display 
a spectrum of traits.  Moreover, a hierarchy exists with regard to the expression of the L. 




Promoter analysis demonstrates that the letST311M mutant has a kinetic delay  
 The PE phenotypes of infectivity, cytotoxicity and lysosome evasion all depend 
on motility (Molofsky et al., 2005).  Since the letST311M mutant was intermediate for each 
of these traits, we predicted that either all cells expressed the flagellin promoter at a 
weaker level than WT or a mixed population of letST311M cells was present.  To 
distinguish between these two models, we monitored promoter expression by 
transforming WT and the letST311M mutant with a reporter construct that contained a 
transcriptional fusion of the flagellin promoter flaA fused to gfp.  Flow cytometry 
indicated that at, an OD600 = 1, the majority of cells in WT cultures had low levels of flaA 
expression (Fig. 2.5A).  At the transition between the E and PE phases (OD600 ~ 3), two 
populations of cells were present in WT samples:  One had low flaA promoter activity 
and another showed robust induction of the flagellin promoter (Fig. 2.5A).  Once WT L. 
pneumophila reached the PE phase (OD600 = 3.4), every cell in the population induced 
flaA to high levels (Fig. 2.5A).  It was striking that the letST311M mutant displayed a 
similar profile of flaA promoter activity when compared to WT L. pneumophila, albeit 
delayed (Fig. 2.5B).  For example, cells in the letST311M mutant population did not induce 
high levels of the flagellin promoter until OD600 = 4.2, a density significantly higher than 
the OD600 = 3.1 for WT flaA expression (compare Fig. 2.5 A and B).  Thus, every cell in 
the letST311M mutant population is able to activate the flaA promoter to WT levels, but the 
cells have a kinetic defect.   
 
Transcriptome analysis indicates that the letST311M mutant has a delayed transcriptional 
profile 
 To deduce whether the letST311M mutant has a transcriptional delay beyond the 
flagellin promoter, the mutant was compared via microarrays to WT L. pneumophila at 
different stages of growth.  At an OD600 = 2, 58 genes were significantly repressed in the 
letST311M mutant when compared to WT (Table 2.3).  Several categories of genes were 
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represented, including genes that are required for flagellum biosynthesis 
(flgDEFGHIJKL/lpg1218-26 and fliHG/lpg1758-9; Table 2.4).  Corresponding to the 
class II genes of the flagellar cascade, these genes are typically induced in WT L. 
pneumophila at the late E and early PE phases (Bruggemann et al., 2006).  In addition, 
several regulatory genes were repressed, such as the two small regulatory RNAs rsmY 
and rsmZ and the response regulator lqsR/lpg2732 (Tables 2.3 and 2.4).  Previous 
microarray experiments revealed that lqsR regulates the expression of genes involved in 
virulence, motility and cell division, consistent with a role for LqsR in the transition from 
the E to the PE phase.  However, the expression of lqsR was also shown to be dependent 
on RpoS and to a lesser extent, LetA (Tiaden et al., 2007).  Therefore, we cannot exclude 
the possibility that the letST311M mutation has an indirect effect on lqsR gene expression.  
Transcriptional analysis also showed that genes encoding poly-hydroxybutyrate synthesis 
(phaB1-3/lpg1059-61) were poorly expressed by the mutant strain (Tables 2.3 and 2.4).   
 Similarly, at an OD600 = 3, which corresponded to the early PE phase, 92 genes 
were significantly reduced in the letST311M mutant as compared to WT L. pneumophila 
(Tables 2.3 and 2.4).  Fifty of these genes encode unknown functions, and most lack 
similarity with any other protein or domain stored in the publicly available databases 
(Table 2.3).  Among the known genes, expression of several Dot/Icm type IV secretion 
substrates and homologs were reduced at OD600 = 3 in the letST311M mutant 
(sdeA/lpg2157, sidF/lpg2584, sidG/lpg1355; Tables 2.3 and 2.4), as was the newly 
identified cytotoxic glycosyltransferase (Belyi et al., 2008).  The expression of several 
regulatory proteins was also clearly affected by the letST311M mutation.  For example, the 
PE-specific sigma factor rpoE/lpg1577 (Bruggemann et al., 2006) was reduced 4-fold in 
the letST311M mutant when compared to WT bacteria.  Also, mRNAs for two proteins that 
contain GGDEF and EAL domains, rre41/lpg0029 and lpg2132, as well as several 
members of putative two-component systems (lpg2145, stuC/lpg2146 and arcB/lpg2181) 
were significantly diminished in the letST311M mutant (Table 2.4).   
 39 
 One especially informative class of genes was the flagellar regulon.  Expression 
of flaA (lpg1340) was decreased four-fold in the letST311M mutant when compared to WT.  
It is important to note that flaA, which encodes flagellin, is located at the bottom of the 
flagellar hierarchy and is commonly referred to as a class IV gene in the flagellar 
biosynthesis cascade (Steinert et al., 2007).  Moreover, expression of the upstream 
flagellar class II genes was diminished in the letST311M mutant at OD600 = 2, but was no 
longer depressed at this later time point (Tables 2.3 and 2.4).  Therefore, both our 
transcriptional profiling and flow cytometry data indicate that the letST311M mutant is 
delayed in induction of the flagellar regulon.   
 When the letST311M mutant was compared to WT at OD600 = 2, the expression of 
only 10 genes was significantly elevated (Table 2.5).  These included: udk/lpg1853, 
which codes for a uridine kinase, secD/lpg2001 and secF/lpg2000, which are both 
predicted to encode membrane proteins involved in protein export, and the carbon storage 
regulator csrA/lpg1593.  Based on the differences in gene induction observed between the 
letST311M mutant and WT L. pneumophila at OD600 = 2, we infer that this cohort of genes 
represent a letST311M intermediate transcriptional profile.  Furthermore, at an OD600 = 3, 
several genes were more highly expressed by the letST311M mutant when compared to WT 
L. pneumophila.  For example, the hemin binding protein hbp/lpg0024, the glutamine 
synthetase glnA/lpg1364, and the cell division protein lpg0915 were induced 2-3 fold 
over WT levels (Table 2.5).  Thus, letST311M bacteria display an intermediate 
transcriptional profile during the early PE phase.   
 
Discussion 
 The L. pneumophila LetA/LetS two-component system belongs to a family of 
signaling molecules that employs a four-step phosphorelay to activate or repress their 
target genes.  The archetype for this family of two-component systems, the Bordetella 
BvgA/BvgS system, predicted that the multi-step design enables the bacteria to display 
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several genotypic and phenotypic phases.  This is in stark contrast to the classical type of 
two-component systems, which are thought to function as on/off switches to regulate 
their cohort of genes.  To investigate whether the BvgA/BvgS paradigm applies to other 
tripartite family members, we analyzed LetA/LetS system of L. pneumophila.  By 
sequence analysis we demonstrated that the H-box regions of the sensor kinases are 
highly conserved among all family members (Fig. 2.1).  Moreover, both the primary 
histidine residues and the threonine residues located four amino acids downstream of the 
autophosphorylation sites are also conserved (Fig. 2.1).  Using as a tool the letST311M 
mutant, which was predicted to employ a sluggish phosphorelay, both our genotypic and 
phenotypic analysis indicate that the tripartite design of LetS enables Legionella to 
customize its traits to combat the stresses and challenges in its local environment.  Based 
on the sequence homology within this family of two-component systems, we predict that 
the multi-step design is widely used by microbes to confer versatility and enhance overall 
fitness.   
 Our data revealed a hierarchy among LetA/LetS-regulated genes and phenotypes 
(Fig. 2.3A).  For example, the letST311M mutant was similar to WT L. pneumophila with 
respect to salt sensitivity.  This phenotype depends on the expression of the Dot/Icm type 
IV secretion system and is thought to reflect a large pore formed by the apparatus that 
allows sodium ions to enter the bacterial cell (Byrne and Swanson, 1998; Sadosky et al., 
1993; Vogel et al., 1996).  In support of this model, dot/icm genes were not significantly 
induced or repressed in the letST311M mutant when compared to WT bacteria, thus 
corroborating our phenotypic data (Fig. 2.3A and data not shown).   
 Unlike sodium-sensitivity, for several other L. pneumophila PE phenotypes, the 
letST311M mutant pattern fell between that of WT and letS null bacteria.  In particular, the 
point mutant was intermediate for its entry and survival in macrophages, cytotoxicity, and 
avoidance of the lysosomal compartment (Fig. 2.4).  Moreover, microscopic examination 
of the letST311M mutant at various points during the L. pneumophila growth phase 
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indicated that less than half of the population of the point mutant was motile at any given 
time (data not shown).  Previous studies indicated that infectivity, cytotoxicity and 
lysosomal degradation are all largely dependent upon motility (Molofsky et al., 2005).  
Thus, the intermediate phenotype displayed by the point mutant in each of these assays 
underscores the interdependency of this set of traits (Fig. 2.4 and data not shown).   
 To assemble the flagellum, L. pneumophila requires a four-tiered regulatory 
cascade, in which the expression and timing of each component must be tightly 
controlled (Steinert et al., 2007).  The behavior of the letST311M mutant illustrates that the 
precise coordination of the flagellar regulon is essential for constructing a functional 
apparatus.  Even though only a subset of the letST311M mutant population become motile 
(data not shown), every cell in the letST311M population eventually induces the promoter 
for flagellin to WT levels, as judged by flow cytometry data (Fig. 2.5).  Furthermore, 
microarray data determined that, at an OD600 = 2, mRNAs for the flagellar class II genes 
(flgDEFGHIJKL/lpg1218-26 and fliHG/lpg1758-9) were diminished in the letST311M 
mutant as compared to WT L. pneumophila (Tables 2.3 and 2.4).  At a later growth phase 
(OD600 = 3), this defect disappeared; instead, expression of the flagellar class IV gene 
flaA was reduced in the letST311M mutant (Tables 2.3 and 2.4).  Accordingly, we infer that 
the motility defect of the letST311M mutant is the result of its kinetic defect that disrupts 
coordination of the flagellar regulatory cascade.   
 In Bordetella, the ability of the BvgA/BvgS system to regulate different classes of 
genes depends on the rate of the phosphorelay, the amount of BvgA~P, and the binding 
affinities for BvgA protein for the promoter regions of Bvg-regulated genes (Cotter and 
Jones, 2003).  Accordingly, high rates of phosphate flow through the relay lead to high 
levels of BvgA~P, which can bind to promoter regions that contain either high or low 
affinity BvgA binding sites (Cotter and Jones, 2003).  Conversely, lower rates of 
phospho-transfer leads to less BvgA~P in the cell (Cotter and Jones, 2003).  As a result, 
BvgA only binds to and activates genes that have high affinity binding sites (Cotter and 
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Jones, 2003).  It is predicted that the intermediate phase displayed in the Bordetella 
bvgST733M mutant reflects a decrease in the intracellular concentration of BvgA~P (Jones 
et al., 2005; Williams et al., 2005).   
 While we have not ruled out the formal possibility that the transcriptional and 
phenotypic defects observed in the L. pneumophila letST311M mutant reflect protein 
stability, we favor a model in which the letST311M mutant transduces the signal more 
slowly or less efficiently through the relay.  In this scenario, the amount of 
phosphorylated LetA (LetA~P) in the cell is significantly less than that of WT L. 
pneumophila, thereby altering the timing of the expression of LetA/LetS-regulated traits.  
Based on our data, we predict that when L. pneumophila is replicating, the two-
component system is either not active or somehow represses a subset of LetA/LetS-
regulated genes.  During this phase of the life cycle, genes that are required for 
replication are induced; these include genes for DNA replication and protein synthesis, 
and also the global repressor of PE phenotypes csrA (Fettes et al., 2001; Molofsky and 
Swanson, 2003).  Perhaps lower levels of LetA~P are sufficient to activate genes of the 
Dot/Icm type IV secretion system, and likewise, induce sodium sensitivity, since for 
these traits the letST311M mutant was transcriptionally and phenotypically similar to WT L. 
pneumophila (Fig. 2.3, 2.6 and data not shown).  We deduce that more LetA~P is needed 
to induce the flagellar cascade, since the letST311M mutant was delayed in transcription of 
the flagellar genes (Fig. 2.5 and 2.6; Tables 2.3 and 2.4) and also intermediate for each of 
the motility-dependent phenotypes (Fig. 2.4 and 2.6).  Finally, high levels of LetA~P are 
likely required for pigmentation, because the letST311M mutant never accumulated 
detectable levels of the soluble pigment (Fig. 2.3 and 2.6).  Likewise, we infer that higher 
levels of LetA~P are needed to transcribe lpg0012, lpg1174 and lpg1895, since the 
mRNA of each was significantly diminished in the letST311M mutant when compared to 
WT bacteria at both OD600 = 2 and OD600 = 3 (Table 2.3 and Fig. 2.6).  Taken together, 
our transcriptional and phenotypic data supports the rheostat model of regulation, 
 43 
whereby microbes use a multi-step two-component system to fine-tune their expression 
of gene hierarchies.   
 Although the Bordetella BvgA/BvgS system has been an informative paradigm 
for this family of signaling molecules, significant differences in the architecture of the 
Bordetella and Legionella regulatory cascades exist.  For example, the Bordetella two-
component system controls many classes of genes through differences in the binding 
affinities of BvgA~P to variations in the consensus sequences of the Bvg-regulated 
promoter regions.  However, no conserved LetA-dependent DNA-binding motifs could 
be identified upstream of any of the LetA/LetS-regulated genes (Sahr et. al., 
unpublished).  Instead, bioinformatics and biochemical data suggest that LetA may only 
bind to and induce two small RNAs, RsmY and RsmZ (Kulkarni et al., 2006).  These 
results imply that the model of LetA/LetS regulation must deviate from the Bordetella 
system.  Moreover, the regulatory cascade that induces the PE phase L. pneumophila 
genes and phenotypes also requires the Csr system (Fettes et al., 2001; Molofsky and 
Swanson, 2003).   
To incorporate these additional features into our model, we predict that, when 
LetS receives a stimulus, it autophosphorylates and transfers the phosphoryl group along 
the relay, culminating with LetA phosphorylation.  Once activated, LetA then binds to its 
two DNA targets, RsmY and RsmZ (Fig. 2.7).  After their transcription, the small RNAs 
are then free to titrate CsrA from its respective cohort of mRNAs, thereby enabling RNA 
polymerase to bind to and translate the transcripts (Fig. 2.7).  According to this model, 
we infer that the letST311M mutant would have less intracellular LetA~P, and likewise less 
RsmY and RsmZ transcribed.  Analogous to the Bordetella system, perhaps CsrA has 
different affinities for particular mRNAs.  If so, the amount of RsmY and RsmZ would 
then affect the order in which mRNAs are relieved from CsrA repression.  Perhaps by 
having the LetA/LetS and Csr systems in tandem, L. pneumophila can adapt to stresses 
more quickly, since mRNA transcripts for critical transmission traits would already have 
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been generated.  Although Bordetella lacks the Csr system, many other members within 
this family of two-component systems do contain this additional level of regulation, 
including A. baumannii, E. coli, S. typhimurium, S. marcescens, P. aeruginosa and V. 
cholerae (Lapouge et al., 2008; Lucchetti-Miganeh et al., 2008).  Thus, the L. 
pneumophila LetA/LetS system can serve as a valuable alternative model for this large 
family of signaling molecules.   
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Table 2.1.  Bacterial strains and plasmids 
 
 
Strain or Plasmid Relevant genotype/phenotype Reference or 
Source 
   
Strains   
   E. coli  
     DH5α 
 
F– endA1 hsdR17 (r– m+) supE44 thi-l recA1 gryA (Nal1) 




     XL10-Gold TetR Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 
supE44 thi-1 recA1 gyrA96 relA1 lac Hte [F′ proAB 
lacIqZΔM15 Tn10(TetR) Amy CamR] 
Stratagene 
     MB596 DH5α pletS This work 
     MB597 DH5α pletST311M This work 
     MB598 DH5α pletS::thyA This work 
     MB610 DH5α pletSH307Q This work 
     MB540 DH5α pBluescript KS+ with thyA Laboratory 
Collection 
   L. pneumophila 
     MB110 
 




     MB355 pflaG (Hammer and 
Swanson, 
1999) 
     MB416 letS-36::kan (Hammer et 
al., 2002) 
     MB417 letS::kan pflaG (Hammer et 
al., 2002) 
     MB599 letS::thyA This work 
     MB600 letST311M This work 
     MB605 letST311M pflaG This work 
     MB611 letSH307Q This work 
Plasmids   
     pGEM-T Multiple cloning site within coding region of β-lactamase α 
fragment linearized with single-T overhangs; 3 kb; AmpR 
Promega 
     pflaG 150 bp flaA promoter fragment fused to GFP, encodes 




     pletS pGEM-T containing 3.1 kb letS fragment PCR amplified 
from Lp02 chromosome and ligated into T overhangs; 6.1 
kb; AmpR 
This work 
     pletST311M pletS with a ACC to ATG change; 6.1 kb; AmpR This work 
     pletSH307Q pletS with a CAT to CAA change; 6.1 kb; AmpR This work 
     pletS::thyA pletS with 1.8 kb thyA fragment inserted into EcoRI site at 
base 436 of letS; 7.9 kb; AmpR 
This work 
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Table 2.2.  Primers for amplification and mutagenesis of letS 




LetS F 5´-AAT AAT GCA GTC CTT ACC C-3´ 
LetS R 5´-TGG ATG ACA CCA CAA GC- 3 ´  
LetS Mutagenesis F
*
 5´-CAT GAG TCA TGA AAT TCG TAT GCC AAT GAA TGG CGT GAT TGG-3´  
LetS Mutagenesis R
*
 5´-CCA ATC ACG CCA TTC ATT GGC ATA CGA ATT TCA TGA CTC ATG-3´  
LetS Mut Seq F 5´-CGA TTG CGT CGA AGT ATG-3´ 
LetS Mut. His F* 5´-TTA TTG CCA ACA TGA GTC AAG AAA TTC GTA CCC CAA TGA ATG GC-3´ 








Figure 2.1.  The Legionella pneumophila LetA/LetS two-component system.   
(A)  Domain architecture of the LetA/LetS two-component system.  LetS, a 103 kDa 
sensor protein, is likely tethered to the inner membrane by two transmembrane (TM) 
domains at its N terminus.  The periplasmic (P) domain is connected to three cytoplasmic 
signaling domains, a transmitter (T), receiver (R) and histidine phosphotransfer domain 
(HPD), via a linker (L) region.  LetA is a 43 kDa activator kinase that contains a receiver 
(R) domain and a helix-turn-helix motif (HTH).  It is predicted that upon receiving a 
signal, LetS autophosphorylates on a conserved histidine residue and then the phosphate 
is sequentially transferred to aspartic acid and histidine residues in LetS and finally to an 
aspartic acid in LetA.  A histidine-to-glutamine substitution at amino acid 307 of LetS 
abolishes LetS activity, while a threonine-to-methionine substitution at position 311 
creates a strain locked in an intermediate phase.  (B)  Sequence alignment of the L. 
pneumophila LetS H-box region with related tripartite sensor kinases.  Amino acid 
alignments were produced using T-Coffee.  Dashes represent gaps introduced to optimize 
sequence alignments.  * indicates identical residues while : and . represent conserved 
and semi-conserved amino acids, respectively.  The H-box region is underlined, and the 
primary histidine and conserved threonine residues are displayed above the alignment. 
Abbreviations: Lp Legionella pneumophila; Bb Bordetella bronchiseptica; Ec 
Escherichia coli; Pa Pseudomonas aeruginosa; St Salmonella typhimurium. 
LetSLp  266 --IELSLEKKKTEEKSRQKSEFIANMSHEIRTPMNGVIGFTNVLLESKLDPL-QL-DYVK  
BvgSBb  642 LLRELHDAKESADAANRAKTTFLATMSHEIRTPMNAIIGMLELALLRPADQEPDR-QSIQ  
ArcBEc  252 --TERKRYQDALERASRDKTTFISTISHELRTPLNGIVGLSRILLDTELTAE-QE-KYLK  
BarAEc  275 QNVELDLAKKRAQEAARIKSEFLANMSHELRTPLNGVIGFTRLTLKTELTPT-QR-DHLN  
EvgSEc  641 LINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKE-QRVEAIS  
TorSEc  426 LVIEHRQARAEAEKASQAKSAFLAAMSHEIRTPLYGILGTAQLLADNPALNA-QR-DDLR  
GacSPa  266 QNIELDLARKEALEASRIKSEFLANMSHEIRTPLNGILGFTNLLQKSELSPR-QQ-DYLT  
BarASt  275 QNVELDLAKKRAQEAARIKSEFLANMSHELRTPLNGVIGFTRLTLKTELNPT-QR-DHLN 




























Figure 2.2.  Histidine 307 of LetS is required for the expression of PE phenotypes.   
(A)  Histidine 307 is required for L. pneumophila to bind, enter and survive within 
macrophages.  PE bacteria were co-cultured with macrophages at an MOI=1, and the 
percent of bacteria remaining after 2 h was calculated.  (B)  The autophosphorylation site 
of LetS is essential for contact-dependent cytotoxicity.  Macrophages were co-cultured 
PE phase WT (circles), letS (squares) and letSH307Q (triangles) bacteria over a range of 
MOIs, and the number of viable macrophages assessed by the reduction of the 
colorimetric dye alamarBlue™.  Shown is a representative graph from three independent 
experiments preformed in triplicate.  (C)  A histidine-to-glutamine substitution at position 
307 of LetS abolishes the ability of L. pneumophila to resist lysosomal degradation.  
Macrophages were infected with PE bacteria at an MOI = 1, and the percent of intact 
bacteria following a 2-h incubation was determined by fluorescence microscopy.  (D)  
Sodium resistance persists if the autophosphorylation site of LetS is disrupted.  PE 
cultures were plated on media with or without 100 mM NaCl, and the percent of sodium 
sensitive bacteria determined.  (E)  Substitution of a glutamine residue at position 307 of 
LetS inhibits pigment production.  WT, letS and letSH307Q bacteria were incubated for 5 
days and the soluble pigment quantified from culture supernatants.  For bar graphs in 
panels A, C, D and E the means ± SD from duplicate samples in three independent 
experiments are displayed.  Asterisks indicate statistically significant differences 


















Figure 2.3.  A strain containing a threonine-to-methionine substitution four residues 
from the proposed autophosphorylation site of LetS exhibits either WT or letS null 
phenotypes.   
(A)  Substitution of a methionine residue at position 311 of LetS does not affect sodium 
resistance.  The percentage of sodium resistant CFU was quantified by plating PE 
bacteria on CYET containing or lacking 100 mM NaCl.  The means ± SD from duplicate 
samples in three independent experiments are displayed and the asterisks represent 
significant differences (P<0.01) in comparison to letS PE cultures.  (B)  Threonine 311 of 
LetS is essential for the production of a melanin-like pigment.  WT, letS and letST311M 
cells were cultured for 5 days and pigment measured from supernatants at OD550.  Shown 
are the means from three independent experiments.  Error bars indicate SD and asterisks 






Figure 2.4.  A strain containing a threonine-to-methionine substitution at position 
311 of LetS displays intermediate phenotypes for several PE traits.   
(A)  letST311M mutants are intermediate in their ability to bind, enter and survive within 
macrophages.  PE microbes were co-cultured with macrophages at an MOI = 1.  
Following a 2-h incubation, macrophages were lysed and the number of bacteria 
remaining calculated.  The means ± SD from duplicate samples in three independent 
experiments are displayed.  Asterisk indicates statistically significant differences 
(P<0.01) when compared to WT microbes and (P<0.05) when compared to letS null 
bacteria.  (B)  A threonine-to-methionine change at amino acid 311 of LetS creates a 
strain that is intermediately cytotoxic.  Macrophages were infected with PE WT (circles), 
letS (squares) and letST311M (triangles) microbes at the MOIs shown and macrophage 
viability measured by the reduction of the dye, alamarBlue™.  A representative graph 
from three independent experiments performed in triplicate is displayed.  (C)  letST311M 
mutants are intermediate for lysosomal degradation when compared with WT and letS 
null bacteria.  Macrophages were infected with PE cultures at an MOI = 1 and the percent 
of intact bacteria following a 2-h incubation quantified by fluorescence microscopy.  
Shown are the means from three independent experiments performed in duplicate.  Error 
bars represent SD and asterisk denotes a statistically significant difference (P<0.01) when 








Figure 2.5.  Flow cytometry indicates that eventually every letST311M cell in the 
population activates the flaA promoter to a similar level.   
To determine what percentage of WT (A) and letST311M (B) populations expressed the 
pflaG reporter, cultures at various optical densities were washed and normalized to 5 × 
105 in PBS.  Promoter activity was analyzed by monitoring GFP fluorescence via flow 
cytometry.  Shown are representative curves from one experiment, and the OD600 of each 
sample is denoted.  Similar results were obtained in three separate experiments.   
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Table 2.3.  Repressed genes for letST311M vs. WT for ODs 2 and 3 
 





lpg1219 flgE lpp1227 lpl1227 flagellar hook protein -6.1 - 
lpg1225 flgK lpp1233 lpl1233 flagellar hook-associated protein -4.9 - 
lpg1226 flgL lpp1234 lpl1234 flagellar hook-associated protein  -4.4 - 
lpg1220 flgF lpp1228 lpl1228 flagellar biosynthesis protein -4.3 - 
lpg0901 - lpp0962 lpl0932 unknown -3.8 - 
lpg0902 - lpp0963 lpl0933 unknown -3.6 - 
lpg0669 - lpp0725 lpl0705 unknown -3.6 - 
lpg1168 - lpp1170 lpl1176 regulatory protein (GGDEF and EAL domains)  -3.4 - 
lpg1454 - lpp1410 lpl1590 multidrug efflux protein -3.2 - 
lpg0277 - lpp0351 lpl0329 regulatory protein (EAL domain) -3.2 - 
lpg1370 fis2 lpp1324 lpl1321 similar to DNA-binding protein Fis -3.1 - 
lpg1055 - lpp2327 - unknown -3.0 - 
lpg2028 hemE lpp2010 lpl2005 uroporphyrinogen decarboxylase -2.9 - 
lpg2622 - lpp2675 lpl2547 weakly similar to cysteine protease -2.9 - 
lpg1223 flgI lpp1231 lpl1231 flagellar P-ring protein precursor -2.9 - 
lpg0426 cspD lpp0493 lpl0469 cold shock-like protein -2.9 - 
lpg2105 - - - transmembrane protein -2.8 - 
lpg0560 phaB1 lpp0620 lpl0603 acetoacetyl-CoA reductase -2.8 - 
lpg2106 - - - unknown -2.7 - 
lpg1224 flgJ lpp1232 lpl1232 flagellar biosynthesis protein -2.6 - 
lpg1667 - lpp1638 lpl1632 similar to metallo-endopeptidases -2.6 - 
lpg0737 - lpp0802 lpl0773 putative secreted protein -2.6 - 
lpg2579 - lpp2631 lpl2501 unknown -2.5 - 
lpg2732 lqsR lpp2788 lpl2657 LqsR response regulator -2.5 - 
lpg2837 - lpp2894 lpl2749 similar to lysophospholipase A -2.5 - 
lpg2457 - lpp2523 lpl2376 two-component response regulator (crystallized) -2.4 - 
lpg1908 gst lpp1883 lpl1874 glutathione S-transferase  -2.4 - 
lpg1218 flgD lpp1226 lpl1226 flagellar basal-body rod modification protein -2.4 - 
lpg0733 - lpp0799 lpl0770 unknown -2.3 - 
lpg1222 flgH lpp1230 lpl1230 flagellar L-ring protein precursor -2.3 - 
lpg1059 phaB3 lpp2322 lpl1056 acetoacetyl-CoA reductase -2.2 - 
lpg2237 - lpp2190 lpl2163 
ABC-type multidrug transport system, ATPase 




 - lpp3021 lpl2878 unknown -2.2 - 
lpg2328 - lpp2276 lpl2248 
unknown - N-terminal similar to Legionella 33 
kDa polypeptide 
-2.2 - 
lpg2258 - lpp2212 lpl2184 unknown -2.1 - 
lpg1221 flgG lpp1229 lpl1229 flagellar biosynthesis protein -2.1 - 
lpg0874 pntB lpp0937 lpl0907 NAD(P) transhydrogenase subunit beta  -2.0 - 
lpg0953 - lpp1015 lpl0982 long-chain acyl-CoA synthetases (AMP-forming) -2.0 - 
lpg1655 - lpp1626 lpl1620 LasB-like zinc metalloprotease (elastase) -2.0 - 
lpg2164 - lpp2102 lpl2091 unknown -1.9 - 
lpg2999 legP lpp3071 lpl2927 eukaryotic zinc metalloproteinase  -1.9 - 
lpg1451 - lpp1406 lpl1593 phosphatidyl/ethanolamine-binding protein -1.9 - 
lpg0623 - lpp0677 lpl0660 predicted membrane protein -1.9 - 
lpg2373 - - - unknown -1.8 - 
lpg2324 - lpp2272 lpl2244 L-gulono-gamma-lactone oxidase -1.8 - 
lpg2401 - lpp2466 lpl2324 putative secreted esterase -1.8 - 
lpg1759 fliG lpp1723 lpl1723 flagellar motor switch protein -1.8 - 
lpg0803 - lpp0865 lpl0836 acyl-CoA dehydrogenase/SOS response -1.8 - 
lpg1779 - lpp1743 lpl1743 unknown  -1.8 - 
lpg2192 - - - molecular chaperone/heat shock protein -1.8 - 









lpg3002 - lpp3074 lpl2930 putative inner membrane protein translocase -1.7 - 
lpg0902a
2
 - lpp0964 lpl0934 unknown -1.7 - 
lpg1758 fliH lpp1722 lpl1722 polar flagellar assembly protein -1.7 - 
lpg0283 - lpp0359 lpl0335 NAD+ formate/lactate dehydrogenase -1.6 - 
lpg1174a
2
 - lpp1177 lpl1183 unknown -5.8 -8.5 
lpg0012 - lpp0012 lpl0012 unknown -3.2 -2.6 
lpg1895 - lpp1864 lpl1859 unknown -1.9 -6.0 
lpg0632 - lpp0686 lpl0669 type IV fimbrial pilin related protein - -7.5 
lpg2803 - lpp2849 lpl2718 unknown - -6.4 
lpg2569 - - - unknown - -5.9 
lpg0741 - lpp0806 lpl0777 unknown - -5.5 
lpg0586 - lpp0636 lpl0620 putative transcriptional regulator - -5.4 
lpg2315 - lpp2263 lpl2235 unknown - -4.8 
lpg0259 - lpp0329 lpl0312 unknown - -4.7 
lpg2187 - lpp2137 lpl2112 unknown - -4.5 
lpg1686 - - - unknown - -4.3 
lpg2862 legC8 - - cytotoxic glucosyltransferase Lgt2 - -4.3 
lpg2990 - lpp3061 lpl2918 unknown - -4.1 
lpg1340 flaA lpp1294 lpl1293 flagellin - -4.0 
lpg1577 rpoE lpp1535 lpl1448 sigma factor RpoE (sigma 24) - -3.9 
lpg0631 - lpp0685 lpl0668 type IV fimbrial biogenesis protein PilV - -3.8 
lpg1386 enhA3 lpp1341 lpl1337 similar to enhanced entry protein EnhA - -3.8 
lpg0910 enhA2 lpp0972 lpl0942 similar to enhanced entry protein EnhA - -3.7 
lpg2603 - lpp2656 lpl2526 unknown - -3.6 
lpg0672 - lpp0728 lpl0708 acetoacetate decarboxylase (crystallized) - -3.6 
lpg2582a
2
 - lpp2636 lpl2506 unknown - -3.5 
lpg2520 - lpp2588 lpl2442 unknown - -3.5 
lpg2364 - - - weakly similar to NAD-dependent DNA ligase - -3.5 
lpg0628 - lpp0682 lpl0665 type IV fimbrial biogenesis PilY1-related protein - -3.4 
lpg1121 - lpp1121 lpl1126 unknown - -3.3 
lpg0286a
2
 - lpp0364 lpl0339 unknown - signal peptide predicted - -3.1 
lpg2157 sdeA lpp2096 lpl2085 SdeA- substrate of the Dot/Icm T4SS - -3.1 
lpg0898 - lpp0959 lpl0929 unknown - -3.0 
lpg1491 - lpp1447 - some similarity with eukaryotic proteins - -3.0 
lpg1339 - lpp1293 lpl1292 unknown - -3.0 
lpg0620 - lpp0674 lpl0657 unknown - -3.0 
lpg1158 - lpp1160 - some similarity with eukaryotic proteins - -3.0 
lpg1669 - lpp1641 lpl1634 unknown - alpha-amylase domain - -3.0 
lpg2524 - - - transcriptional regulator, LuxR family - -2.9 
lpg1355 sidG lpp1309 - SidG - substrate of the Dot/Icm T4SS - -2.9 
lpg2145 - lpp2083 lpl2073 putative two-component response regulator  - -2.9 
lpg0629 - lpp0683 lpl0666 Tfp pilus assembly protein PilX - -2.9 
lpg0088 - lpp0102 lpl0087 similar to arginine-binding periplasmic protein - -2.9 
lpg2521 - lpp2589 lpl2443 unknown - transmembrane protein - -2.8 
lpg2527 - lpp2592 lpl2447 unknown - -2.8 
lpg0625 - lpp0679 lpl0662 similar to unknown eukaryotic proteins - -2.8 
lpg2146 stuC lpp2084 lpl2074 sensor histidine kinase - -2.8 
lpg1290 - lpp1253 - unknown - -2.8 
lpg1963 - - - unknown - -2.8 
lpg2498a
2
 - lpp2567 lpl2421 unknown - -2.7 
lpg0673 - lpp0729 lpl0709 unknown - signal peptide protein - -2.7 
lpg1207 - lpp1209 lpl1215 
similar to YbaK/prolyl-tRNA synthetase 
associated region 
- -2.7 
lpg2877 - lpp2936 lpl2790 unknown - -2.7 
lpg0627 pilE lpp0681 lpl0664 type-IV pilin - -2.6 
lpg0589 - lpp0639 lpl0623 unknown - -2.6 
lpg1968a
2
 - lpp1951 lpl1940 unknown - -2.6 
lpg0871 - lpp0934 lpl0903 unknown - -2.6 
lpg0614 - lpp0665 lpl0649 unknown - -2.6 
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1 Fold Change (FC) at the corresponding OD.  If no FC is indicated, the gene was either not 
differentially expressed or the statistical analyses failed due to FC variability.   
2  These genes were not predicted in the Philadelphia strain.  Their ID therefore became the ID of 
the gene located upstream on the chromosome followed by “a”.  For the exact location and 
orientation of these genes see Table 2.S1. 
 
 





lpg1485 - lpp1441 lpl1543 unknown - -2.5 
lpg2181 arcB lpp2133 lpl2108 putative histidine kinase/response regulator - -2.5 
lpg0037 artJ1 lpp0036 lpl0037 
similar to arginine 3rd transport system 
periplasmic binding protein 
- -2.5 
lpg1115 kaiC2 lpp1116 lpl1120a putative circadian clock protein KaiC - -2.5 
lpg0258 - lpp0328 lpl0311 unknown - -2.5 
lpg2132 - lpp2071 lpl2061 regulatory protein (GGDEF domain) - -2.5 
lpg1113 - lpp1113 lpl1117 unknown - -2.4 
lpg2147 - lpp2086 lpl2075 unknown - -2.4 
lpg1496 - lpp1453 lpl1530 some similarities with sidE protein - -2.4 
lpg1080 - - - 
putative deoxyguanosine triphosphate 
triphosphohydrolase 
- -2.4 
lpg2907 - lpp2976 lpl2824 unknown - -2.4 
lpg2049 - lpp2032 lpl2027 unknown - -2.4 
lpg2719 - lpp2776 lpl2647 unknown - -2.4 
lpg0671 ndh lpp0727 lpl0707 NADH dehydrogenase - -2.3 
lpg2268 - lpp2222 lpl2194 unknown - -2.3 
lpg2246 - lpp2200 lpl2172 unknown - -2.2 
lpg0039 - lpp0040 lpl0039 unknown - -2.2 
lpg0587 yqgF lpp0637 lpl0621 Holliday junction resolvase-like protein - -2.2 
lpg1112 - lpp0639 lpl1116 unknown - -2.2 
lpg0245 - lpp0315 lpl0299 NAD-glutamate dehydrogenase - -2.2 
lpg2759 - lpp2807 lpl2676 unknown - -2.2 
lpg2093 - - - unknown - -2.2 
lpg2108 - - - unknown - -2.2 
lpg0121 - lpp0134 lpl0119 ABC transporter, permease protein - -2.2 
lpg0514a
2
 - lpp0577 lpl0553 unknown - -2.1 
lpg1793 - lpp1757 lpl1757 unknown - -2.1 
lpg0645 - - - truncated structural toxin protein RtxA - -2.1 
lpg2907 - lpp2976 lpl2824 unknown - -2.1 
lpg0527 - lpp0592 lpl0573 signal transduction protein - -2.1 
lpg2351 - lpp2300 lpl2273 unknown - -2.1 
lpg1114a
2
 - lpp1115 lpl1119 KaiB-like circadian clock protein - -2.1 
lpg1796 - lpp1760 lpl1760 transcriptional regulator, LysR family - -2.0 
lpg2075 - - - DNA adenine methylase - -2.0 
lpg0029 rre41 lpp0029 lpl0030 regulatory protein (GGDEF and EAL domains) - -1.9 
lpg2426 mdcA lpp2493 - malonate decarboxylase- alpha subunit - -1.9 
lpg2584 sidF lpp2637 lpl2507 SidF - substrate of the Dot/Icm system - -1.9 
lpg0550 - lpp0611 lpl0592abc 
similar to D-amino acid dehydrogenase with a C-
terminal cAMP binding motif 
- -1.9 
lpg2526 - lpp2591 lpl2446 unknown - -1.7 
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Table 2.4.  Subset of repressed genes in the letST311M mutant as compared to WT 
1 Fold Change (FC) at the corresponding OD.  If no FC is indicated, the gene was either not 
differentially expressed or the statistical analyses failed due to FC variability. 
2 These genes were not predicted in the Philadelphia strain.  Their ID therefore became the ID of 
the gene located upstream on the chromosome followed by “a”.  For the exact location and 
orientation of these genes see Table 2.S1. 
 
 





lpg0277 - lpp0351 lpl0329 regulatory protein (EAL domain) -3.2 - 
lpg1168 - lpp1170 lpl1176 regulatory protein (GGDEF and EAL domains)  -3.4 - 
lpg2457 - lpp2523 lpl2376 two-component response regulator (crystallized) -2.4 - 
Regulation 
lpg2732 lqsR lpp2788 lpl2657 LqsR response regulator -2.5 - 
lpg1218 flgD lpp1226 lpl1226 flagellar basal-body rod modification protein -2.4 - 
lpg1219 flgE lpp1227 lpl1227 flagellar hook protein -6.1 - 
lpg1220 flgF lpp1228 lpl1228 flagellar biosynthesis protein -4.3 - 
lpg1221 flgG lpp1229 lpl1229 flagellar biosynthesis protein -2.1 - 
lpg1222 flgH lpp1230 lpl1230 flagellar L-ring protein precursor -2.3 - 
lpg1223 flgI lpp1231 lpl1231 flagellar P-ring protein precursor -2.9 - 
lpg1224 flgJ lpp1232 lpl1232 flagellar biosynthesis protein -2.6 - 
lpg1225 flgK lpp1233 lpl1233 flagellar hook-associated protein -4.9 - 
lpg1226 flgL lpp1234 lpl1234 flagellar hook-associated protein  -4.4 - 
lpg1758 fliH lpp1722 lpl1722 polar flagellar assembly protein -1.7 - 
Flagellum 
synthesis 
lpg1759 fliG lpp1723 lpl1723 flagellar motor switch protein -1.8 - 
lpg0560 phaB1 lpp0620 lpl0603 acetoacetyl-CoA reductase -2.8 - 
lpg0561 phaB2 lpp0621 lpl0604 acetoacetyl-CoA reductase  -1.8 - 
Putatively 
involved in 
PHB synthesis lpg1059 phaB3 lpp2322 lpl1056 acetoacetyl-CoA reductase -2.2 - 
lpg1174a
2
 - lpp1177 lpl1183 unknown -5.8 -8.5 
lpg2803 - lpp2849 lpl2718 unknown - -6.4 
lpg1895 - lpp1864 lpl1859 unknown -1.9 -6.0 
lpg2569 - - - unknown - -5.9 
Unknown 
lpg0741 - lpp0806 lpl0777 unknown - -5.5 
Flagellum lpg1340 flaA lpp1294 lpl1293 flagellin - -4.0 
lpg1355 sidG lpp1309 - SidG - substrate of the Dot/Icm T4SS - -2.9 
lpg2157 sdeA lpp2096 lpl2085 SdeA- substrate of the Dot/Icm T4SS - -3.1 
lpg2584 sidF lpp2637 lpl2507 SidF - substrate of the Dot/Icm system - -1.9 
lpg2862 legC8 - - cytotoxic glucosyltransferase Lgt2 - -4.3 
lpg0910 enhA2 lpp0972 lpl0942 similar to enhanced entry protein EnhA - -3.7 
Virulence 
lpg1386 enhA3 lpp1341 lpl1337 similar to enhanced entry protein EnhA - -3.8 
lpg0625 - lpp0679 lpl0662 similar to unknown eukaryotic proteins - -2.8 
lpg1491 - lpp1447 - some similarity with eukaryotic proteins - -3.0 
Eukaryotic-
like 
lpg1158 - lpp1160 - some similarity with eukaryotic proteins - -3.0 
lpg1577 rpoE lpp1535 lpl1448 sigma factor RpoE (sigma 24) - -3.9 
lpg0586 - lpp0636 lpl0620 putative transcriptional regulator - -5.4 
lpg1114a 
2
 - lpp1115 lpl1119 KaiB-like circadian clock protein - -2.1 
lpg1115 kaiC2 lpp1116 lpl1120a putative circadian clock protein KaiC - -2.5 
lpg1796 - lpp1760 lpl1760 transcriptional regulator. LysR family - -2.0 
lpg2145 - lpp2083 lpl2073 putative two-component response regulator  - -2.9 
lpg2146 stuC lpp2084 lpl2074 sensor histidine kinase - -2.8 
lpg2181 arcB lpp2133 lpl2108 putative histidine kinase/response regulator - -2.5 
lpg2524 - - - transcriptional regulator. LuxR family - -2.9 
lpg0029 rre41 lpp0029 lpl0030 regulatory protein (GGDEF and EAL domains) - -1.9 
Regulation 
lpg2132 - lpp2071 lpl2061 regulatory protein (GGDEF domain) - -2.5 
lpg0627 pilE lpp0681 lpl0664 type IV pilin - -2.6 
lpg0628 - lpp0682 lpl0665 type IV fimbrial biogenesis PilY1-related protein - -3.4 
lpg0629 - lpp0683 lpl0666 Tfp pilus assembly protein PilX - -2.9 
lpg0631 - lpp0685 lpl0668 type IV fimbrial biogenesis protein PilV - -3.8 
Type IV pilus 
lpg0632 - lpp0686 lpl0669 type IV fimbrial pilin related protein - -7.5 
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Table 2.5.  Induced genes for letST311M vs. WT at ODs 2 and 3 
 
1 Fold Change (FC) at the corresponding OD.  If no FC is indicated, the gene was either not 
differentially expressed or the statistical analyses failed due to FC variability.   
2 These genes were not predicted in the Philadelphia strain.  Their ID therefore became the ID of 
the gene located upstream on the chromosome followed by “a”.  For the exact location and 




















lpg0286a unknown - signal peptide predicted + 341722 341952 77 
lpg0514a unknown + 556062 556325 88 
lpg0902a unknown + 647400 647804 135 
lpg1174a unknown + 1299590 1299835 82 
lpg2498a unknown + 2816627 2816851 75 
lpg2582a unknown + 2912984 2913163 60 
lpg1114a unknown - 1221307 1221035 91 
lpg1136a unknown - 1251794 1251573 74 
lpg1966a unknown - 2206294 2206067 76 
lpg1968a unknown - 2208173 2207934 80 
lpg2950a unknown - 3339455 3339189 89 
 





lpg1489 - lpp1445 lpl1539 unknown 2.3 - 
lpg1776 - lpp1740 lpl1740 unknown 2.0 - 
lpg2002 yajC lpp1983 lpl1978 preprotein translocase subunit YajC 2.0 - 
lpg1136a
2
 - lpp1138 lpl1143 unknown 1.9 - 
lpg1966a
2
 - lpp1948 lpl1937 unknown 1.9 - 
lpg0420 eda lpp0487 lpl0463 
2-deydro-3-deoxyphosphogluconate aldolase / 
4-hydroxy-2-oxoglutarate aldolase 
1.9 - 
lpg1593 - lpp1551 lpl1432 similar to carbon storage regulator CsrA 1.9 - 
lpg2001 secD lpp1982 lpl1977 protein-export membrane protein SecD 1.8 - 
lpg2000 secF lpp1981 lpl1976 protein-export membrane protein SecF 1.7 - 
lpg1853 udk lpp1820 lpl1819 uridine kinase 1.6 - 
lpg0915 - lpp0976 lpl0946 similar to cell division protein FtsL - 2.8 
lpg0892 - lpp0953 lpl0923 kynurenine 3-monooxygenase - 2.7 
lpg0024 hbp lpp0024 lpl0025 hemin binding protein - 2.3 
lpg1364 glnA lpp1318 lpl1315 glutamine synthetase - 2.0 



















Figure 2.6.  The LetA/LetS System acts as a rheostat to fine-tune its phenotypic 
profile.   
While L. pneumophila are in the E phase of growth, the LetA/LetS system is either 
inactive, or may regulate a subset of unidentified genes.  At this time point, genes that are 
essential for L. pneumophila replication are induced, for example the post-transcriptional 
regulator csrA.  When LetS receives an appropriate signal, the sensor kinase 
autophosphorylates, and as phosphate flows through the relay, the amount of LetA~P 
accumulates.  It is predicted that the amount of LetA~P required to activate the Dot/Icm 
type IV secretion system and sodium sensitivity is low, as letST311M mutants are similar to 
WT for these traits.  Perhaps intermediate levels of LetA~P are required to activate the 
PE phenotypes of infectivity, cytotoxicity and lysosomal avoidance as letST311M mutants 
exhibit intermediate phenotypes when compared to WT and letS null bacteria.  Also, 
intermediate levels of LetA~P are likely needed to induce motility, since a kinetic defect 
was observed in genes of the flagellar cascade for the letST311M mutant.  Presumably, 
substantial levels of LetA~P are required for pigmentation as letST311M mutants do not 
accumulate substantial levels of the soluble pigment.  Likewise, high levels of LetA~P 
are probably required to induce lpg0012, lpg1174 and lpg1895, since the letST311M mutant 
was repressed for these genes at both OD600 = 2 and OD600 = 3 when compared to WT L. 











































Figure 2.7.  Model for LetA/LetS regulation.   
Upon receiving an appropriate signal, LetS autophosphorylates on a histidine (H) residue 
located in the transmitter (T) domain.  The signal is then transduced to an aspartic acid 
(D) in the receiver (R) and then to a second histidine (H) located in the histidine 
phosphotransfer domain (HPD) of LetS.  Finally, the phosphoryl group is transferred to 
an aspartic acid (D) in the receiver (R) domain of LetA.  Once phosphorylated, LetA 
binds DNA via a helix-turn-helix (HTH) motif to activate transcription of its targets, 
RsmY and RsmZ.  CsrA binds near the ribosomal binding site of mRNAs, which 
destabilizes the transcripts and ultimately inhibits their translation.  The presence of 
ample amounts of RsmY and RsmZ titrate CsrA away from its targets, which enables 
translation of the mRNAs.  We postulate that the rate that phosphate flows through the 
relay controls the amount of phosphorylated LetA present in the cell, and likewise the 
amount of RsmY and RsmZ that are transcribed.  This in turn affects the number of CsrA 














LEGIONELLA PNEUMOPHILA COUPLES FATTY ACID FLUX TO 
MICROBIAL DIFFERENTIATION AND VIRULENCE  
 
Summary 
Essential to the life cycle of Legionella pneumophila is its ability to alternate 
between at least two distinct phenotypes: a non-infectious, replicative form required for 
intracellular growth and an infectious, transmissive form that is vital for dissemination.  
Although amino acids are known to govern this developmental switch, we postulated that 
L. pneumophila could use other metabolic cues to regulate its differentiation.  By 
applying phenotypic microarrays, we demonstrate that when replicative L. pneumophila 
encounter excess short chain fatty acids (SCFAs), the bacteria restrict growth and quickly 
activate transmissive traits.  Their response to SCFAs is dependent on the two-component 
system LetA/LetS and the stringent response enzyme SpoT.  Using the metabolic 
inhibitors cerulenin and TOFA, we deduced that alterations in the fatty acid biosynthetic 
pathway signal L. pneumophila to induce mechanisms that promote transmission.  
Moreover, western analysis determined that perturbations in fatty acid biosynthesis alter 
the distribution of acylated acyl carrier proteins in L. pneumophila, a process believed to 
be monitored by SpoT, an enzyme that generates the alarmone ppGpp which coordinately 
induces transmission traits.  We propose that by coupling phase differentiation to its 
metabolic state, L. pneumophila can swiftly acclimate to environmental fluctuations or 







Legionella pneumophila is a promiscuous, gram-negative pathogen commonly 
found in freshwater systems.  In these aquatic environments, L. pneumophila efficiently 
parasitizes at least 14 different species of amoebae, two species of ciliated protozoa, and 
one slime mold (Fields et al., 2002).  Moreover, Legionella can exist as a free-living 
microbe by establishing multispeciated biofilms in both natural and potable water 
systems, which often serve as reservoirs of contamination (Fields et al., 2002).  
Consequently, if susceptible individuals inadvertently aspirate bacteria-laden aerosols, 
the bacteria can colonize alveolar macrophages to cause the severe pneumonia 
Legionnaires’ disease.  Due to the disparate conditions under which L. pneumophila can 
survive, the bacteria must utilize mechanisms to monitor their milieu and swiftly 
acclimate to their surroundings.   
To tolerate environmental fluctuations, many bacteria alter their cellular 
physiology and morphology in a process known as differentiation.  For example, the 
sexually transmitted bacterium Chlamydia trachomatis alternates between an 
extracellular, metabolically inert elementary body (EB) required for host transmission 
and an intracellular, metabolically active reticulate body (RB) that undergoes repeated 
cycles of cell division (Abdelrahman and Belland, 2005; Samuel et al., 2003).  Likewise, 
the etiologic agent of human Q fever, Coxiella burnetii, displays two morphological cell 
types, a replicative large cell variant (LCV) and a highly resistant small cell variant 
(Heinzen et al., 1999).  Within sessile biofilm communities, the opportunistic pathogen 
Pseudomonas aeruginosa alternates between distinct motile and non-motile cell types 
(Purevdorj-Gage et al., 2005).  By employing cellular differentiation, each of these 
bacterial pathogens can evade the defense mechanisms of their hosts, and likewise 
promote self-preservation.   
 Similar to the aforementioned pathogens, ground-breaking work by Rowbotham 





nonmotile, thin-walled replicative form and a motile, thick-walled infectious form that 
contains stores of an energy-rich polymer β-hydroxybutyrate (Rowbotham, 1986).  
Subsequent studies have corroborated these early findings and determined that the 
replicative and transmissive phases of the L. pneumophila life cycle are reciprocal (Alli et 
al., 2000; Byrne and Swanson, 1998; Hammer and Swanson, 1999; Molofsky and 
Swanson, 2003; Watarai et al., 2001b; Wieland et al., 2002).  The current model suggests 
that when phagocytic cells engulf transmissive Legionella, the bacteria avoid lysosomal 
degradation by establishing vacuoles isolated from the endosomal network, a process 
mediated by the Dot/Icm type IV secretion system and the shedding of vesicles rich in 
lipopolysaccharide (Berger and Isberg, 1993; Berger et al., 1994; Fernandez-Moreira et 
al., 2006; Joshi et al., 2001).  If conditions in the vacuolar compartment are favorable, the 
post-transcriptional regulator CsrA and the sRNA chaperone Hfq repress transmissive 
traits, thereby enabling L. pneumophila to replicate profusely (Fettes et al., 2001; 
McNealy et al., 2005; Molofsky and Swanson, 2003).  However, once nutrient supplies 
are exhausted, bacterial replication halts, and the progeny initiate a global change in their 
metabolism known as the stringent response (Gal-Mor et al., 2002; Hammer and 
Swanson, 1999).  Activation of this pathway generates the alarmone, ppGpp, which 
coordinates bacterial differentiation.  In particular, a major shift in the L. pneumophila 
transcriptional profile is mediated by alternative sigma factors as the LetA/LetS two-
component system relieves CsrA repression on transmissive traits (Bruggemann et al., 
2006; Hammer and Swanson, 1999; Hammer et al., 2002; Molofsky and Swanson, 2003).  
As a consequence, L. pneumophila expresses a panel of traits that are vital for 
dissemination, including cytotoxicity, motility and lysosome evasion (Bachman and 
Swanson, 2001, 2004a, b; Hammer et al., 2002; Jacobi et al., 2004; Lynch et al., 2003).   
 L. pneumophila responds to metabolic cues to govern its phase differentiation.  
Amino acid concentrations appear to be critical, as fluctuations in their availability alter 





gauge whether the threonine supply in its vacuolar compartment is sufficient to sustain 
growth (Sauer et al., 2005).  Moreover, the macrophage amino acid transporter SLC1A5 
(hATB0,+) is required to support replication of intracellular L. pneumophila (Wieland et 
al., 2005).  Studies of broth cultures predict that when amino acid supplies are depleted, 
uncharged tRNAs accumulate, and the stringent response enzyme RelA produces the 
ppGpp signaling molecule, which triggers L. pneumophila differentiation (Gal-Mor et al., 
2002; Hammer and Swanson, 1999; Zusman et al., 2002).  However, since L. 
pneumophila relA mutants replicate as efficiently as WT within macrophages, other cues 
or regulators must contribute (Zusman et al., 2002).   
 Since Legionella persist in diverse environments, we postulated that signals other 
than amino acids also induce its differentiation.  Indeed, the L. pneumophila genome 
encodes SpoT, a second ppGpp synthetase that equips Escherichia coli to generate the 
alarmone in response to additional stresses, such as phosphate starvation or inhibition of 
fatty acid biosynthesis (Battesti and Bouveret, 2006; Gong et al., 2002; Magnusson et al., 
2005; Seyfzadeh et al., 1993; Zusman et al., 2002).  By screening hundreds of 
metabolites via phenotypic microarrays, and then applying a series of pharmacological, 
biochemical and genetic tests, we determined that, in response to perturbations in fatty 
acid biosynthesis, replicative L. pneumophila rely on SpoT to activate the stringent 
response pathway and coordinately express its transmissive traits, thereby coupling phase 




Bacterial strains, culture conditions and reagents.  L. pneumophila strain Lp02 (thyA 
hsdR rpsL; MB110), a virulent thymine auxotroph, was the parental strain for all mutants 
constructed (Berger and Isberg, 1993).  MB355 contains the pflaG plasmid that encodes 





promoter to gfp (Hammer and Swanson, 1999; Hammer et al., 2002).  MB414 contains 
letA-22 and MB417 encodes letS-36, mariner insertion alleles of lpg2646 and lpg1912, 
respectively, that confer resistance to kanamycin (Hammer et al., 2002).  Both MB414 
and MB417 contain the pflaG reporter plasmid.  To obtain letA and letS mutants lacking 
pflaG, the mutant alleles from MB414 and MB417 were transferred onto the Lp02 
chromosome by natural competence to generate MB413 and MB416, respectively 
(Hammer et al., 2002).  MB684 has a kanamycin cassette inserted into relA (lpg1457) 
and contains the pflaG reporter plasmid (Appendix A).  MB685 has a gentamicin cassette 
inserted into relA, a kanamycin cassette inserted into spoT (lpg2009), and carries the 
pflaG plasmid (Appendix A).   
 To construct a pta ackA2 (lpg2261 and lpg2262) deletion mutant, the 3.3 kb pta 
ackA2 locus was amplified from Lp02 genomic DNA using forward primer 5′-
GCAACTCGTATGCCATAC and reverse primer 5′-GTAAATCCATCGCTTTGGG.  
The PCR fragment was purified and ligated to pGEM-T (Promega), transformed into E. 
coli DH5α, and the resulting plasmid designated as pGEM-T-PtaAckA2 (MB619).  A 1.8 
kb region of the pta ackA2 open reading frame was removed by digestion with XmaI and 
NheI, and the remaining pGEM-T-PtaAckA2 fragment was blunted with Klenow and 
treated with Antarctic phosphatase (New England Biolabs).  The 1.3-kb kanamycin 
resistance cassette from pUC4K was removed via EcoRI digestion, blunted with Klenow 
and ligated into the digested pGEM-T-PtaAckA2 plasmid to create pGEM-T-
PtaAckA2::Kan (MB681).  After verification by PCR, the deletion/insertion alleles were 
transformed into Lp02 via natural competence and selected for by antibiotic resistance 
(Stone and Abu Kwaik, 1999).  The incorporation of the desired mutation into the Lp02 
background was confirmed by PCR and the resulting strain designated as MB641.  To 
monitor the induction of the flaA promoter by fluorometry, MB641 was transformed with 
pflaG.  Two independent isolates were tested and found similar in fluorometry assays; 





Bacteria were cultured at 37°C in 5 ml aliquots of N-(2-acetamido)-2-
aminoethanesulfonic acid (ACES; Sigma)-buffered yeast extract (AYE) broth and 
supplemented with 100 µg/ml thymidine when necessary.  For all experiments, 
exponential (E) cultures were defined as having an optical density at 600 nm (OD600) of 
0.5 to 0.85 and post-exponential (PE) cultures as having an OD600 of 3.4 to 4.5.  To 
obtain colony-forming units (CFU), L. pneumophila were plated on ACES-buffered 
charcoal-yeast extract agar supplemented with 100 µg/ml thymidine (CYET) and 
incubated at 37°C for 4-5 days.   
  
Biolog Phenotype MicroArray™ Analysis.  To discover novel compounds that induce L. 
pneumophila differentiation, Phenotype MicroArray™ (PM) plates were purchased from 
Biolog (San Diego).  The 96-well plates screened (PM1, PM2A, PM3B, PM4A and PM5) 
contained sources of carbon, nitrogen, sulfur, phosphorous and various nutrients.  100 µl 
of E phase MB355 cultured in AYE media was added to each well of the Biolog plates, 
and the plates were incubated at 37°C while shaking.  After 3 h, cultures were transferred 
to black, clear-bottom tissue culture plates (Costar), and the relative fluorescence 
intensity was quantified using a Synergy™ HT microplate reader (Bio-Tek).  The settings 
for fluorescence measurements were 485 nm excitation, 530 nm emission and sensitivity 
of 50.  To identify less potent triggers of L. pneumophila differentiation, the 
MicroArray™ plates were incubated for an additional 3 h and monitored for flaAgfp 
induction as described above.  Inducers were defined as having a 1.2-7.8 fold increase in 
fluorescence at 6 h when compared to the negative control well of the Biolog plates in at 
least 3 independent experiments.   
 
Fluorometry.  To monitor expression of the flagellin promoter, L. pneumophila strains 
containing the flaAgfp reporter plasmid pflaG were cultured in AYE media.  Cultures 





(tetradecyloxy)-2-furoic acid (TOFA; Cayman Chemical) when they reached OD600 = 
0.50-0.85 (T = 0).  L. pneumophila cultures supplemented with water or DMSO served as 
negative and vehicle controls, respectively.  At the times indicated, the cell density of 
each culture was measured as OD600.  To analyze similar bacterial concentrations, 
aliquots were collected by centrifugation, and the cell densities were normalized to OD600 
= 0.01 in PBS.  An aliquot of each sample (200 µL) was transferred to black 96-well 
plates (Costar), and the relative fluorescence intensity was measured using a Synergy™ 
HT microplate reader (485 nm excitation, 530 nm emission and sensitivity of 50).   
 
Macrophage cultures.  Macrophages were isolated from femurs of female A/J mice 
(Jackson Laboratory) and cultured in RPMI-1640 containing 10% heat-inactivated fetal 
bovine serum (RPMI/FBS; Gibco BRL) as described previously (Swanson and Isberg, 
1995).  Following a 7-day incubation in L-cell supernatant-conditioned media, 
macrophages were plated at either 5 × 104 or 2.5 × 105 per well for cytotoxicity and 
degradation assays, respectively.   
 
Cytotoxicity.  To measure contact-dependent cytotoxicity of L. pneumophila following 
macrophage infection, PE bacteria or E phase cultures supplemented with water or 10 
mM fatty acids for 3 h were added to macrophage monolayers at the indicated 
multiplicities of infection (MOI).  After centrifugation at 400 × g for 10 min at 4°C 
(Molofsky et al., 2005), the cells were incubated for 1 h at 37°C.  For quantification of 
macrophage viability, RPMI/FBS containing 10% alamarBlue™ (Trek Diagnostic 
Systems) was added to the monolayers for 6-12 h, and the reduction of the colorimetric 
dye was measured spectrophotometrically as described (Byrne and Swanson, 1998; 
Hammer and Swanson, 1999; Molofsky et al., 2005).  Each sample was analyzed in 






Lysosomal degradation.  The percentage of intracellular L. pneumophila that remained 
intact after a 2 h macrophage infection was quantified by fluorescence microscopy.  
Briefly, macrophages were plated at 2.5 × 105 onto coverslips in 24 well plates.  Then, PE 
bacteria or E phase microbes supplemented with either water or 10 mM fatty acids for 3 h 
were added to macrophage monolayers at an MOI ~ 1.  The cells were centrifuged at 400 
× g for 10 min at 4°C and then incubated for 2 h at 37°C.  Uninternalized bacteria were 
removed by washing the monolayers with RPMI/FBS three times, and the macrophages 
were fixed, permeabilized and stained for L. pneumophila as described (Molofsky et al., 
2005).  For each sample, duplicate coverslips were scored for intact rods versus degraded 
particles in three independent experiments (Bachman and Swanson, 2001; Molofsky and 
Swanson, 2003).   
 
Sodium sensitivity.  To calculate the percentage of L. pneumophila that are sensitive to 
sodium, PE bacteria or E cultures supplemented with either water or 10 mM fatty acids 
for 3 h were plated onto CYET and CYET containing 100 mM NaCl.  After a 6-day 
incubation at 37°C, CFUs were enumerated and the percentage of sodium sensitive 
microbes calculated as described (Byrne and Swanson, 1998).   
 
Analysis of L. pneumophila acyl-ACPs.  For purification of acyl-ACPs, WT L. 
pneumophila were cultured to the E phase at 37°C on an orbital shaker in 250 ml AYE 
containing 100 µg/ml thymidine.  Upon reaching an OD600 between 0.5-0.85, the cultures 
were supplemented with water, 10 mM fatty acid or 0.5 µg/ml cerulenin and then 
cultured for an additional 3 h at 37°C while shaking.  After the incubation period, cells 
were harvested by centrifugation at 4,000 × g for 20 min at 4°C, and the cell pellets were 
stored at -80°C.  The cells were thawed on ice, and the pellets were resuspended in 12.5 
ml ACP buffer (200 mM NaCl, 20 mM Tris-HCl, pH 6, 1 mM EDTA).  To prevent 





12.5 ml suspension.  Cells were lysed by sonication and the lysates cleared by 
centrifugation at 7,000 × g for 1 h at 4°C.  Sequence data predicts that L. pneumophila 
contains three ACPs ranging from 8.6-15.3 kDa.  Thus, large molecular weight proteins 
were easily removed from the lysates via 50K and 30K centrifugal filter devices (Amicon 
Ultra; Millipore).  The remaining ACP fractions were concentrated with 5K centrifugal 
filter devices, which also removed small molecular weight proteins and salts from the 
samples (Amicon Ultra; Millipore).  The protein concentration of each sample was 
determined using the Bio-Rad Protein Assay, and samples were stored at -20°C. To 
detect intracellular acyl-ACPs, purified L. pneumophila ACPs were separated on native 
polyacrylamide urea gels.  Briefly, 13% nondenaturing gels were prepared, and urea was 
added to either 0.5 M or 2.5 M for short chain fatty acid (SCFA) or long chain fatty acid 
(LCFA) gels, respectively (Jackowski and Rock, 1983; Post-Beittenmiller et al., 1991; 
Rock and Cronan, 1981).  After electrophoresis in 192 mM glycine, 25 mM Tris buffer, 
samples were transferred to polyvinylidene difluoride (PVDF) membrane (Bio-Rad), and 
the membranes blocked in TBS-T (20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.05% 
Tween 20) containing 5% nonfat milk.  To detect ACP proteins from L. pneumophila, the 
membranes were probed with an E. coli primary ACP antibody (gift from C. O. Rock, 
Memphis, TN) diluted 1:500 and a secondary goat anti-rabbit antibody conjugated to 
horseradish peroxidase (Pierce) diluted 1:8000 (Jackowski and Rock, 1983) and then 
developed with SuperSignal® West Pico Chemiluminescent Substrate (Pierce).   
 
Detection of ppGpp.  Accumulation of the ppGpp signaling molecule in response to flux 
in fatty acid metabolism was detected by thin-layer chromatography (TLC) as described 
(Cashel, 1969, 1994; Hammer and Swanson, 1999).  Briefly, E phase Lp02 cultures were 
diluted to an OD600 = 0.25 and labeled with approximately 100 µCi/ml carrier-free [32P]-
phosphoric acid (ICN Pharmaceuticals) for 6 h, or two generation times, at 37°C on a 





with water, 10 mM acetic acid, 10 mM propionic acid or 0.5 µg/ml cerulenin and 
incubated for an additional 1.5 h at 37°C.  For the PE control sample, 100 µCi/ml carrier-
free [32P]-phosphoric acid was added to late E phase Lp02, and the cultures incubated at 
37°C on a roller drum until reaching PE, or approximately 6 h.  To extract the 
nucleotides, 50 µl aliquots were removed from each culture and added to 13 M formic 
acid and then incubated on ice for 15 min.  Samples were subjected to two freeze-thaw 
cycles and stored at -80°C until chromatography.  Formic acid extracts (9 µL for PE 
samples and 25 µL for E samples) were applied to a PEI-cellulose TLC plate (20 × 20) 
and developed with 1.5 M KH2PO4, pH 3.4 as described (Cashel, 1969, 1994; Hammer 
and Swanson, 1999).  TLC plates were exposed to autoradiography film for 72 h and 
developed in a phosphoimager.  To monitor growth following water, fatty acid or 
cerulenin supplementation, optical densities were determined for non-radioactive cultures 




 Phenotype microarrays identify novel cues of L. pneumophila differentiation 
To discern whether a variety of signals trigger L. pneumophila differentiation, we 
employed Biolog Phenotype MicroArray™ plates to screen a library containing sources 
of carbon, nitrogen, sulfur and phosphorous.  Exponential (E) L. pneumophila carrying a 
gfp reporter for flagellin, a marker of transmissive bacteria, were cultured in the 
microarray plates, and the relative fluorescence was quantified over time.  Of the 387 
compounds screened, only 22 (6%) induced flaAgfp expression during the E phase of 
growth (Table 3.2).  Among these were deoxyadenosine, deoxyribose, 2-deoxy-D-
glucose-6-phosphate, dihydroxyacetone, nitrite, hydroxylamine, parabanic acid and 
methionine-alanine dipeptide.  However, the predominant class of compounds (12 of 22) 





acid all triggered flaAgfp expression.  Also eliciting a positive response were two 
detergents, Tween 20 and Tween 80; however, it is noteworthy that both detergents also 
contain carboxylic acid groups: lauric and oleic acids, respectively (Table 3.2).  High 
concentrations of formate, acetate, propionate and butyrate are known to inhibit the 
growth of many microorganisms (Meynell 1963 and Bohnhoff 1964), including L. 
pneumophila (Warren and Miller, 1979).  Moreover, acetate, propionate and butyrate 
regulate Salmonella typhimurium invasion gene expression in vitro at concentrations that 
correlate with their relative abundance in the intestinal tract (Lawhon et al., 2002).  
Therefore, we postulated that L. pneumophila monitors SCFAs to coordinate its life 
cycle.   
 
Excess short chain fatty acids inhibit L. pneumophila growth and induce motility 
To verify the results from the phenotypic microarrays, we performed quantitative 
assays with two SCFAs, acetic and propionic acid.  As predicted from the Biolog screen, 
when E cultures were treated with either 10 mM acetic or propionic acid, L. pneumophila 
immediately activated the flaA promoter (Fig. 3.1B and D) and stopped replicating (Fig. 
3.1A and C).  In contrast, control cultures supplemented with water did not induce the 
flaA promoter until 9 h, a time when L. pneumophila normally transitions to the post-
exponential (PE) phase (Fig. 3.1, circles).  Microscopic examination revealed that the 
SCFAs also induced motility (data not shown), as expected (Hammer and Swanson, 
1999).  The growth inhibition of L. pneumophila was not attributed to a loss in viability, 
as judged by the constant CFU of the cultures (data not shown).   
To determine whether the response by L. pneumophila to SCFAs was a 
consequence of alterations in pH, E bacteria were treated with two inorganic acids, 
hydrochloric or perchloric acid, and then monitored for growth and fluorescence.  When 
added to a range of concentrations (1.25-20 mM), neither hydrochloric nor perchloric 





also data not shown).  Moreover, the pH of Legionella cultures supplemented with acetic 
or propionic acid did not differ significantly from identical cultures supplemented with 
water, nor did the pH of the fatty acid-treated cultures vary detectably over the course of 
the experiment (data not shown).  Finally, when E cultures were supplemented with non-
acidic forms of acetate, namely calcium acetate or magnesium acetate, L. pneumophila 
replication halted, and the bacteria activated the flagellin promoter to a level similar to 
that displayed after acetic acid addition (data not shown).  Therefore, L. pneumophila 
appear to respond to a signal generated by SCFAs that is distinct from pH.   
 
Fatty acid supplementation stimulates L. pneumophila differentiation 
Since both acetic and propionic acid induced motility and inhibited bacterial 
replication, we next investigated whether the SCFAs also trigger other L. pneumophila 
transmissive phase phenotypes, including cytotoxicity to phagocytic cells, the avoidance 
of lysosomal degradation and sodium sensitivity (Byrne and Swanson, 1998).  Indeed, 
after supplementation with either acetic or propionic acid, E phase L. pneumophila 
became as cytotoxic to bone marrow-derived macrophages as PE control cultures (Fig. 
3.2A).  Importantly, SCFAs alone were not cytotoxic (Table 3, letA and letS mutants; also 
data not shown).  Further, when E phase L. pneumophila were supplemented with 
SCFAs, the majority of the bacteria also acquired the capacity to evade lysosomes, as 
judged by immunofluorescence microscopy (Fig. 3.2B).  Although only 15% of E phase 
L. pneumophila avoided degradation (Fig 3.2B, water sample), greater than 50% of those 
exposed to acetic or propionic acid escaped the lysosomal compartment (Fig. 3.2B).  
Finally, 10 mM acetic or propionic acid also triggered sodium sensitivity in E phase 
microbes (Fig. 3.2C).  Thus, our Biolog screen accurately predicted that exposure to 10 
mM SCFAs induces L. pneumophila differentiation to the transmissive phenotype.  





generate high-energy intermediates that affect two-component phosphorelay systems or 
instead alter fatty acid metabolism.   
 
To respond to fatty acids, L. pneumophila requires the LetA/LetS two-component system, 
but not generation of acetyl-phosphate and propionyl-phosphate 
At the crux of L. pneumophila’s differentiation circuitry is the two-component 
system LetA/LetS, which regulates all known transmissive phase phenotypes (Lynch et 
al., 2003).  To discern whether the response of L. pneumophila to the SCFAs is 
dependent on the signal transduction system, we cultured letA and letS mutants 
containing the flaAgfp reporter construct to the E phase, supplemented the cultures with 
10 mM acetic or propionic acid, and then monitored both optical density and fluorescence 
of the cultures over time.  When confronted with SCFAs, the letA and letS mutants 
resembled wild-type (WT) L. pneumophila in restricting their growth (Table 3.3).  In 
contrast, L. pneumophila required the LetA/LetS system to induce flagellin expression in 
response to 10 mM acetic acid (Fig. 3.3A); albeit to a lesser degree, LetA/LetS also 
mediated the response to propionic acid, a SCFA that exerts a stronger effect on the 
flagellin promoter (Fig. 3.3B).  Furthermore, microscopic examination demonstrated that 
L. pneumophila requires LetA/LetS to trigger motility in response to either 10 mM acetic 
or propionic acid (Table 3.3).  Likewise, the two-component system was required for 
expression of three other transmissive traits: cytotoxicity, lysosome avoidance, and 
sodium sensitivity (Table 3.3).  Therefore, when L. pneumophila encounters a sudden 
increase in SCFAs, a pathway that includes the LetA/LetS phosphorelay coordinates 
bacterial differentiation.   
The response regulators of many two-component systems can use the high-energy 
intermediates acetyl-phosphate and propionyl-phosphate to catalyze their own 
phosphorylation (Wolfe, 2005).  For example, acetyl-phosphate stimulates the S. 





2002) and also activates the Bordetella pertussis BvgA response regulator independently 
of its cognate histidine kinase (Boucher et al., 1994).  Therefore, we tested whether 
exogenous acetic or propionic acid must be converted to acetyl- and propionyl-phosphate 
before activating the LetA/LetS signal transduction system.  For this purpose, we 
constructed and analyzed a L. pneumophila mutant that lacks the two enzymes that 
synthesize the phosphate intermediates, phosphotransacetylase and acetyl kinase, 
encoded by the pta and acka2 genes, respectively (McCleary et al., 1993; Wolfe, 2005).  
By monitoring the induction of the flagellin promoter, it was evident that both the 
phosphotransacetylase and acetyl kinase enzymes were dispensable for L. pneumophila to 
differentiate when confronted by excess acetic or propionic acid (Fig. 3.4).  Thus, SCFAs 
trigger L. pneumophila differentiation by a mechanism other than generating acetyl- and 
propionyl-phosphate intermediates that activate the LetA/LetS system.   
When fatty acid biosynthesis is inhibited, a physical interaction between acyl 
carrier protein (ACP) and SpoT enables E. coli to enter stationary phase (Battesti and 
Bouveret, 2006).  The stringent response alarmone ppGpp also coordinates L. 
pneumophila differentiation (Hammer and Swanson, 1999).  Therefore, we investigated 
whether L. pneumophila monitors fatty acid metabolism to govern its life cycle.   
 
Perturbations in fatty acid biosynthesis trigger L. pneumophila differentiation 
The degradation and biosynthetic pathways of fatty acid metabolism are tightly 
controlled, as their simultaneous activation would be futile.  The point of regulation lies 
in the irreversible conversion of acetyl-CoA to malonyl-CoA, which is governed by the 
acetyl-CoA carboxylase complex (ACC) (Magnuson et al., 1993).  In mammalian cells, 
the inhibitor 5-(tetradecyloxy)-2-furoic acid (TOFA) blocks the ACC complex and 
prevents acetate from being incorporated into fatty acids (McCune and Harris, 1979; 
Panek et al., 1977).  Accordingly, malonyl-CoA levels in the cell are significantly 





1979).  Therefore, to begin to test the hypothesis that SCFA supplements impinge upon 
either fatty acid degradation or biosynthesis, we first investigated whether acetic and 
propionic acid still trigger L. pneumophila differentiation when the conversion of acetyl-
CoA to malonyl-CoA is blocked by TOFA.  As expected, E cultures supplemented with 
10 mM acetic or propionic acid prematurely activated the flagellin promoter (Fig. 3.5B 
and C).  However, when cultures were simultaneously supplemented with SCFAs and 
TOFA, which is predicted to inhibit ACC, the bacteria did not differentiate (Fig. 3.5B and 
C).  When treated with TOFA alone, L. pneumophila growth was restricted (data not 
shown) but viability was maintained, as the number of CFU was similar between 0 and 
24 h after TOFA treatment (data not shown).  Since activity of the ACC complex was 
required for SCFAs to initiate L. pneumophila differentiation, we deduced that addition 
of 10 mM acetic or propionic acid likely affects the fatty acid biosynthetic pathway.   
 As an independent test of the model that perturbations in fatty acid biosynthesis 
trigger L. pneumophila differentiation, we exploited the antibiotic cerulenin, which 
irreversibly blocks two key fatty acid enzymes, FabB and FabF (Buttke and Ingram, 
1978; Ulrich et al., 1983; Vance et al., 1972).  As with TOFA, cerulenin treatment 
inhibits fatty acid biosynthesis.  However, rather than depleting malonyl-CoA 
concentrations, cerulenin causes malonyl-CoA to accumulate in the cell (Heath and Rock, 
1995).  When WT L. pneumophila was cultured to the E phase and supplemented with 
0.5 µg/ml cerulenin, bacterial replication stopped (data not shown), and the flaA promoter 
was activated (Fig. 3.5D).  Similar to propionic acid (Fig. 3.3B), the response to cerulenin 
was partially dependent on the LetA/LetS two-component system (data not shown).   
In eukaryotic cells, the simultaneous addition of cerulenin and TOFA decreases 
malonyl-CoA levels and blocks fatty acid biosynthesis (Pizer et al., 2000).  Therefore, to 
test the prediction that TOFA also negates the effect of cerulenin on prokaryotic cells, we 
treated E phase L. pneumophila with both inhibitors and then monitored flagellin 





promoter, a marker of the transmissive phase (Fig. 3.5E), cultures treated with both 
cerulenin and TOFA did not differentiate (Fig. 3.5E).  Taken together, the effects of both 
SCFA supplementation and the pharmacological inhibitors of particular fatty acid 
biosynthetic enzymes indicate that, when fatty acid biosynthesis is disrupted, L. 
pneumophila responds by differentiating to the transmissive phase.   
 
Short chain fatty acid supplementation alters the L. pneumophila profile of acylated acyl 
carrier proteins   
A critical component of fatty acid and lipid biosynthesis is ACP.  This small, 
acidic protein is post-translationally modified by a 4´-phosphopantetheine group, which 
enables fatty acid intermediates to bind to the holo-protein through a thioester linkage 
(Magnuson et al., 1993).  Once modified, holo-ACP carries the growing fatty acid chain 
through successive rounds of fatty acid biosynthesis, elongating the fatty acid each cycle.  
To ascertain by a biochemical approach whether SCFA supplementation alters the fatty 
acid biosynthetic pathway, we analyzed L. pneumophila acyl-ACP pools by western 
analysis after their separation through native polyacrylamide gels designed either for 
SCFAs or long chain fatty acids (Post-Beittenmiller et al., 1991; Rock and Cronan, 
1981).   
When E cultures were supplemented with 10 mM acetic or propionic acid for 3 h, 
the profiles of the acyl-ACPs were significantly different than identical cultures 
supplemented with water (Fig. 3.6).  In fact, cultures treated with the SCFAs resembled 
the PE control, as similar ACP bands were depleted in each of the samples.  Likewise, 
when cultures were supplemented with cerulenin, the ACP pools differed greatly from 
the water control and instead showed a substantial depletion in a majority of the ACP 
species (Fig. 3.6).  Therefore, these biochemical data lend further support to the model 






Alterations in the fatty acid biosynthetic pathway stimulates the stringent response 
Many microbes produce ppGpp to adapt to nutritional and metabolic stresses such 
as deprivation of amino acids, carbon, iron, phosphorous and fatty acids (Srivatsan and 
Wang, 2008).  Moreover, a regulatory role for ACP in the stringent response has recently 
been described:  SpoT directly interacts with the functional form of ACP, and single 
amino acid substitutions that disrupt this interaction abrogates SpoT-dependent ppGpp 
accumulation when fatty acid biosynthesis is inhibited (Battesti and Bouveret, 2006).  
Accordingly, it has been suggested that SpoT senses an intermediate in fatty acid 
biosynthesis to trigger ppGpp accumulation in the cell (Battesti and Bouveret, 2006; 
DiRusso and Nystrom, 1998).   
To ascertain whether WT L. pneumophila accumulates ppGpp in response to 
perturbations in fatty acid biosynthesis, nucleotide pools were labeled with 32P during E 
phase growth, and then cultures were supplemented with water, acetic acid, propionic 
acid, or cerulenin for 1.5 h.  Indeed, E cultures supplemented with propionic acid 
accumulated modest levels of ppGpp when compared to background levels of the 
alarmone in the water control (Fig. 3.7A).  As expected from our phenotypic data 
(relative fluorescence in Fig. 3.1B and D), 10 mM acetic acid resulted in only trace levels 
of ppGpp, similar to the water control (Fig. 3.7A).  Furthermore, when E cultures were 
treated with cerulenin, L. pneumophila produced detectable levels of the ppGpp 
alarmone, indicating that the stringent response pathway is induced when fatty acid 
biosynthesis is inhibited (Fig. 3.7A).   
 To test genetically whether L. pneumophila differentiation in response to 
perturbations in fatty acid biosynthesis was coordinated by ppGpp, we analyzed whether 
either the RelA or SpoT enzymes were required for the bacterial response to SCFAs.  
When E cultures were supplemented with either 10 mM acetic or propionic acid, relA 
mutant L. pneumophila differentiated, similar to WT (Fig. 3.7B and C).  In contrast, relA 





acids (Fig. 3.7B and C).  Together, these data suggest that, when L. pneumophila 
encounter excess SCFAs, SpoT equips the bacteria to invoke the stringent response 
pathway to elicit swift changes in gene expression and rapidly adapt to metabolic stress.   
 
Discussion 
 Since L. pneumophila persist within many different environments, we predicted 
that various metabolites cue its differentiation.  To identify such metabolic triggers, we 
screened several hundred compounds via phenotype microarrays.  Out of 387 compounds 
tested, only 22 triggered the premature transition from the replicative to the transmissive 
phase, with the majority being carboxylic acids (Table 3.2).  Importantly, several of the 
compounds that elicited a positive response in the screen were independently verified to 
induce other transmissive phenotypes (Fig. 3.2, Table 3.3 and data not shown).  Previous 
studies postulated that when amino acid concentrations are limited, uncharged tRNAs 
accumulate and the RelA enzyme synthesizes ppGpp, an alarmone that activates the 
regulatory cascade that governs L. pneumophila differentiation (Hammer and Swanson, 
1999; Zusman et al., 2002).  Here we expand this paradigm by showing that ppGpp also 
accumulates when fatty acid biosynthesis is perturbed, perhaps due to a direct interaction 
between SpoT and ACP (Battesti and Bouveret, 2006).  Indeed, preliminary genetic data 
indicate that when SpoT can no longer interact with ACP, L. pneumophila fails to 
differentiate in response to alterations in fatty acid biosynthesis (Appendix A).  Thus, the 
stringent response machinery equips L. pneumophila to monitor both protein and fatty 
acid biosynthesis to judge when to exit one host and search for another.   
 Although the mechanism by which L. pneumophila detects fluctuations in fatty 
acid biosynthesis remains to be elucidated, it has been suggested that SpoT equips E. coli 
to sense either an accumulation or a depletion of an intermediate in this biosynthetic 
pathway (Battesti and Bouveret, 2006; DiRusso and Nystrom, 1998).  Recent work with 





molecule that may act as a signal during stress and starvation (Schujman et al., 2008).  
Similarly, our data using inhibitors of fatty acid biosynthesis indicate that malonyl-CoA 
levels may cue the phenotypic switch from the replicative to the transmissive form.  E 
phase L. pneumophila immediately induce the flaAgfp reporter when treated with 
cerulenin, an inhibitor of fatty acid biosynthesis that causes malonyl-CoA to accumulate 
(Heath and Rock, 1995).  Conversely, TOFA, which is predicted to deplete the levels of 
malonyl-CoA present in the cell, does not stimulate E phase L. pneumophila to activate 
the flaA promoter (Cook et al., 1978; McCune and Harris, 1979).  Therefore, L. 
pneumophila may monitor the levels of malonyl-CoA in the cell to regulate its 
phenotypic switch.   
 Alternatively, L. pneumophila may monitor the acyl chains attached to ACP.  For 
example, the bacteria may recognize when acyl-ACPs levels are sparse or their ratio is 
altered, thereby leading to an accumulation or a depletion in one or more of the acyl-ACP 
species.  Indeed, when E phase L. pneumophila were treated with either excess SCFAs or 
cerulenin, the acyl-ACPs in the cell were significantly depleted, as determined by western 
analysis (Fig. 3.6).  Thus, L. pneumophila may monitor the depletion in acyl-ACPs via a 
SpoT-ACP interaction, which enables the cell to swiftly produce ppGpp when deemed 
appropriate.  Since studies in E. coli suggest that fatty acid biosynthesis contains 
numerous intermediate compounds, more detailed studies are needed to determine which, 
if any, of the intermediates can trigger L. pneumophila differentiation.  Furthermore, 
sequence data predict that L. pneumophila contains three ACPs (lpg0359, lpg1396 and 
lpg2233) which each contain the critical serine residue that is likely modified by a 4'-
phosphopantetheine moiety (Magnuson et al., 1993).  Our data do not address which 
ACP(s) are involved, as the specificity of the ACP antibody has not been determined 
(Fig. 3.6).  Therefore, whether these ACPs are functionally redundant or whether each 





 We propose that by coupling the stringent response to fatty acid metabolism L. 
pneumophila can quickly alter its transcriptional profile.  One important observation was 
that the levels of ppGpp observed in response to SCFAs and cerulenin was significantly 
less than that of PE bacteria (Fig. 3.7A).  This is consistent with the previous report that 
E. coli produces low levels of ppGpp in response to fatty acid starvation (Seyfzadeh et 
al., 1993).  The low levels of ppGpp we observed also likely reflect our labeling 
conditions:  Due to the fastidious nature of L. pneumophila, a phosphate-limited media, 
such as that used to label nucleotides efficiently in E. coli (Seyfzadeh et al., 1993), was 
not a viable option for these studies.  Nevertheless, since every PE trait is induced when 
E phase L. pneumophila are treated with excess SCFAs or cerulenin, even the modest 
level of ppGpp detected in the cell is sufficient to trigger differentiation (Fig. 3.2, Table 
3.3).  By analogy to E. coli, we favor a model by which sigma factor competition enables 
L. pneumophila to fine-tune its gene expression profile (Magnusson et al., 2005).  
Perhaps when fatty acid biosynthesis is altered, the quantity of ppGpp produced by L. 
pneumophila is sufficient to recruit the appropriate cohort of its six alternative sigma 
factors to RNAP, thereby specifically inducing the PE traits necessary to promote host 
transmission and survival in the extracellular environment (Cazalet et al., 2004; Chien et 
al., 2004).   
 Compared with acetic acid, excess propionic acid consistently induced more 
robust flaA expression by L. pneumophila (Fig. 3.1B and D).  In the same vein, propionic 
acid appeared to have a less stringent requirement for the LetA/LetS system than acetic 
acid did (Fig. 3.3).  Nevertheless, when letA and letS mutants were treated with excess 
acetic or propionic acid, the mutants were equally defective for the early induction of PE 
phenotypes (Table 3.3).  And, although letA and letS mutants treated with SCFAs were 
unable to trigger motility, cytotoxicity, lysosomal degradation or sodium sensitivity, the 





bacteria similarly.  On the other hand, growth inhibition in L. pneumophila occurs by a 
LetA/LetS independent mechanism that remains to be delineated.   
 While our in vitro data indicate that L. pneumophila monitors perturbations in 
fatty acid biosynthesis to regulate its differentiation, it is not known whether SCFAs also 
cue bacterial differentiation within the vacuolar compartment of phagocytic cells, as the 
composition of the Legionella-containing vacuole in freshwater protozoa and alveolar 
macrophages has yet to be elucidated.  Although broth studies predict that L. 
pneumophila utilizes relA to produce ppGpp when amino acid supplies are exhausted, 
relA is dispensable for intracellular growth in both human macrophages and amoebae 
(Hammer and Swanson, 1999; Zusman et al., 2002).  In contrast, intracellular L. 
pneumophila do require SpoT to differentiate from the replicative to the transmissive 
phase and to initiate secondary infections in bone marrow-derived mouse macrophages 
(Appendix A).  Therefore, L. pneumophila employs SpoT to monitor either fatty acids or 
other metabolites in the vacuolar compartment to regulate its differentiation and 
virulence.   
There are several ways in which L. pneumophila could encounter alterations in 
the fatty acids that are present in its intracellular niche.  For example, when the TCA 
cycle does not operate completely or when bacterial cells are flooded with excess carbon, 
microbes will excrete acetate into their extracellular milieu, a process known as 
acetogenesis (Wolfe, 2005).  Perhaps when nutrients are abundant during the replicative 
phase, L. pneumophila excretes excess carbon as SCFAs, which accumulate in the 
vacuolar compartment.  Upon reaching a certain threshold, the high concentrations of 
SCFAs present in the vacuole could serve as a signal for differentiation, escape, and 
subsequent host transmission.  L. pneumophila also possesses lipolytic enzymes that may 
degrade either host or their own membranes to generate free fatty acids.  When starved 
for essential nutrients, some bacteria do degrade phospholipids within their own cell 





pneumophila may monitor external sources of fatty acids that are derived from the host 
plasma or phagosomal membranes.  Consistent with this idea, within mouse macrophages 
L. pneumophila replicate within a lysosomal compartment (Sturgill-Koszycki and 
Swanson, 2000), the site for membrane degradation.  Interestingly, alveolar macrophages 
can phagocytose pulmonary surfactant, which is rich in phosphatidylcholine, 
phosphatidylglycerol and palmitic acid (Grabner and Meerbach, 1991), and L. 
pneumophila can use a secreted phospholipase A enzyme to deplete phosphatidylcholine 
and phosphatidylglycerol from lung surfactant to release free fatty acids (Flieger et al., 
2000).  By this scenario, the accidental human host may in fact exacerbate the infection 
process by stimulating synthesis of flagellin, which in turn provokes an inflammatory cell 
death pathway by macrophages (Molofsky et al., 2005; Molofsky et al., 2006; Ren et al., 
2006).   
Due to limitations of our Biolog screen, we cannot rule out the possibility that 
additional metabolites present on the arrays also cue intracellular differentiation of L. 
pneumophila.  Since the permeability of the L. pneumophila membrane for each of the 
compounds on the phenotypic microarrays is unknown, we cannot exclude the possibility 
that some compounds were unable to cross the cell membrane.  Furthermore, titration 
curves indicate that the inducers may only trigger differentiation within a narrow 
concentration range (data not shown).  In particular, in E phase L. pneumophila, the 
SCFAs induce flaAgfp expression only when present between 5-10 mM (data not shown).  
Since the phenotype microarrays have only one concentration of each compound on the 
plate, we cannot rule out that additional inducers of L. pneumophila differentiation might 
exist.  Indeed, nicotinic acid, which is present on Biolog plate PM5 at 10 µM, did not 
cause growth restriction or induction of the flaAgfp reporter.  However, both genomic 
microarray and phenotypic data indicate that 5 mM nicotinic acid triggers L. 





 Since person-to-person transmission of L. pneumophila has never been 
documented, the capacity of L. pneumophila to mount a productive infection stems from 
its remarkable ability to exploit physiological and metabolic pathways that operate within 
both professional phagocytes and amoebae.  In particular, L. pneumophila has evolved a 
mechanism to monitor fatty acid biosynthesis and use this information to regulate 
expression of its transmission traits, thereby enhancing its fitness when confronted by 






Table 3.1.  Bacterial strains and plasmids 
 
Strain or Plasmid Relevant genotype/phenotype Reference or Source 
   
Strains   
   E. coli  
     DH5α 
 
F– endA1 hsdR17 (r– m+) supE44 thi-l recA1 gryA (Nal1) 
relA1 ∆ (lacZYA-argF–)U169 φ80dlacZ∆M15 λpirRK6 
 
  Laboratory collection 
     MB619 DH5α pGEM-T-PtaAckA2   This work 
     MB681 DH5α pGEM-T-PtaAckA2::Kan   This work 
   L. pneumophila 
     MB110 
 
wild type; thyA hsdR rpsL 
 
  (Berger and Isberg, 
1993) 
     MB355 pflaG   (Hammer and Swanson, 
1999) 
     MB413 letA-22::kan   (Hammer et al., 2002) 
     MB414 letA-22::kan pflaG   (Hammer et al., 2002) 
     MB416 letS-36::kan   (Hammer et al., 2002) 
     MB417 letS-36::kan pflaG   (Hammer et al., 2002) 
     MB641 pta ackA2::kan   This work 
     MB682 pta ackA2::kan pflaG   This work 
     MB684 relA::kan pflaG   Appendix A 
     MB685 relA::gent spoT::kan pflaG   Appendix A 
Plasmids   
     pGEM-T Multiple cloning site within coding region of β-
lactamase α fragment linearized with single-T 
overhangs; 3 kb; AmpR 
  Promega 
     pflaG 150 bp flaA promoter fragment fused to GFP, encodes 
thymidylate synthetase; 10.5 kb; AmpR 
  (Hammer and Swanson, 
1999) 
     pGEM-T-PtaAckA2 pGEM-T containing 3.3 kb pta ackA2 locus PCR 
amplified from Lp02 chromosome and ligated into T 
overhangs; 6.3 kb; AmpR 
  This work 
     pUC4K pUC4 containing 1.3 kb kanamycin cassette   Pharmacia 
     pGEM-T-    
     PtaAckA2::Kan 
pGEM-T-PtaAckA2 with 1.3 kb kanamycin cassette 
inserted between XmaI and NheI sites in the pta ackA2 
ORF resulting in a 1.8 kb deletion 
 







Table 3.2.  Compounds that trigger premature differentiation in L. pneumophila 
 
 
Compound* Biolog Plate 
Carboxylic Acids  
     Formic acid PM1 
     Acetic acid PM1 
     Propionic acid PM1 
     Butyric acid PM2A 
     α-Ketovaleric acid PM2A 
     Caproic acid PM2A 
     Itaconic acid PM2A 
     Sorbic acid PM2A 
     4-hydroxybenzoic acid PM2A 
     m-hydroxy phenyl acetic acid PM1 
     p-hydroxy phenyl acetic acid PM1 
     Monomethyl succinate PM1 
Detergents  
     Polyoxyethylene sorbitan monolaurate      
          (Tween 20) 
PM5 
     Polyoxyethylene sorbitan monooleate  
          (Tween 80) 
PM1 
Other  
     2-Deoxy D glucose-6-phosphate PM4A 
     Deoxyadenosine PM1 
     Deoxyribose PM2A 
     Dihydroxyacetone PM2A 
     Hydroxylamine PM3B 
     Met-Ala dipeptide PM3B 
     Nitrite PM3B 
     Parabanic acid PM3B 
 
                          *Approximate concentrations: carbon sources 5-20 mM, nitrogen  




































Figure 3.1.  Growth inhibition and the premature expression of motility are specific 
to fatty acid addition.   
WT L. pneumophila carrying the flaAgfp reporter construct were cultured to the E phase 
and then supplemented with water or 10 mM acid.  At the times indicated, samples were 
collected and optical density and relative fluorescence were analyzed.  The addition of 
acetic acid (AA; closed squares) or propionic acid (PA; closed triangles) causes growth 
inhibition (A, C, E) and early motility (B, D, F), whereas cultures supplemented with 
hydrochloric acid (HCl; open squares) or perchloric acid (HClO4; open triangles) do not 
(E and F).  For all experiments, E cultures supplemented with water (H2O; closed 
circles), which enter the PE phase around 9 h, served as a negative control.  Shown are 































Figure 3.2.  Fatty acid supplementation of WT L. pneumophila induces the early 
expression of multiple transmissive phase phenotypes.   
(A)  Macrophage viability was assessed by quantifying the reduction of the colorimetric 
dye alamarBlue™ following a 1 h incubation of macrophages with PE cultures 
(diamonds) or E cultures supplemented with water (circles), acetic acid (squares) or 
propionic acid (triangles).  Shown is a representative graph from three independent 
experiments preformed in triplicate.  (B)  Lysosome evasion was determined by culturing 
L. pneumophila strains with macrophages at an MOI = 1 and quantifying the percent of 
intact bacteria following a 2-hour incubation by fluorescence microscopy.  Displayed are 
the means from duplicate samples in three independent experiments.  Error bars indicate 
SD and asterisks designate significant differences (P<0.01) when compared to water 
control.  (C)  The percent of sodium resistant bacteria was measured by plating cultures 
on media with or without 100 mM NaCl and then calculated as described (Byrne and 
Swanson, 1998).  Shown are the means ± SD from duplicate samples in three 
independent experiments.  Asterisks denote statistically significant differences (P<0.01) 







Figure 3.3.  The LetA/LetS signal transduction system is required for full induction 
of premature motility.   
WT (circles), letA (triangles) or letS (squares) L. pneumophila containing the flaAgfp 
reporter were grown to the E phase and then supplemented with water (closed symbols), 
10 mM acetic acid (open symbols; Fig. 3.3A) or 10 mM propionic acid (open symbols; 
Fig. 3.3B).  Samples were collected and analyzed for fluorescence at the times indicated.  






Table 3.3.  Phenotypic response of letA and letS mutants 3 hours after fatty acid 
supplementation.   
 
 
a. Growth of L. pneumophila was monitored by measuring the OD600 of the cultures 3 h 
after supplementation.  Although letA and letS cultures supplemented with fatty acids do 
not display PE phenotypes, bacterial growth is completely inhibited.  Data represent at 
least three independent experiments.   
b. Motility was assessed by phase-contrast microscopy and is based on numerous 
independent trials.  (-) indicates cultures that were <10% motile, (+) indicates 10-25% 
motility, (++) indicates 25-75% motility, and (+++) indicates high levels of directed 
motility (>75%).   
c. Cytotoxicity of L. pneumophila for macrophages was measured as described in Fig. 2.  
(+) indicates >50% of the macrophages were viable following incubation with bacteria at 
MOIs ranging from 0-20, whereas (-) represents <50% macrophage viability.  Data 
reported are from three independent experiments performed in triplicate.   
d. The percent of bacteria that remain intact following a 2 h incubation within 
macrophages was determined as in Fig. 2.  (+) indicates that >50% of the bacteria 
avoided lysosomal degradation, and (-) indicates that the number of bacteria remaining 
intact at 2 h did not significantly differ from exponential cultures supplemented with 
water (negative control).  Data represent the mean ± SD from duplicate samples in three 
independent experiments.   
e. The percent of sodium resistant bacteria was determined as described in Fig 2.  The 
values represent the mean ± SD for three independent experiments performed in 
duplicate.   
 











       Wild-type PE control + +++ + + + 
 E + H2O – – – – – 
 E + Acetic acid + ++ + + + 
 E + Propionic acid + ++ + + + 
       
letA PE control + – – – – 
 E + H2O – – – – – 
 E + Acetic acid + – – – – 
 E + Propionic acid + – – – – 
       
letS PE control + – – – – 
 E + H2O – – – – – 
 E + Acetic acid + – – – – 
 E + Propionic acid + – – – – 









Figure 3.4.  Induction of motility by fatty acid addition is independent of pta ackA2.   
Broth cultures of WT (closed symbols) or pta ackA2 (open symbols) L. pneumophila 
containing pflaG were grown to the E phase and then supplemented with water (H2O) 
(circles), 10 mM acetic acid (AA) (squares; Fig. 3.4A), or 10 mM propionic acid (PA) 
(triangles; Fig. 3.4B).  Samples were taken at 3 h intervals and their relative fluorescence 
assessed by fluorometry.  Displayed are representative graphs from three independent 


















Figure 3.5.  Alterations in fatty acid biosynthesis induce L. pneumophila 
differentiation.   
(A)  Schematic of fatty acid metabolism indicating where TOFA and cerulenin inhibitors 
act.  (B and C)  Inhibition of the conversion of acetyl-CoA to malonyl-CoA abrogates the 
early differentiation that is triggered by fatty acid supplementation.  E cultures containing 
pflaG were supplemented with either 10 mM acetic acid (AA; squares; Fig 3.5A) or 10 
mM propionic acid (PA; triangles, Fig. 3.5B) with (open shapes) or without (closed 
shapes) the acetyl-CoA carboxylase inhibitor TOFA (5 µg/ml), and the fluorescence was 
monitored over time.  Identical cultures supplemented with water (closed circles) or 
DMSO (vehicle control, data not shown) were analyzed as controls.  Displayed are 
representative graphs from three independent experiments.  (D)  Inhibition of fatty acid 
biosynthesis stimulates early differentiation.  E cultures of WT L. pneumophila carrying 
the flaAgfp plasmid were supplemented with the fatty acid biosynthesis inhibitor, 
cerulenin (Cer, 0.5 µg/ml; open circles), and the relative fluorescence monitored over 
time.  Identical cultures supplemented with DMSO (closed circles) served as vehicle 
controls.  A representative graph from three independent experiments is shown.  (E)  
TOFA negates L. pneumophila differentiation triggered by cerulenin.  WT Legionella 
containing pflaG were cultured to the E phase and then supplemented with cerulenin 
(Cer; closed squares) or cerulenin plus TOFA (open squares).  Identical cultures treated 
with water (H2O; closed circles) or TOFA alone (open circles) are shown as controls.  
























Figure 3.6.  Perturbations in fatty acid biosynthesis alter L. pneumophila acyl-ACP 
profiles.   
E phase L. pneumophila were incubated with water (H2O), acetic acid (AA), propionic 
acid (PA), or cerulenin (Cer) for 3 h, then acyl-ACPs were extracted, purified and 
separated on 13% short chain fatty acid (A) or 13% long chain fatty acid (B) native 
polyacrylamide gels.  ACP species were detected by western blotting.  Arrows denote 
protein bands that differ between the E control and the treatment samples.  Also shown 
are acyl-ACP pools from PE bacteria.  Representative films from three independent 








Figure 3.7.  L. pneumophila employs the stringent response to induce differentiation 
when fatty acid biosynthesis is altered.   
(A)  Addition of fatty acids triggers ppGpp production in the E phase.  After labeling 
nucleotide pools with 32P, E cultures of WT L. pneumophila were supplemented with 
water, 10 mM SCFAs or 0.5 µg/ml cerulenin for 1.5 h to stimulate ppGpp synthesis.  
Extracts were prepared and nucleotides separated by TLC.  For the PE control, late E 
phase cultures were labeled with 32P until reaching the PE phase (approximately 6 h).  
Cell extracts and TLC were performed similar to E cultures.  Representative 
chromatograms from two or more independent experiments are shown for each condition.  
(B and C)  L. pneumophila requires SpoT to sense SCFAs.  WT (circles), relA (triangles) 
or relA spoT (squares) L. pneumophila containing the flaAgfp reporter were cultured to 
the E phase and then supplemented with water (closed symbols), 10 mM acetic acid 
(open symbols; Fig. 3.7B) or 10 mM propionic acid (open symbols; Fig. 3.7C).  At the 
times indicated, aliquots of the cultures were analyzed for fluorescence.  Representative 










Figure 3.8.  L. pneumophila monitors flux in fatty acid biosynthesis to coordinate 







NICOTINIC ACID MODULATES LEGIONELLA PNEUMOPHILA GENE 
EXPRESSION AND VIRULENCE PHENOTYPES 
 
Summary 
 When bacteria encounter various environmental fluctuations or stresses, they can 
activate transcriptional and phenotypic programs to coordinate an appropriate response.  
Indeed, the intracellular pathogen Legionella pneumophila converts from a non-infectious 
replicative form to an infectious transmissive form when the bacterium encounters 
alterations in either amino acid concentrations or fatty acid biosynthesis.  Here we report 
that nicotinic acid (NA) also triggers L. pneumophila phase differentiation.  In particular, 
when replicative L. pneumophila are supplemented with 5 mM NA, the bacteria induce 
numerous transmissive phase phenotypes, including motility, cytotoxicity towards 
macrophages, sodium sensitivity and lysosome avoidance.  Moreover, transcriptional 
profile analysis determined that NA regulates a panel of genes similar to transmissive 
phase L. pneumophila.  In addition, NA alters the expression of 246 genes that were 
unique for NA supplementation.  While nearly 25% of these genes lack an assigned 
function, the most highly expressed gene following NA treatment is predicted to encode a 
membrane transporter.  Since Bordetella and E. coli also differentiate in response to NA, 
knowledge of NA regulation by L. pneumophila will shed light on the mode of action and 






 Normally found in fresh water systems as a parasite of protozoa, Legionella 
pneumophila can also infect alveolar macrophages to cause the life-threatening 
pneumonia, Legionnaires’ disease.  Moreover, in aquatic environments L. pneumophila 
can exist as either a planktonic cell or persist within a sessile biofilm community.  To 
survive within these diverse ecological niches, L. pneumophila has evolved methods to 
swiftly adapt to changing conditions by modifying its cellular physiology and 
morphology in a process known as differentiation.  Under nutrient rich conditions, the 
post-transcriptional regulator CsrA suppresses transmissive traits and activates regulatory 
pathways that enable robust replication (Fettes et al., 2001; Molofsky and Swanson, 
2003).  Once conditions deteriorate, proliferation halts and L. pneumophila initiates the 
stringent response to synthesize the second messenger, ppGpp (Hammer and Swanson, 
1999; Zusman et al., 2002).  Simultaneously, the LetA/LetS two-component system is 
activated to relieve CsrA repression on transmissive traits (Hammer et al., 2002; 
Molofsky and Swanson, 2003).  As a result, L. pneumophila induces traits that promote 
transmission and survival in the harsh environment, including: motility, cytotoxicity 
towards phagocytic cells, sodium sensitivity, and the ability to avoid lysosomes 
(Bachman and Swanson, 2001, 2004a, b; Hammer et al., 2002; Jacobi et al., 2004; Lynch 
et al., 2003).   
To acclimate to its surroundings, L. pneumophila must monitor the external 
milieu and translate a perceived stimulus into a coordinated response.  Indeed, when 
amino acids are depleted, the stringent response enzyme RelA senses the accumulation of 
uncharged tRNAs at the ribosome and produces the alarmone ppGpp (Hammer and 
Swanson, 1999; Zusman et al., 2002).  Additionally, L. pneumophila can monitor flux in 
fatty acid biosynthesis through an interaction between a second stringent response 
enzyme, SpoT, and a central component of fatty acid metabolism, acyl carrier protein 





the stringent response, the end result is the same.  Thus, both enzymes enable L. 
pneumophila to assess its metabolic state and, when necessary, initiate transmission to a 
new niche.  Since L. pneumophila persists in many different environments, it is 
conceivable that metabolic cues other than amino acids and fatty acids induce its 
differentiation.   
 One common way that microbes respond to external stimuli is via two-component 
signal transduction systems (Calva and Oropeza, 2006).  For many two-component 
systems, the cues that initiate autophosphorylation and the subsequent phosphorelay are 
unknown.  However, it is predicted that numerous environmental stimuli or conditions 
can activate these systems (Calva and Oropeza, 2006).  At the core of L. pneumophila’s 
differentiation circuitry is LetA/LetS, a two-component system that regulates all known 
transmission traits (Hammer et al., 2002; Lynch et al., 2003).  Although the precise 
signal that activates the LetA/LetS system has not been identified, phenotypic studies 
indicate that multiple cues operate via the phosphorelay to trigger L. pneumophila phase 
differentiation.   
 The pyridine derivative nicotinic acid (NA) can activate microbial two-
component systems, and consequently, modulate the genes and phenotypes that are 
governed by these regulatory proteins.  Notably, studies in Bordetella pertussis have 
deduced that NA regulates a spectrum of gene expression states and virulence factors, 
such as pertussis toxin, adenylate cyclase toxin and filamentous hemagglutinin (Cotter 
and DiRita, 2000; Cummings et al., 2006; McPheat et al., 1983; Schneider and Parker, 
1982).  Moreover, the Bordetella two-component system BvgA/BvgS, which controls 
most known virulence and colonization factors, is modulated by the concentration of NA 
in the media (Miller et al., 1989).  Likewise, NA also regulates the Escherichia coli 
EvgA/EvgS system, which confers multi-drug resistance and acid tolerance (Eguchi et 
al., 2003; Masuda and Church, 2002, 2003; Nishino and Yamaguchi, 2001; Nishino et 





EvgA/EvgS systems belong to a family of proteins that employ a multi-step phosphorelay 
to activate their response pathways, but the mechanism by which NA modulates these 
two-component systems is not understood.   
 Since the LetA/LetS system belongs to the same family of signal transducing 
proteins as BvgA/BvgS and EvgA/EvgS, we postulated that NA might similarly modulate 
the expression of L. pneumophila transmission genes and phenotypes.  To test this 
hypothesis, we performed phenotypic and transcriptional analyses of NA-treated L. 
pneumophila.  Our data indicate that NA supplementation controls the expression of a 
unique cohort of genes and also triggers L. pneumophila differentiation.  Moreover, NA 
activated the expression of a putative membrane transporter, which may help unravel the 




Bacterial strains, culture conditions and reagents.  L. pneumophila strain Lp02 (thyA 
hsdR rpsL; MB110), a virulent thymine auxotroph derived from the serogroup 1 clinical 
isolate Philadelphia 1, was the parental strain for all mutants constructed (Berger and 
Isberg, 1993).  MB355 contains the pflaG plasmid that encodes thymidylate synthetase as 
a selectable marker and a transcriptional fusion of the flaA promoter to gfp (Hammer and 
Swanson, 1999; Hammer et al., 2002).  MB414 contains letA-22 and MB417 encodes 
letS-36, mariner insertion alleles of lpg2646 and lpg1912, respectively, that confer 
resistance to kanamycin (Hammer et al., 2002).  Both MB414 and MB417 contain the 
pflaG reporter plasmid.  For phenotypic assays, bacteria were cultured at 37°C in 5 ml of 
N- (2-acetamido)-2-aminoethanesulfonic acid (ACES; Sigma)-buffered yeast extract 
(AYE) broth.  When necessary, cultures were supplemented with 100 µg/ml thymidine.  
In all experiments, replicative phase or exponential (E) cultures were defined as having 





exponential (PE) cultures were defined as having an OD600 of 3.4 to 4.5.  To obtain 
colony-forming units (CFU), L. pneumophila were plated on ACES-buffered charcoal-
yeast extract agar supplemented with 100 µg/ml thymidine (CYET) and incubated for 4-5 
days at 37°C.   
 
Macrophage cultures.  Bone marrow-derived macrophages were isolated from femurs of 
female A/J (Jackson Laboratory) mice and cultured in RPMI-1640 containing 10% heat-
inactivated fetal bovine serum (RPMI/FBS; Gibco BRL) as previously described 
(Swanson and Isberg, 1995).  Following a 7-day incubation in L-cell supernatant-
conditioned media, macrophages were plated at either 2.5 × 105 or 5 × 104 per well for 
lysosomal degradation and cytotoxicity assays, respectively.   
 
Fluorometry.  To monitor expression of the flagellin promoter, L. pneumophila strain 
MB355, which contains the pflaG reporter plasmid, was cultured in AYE media without 
thymidine at 37°C on a rotating wheel.  When cultures reached an OD600 = 0.50-0.85 (T = 
0) they were supplemented with either 5 mM nicotinic acid or water, and at the times 
indicated, the cell density of each culture was measured at OD600.  To analyze similar 
bacterial concentrations, aliquots were collected by centrifugation, and the cell densities 
were normalized to OD600 = 0.01 in PBS.  An aliquot of each sample (200 µL) was 
transferred to black 96-well plates (Costar), and the relative fluorescence intensity was 
measured using a Synergy™ HT microplate reader (485 nm excitation, 530 nm emission 
and sensitivity of 50).   
 
Lysosomal degradation.  The percentage of intracellular L. pneumophila that remained 
intact following a 2 h macrophage infection was quantified by fluorescence microscopy.  
Briefly, macrophages were plated at 2.5 × 105 onto coverslips in 24 well plates.  Then, PE 





h were added to macrophage monolayers at an MOI ~ 1.  The cells were centrifuged at 
400 × g for 10 min at 4°C and then incubated for 2 h at 37°C.  Uninternalized bacteria 
were removed by washing the monolayers with RPMI/FBS three times, and the 
macrophages were fixed, permeabilized and stained for L. pneumophila as described 
(Molofsky et al., 2005).  For each sample, at least 100 macrophages on duplicate 
coverslips were scored for intact rods versus degraded particles in three independent 
experiments (Bachman and Swanson, 2001; Molofsky and Swanson, 2003).   
 
Cytotoxicity.  To determine contact-dependent cytotoxicity of L. pneumophila following 
macrophage infection, PE bacteria or E phase cultures supplemented with water or 5 mM 
nicotinic acid for 3 h were added to macrophage monolayers at the indicated 
multiplicities of infection (MOI).  After centrifugation at 400 × g for 10 min at 4°C 
(Molofsky et al., 2005), the cells were incubated at 37°C for 1 h.  To quantify 
macrophage viability, RPMI/FBS containing 10% alamarBlue™ (Trek Diagnostic 
Systems) was added to the monolayers for 6-12 h, and the reduction of the colorimetric 
dye was measured spectrophotometrically as described (Byrne and Swanson, 1998; 
Hammer and Swanson, 1999; Molofsky et al., 2005).  Each sample was analyzed in 
triplicate wells in three or more independent experiments.   
 
Sodium sensitivity.  To calculate the percentage of L. pneumophila that are sensitive to 
sodium, PE bacteria or E cultures supplemented with either water or 5 mM nicotinic acid 
for 3 h were plated onto CYET and CYET containing 100 mM NaCl.  After a 6-day 
incubation at 37°C, CFUs were enumerated and the percentage of sodium sensitive 






Statistical analyses for phenotypic assays.  To calculate p-values for lysosomal 
degradation and sodium sensitivity assays, one-way analysis of variance (ANOVA) was 
used for at least 3 independent samples.   
 
RNA isolation, RNA labeling and microarray hybridization.  WT L. pneumophila were 
cultured on an orbital shaker at 37ºC to OD600 = 0.65 in 150 ml AYE containing 100 
µg/ml thymidine.  Upon reaching the appropriate optical density, cultures were 
supplemented with either water or 5 mM nicotinic acid, and then incubated for an 
additional 30 min or 3 h at 37ºC on an orbital shaker.  Following the incubation period, 
10 ml aliquots were centrifuged at 6000 × g for 2 min at 4ºC.  The culture supernatants 
were discarded and the pellets stored at -80ºC.  Total RNA was extracted using TRIzol 
(Invitrogen) as described previously (Milohanic et al., 2003).  The RNA was reverse-
transcribed and labeled with Cy3 or Cy5 according to the manufacture’s instructions 
(Amersham Biosciences).  The microarrays were designed to contain gene-specific 
70mer oligonucleotides based on all predicted genes within the genome of L. 
pneumophila strain Paris (CR628336) and its plasmid (CR628338) as described 
previously (Bruggemann et al., 2006).  Hybridizations were performed following the 
manufacturers’ recommendations (Corning) using 250 pmol of Cy3 and Cy5 labeled 
cDNA.  Slides were scanned on a GenePix 4000A scanner (Axon Instruments) and the 
laser power and PMT were adjusted to balance the two channels.  The resulting files were 
analyzed using Genepix Pro 5.0 software.  Spots were excluded from analysis if they 
contained high background fluorescence, slide abnormalities or weak intensity.  To 
obtain statistical data for the gene expression profiles, all microarrays were performed in 
duplicate with a dye swap.    
 
Data and statistical analysis for microarrays.  Data normalization and differential 





background subtraction was performed, but a careful graphical examination of all the 
slides was performed to ensure a homogeneous, low-level background in both channels.  
A loess normalization (Yang et al., 2002) was performed on a slide-by-slide basis 
(BioConductor package marray; 
http://bioconductor.org/packages/2.2/bioc/html/marray.html).  Differential analysis was 
carried out separately for each comparison between the two time points, using the VM 
method (VarMixt package (Delmar et al., 2005)), together with the Benjamini and 
Yekutieli (Reiner et al., 2003) p-value adjustment method.  If not stated otherwise, only 
differently expressed genes with 1.4-fold-changes were taken into consideration.  Empty 
and flagged spots were excluded from the data set, and only genes without missing values 




Nicotinic acid inhibits L. pneumophila growth and induces motility 
To discern whether nicotinic acid (NA) triggers L. pneumophila differentiation, 
wild-type (WT) bacteria that contained the flaAgfp reporter construct were cultured to the 
exponential (E) phase and supplemented with either water or 5 mM NA.  When E 
cultures were treated with NA, replication stopped (Fig. 4.1A, squares), and the bacteria 
immediately activated the flaA promoter (Fig. 4.1B, squares).  In contrast, control 
cultures supplemented with water did not induce the flaA promoter until 9 h, a time when 
L. pneumophila normally transitions to the post-exponential (PE) phase (Fig. 4.1B, 
circles).  In support of the fluorometry data, microscopic examination revealed that NA 
also triggered motility (data not shown).  Thus, in response to a signal generated by NA, 







NA supplementation stimulates L. pneumophila differentiation 
To determine whether NA induces transmission traits apart from growth 
inhibition and motility induction, we tested NA-treated L. pneumophila for other PE 
phenotypes, including: the avoidance of lysosomal degradation, cytotoxicity to 
phagocytic cells and sodium sensitivity (Byrne and Swanson, 1998).  Indeed, when E 
phase L. pneumophila were supplemented with 5 mM NA, the majority of the bacteria 
acquired the capacity to evade lysosomes, as judged by immunofluorescence microscopy 
(Fig. 4.2A).  While less than 15% of E phase Legionella avoided degradation, greater 
than 70% of E bacteria exposed to 5 mM NA escaped the lysosomal compartment (Fig. 
4.2A).  Further, after NA treatment, E phase L. pneumophila became as cytotoxic to bone 
marrow-derived macrophages as PE control cultures (Fig. 4.2B).  Finally, 5 mM NA also 
triggered sodium sensitivity of E phase microbes, albeit to a slightly less degree than PE 
L. pneumophila (Fig. 4.2C).  Taken together, our phenotypic data suggest that 5 mM NA 
triggers L. pneumophila differentiation to the transmissive phenotype.   
 
L. pneumophila requires the LetA/LetS two-component system to respond to NA 
 Work in Bordetella and E. coli indicates that NA elicits transcriptional and 
phenotypic responses through a two-component system.  To analyze whether the 
response of L. pneumophila to NA is dependent on the homologous LetA/LetS signal 
transduction system, we cultured letA and letS mutants containing the flaAgfp reporter 
construct to the E phase, supplemented the cultures with 10 mM NA, and then monitored 
both optical density and fluorescence of the cultures over time.  When treated with NA, 
the letA and letS mutants resembled WT L. pneumophila in restricting their growth (Fig. 
4.3A).  In contrast, L. pneumophila partially required the LetA/LetS system to completely 
induce flagellin expression in response to 10 mM NA (Fig. 4.3B).  Furthermore, 
microscopic examination demonstrated that L. pneumophila requires LetA/LetS to trigger 





pneumophila LetA/LetS two-component system is required to fully activate the flaA 
promoter and induce motility following NA supplementation.   
 
Transcriptome analysis of replicative and transmissive L. pneumophila indicates that 
profound changes in gene expression exist between the phenotypic phases 
 To identify the transcriptional changes that occur when L. pneumophila 
transitions from the replicative to the transmissive phase, we employed multiple-genome 
DNA microarrays to analyze E and PE bacteria (Cazalet et al., 2004; Chien et al., 2004).  
Overall, 924 genes were more highly expressed in the PE phase (synonymously, 
repressed in the E phase; Fig. 4.4 and Table 4.S1) and 751 L. pneumophila genes were 
repressed in the PE phase (synonymously, elevated in the E phase; Fig. 4.4 and Table 
4.S2).  Importantly, our microarray data confirm transcriptional and regulatory data 
which indicate that L. pneumophila displays distinct gene expression patterns and 
phenotypes in the replicative and transmissive phases (Bruggemann et al., 2006; Byrne 
and Swanson, 1998; Edwards and Swanson, 2006).   
Several categories of genes were significantly induced in the PE phase when 
compared to the E phase.  These include genes that are required for flagellum 
biosynthesis (Bruggemann et al., 2006; Heuner and Steinert, 2003).  In addition, 
numerous regulatory genes were activated in the PE phase, such as the sigma factors rpoS 
and rpoE, the transmission trait enhancer letE, and the stringent response enzyme relA 
(Bachman and Swanson, 2001, 2004a, b; Hales and Shuman, 1999; Hammer and 
Swanson, 1999; Zusman et al., 2002).  Other regulatory genes that were preferentially 
expressed in the PE phase include several two-component systems and members of the 
GGDEF/EAL family of proteins (Tables 4.1 and 4.S1).  As expected, many genes of the 
Dot/Icm type IV secretion system had elevated levels of expression in the PE phase, 
notably icmCPRSTV, dotV and sdbC (Segal et al., 2005).  Finally, transcriptional analysis 





and phaB2), as well as several families of transporters and efflux pumps, were more 
highly expressed in PE phase when compared to E phase bacteria (Tables 4.1 and 4.S1).   
 
Microarrays determine that NA regulates a panel of genes similar to PE L. pneumophila 
 Since NA supplementation triggers L. pneumophila differentiation, and 
transcriptional microarrays indicate that vastly different expression profiles are displayed 
between the replicative and transmissive phases, we predicted that the transcriptional 
program induced by NA supplementation would be quite extensive.  To learn whether 
NA-treated L. pneumophila differ from PE phase microbes, we employed microarrays to 
compare E phase L. pneumophila treated with 5 mM NA to similar cultures supplemented 
with water.  Indeed, when E phase bacteria were treated with NA, the expression levels of 
714 genes were significantly elevated and 435 genes were repressed when compared to 
the water control (Fig. 4.4 and data not shown).  Similar to PE L. pneumophila, when NA 
was added to E phase bacteria, 14 genes of the flagellar apparatus were induced, 
including: flaA, fliADS, flgDFIJKLM, fleN, flhB and motB2 (Bruggemann et al., 2006; 
Heuner and Steinert, 2003).  Moreover, the expression of numerous genes involved in 
virulence was activated by NA supplementation, such as components of the Dot/Icm type 
IV secretion system (icmBGOX), substrates of the secretion system (ralF, lidA, sdcA, 
sdhB1, sdbAB, sdeBCD, sidACDFGHH') and enhanced entry proteins enhABC (Segal et 
al., 2005).  By comparing the microarray data from PE bacteria to the transcriptional data 
from E phase L. pneumophila treated with NA, it was apparent that the profiles were 
comparable; bacteria from the two sample sets had 600 induced and 303 repressed genes 
in common (Fig. 4.4 and Tables 4.S3 and 4.S4).  Accordingly, we conclude that the 
phenotypic switch triggered by NA supplementation is due to the induction of a 







Transcriptional analysis identifies genes unique for NA modulation 
 While NA modulates the genotypic and phenotypic profiles of B. pertussis and E. 
coli, the mechanism by which NA elicits a response is not understood.  To uncover the L. 
pneumophila genes and pathways controlled by NA supplementation, we analyzed the 
transcriptional profiles of E phase bacteria treated with 5 mM NA for 3 h compared to 
similar cultures supplemented with water.  Using the microarray data set from replicative 
and transmissive phase L. pneumophila as a reference, we identified 246 genes that were 
uniquely regulated by NA supplementation (Fig. 4.4 and Tables 4.2 and 4.3).  Of the 
genes that were highly induced following NA treatment, nearly 40% have no predicted 
function (44 genes out of 114 total, Table 4.2).  Several regulatory genes had elevated 
expression levels, including the two-component regulator lpg0098 and the transcriptional 
regulators from the MarR and LysR families, lpg1212 and lpg0274, respectively (Table 
4.2).  Also, the induction of two virulence genes, icmD/dotP and icmJ/dotN, was 
particular to NA addition (Segal et al., 2005).   
The most striking observation was that the two genes with the highest level of 
transcriptional activation in response to NA lie in an operon; lpg0272 and lpg0273 were 
9-fold and 35-fold elevated, respectively (Table 4.2 and Fig. 4.5).  The lpg0272 locus is 
predicted to encode a 14.6 kDa cysteine transferase, and lpg0273 encodes a 44.9 kDa 
membrane protein belonging to the Major Facilitator Superfamily (MFS) of transporters 
(Fig. 4.5).  Directly downstream of the lpg0272-3 operon, but positioned in the opposite 
orientation, is the LysR transcriptional regulator (lpg0274), whose expression is elevated 
in response to NA, as described above (Fig. 4.5).  Upstream of the lpg0272-3 operon, but 
again in the opposite direction, are two genes involved in nicotinate and nicotinamide 
metabolism, lpg0270-1 (Fig. 4.5).  However, according to our microarray data, lpg0270-1 
are neither induced nor repressed following a 3 h treatment with NA when compared to 
the water control.  Whether NA affects lpg0270-1 expression at time points other than 3 h 





distinct set of L. pneumophila genes; furthermore, the phenotypic modulator might 
initiate differentiation through a membrane transporter.   
 
Discussion 
 A variety of microbes sense NA concentrations to modulate their genotypic and 
phenotypic expression profiles.  For example, the respiratory pathogen B. pertussis 
controls hundreds of genes and virulence traits depending on the concentration of NA 
that is present in the culture media (Cotter and DiRita, 2000; Cummings et al., 2006; 
McPheat et al., 1983; Schneider and Parker, 1982).  Similarly, in E. coli, NA regulates 
the expression of motility, the outer membrane porin protein OmpC and the alcohol 
dehydrogenase protein AdhE (Han et al., 1999; Leonardo et al., 1996; Utsumi et al., 
1994).  In addition, NA concentrations control the expression of adhesion genes in the 
urinary tract pathogen Candida glabrata (Domergue et al., 2005).   
Both amino acid and fatty acid concentrations are known to cue L. pneumophila 
differentiation; however, due to the variety of ecological locals this microbe can exploit, 
we postulated that NA might serve as an additional signal for its phenotypic switch.  
Indeed, when E phase L. pneumophila were treated with 5 mM NA, growth was restricted 
and the bacteria activated the flagellin promoter (Fig. 4.1).  Moreover, microscopy 
indicated that NA induced motility 3 h after supplementation, thus corroborating the 
fluorometry data (Fig. 4.1 and data not shown).  NA also modulates other L. pneumophila 
PE phenotypes:  When NA was added to E phase cultures, the bacteria largely avoided 
degradation in the lysosomal compartment and became cytotoxic towards macrophages 
(Fig. 4.2).  Additionally, NA-treated L. pneumophila were sensitive to sodium as 
indicated by a loss in CFU when compared to the E phase control (Fig. 4.2).  Higher 
concentrations of NA failed to trigger L. pneumophila differentiation, as judged by a lack 
of lysosome avoidance and cytotoxicity, as well as salt tolerance (data not shown).  At 





govern phase differentiation or whether the viability of the bacteria is affected.  Together, 
our phenotypic data determined that NA modulates PE-specific L. pneumophila 
phenotypes, and further validate the flaAgfp reporter construct as an indicator of L. 
pneumophila differentiation.   
 B. pertussis and E. coli respond to NA via the two-component systems 
BvgA/BvgS and EvgA/EvgS, respectively.  While many two-component signal 
transduction systems use a two-step phosphorelay to activate gene expression, the B. 
pertussis and E. coli systems belong to a family of proteins that use a four-step 
phosphorelay to customize their expression profiles (Cotter and Miller, 1997).  
Importantly, the L. pneumophila LetA/LetS system, which regulates PE phenotypes, also 
belongs to this unorthodox family of signaling molecules.  Similar to the BvgA/BvgS and 
EvgA/EvgS systems, NA also coordinates L. pneumophila differentiation through 
LetA/LetS.  As indicated by fluorometry, complete induction of motility is dependent on 
both LetA and LetS (Fig. 4.3).  Conversely, inhibition of L. pneumophila growth by NA 
occurs by a LetA/LetS independent mechanism (Fig. 4.3) that remains to be elucidated.  
Besides the aforementioned two-component systems, numerous microbes employ this 
family of signal transduction systems to regulate their response pathways, including: 
GacA/GacS of Acinetobacter baumannii, PigQ/PigW of Serratia marcescens, VarA/VarS 
of Vibrio cholerae, SirA/BarA of Salmonella, GacA/GacS of Pseudomonas and the 
UvrY/BarA and TorR/TorS systems of E. coli (Heeb and Haas, 2001; Lapouge et al., 
2008; Perraud et al., 1999).  Therefore, we predict that other members within this family 
of two-component systems may sense NA to regulate their genotypic and phenotypic 
expression profiles.   
 It is now well documented that the L. pneumophila life cycle includes two 
reciprocal phases (Bruggemann et al., 2006; Byrne and Swanson, 1998; Molofsky and 
Swanson, 2004).  When conditions are favorable, L. pneumophila suppresses its 





exhausted, replication halts, and the bacteria activate traits that promote efficient host 
transmission.  Accordingly, L. pneumophila displays a pattern of genes and phenotypes 
that are unique for the replicative and transmissive phases (Bruggemann et al., 2006; 
Molofsky and Swanson, 2004).  To discern the gene expression profiles of the two phases 
of the L. pneumophila life cycle, we analyzed broth-grown microbes in the E and PE 
phases by microarrays.  Remarkably, 1675 genes were differentially regulated between 
replicative and transmissive bacteria; 751 genes were repressed and 924 genes were 
induced in the PE phase when compared to E phase microbes (Fig. 4.4, Tables 4.S1 and 
4.S2).  As expected from phenotypic analyses, genes that encode components of the 
flagellar apparatus and the Dot/Icm type IV secretion system were highly expressed in 
the PE phase in comparison to E phase L. pneumophila (Byrne and Swanson, 1998; Segal 
et al., 2005).  Conversely, the post-transcriptional regulator CsrA, which represses all 
transmissive traits, was not expressed in PE bacteria (Table 4.S1).  Moreover, genes for 
cell division, metabolic pathways and biosynthetic pathways were repressed in the PE 
phase as compared to E phase microbes (Table 4.S1).  Thus, our transcriptional data 
support the model that L. pneumophila undergoes a radical shift in gene expression 
programs between the replicative and transmissive phases of its biphasic life cycle.  In 
addition, our microarray data set supports the work of Brüggemann et. al., which 
demonstrated that other virulent strains of L. pneumophila undergo a dramatic change in 
their gene expression profiles both in liquid cultures and during amoebae infections, thus 
validating the model of the reciprocal phases of the L. pneumophila life cycle 
(Bruggemann et al., 2006).   
 Since a large transcriptional program is induced upon entry into the PE phase 
(Bruggemann et al., 2006), we predicted that the phenotypic switch triggered by NA 
would be due to an alteration in gene expression.  To discern which L. pneumophila 
genes are controlled by NA, we compared the gene expression profiles of PE bacteria to 





the microarrays indicated that NA regulates the expression of 1149 genes, a large number 
of which are either induced or repressed in the PE phase (a total of 903 genes are shared 
between the two conditions tested; Fig. 4.4 and data not shown).  Similar to PE bacteria, 
NA supplementation activated the expression of numerous components of the flagellar 
apparatus (Bruggemann et al., 2006; Heuner and Steinert, 2003).  This corroborates our 
phenotypic data, which deduced that E phase L. pneumophila activate motility 3 h after 
NA treatment (data not shown).  Moreover, previous data indicate that both cytotoxicity 
and lysosome avoidance are mostly dependent upon motility (Molofsky et al., 2005).  
Therefore, since our transcriptional data determined that most of the flagellar genes are 
induced by NA treatment, it was not surprising that when 5 mM NA was added to E 
phase L. pneumophila, the bacteria became cytotoxic towards macrophages and largely 
avoided the lysosomal compartment (Fig. 4.2 A and B and data not shown).  In addition, 
the microarrays determined that NA activates the expression of several Dot/Icm type IV 
secretion genes (data not shown).  The presence of the secretion system is thought to 
form a large pore by which sodium can enter the bacterial cell ((Byrne and Swanson, 
1998; Sadosky et al., 1993; Vogel et al., 1996).  Indeed, the expression of the apparatus 
correlated with the sodium sensitivity phenotype displayed by PE bacteria and E phase L. 
pneumophila supplemented with NA (Fig. 4.2C).  Based on our data, we infer that the 
differentiation that is triggered by NA is largely dependent upon a shift in the 
transcriptional profile of the bacterium towards that of PE L. pneumophila.   
 Although data clearly indicate that NA controls microbial genes and phenotypes, 
the mode by which the modulator exerts its effect has not been elucidated.  To determine 
the cohort of genes that are unique for NA regulation, we compared the transcriptional 
profile of PE genes to E phase L. pneumophila that were treated with 5 mM NA.  While 
nearly 250 genes were specific for NA supplementation, genes within the lpg0272-3 
operon had the highest level of expression (Table 4.2).  Preliminary data suggest that 





(data not shown).  Since lpg0272 encodes a cysteine transferase, and L. pneumophila 
requires cysteine for growth, this auxotrophy may account for our failed attempts to 
disrupt the operon (Fig. 4.5).   
Sequence data predict that lpg0273 encodes a membrane protein that belongs to 
the MFS of transporters (Fig. 4.5).  We speculate that lpg0273 may function either as an 
importer or exporter for small metabolites, a process which L. pneumophila monitors to 
control its differentiation.  The transcriptional regulator lpg0274, which lies within the 
same region of the L. pneumophila chromosome as lpg0272-3, also showed elevated 
levels of gene expression after NA treatment (Fig. 4.5 and Table 4.2).  The significance 
for the close proximity of transcriptional regulator to lpg0272-3 has not been assessed.  
However, we postulate that lpg0274 might be involved in the transcriptional and 
phenotypic changes that are elicited by NA.  Finally, it is interesting to note that up-
stream of the lpg0272-3 operon lie two genes involved in nicotinate and nicotinamide 
metabolism (lpg0270-1; Fig. 4.5).  While the gene expression levels of lpg0270-1 were 
not altered under the conditions tested, their contribution to the same metabolic pathways 
as NA lends further support to the hypothesis that lpg0272-3 is directly involved in NA 
signaling.   
 One mechanism by which NA could exert its effect is by controlling a class of 
proteins known as sirtuins.  These highly conserved nicotinamide adenine dinucleotide 
(NAD+)-dependent deacetylase enzymes regulate a range of proteins by affecting the 
acetylation and deacetylation states of their particular substrates (Blander and Guarente, 
2004).  Moreover, it has been proposed that nicotinamide, the amide of NA, is the 
metabolite that controls sirtuin activity in vivo (Starai et al., 2004).  Recent work in 
Salmonella enterica has determined that microbes contain homologous of the sirtuin 
proteins (Starai et al., 2002).  In particular, S. enterica encodes the sirtuin CobB, which 
controls the activity of acetyl-coA synthetase (ACS), and likewise, the conversion of 





suggests that alterations in acetate concentrations can perturb the fatty acid biosynthetic 
pathway and trigger L. pneumophila differentiation (Chapter 3).  Genome analysis 
indicates that almost all microbes contain a CobB homologue.  Thus, we predict that L. 
pneumophila encodes a sirtuin that regulates acetate levels similar to S. enterica.  
According to this model, NA supplementation would affect a L. pneumophila sirtuin, 
which in turn impacts fatty acid biosynthesis and differentiation.  While analyses of the L. 
pneumophila genome have not identified obvious sirtuin candidates, our transcriptional 
data predict that 44 genes of unknown function are induced following NA treatment. 
Therefore, we envision that one of these genes could encode a novel protein that has 
sirtuin-like activity (Table 4.2).   
 In summary, our data indicate that NA controls the genotypic and phenotypic 
profiles of L. pneumophila through the use of the LetA/LetS two-component system.  
Since numerous microbes employ analogous signal transduction systems to coordinate 
their response pathways, we predict that the repertoire of bacteria modulated by NA is 
larger than currently appreciated.  Furthermore, our transcriptional analysis of the 
replicative and transmissive phases supports the model of the L. pneumophila biphasic 
life cycle.  Finally, while our microarray studies demonstrate that NA induces an 
expression program largely similar to that of PE bacteria, we did identify a novel group 
of genes that are regulated by NA.  We predict that this class of genes will provide a 
valuable resource for experimentalists to uncover the biochemical pathways that mediate 








Figure 4.1.  Nicotinic acid supplementation triggers growth inhibition and the 
premature expression of motility.   
WT L. pneumophila carrying the flaAgfp reporter construct were cultured to the E phase 
and then supplemented with water (H2O; circles) or 5 mM nicotinic acid (NA; squares).  
At the times indicated, samples were collected and optical density and relative 
fluorescence were analyzed.  Whereas NA causes growth inhibition (A) and early 
motility (B), cultures supplemented with H2O, do not enter the PE phase until 9 h 
following supplementation, as indicated by less growth (A) and induction of the flaA 
reporter (B) at this time point.  Shown are representative graphs from three or more 









Figure 4.2.  Nicotinic acid supplementation of WT L. pneumophila induces the early 
expression of multiple transmissive phase phenotypes.   
(A)  Lysosome evasion was determined by culturing L. pneumophila strains for 2 h with 
macrophages at an MOI = 1, and then quantifying the percent of intact bacteria by 
fluorescence microscopy.  Displayed are the means from duplicate samples in three 
independent experiments.  Error bars indicate SD, and asterisks designate significant 
differences (P<0.01) when compared to water control.  (B)  Macrophage viability was 
assessed by quantifying the reduction of the colorimetric dye alamarBlue™ following a 
1-hour incubation of macrophages with PE cultures (triangles) or E cultures 
supplemented with water (H2O; circles) or nicotinic acid (NA; squares).  Shown is a 
representative graph from three independent experiments preformed in triplicate.  (C)  
The percent of sodium resistant bacteria was measured by plating cultures on media with 
or without 100 mM NaCl, and then the viable CFU calculated as described (Byrne and 
Swanson, 1998).  Values shown = mean [(E + NA or PE control)/(E + H2O) × 100%].  
Error bars represent SD from duplicate samples in three independent experiments.  
Asterisks denote statistically significant differences (P<0.01) when compared to water 









Figure 4.3.  LetA/LetS is dispensable for growth inhibition, but required for full 
induction of motility following NA treatment.   
WT (circles), letA (triangles) or letS (squares) L. pneumophila containing the flaAgfp 
reporter were grown to the E phase and then supplemented with water (closed symbols), 
or 10 mM NA (open symbols).  Samples were collected and analyzed for OD600 (A) or 
fluorescence (B) at the times indicated.  Shown are representative graphs from three 





Table 4.1.  Subset of genes induced in the PE phase as compared to the E phase 
 
1 Fold Change (FC) 
Family Gene ID Name Paris ID Lens ID Gene product FC
1
lpg1216 flgB lpp1224 lpl1224 flagellar basal-body rod protein FlgB 1.7
lpg1217 flgC lpp1225 lpl1225 flagellar basal-body rod protein FlgC 2.5
lpg1219 flgE lpp1227 lpl1227 flagellar hook protein FlgE 39.4
lpg1784 flhF lpp1748 lpl1784 flagellar biosynthesis protein FlhF 7.6
lpg1221 flgG lpp1229 lpl1229 flagellar biosynthesis protein FlgG 4.5
lpg1222 flgH lpp1230 lpl1230 flagellar L-ring protein precursor FlgH 4.3
lpg1785 flhA lpp1749 lpl1749 flagellar biosynthesis protein flhA 1.8
lpg1761 fliE lpp1725 lpl1725 flagellar hook-basal body complex protein FliE 2.6
lpg1760 fliF lpp1724 lpl1724 flagellar M-ring protein FliF 2.2
lpg1759 fliG lpp1723 lpl1723 flagellar motor switch protein FliG 2.2
lpg1758 fliH lpp1722 lpl1722 polar flagellar assembly protein FliH 2.0
lpg1757 fliI lpp1721 lpl1721 flagellum-specific ATP synthase FliI 1.6
lpg1791 fliN lpp1755 lpl1755 flagellar motor switch protein FliN 2.0
lpg1789 fliP lpp1753 lpl1753 flagellar biosynthetic protein FliP 1.7
lpg1781 motA1 lpp1745 lpl1745 flagellar motor protein MotA 6.7
lpg2962 - lpp3034 lpl2892 similar to sodium-type flagellar protein MotY 6.5
lpg1284 rpoS lpp1247 lpl1247 RNA polymerase sigma factor RpoS (sigma 38) 1.9
lpg1577 rpoE lpp1535 lpl1448 sigma factor RpoE (sigma 24)   3.0
lpg0537 letE lpp0602 lpl0583 transmission trait enhancer protein LetE 1.8
lpg1457 relA lpp1413 lpl1571 GTP pyrophosphokinase 1.7
lpg0853 fleQ lpp0915 lpl0884 transcriptional regulator FleQ 1.9
lpg0891 - lpp0952 lpl0922 regulatory protein (GGDEF and EAL domains) 12.7
lpg2655 - lpp2708 lpl2581 sensory box protein (EAL and GGDEF domains) 2.9
lpg0879 - lpp0942 lpl0912 two-component response regulator (GGDEF domain) 2.3
lpg1357 - lpp1311 lpl1308 regulatory protein (GGDEF and EAL domains) 1.8
lpg1173 pilS lpp1175 lpl1181 sensor protein PilS 3.3
lpg1762 fleR lpp1726 lpl1726 similar to two-component response regulator 2.4
lpg0714 - lpp0780 lpl0751 similar to two-component sensor histidine kinase 1.6
lpg2723 - lpp2780 - similar to transcriptional regulator - ArsR family 3.8
lpg0280 - lpp0355 lpl0332 similar to transcriptional regulator lysR family 1.7
lpg0453 icmC/dotE lpp0519 lpl0495 icmC/dotE 2.2
lpg0445 icmP/dotM lpp0511 lpl0487 icmP/dotM 2.4
lpg0443 icmR lpp0509 lpl0485 icmR 2.3
lpg0442 icmS lpp0508 lpl0484 icmS 2.1
lpg0441 icmT lpp0507 lpl0483 icmT 3.9
lpg2687 icmV lpp2741 lpl2614 icmV 1.9
lpg0472 dotV lpp0537 lpl0513 dotV 2.1
lpg2391 sdbC lpp2458 lpl2315 SdbC proteins - substrate of the Dot/Icm system 2.3
lpg0560 phaB1 lpp0620 lpl0603 acetoacetyl-CoA reductase 2.3
lpg0561 phaB2 lpp0621 lpl0604 acetoacetyl-CoA reductase 1.9
lpg0610 - lpp0661 lpl0645 similar to major facilitator family transporter 3.8
lpg1893 - lpp1860 lpl1855 similar to major facilitator family transporter 2.6
lpg1404 - lpp1359 lpl1355 similar to major facilitator family transporter 2.0
lpg2237 abcT3 lpp2190 lpl2163 similar to multidrug resistance ABC transporter 3.3
lpg1008 helA lpp2371 lpl1046 similar to cation efflux system protein CzcA 1.8
lpg2481 - lpp2545 lpl2401 membrane protein- similar to metabolite efflux pump 2.8
lpg2178 mexF2 lpp2130 lpl2104 similar to RND multidrug efflux transporter  2.5
lpg2193 - lpp2142 lpl2117 similar to sulfate transporters 2.0
lpg1063 proP6 lpp1082 lpl1060 proline/betaine transporter 1.7
lpg1007 helB lpp2372 lpl1045 cation efflux system HelB 1.7
lpg0430 - lpp0497 lpl0473 similar to multidrug resistance efflux pump 1.6
lpg1479 - lpp1435 lpl1549 similar to potassium efflux system kefA 1.6
lpg0231 - lpp0301 lpl0284 similar to cation transport ATPase 1.6

















Gene ID Name Paris ID Lens ID Description FC1
lpg0273 - lpp0347 lpl0325 similar to transporter of the major facilitator superfamily (MFS)  35.0
lpg0272 - lpp0346 lpl0324 cysteine transferase 9.3
lpg1121 - lpp1121 lpl1126 unknown 6.1
lpg0689 - lpp0744 lpl0725 weakly similar to DNA-binding ferritin-like protein (oxidative damage protectant) 5.0
lpg2350 - lpp2299 lpl2272 similar to alkyl hydroperoxide reductase AhpC 4.8
lpg0436 legA11 lpp0503 lpl0479 ankyrin repeat protein 4.6
lpg1697 - lpp1662 lpl1656 conserved hypothetical protein 3.6
lpg1230 - lpp1038 lpl1003 similar to conserved hypothetical protein 3.5
lpg2392 legL6 lpp2459 lpl2316 leucine-rich repeat-containing protein 3.5
lpg2217 - lpp2169 lpl2142 similar to chitinase 3.3
lpg0213 - lpp0272 lpl0267 similar to membrane protein LrgB  3.1
lpg2315 - lpp2263 lpl2235 unknown 3.0
lpg1136a2 - lpp1138 lpl1143 unknown 2.9
lpg2166 - lpp2104 lpl2093 unknown 2.9
lpg1716 - lpp1681 lpl1675 unknown 2.8
lpg2621 - lpp2674 lpl2544 similar to acid phosphatase- class B 2.7
lpg1489 - lpp1445 lpl1539 unknown 2.7
lpg1966a2 - lpp1948 lpl1937 unknown 2.6
lpg0075 - lpp0089 lpl0077 similar to conserved hypothetical protein 2.4
lpg0086 - lpp0100 lpl0085 putative membrane protein 2.4
lpg2762 - lpp2810 lpl2679 unknown 2.3
lpg0044 - lpp0045 - similar to sterol desaturase 2.3
lpg0750 hisH lpp0816 lpl0787 similar to imidazole glycerol phosphate synthase subunit HisH 2.3
lpg0171 legU1 lpp0233 lpl0234 protein with a F-box domain 2.2
lpg1550 - lpp1507 lpl1476 conserved hypothetical protein 2.2
lpg0986 - lpp1057 lpl1019 putative membrane protein similar to conserved hypothetical protein 2.2
lpg2414 - lpp2483 lpl2338 unknown 2.2
lpg2665 - lpp2719 lpl2592 similar to dienelactone hydrolase family protein  2.1
lpg0454 icmD/dotP lpp0520 lpl0496 icmD/dotP 2.1
lpg2813 vipE lpp2865 lpl2728 vipE 2.1
lpg0098 - lpp0112 lpl0098 two-component sensor and regulator, histidine kinase response regulator 2.1
lpg0722 - lpp0788 lpl0759 unknown 2.0
lpg2353 yrfE lpp2302 lpl2275 similar to MutT/nudix family protein 2.0
lpg1631 - lpp1601 - similar to 3-oxoacyl-[acyl-carrier-protein] synthase III 2.0
lpg1124 - lpp1125 lpl1129 unknown 2.0
lpg2937 fum lpp3005 lpl2866 fumarate hydratase- class II 2.0
lpg1710 - lpp1675 lpl1669 weakly similar to cytochrome c5 2.0
lpg2850 - lpp2908 lpl2762 similar to cold shock protein 1.9
lpg1580 - lpp1538 lpl1445 some similarities to cytochrome B561 1.9
lpg0286 - lpp0362 lpl0338 similar to oxidoreductase- short chain dehydrogenase/reductase family  1.9
lpg0154 - lpp0218 lpl0215 unknown 1.9
lpg2218 - lpp2170 lpl2143 similar to choline monooxygenase 1.9
lpg2600 - lpp2653 lpl2523 similar to membrane bound acyltransferase 1.9
lpg0301 - lpp0379 lpl0354 similar to eukaryotic proteins 1.8
lpg1927 - lpp1902 lpl1891 similar to conserved hypothetical protein 1.8
lpg1147 - lpp1149 lpl1153 similar to acetyltransferase 1.8
lpg0819 - lpp0038 - similar to transposase (IS4 family) 1.8
lpg0526 - lpp0591 lpl0572 unknown 1.8
lpg1212 - lpp1214 lpl1220 similar to transcriptional regulator- MarR family 1.8
lpg2194 - lpp2143 lpl2118 similar to carbonic anhydrase proteins 1.8
lpg1390 - lpp1345 lpl1341 unknown 1.8
lpg0374 - lpp0441 lpl0417 unknown 1.7
lpg1735 gatC lpp1700 lpl1699 glutamyl-tRNA (Gln) amidotransferase (subunit C) 1.7
lpg0677 - lpp0733 lpl0713 unknown 1.7






1 Fold Change (FC) 
Gene ID Name Paris ID Lens ID Description FC1
lpg2929 panD lpp2996 lpl2856 aspartate-1-decarboxylase  1.7
lpg2889 gidA2 lpp2948 lpl2802 highly simislar to glucose-inhibited division protein A GidA 1.7
lpg1896 ychJ lpp1865 lpl1860 similar to hypothetical protein 1.7
lpg0455 icmJ/dotN lpp0521 lpl0497 icmJ/dotN 1.7
lpg2398 - lpp2464 lpl2321 similar to aminoglycoside 6-N-acetyltransferase 1.7
lpg2008 - lpp1989 lpl1984 similar to putative endoribonuclease L-PSP 1.7
lpg2970 - lpp3042 lpl2900 similar to glycerophosphoryl diester phosphodiesterase (ATA start codon) 1.6
lpg1679 - lpp1651 lpl1644 similar to hypothetical proteins 1.6
lpg0588 pyrB lpp0638 lpl0622 similar to aspartate carbamoyltransferase 1.6
lpg0554 dinP lpp0614 lpl0597 similar to DNA damage inducible protein P 1.6
lpg0627 pilE3 lpp0681 lpl0664 type-IV pilin 1.6
lpg2648 cinA lpp2701 lpl2573 belong to the CinA protein family 1.6
lpg2877 - lpp2936 lpl2790 unknown 1.6
lpg1204 pyrE lpp1206 lpl1212 orotate phosphoribosyltransferase 1.6
lpg2014 - lpp1996 lpl1991 similar to conserved hypothetical protein 1.5
lpg1488 legC5 lpp1444 lpl1540 unknown 1.5
lpg0543 prsA lpp0607 lpl0588 ribose-phosphate pyrophosphokinase 1.5
lpg0877 - lpp0940 lpl0910 similar to uncharacterized proteins 1.5
lpg2413 - lpp2482 lpl2337 unknown 1.5
lpg1824 - lpp1787 lpl1788 similar to acyl-CoA dehydrogenase 1.5
lpg1858 hubB lpp1826 lpl1822 similar to DNA-binding protein HU-beta 1.5
lpg0882 - lpp0944 lpl0914 predicted transmembrane protein 1.5
lpg1850 - lpp1817 lpl1816 hypothetical protein (rhodanese domain) 1.5
lpg1835 - lpp1798 lpl1799 29 kDa immunogenic protein 1.5
lpg0534 sucC lpp0599 lpl0580 succinyl-CoA synthetase- beta subunit 1.5
lpg0274 - lpp0348 lpl0326 transcriptional regulator, LysR family 1.5
lpg1954 - lpp1936 - unknown 1.5
lpg2623 - lpp2676 lpl2548 unknown membrane protein 1.5
lpg2358 rpsU lpp2307 lpl2280 30S ribosomal protein S21 1.5





Table 4.3.  Genes repressed by 5 mM NA when compared to PE L. pneumophila 
 
Gene ID Name Paris ID Lens ID Description FC Ratio1
lpg0913 - lpp0974 lpl0944 MraZ protein -3.4
lpg1763 flrB lpp1727 lpl1727 similar to sensor histidine kinase -3.0
lpg2328 - lpp2276 lpl2248 unknown- N-terminal similar to Legionella 33 kDa polypeptide -2.7
lpg2517 - lpp2585 lpl2439 similar to transcriptional regulator of the Lrp family -2.6
lpg0097 - lpp0111 lpl0097 similar to unknown protein- truncated -2.4
lpg2045 - lpp2028 lpl2023 similar to ABC-type transport system used for resistance to organic solvents -2.4
lpg2675 dotC lpp2729 lpl2602 defect in organelle trafficking lipoprotein DotC -2.3
lpg2514 lprN lpp2582 - similar to outer membrane efflux protein (RND multidrug efflux) -2.3
lpg1792 fliM lpp1756 lpl1756 flagellar motor switch protein FliM -2.2
lpg0449 icmL/dotI lpp0515 lpl0491 icmL/dotI -2.1
lpg1320 lspD lpp1275 lpl1274 type II protein secretion LspD -2.1
lpg0451 icmE/dotG lpp0517 lpl0493 icmE/dotG -2.1
lpg2703 petC lpp2758 lpl2631 similar to ubiquinol-cytochrome c oxydoreductase- cytochrome c1 -2.1
lpg0979 aacA42 - - aminoglycoside N(6')acetyltransferase, similar to aacA41 -2.1
lpg0447 lphA/dotK lpp0513 lpl0489 lphA/dotK -2.1
lpg0092 rnr/lidP, vacB lpp0106 lpl0091 similar to exoribonuclease RNase R -2.0
lpg0920 - lpp0981 lpl0951 phosphatidylglycerophosphatase B -2.0
lpg0660 - lpp0715 lpl0697 similar to ABC transporter (permease) -2.0
lpg1063 proP6 - lpl1060 proline/betaine transporter ProP6 -2.0
lpg0448 icmM/dotJ lpp0514 lpl0490 icmM/dotJ -2.0
lpg0895 - lpp0956 lpl0926 unknown -2.0
lpg0950 - lpp1012 lpl0979 similar to hydrolase -2.0
lpg1681 - lpp1654 lpl1647 unknown -1.9
lpg2698 amiB lpp2753 lpl2626 similar to N-acetylmuramoyl-L-alanine amidase -1.9
lpg1706 astA lpp1671 lpl1665 arginine N-succinyltransferase- beta chain  -1.9
lpg0552 sugE lpp0613 lpl0595 similar to suppressor of groEL  -1.9
lpg0175 - lpp0237 lpl0237 similar to pyoverdine biosynthesis protein PvcB -1.9
lpg0957 - lpp1019 lpl0986 similar to hypothetical protein -1.9
lpg2439 - lpp2506 lpl2360 similar to conserved hypothetical protein -1.9
lpg0093 - lpp0107 lpl0092 similar to RNA methyltransferase -1.9
lpg1006 helC lpp2373 lpl1044 efflux protein presumed to function with HelB and HelA -1.9
lpg0002 dnaN lpp0002 lpl0002 DNA polymerase III- beta chain -1.9
lpg1788 fliQ lpp1752 lpl1752 flagellar biosynthetic protein FliQ -1.8
lpg0025 rcp lpp0025 lpl0026 -1.8
lpg1652 iolG lpp1623 lpl1618 similar to myo-inositol 2-dehydrogenase -1.8
lpg0766 - lpp0831 lpl0807 unknown -1.8
lpg1557 pabB lpp1514 lpl1469 similar to para-aminobenzoate synthase- component I -1.8
lpg0831 - lpp0893 lpl0862 similar to flavin-containing monooxygenases -1.8
lpg2802 - lpp2848 lpl2717 similar to DnaA- ATPase involved in DNA replication initiation -1.8
lpg1707 aruD lpp1672 lpl1666 succinylglutamic semialdehyde dehydrogenase -1.8
lpg0247 - lpp0317 lpl0301 unknown -1.8
lpg2809 pepN2 lpp2855 lpl2724 aminopeptidase N -1.8
lpg0466 dcoA lpp0531 lpl0507 oxaloacetate decarboxylase alpha-chain -1.8
lpg1730 ugpE lpp1695 lpl1694 similar to glycerol-3-phosphate ABC transporter- permease component -1.8
lpg0932 aroK lpp0994 lpl0963 shikimate kinase I -1.8
lpg0828 - lpp0890 lpl0859 similar to unknown proteins -1.8
lpg1459 yfdZ lpp1415 lpl1569 similar to putative aminotransferase -1.8
lpg0699 - lpp0754 lpl0736 similar to outer membrane protein TolC -1.8
lpg2980 parC lpp3051 lpl2908 DNA topoisomerase IV- A subunit -1.8
lpg2175 - lpp2127 lpl2101 similar to hypothetical hydrolase proteins -1.7







Gene ID Name Paris ID Lens ID Description FC Ratio1
lpg1426 - lpp1381 lpl1377 unknown -1.7
lpg1416 - lpp1371 lpl1367 similar to purine nucleoside phosphorylase proteins -1.7
lpg0964 - lpp1026 lpl0993 membrane protein- similar to 4-hydroxybenzoate octaprenyltranferase -1.7
lpg2340 kdtA lpp2288 lpl2261 3-deoxy-D-manno-oct-2-ulosonic acid transferase/LPS core biosynthesis -1.7
lpg1867 - lpp1832 lpl1829 similar to site specific recombinase- phage integrase family -1.7
lpg2782 nuoH lpp2829 lpl2698 NADH-quinone oxidoreductase chain H -1.7
lpg2448 - - - transposase, ISSod6 -1.7
lpg1432 - lpp1387 lpl1609 similar to oxidase -1.7
lpg0283 - lpp0359 lpl0335 similar to NAD+-dependent formate dehydrogenase  -1.7
lpg1766 ftsK lpp1730 lpl1730 similar to cell division protein FtsK -1.7
lpg2029 folB lpp2011 lpl2006 similar to dihydroneopterin aldolase -1.7
lpg2892 parB2 lpp2951 lpl2805 similar to chromosome partitioning protein parB -1.7
lpg0255 - lpp0325 lpl0308 similar to outer membrane protein -1.7
lpg1533 ydgR lpp1490 lpl1493 similar to peptide transport proteins -1.7
lpg2858 - lpp2916 lpl2770 similar to unknown protein -1.7
lpg1334 - lpp1288 lpl1287 similar to 2-methylthioadenine synthetase -1.7
lpg2678 - lpp2732 lpl2605 similar to unknown protein -1.7
lpg1293 ispZ lpp1256 lpl1255 similar to intracellular septation protein  -1.7
lpg2341 djlA lpp2289 lpl2262 similar to DnaJ-like protein                             -1.7
lpg0742 - lpp0807 lpl0778 similar to unknown proteins -1.7
lpg2033 recG1 lpp2015 lpl2010 ATP-dependent DNA helicase RecG -1.7
lpg2734 - lpp2790 lpl2659 similar to signal transduction histidine kinase -1.6
lpg2618 murF lpp2671 lpl2541 UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase -1.6
lpg1789 fliP lpp1753 lpl1753 flagellar biosynthetic protein FliP -1.6
lpg0264 - lpp0335 lpl0316 weakly similar to amidase -1.6
lpg2731 - lpp2788 lpl2657 putative response regulator -1.6
lpg0956 - lpp1018 lpl0985 unknown -1.6
lpg0774 - lpp0839 lpl0815 unknown -1.6
lpg2832 - lpp2889 lpl2744 unknown -1.6
lpg2854 - lpp2912 lpl2766 hypothetical tetratricopeptide repeat protein -1.6
lpg0692 dppF lpp0747 lpl0728 similar to ABC transporter ATP-binding protein -1.6
lpg0141 prlC lpp0156 lpl0141 oligopeptidase A -1.6
lpg0681 - - lpl0718 putative lipoprotein -1.6
lpg1276 - lpp1239 lpl1239 similar to electron transfer flavoprotein-ubiquinone oxidoreductase -1.6
lpg2596 - lpp2649 lpl2519 similar to unknown protein -1.6
lpg1608 - lpp1573 - similar to MutT/nudix family protein -1.6
lpg0174 pvcA lpp0236 lpl0236 similar to pyoverdine biosynthesis protein PvcA  -1.6
lpg2072 - - - unknown -1.6
lpg2379 - - - unknown -1.6
lpg2620 smc lpp2673 lpl2543 similar to chromosome partition protein smc -1.6
lpg2825 - similar to cold shock protein -1.6
lpg0187 - lpp0248 - similar to Zn metalloprotein -1.6
lpg0450 icmK/dotH lpp0516 lpl0492 icmK/dotH -1.6
lpg2031 argS lpp2013 lpl2008 arginine tRNA synthetase -1.6
lpg2252 - lpp2206 lpl2178 similar to glutamine synthase -1.6
lpg1506 - lpp1463 lpl1520 putative membrane protein -1.6
lpg2697 mutL lpp2752 lpl2625 DNA mismatch repair protein MutL -1.6
lpg0929 pilO lpp0991 lpl0960 Tfp pilus assembly protein PilO -1.6
lpg1562 merA lpp1519 lpl1464 -1.6
lpg0514 - - lpl0552 unknown -1.6
lpg2044 - lpp2027 lpl2022 similar to conserved hypothetical protein -1.6
lpg1675 purC lpp1647 lpl1640 phosphoribosylamidoimidazole-succinocarboxamide synthase -1.6










1 Fold Change (FC) 
Gene ID Name Paris ID Lens ID Description FC Ratio1
lpg0106 - lpp0120 lpl0106 similar to putative xanthine/uracil permeases -1.6
lpg0708 - lpp0763 lpl0745 weakly similar to L. pneumophila  IcmL protein -1.6
lpg0426 cspD lpp0493 lpl0469 similar to cold shock-like protein CspD -1.5
lpg0914 mraW lpp0975 lpl0945 similar to S-adenosyl-methyltransferase MraW -1.5
lpg2875 glmU lpp2934 lpl2788 -1.5
lpg0117 gcvH lpp0131 lpl0116 similar to glycine cleavage system H protein -1.5
lpg1417 gyrA lpp1372 lpl1368 DNA gyrase- subunit A- type II topoisomerase -1.5
lpg1836a - lpp1800 lpl1801 unknown -1.5
lpg1188 kup21 lpp1190 lpl1196 similar to low affinity potassium transport system protein Kup -1.5
lpg0746 iraB lpp0812 lpl0783 di/tripeptide transporter homolog IraB iron acquisition -1.5
lpg1794 - lpp1758 lpl1758 similar to oxidoreductase -1.5
lpg0947 - lpp1009 lpl0976 similar to 2-oxoglutarate ferredoxin oxidoreductase alpha subunit -1.5
lpg0224 - lpp0283 lpl0278 similar to toxin secretion ABC transporter ATP-binding protein -1.5
lpg0925 ponA lpp0987 lpl0956 similar to peptidoglycan synthetase; penicillin-binding protein 1A -1.5
lpg1425 pyrF lpp1380 lpl1376 orotidine 5`-phosphate decarboxylase -1.5
lpg1626 - lpp1596 lpl1397 putative copper efflux ATPase -1.5
lpg2866 priA lpp2924 lpl2778 primosomal protein N (replication factor Y) -1.5
lpg0483 legA12 lpp0547 lpl0523 protein with ankyrin domain -1.5
lpg2797 rrmJ lpp2843 lpl2712 ribosomal RNA large subunit methyltransferase (cell division protein FtsJ) -1.5
lpg0916 pbpB lpp0977 lpl0947 peptidoglycan synthetase FtsI precursor -1.5
lpg0427 - lpp0494 lpl0470 similar to N-terminus of diadenosine tetraphosphate (Ap4A) hydrolase -1.5
lpg2842 - lpp2901 lpl2754 similar to PhoH protein -1.5
lpg2634 - lpp2687 lpl2559 similar to aminopeptidase -1.5
lpg0059 - lpp0062 lpl0061 unknown -1.5
lpg0813 mreD lpp0875 lpl0846 rod shape-determining protein MreD -1.5
lpg1035 pcoA lpp2345 - similar to copper efflux ATPase -1.5
lpg2718 - lpp2775 lpl2646 unknown -1.5
lpg1868 - lpp1833 lpl1830 similar to ABC transporter- ATP-binding protein -1.5









Figure 4.4.  Comparison of genes regulated in the PE phase and NA-supplemented 
L. pneumophila.   
Black bars indicated genes with high levels of transcriptional activation, while white bars 
denote repressed genes.  Together, 1038 are induced and 883 genes are repressed in both 
the PE phase and NA-treated E phase L. pneumophila.  Transcriptional analysis indicates 
that only a subset of the regulated genes is shared between the two conditions tested.  
Specific to PE bacteria, 324 genes are highly activated, while 448 genes are repressed.  
Microarrays predict that 246 genes are uniquely regulated by NA following a 3 h 








Figure 4.5.  Region of the L. pneumophila chromosome that contains lpg0272-3. 
Arrows indicate orientation of the genes.  Sizes (bp) of the genes are indicated above, 
while the predicted function of each gene is listed below.  Red indicates genes with 
significantly elevated expression levels when treated with 5 mM NA.  Gray indicates 





Table 4.S1.  Genes induced in PE phase as compared to E phase L. pneumophila 
Gene ID Name Paris ID Lens ID Description FC1
lpg1219 flgE lpp1227 lpl1227 flagellar hook protein FlgE 39.4
lpg0891 - lpp0952 lpl0922 regulatory protein (GGDEF and EAL domains) 12.7
lpg0623 - lpp0677 lpl0660 unknown 7.8
lpg1784 flhF lpp1748 lpl1784 flagellar biosynthesis protein FlhF 7.6
lpg0848 - lpp0910 lpl0879 similar to conserved hypothetical protein 7.3
lpg2952 - lpp3023 lpl2881 unknown 7.2
lpg1781 motA1 lpp1745 lpl1745 flagellar motor protein MotA 6.7
lpg2962 - lpp3034 lpl2892 similar to sodium-type flagellar protein MotY 6.5
lpg0550 - lpp0611 - weakly similar to D-amino acid dehydrogenase- C-terminal cAMP binding motif 6.1
lpg0012 - lpp0012 lpl0012 unknown 5.5
lpg0804 - lpp0866 lpl0837 similar to hydrolase 5.5
lpg0871 - lpp0934 lpl0903 unknown 5.5
lpg2324 - lpp2272 lpl2244 L-gulono-gamma-lactone oxidase 4.9
lpg2818 - lpp2871 lpl2734 similar to hypothetical protein 4.8
lpg0953 - lpp1015 lpl0982 similar to long-chain-fatty-acid-CoA ligase 4.6
lpg1221 flgG lpp1229 lpl1229 flagellar biosynthesis protein FlgG 4.5
lpg0034 - lpp0033 lpl0034 unknown 4.5
lpg2210 - lpp2161 lpl2135 unknown 4.4
lpg0426 cspD lpp0493 lpl0469 similar to cold shock-like protein CspD 4.4
lpg1222 flgH lpp1230 lpl1230 flagellar L-ring protein precursor FlgH 4.3
lpg2401 - lpp2466 lpl2324 unknown 4.2
lpg0733 - lpp0799 lpl0770 unknown 4.0
lpg0441 icmT lpp0507 lpl0483 icmT 3.9
lpg0038 legA10 lpp0037 lpl0038 ankyrin repeat-containing protein   3.9
lpg2723 - lpp2780 - similar to transcriptional regulator- ArsR family 3.8
lpg0469 - lpp0534 lpl0510 endonuclease/exonuclease/phosphatase family protein 3.8
lpg0610 - lpp0661 lpl0645 similar to major facilitator family transporter 3.8
lpg2333 - lpp2281 lpl2253 similar to membrane-associated metalloprotease proteins 3.7
lpg1752 - lpp1716 lpl1716 unknown 3.5
lpg1660 legL3 lpp1631 lpl1625 leucine-rich repeat-containig protein 3.5
lpg1173 pilS lpp1175 lpl1181 sensor protein PilS 3.3
lpg0915 - lpp0976 lpl0946 similar to cell division transmembrane protein FtsL 3.3
lpg2385 - lpp2447 lpl2303 some similarity with eukaryotic proteins 3.3
lpg2237 abcT3 lpp2190 lpl2163 similar to multidrug resistance ABC transporter ATP-binding protein 3.3
lpg1667 - lpp1638 lpl1632 unknown 3.3
lpg1183 - lpp1186 lpl1192 unknown 3.2
lpg0236 - lpp0306 lpl0290 unknown 3.2
lpg1427 - lpp1382 lpl1378 similar to short-chain dehydrogenase 3.2
lpg0883 - lpp0945 lpl0915 unknown 3.1
lpg2038 - lpp2021 lpl2016 similar to cell division protein ftsB homolog 3.0
lpg1577 rpoE lpp1535 lpl1448 sigma factor RpoE (sigma 24)   3.0
lpg2186 pksJ lpp2136 lpl2111 polyketide synthase, type I 2.9
lpg2655 - lpp2708 lpl2581 sensory box protein, EAL and GGDEF domain 2.9
lpg1293 ispZ lpp1256 lpl1255 intracellular septation protein A 2.9
lpg1146 - lpp1148 lpl1152 similar to thermostable carboxypeptidase 1 2.8
lpg0824 - lpp0886 lpl0855 rhomboid family protein 2.8
lpg1044 - lpp2337 - similar to NADH oxidoreductase 2.8
lpg1108 - lpp1108 lpl1108 putative lipase 2.8
lpg2481 - lpp2545 lpl2401 integral membrane protein- similar to metabolite efflux pump 2.8
lpg2681 - lpp2735 lpl2608 similar to aldolase 2.8
lpg0609 alaS lpp0660 lpl0644 similar to a domain of alanyl-tRNA synthetase 2.8
lpg1750 clpB lpp1714 lpl1714 endopeptidase Clp ATP-binding chain B (ClpB) 2.7
lpg2016 - lpp1998 lpl1993 hypothetical gene, YGGT family protein 2.7






Gene ID Name Paris ID Lens ID Description FC1
lpg2410 - lpp2479 lpl2334 similar to conserved hypothetical protein 2.7
lpg1176 - lpp1179 lpl1185 Zn-dependent protease 2.6
lpg2530 aroF lpp2595 lpl2451 phospho-2-dehydro-3-deoxyheptonate aldolase 2.6
lpg1893 - lpp1860 lpl1855 similar to major facilitator family transporter (MFS) 2.6
lpg1056 - lpp2325 lpl1053 guanylate cyclase 2.6
lpg2851 hemG lpp2909 lpl2763 protoporphyrinogen oxidase 2.6
lpg2883 - lpp2942 lpl2796 3-octaprenyl-4-hydroxybenzoate carboxy-lyase 2.6
lpg1761 fliE lpp1725 lpl1725 flagellar hook-basal body complex protein 2.6
lpg2204 - lpp2155 lpl2129 similar to alginate o-acetyltransferase AlgI 2.6
lpg0614 - lpp0665 lpl0649 similar to hypothetical protein 2.6
lpg2348 sodC lpp2297 lpl2270 superoxide dismutase [Cu-Zn] precursor 2.6
lpg1702 - lpp1667 lpl1661 unknown 2.6
lpg0365 - lpp0430 lpl0406 unknown 2.6
lpg0798 - lpp0860 lpl0831 similar to unknown proteins 2.6
lpg0697 sul1 lpp0752 lpl0734 similar to inorganic transporter and to carbonic anhydrase (bi-functional)  2.6
lpg1745 - lpp1709 lpl1709 similar to iron-sulpher cluster proteins NifU 2.5
lpg2733 - lpp2789 lpl2658 putative membrane protein 2.5
lpg2837 - lpp2894 lpl2749 2.5
lpg2178 mexF2 lpp2130 lpl2104 similar to RND multidrug efflux transporter  2.5
lpg2531 - lpp2596 lpl2452 similar to chorismate mutase (N-terminal part) 2.5
lpg1217 flgC lpp1225 lpl1225 flagellar basal-body rod protein FlgC 2.5
lpg0445 icmP/dotM lpp0511 lpl0487 icmP/dotM 2.4
- lpp2413 weakly similar to serine/threonine protein kinase 2.4
lpg2405 mutT lpp2470 lpl2328 mutator MutT protein 2.4
lpg0874 pntB lpp0937 lpl0907 NAD(P) transhydrogenase subunit beta 2.4
lpg1762 fleR lpp1726 lpl1726 similar to two-component response regulator 2.4
lpg1668 - lpp1639 lpl1633 unknown 2.3
lpg2391 sdbC lpp2458 lpl2315 SdbC proteins- putative substrate of the Dot/Icm system 2.3
lpg0560 phaB1 lpp0620 lpl0603 acetoacetyl-CoA reductase 2.3
lpg2225 - lpp2176 lpl2150 similar to other proteins 2.3
lpg0443 icmR lpp0509 lpl0485 icmR 2.3
lpg2532 aspB lpp2598 lpl2454 similar to aspartate aminotransferase 2.3
lpg1150 - lpp1152 lpl1156 similar to E. coli Ada protein (O-6-methylguanine-DNA methyltransferase) 2.3
lpg0879 - lpp0942 lpl0912 two-component response regulator with GGDEF domain 2.3
lpg2239 - lpp2192 - unknown 2.3
lpg1054 atpD1 lpp2328 ATP synthase F1, beta chain    2.3
lpg2997 - lpp3068 lpl2925 similar to alkane monooxygenase 2.2
lpg0823 - lpp0885 lpl0854 hypothetical gene 2.2
lpg1413 glpD lpp1368 lpl1364 glycerol-3-phosphate dehydrogenase 2.2
lpg2664 - lpp2718 lpl2591 similar to biotin carboxylase (A subunit of acetyl-CoA carboxylase) 2.2
lpg1674 purF lpp1646 lpl1639 amidophosphoribosyltransferase 2.2
lpg1130 cyaA4 lpp1131 lpl1135 adenylate cyclase 2.2
lpg0453 icmC/dotE lpp0519 lpl0495 icmC/dotE 2.2
lpg2307 grxC lpp2255 lpl2226 similar to glutaredoxin Grx     2.2
lpg1655 lasB lpp1626 lpl1620 class 4 metalloprotease 2.2
lpg2298 legC7 lpp2246 lpl2217 inclusion membrane protein A 2.2
lpg1759 fliG lpp1723 lpl1723 flagellar motor switch protein 2.2
lpg1890 legLC8 lpp1857 lpl1852 unknown 2.2
lpg1634 - lpp1604 - similar to oxidoreductase proteins  2.2
lpg1760 fliF lpp1724 lpl1724 flagellar M-ring protein 2.2
lpg2195 - lpp2144 lpl2119 hypothetical gene 2.2
lpg0246 - lpp0316 lpl0300 unknown 2.2
lpg1900 - lpp1873 lpl1864 unknown 2.2
lpg2424 - lpp2489 lpl2347 unknown 2.2
lpg0803 - lpp0865 lpl0836 similar to acyl-CoA dehydrogenase 2.2
lpg1568 thiDE lpp1526 lpl1457 similar to phosphomethylpyrimidine kinase/thiamin-phosphate pyrophosphorylase 2.1
lpg1401 pilZ lpp1356 lpl1352 similar to type 4 fimbrial biogenesis protein PilZ 2.1
lpg2874 - lpp2933 lpl2787 unknown 2.1







Gene ID Name Paris ID Lens ID Description FC1
lpg1136 - lpp1137 lpl1142 similar to hypothetical protein 2.1
lpg2382 - lpp2444 lpl2300 unknown 2.1
lpg0442 icmS lpp0508 lpl0484 icmS 2.1
lpg1248 virB9 lpp0177 lpl0159 Legionella  vir homologue protein 2.1
lpg1888 - lpp1855 lpl1850 unknown 2.1
lpg0026 - lpp0026 lpl0027 similar to amino acid permease 2.1
lpg1066 - lpp1085 lpl1063 unknown 2.1
lpg0472 dotV lpp0537 lpl0513 dotV 2.1
lpg1632 - lpp1602 - similar to glycosyltransferase 2.0
lpg1368 - lpp1322 lpl1319 unknown 2.0
lpg0203 yfhG lpp0263 lpl0258 similar to hypothetical protein 2.0
lpg1617 - lpp1587 lpl1406 weakly similar to cytochrome C family proteins 2.0
lpg2048 - lpp2031 lpl2026 unknown 2.0
lpg2436 - lpp2503 lpl2357 putative membrane protein 2.0
lpg2682 - lpp2736 lpl2609 similar to hypothetical proteins 2.0
lpg1758 fliH lpp1722 lpl1722 polar flagellar assembly protein FliH 2.0
lpg2193 - lpp2142 lpl2117 similar to sulfate transporters 2.0
lpg2806 - lpp2852 lpl2721 unknown 2.0
lpg0262 - lpp0333 lpl0314 bacteriophage-related DNA polymerase 2.0
lpg2828 - lpp2882 lpl2743 unknown 2.0
lpg1791 fliN lpp1755 lpl1755 flagellar motor switch protein FliN 2.0
lpg1404 - lpp1359 lpl1355 similar to major facilitator membrane proteins 2.0
lpg0210 - lpp0269 lpl0264 unknown 2.0
lpg1892 - lpp1859 lpl1854 signal peptide predicted 2.0
lpg1450 - lpp1405 - similar to oxidoreductase 2.0
lpg1907 - lpp1882 lpl1871 unknown 2.0
lpg1048 - lpp2334 - similar to ATP synthase alpha chain 2.0
lpg1169 - lpp1171 lpl1177 similar to unknown protein 2.0
lpg0561 phaB2 lpp0621 lpl0604 acetoacetyl-CoA reductase 1.9
lpg0249 - lpp0319 lpl0303 similar to fatty acid desaturase 1.9
lpg2019 - lpp2001 lpl1996 similar to serine protease 1.9
lpg0663 - lpp0720 lpl0700 similar to soluble lytic murein transglycosylase 1.9
lpg0853 fleQ lpp0915 lpl0884 transcriptional regulator FleQ 1.9
lpg1721 yfhC lpp1686 lpl1685 deaminase 1.9
lpg1322 cyaA lpp1277 lpl1276 adenylate cyclase 1 protein 1.9
lpg2687 icmV lpp2741 lpl2614 intracellular multiplication protein IcmV 1.9
lpg1722 guaA lpp1687 lpl1686 similar to GMP synthetase (glutamine-hydrolyzing) 1.9
lpg0058 - lpp0061 lpl0060 similar to glutaredoxin 1.9
lpg1891 - lpp1858 lpl1853 similar to hypothetical protein 1.9
lpg1773 - lpp1737 lpl1737 unknown 1.9
lpg0850 - lpp0912 lpl0881 similar to conserved hypothetical protein 1.9
lpg1524 pilD lpp1481 lpl1502 type 4 prepilin-like proteins leader peptide processing enzyme 1.9
lpg1297 folD lpp1261 lpl1260 methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase 1.9
lpg1284 rpoS lpp1247 lpl1247 RNA polymerase sigma factor RpoS 1.9
lpg2491 - lpp2556 lpl2412 similar to conserved hypothetical protein 1.9
lpg0217 purK lpp0276 lpl0271 phosphoribosylaminoimidazole carboxylase- ATPase subunit 1.8
lpg1947 - lpp1930 - unknown 1.8
lpg2468 - lpp2533 lpl2388 similar to coenzyme F42 unknown-reducing hydrogenase- gamma subunit 1.8
lpg1785 flhA lpp1749 lpl1749 flagellar biosynthesis protein flhA 1.8
lpg1289 - lpp1252 lpl1252 unknown 1.8
lpg2972 - lpp3044 lpl2902 similar to putative translation initiation protein 1.8
lpg2412 ampC lpp2481 lpl2336 similar to beta-lactamase precursor (cephalosporinase) 1.8
lpg1430 ubiA lpp1385 lpl1381 similar to 4-hydroxybenzoate-octaprenyltransferase 1.8
lpg0079 - lpp0093 lpl0081 similar to monooxygenase 1.8
lpg1250 virB6 lpp0175 lpl0157 Legionella  vir homologue protein 1.8
lpg1128 - lpp1129 lpl1134 similar to guanine deaminase 1.8






Gene ID Name Paris ID Lens ID Description FC1
lpg2579 - lpp2631 lpl2501 unknown 1.8
lpg1008 helA lpp2371 lpl1046 similar to cation efflux system protein CzcA- may function with HelC and HelB 1.8
lpg1449 - lpp1404 - unknown 1.8
lpg2170 - lpp2108 lpl2097 predicted membrane protein 1.8
lpg1357 - lpp1311 lpl1308 regulatory protein (GGDEF and EAL domains) 1.8
lpg0103 vipF lpp0117 lpl0103 N-terminal acetyltransferase, GNAT family 1.8
lpg2226 - lpp2177 lpl2151 isovaleryl CoA dehydrogenase 1.7
lpg0997 - lpp1068 lpl1030 unknown 1.7
lpg2389 katB lpp2454 lpl2313 catalase-peroxidase KatB 1.7
lpg1789 fliP lpp1753 lpl1753 flagellar biosynthetic protein FliP 1.7
lpg2683 dlpA lpp2737 lpl2610 DlpA protein (isocitrate and isopropylmalate dehydrogenases family protein) 1.7
lpg1937 - lpp1918 lpl1907 similar to conserved hypothetical protein 1.7
lpg1172 lidL lpp1174 lpl1180 similar to conserved hypothetical protein- similar to C-terminal part of EnhC protein 1.7
lpg0496 argF lpp0558 lpl0534 ornithine carbamoyltransferase 1.7
lpg1822 - lpp1785 lpl1786 predicted transmembrane protein 1.7
lpg2975 - lpp3047 lpl2904 unknown 1.7
lpg1665 - lpp1636 lpl1630 similar to putative membrane proteins 1.7
lpg1063 proP6 lpp1082 lpl1060 proline/betaine transporter 1.7
lpg1874 - lpp1839 lpl1836 similar to general secretion pathway protein L 1.7
lpg1457 relA lpp1413 lpl1571 GTP pyrophosphokinase 1.7
lpg0280 - lpp0355 lpl0332 similar to transcriptional regulator lysR family 1.7
lpg1104 - lpp1103 lpl1103 unknown 1.7
lpg0963 - lpp1025 lpl0992 unknown 1.7
lpg2349 - lpp2298 lpl2271 similar to alkyl hydroperoxide reductase AhpD 1.7
lpg1022 deoA lpp2359 similar to thymidine/pyrimidine-nucleoside phosphorylase 1.7
lpg2235 - lpp2188 lpl2161 similar to sterol desaturase-related protein 1.7
lpg1603 plaB lpp1568 lpl1422 phospholipase 1.7
lpg1216 flgB lpp1224 lpl1224 flagellar basal-body rod protein FlgB 1.7
lpg2179 - lpp2131 - similar to peptide synthase 1.7
lpg1806 - lpp1769 lpl1770 similar to hypothtical proteins 1.7
lpg1405 - lpp1360 lpl1356 similar to multidrug translocase 1.7
lpg1370 fis2 lpp1324 lpl1321 similar to DNA-binding protein Fis 1.7
lpg1007 helB lpp2372 lpl1045 cation efflux system HelB 1.7
lpg0196 - lpp0254 lpl0252 unknown 1.7
lpg0837 - lpp0899 lpl0868 similar to conserved hypothetical protein 1.7
lpg0271 pncA lpp0345 lpl0323 nicotinamidase/pyrazinamidase 1.6
lpg2485 - lpp2549 lpl2405 protein with TPR motifs (protein-protein interaction motif) 1.6
lpg0716 - lpp0782 lpl0753 unknown 1.6
lpg0999 - lpp1070 lpl1032 similar to conserved hypothetical protein 1.6
lpg0990 - lpp1061 lpl1023 similar to unknown proteins 1.6
lpg0714 - lpp0780 lpl0751 similar to two-component sensor histidine kinase 1.6
lpg2796 ftsH lpp2842 lpl2711 cell division protease ftsH 1.6
lpg0430 - lpp0497 lpl0473 similar to multidrug resistance efflux pump 1.6
lpg1737 gatB lpp1702 lpl1701 glutamyl-tRNA (Gln) amidotransferase (subunit B) 1.6
lpg2738 hemY lpp2794 lpl2663 protoporphyrinogen IX and coproporphyrinogen III oxidase HemY 1.6
lpg0935 - lpp0997 lpl0966 similar to universal stress protein A 1.6
lpg2875 glmU lpp2934 lpl2788 1.6
lpg1479 - lpp1435 lpl1549 similar to potassium efflux system kefA 1.6
lpg0876 pntAa lpp0939 lpl0909 pyridine nucleotide transhydrogenase- alpha subunit  1.6
lpg0231 - lpp0301 lpl0284 similar to cation transport ATPase 1.6
lpg0949 - lpp1011 lpl0978 predicted membrane protein- similar to transporter 1.6
lpg1955 - lpp1937 lpl1924 similar to other protein 1.6
lpg1757 fliI lpp1721 lpl1721 flagellum-specific ATP synthase FliI 1.6
lpg0734 - lpp0800 lpl0771 similar to glutamine-dependent NAD(+) synthetase 1.6
lpg0140 - lpp0155 lpl0140 unknown 1.6
lpg1723 guaB lpp1688 lpl1687 similar to IMP dehydrogenase/GMP reductase 1.6
lpg2013 pilT lpp1995 lpl1990 twitching motility protein PilT 1.6
lpg0563 - lpp0623 lpl0606 unknown 1.6
lpg2342 - lpp2290 lpl2263 unknown 1.6
lpg2824 recN2 lpp2877 lpl2739 DNA repair protein recN 1.6
lpg2614 murC lpp2667 lpl2537 UDP-N-acetylmuramate--L-alanine ligase 1.6
lpg2676 dotB lpp2730 lpl2603 defect in organelle trafficking protein DotB (ATPase)  1.6
lpg2959 - lpp3030 lpl2888 conserved hypothetical protein 1.6
lpg2737 hemX lpp2793 lpl2662 similar to uroporphyrinogen III methylase HemX 1.5







1 Fold Change (FC)
Gene ID Name Paris ID Lens ID Description FC1
lpg2852 amiC lpp2910 lpl2764 similar to amidase 1.5
lpg1480 mutH lpp1436 lpl1548 similar to DNA mismatch repair protein mutH 1.5
lpg2177 - lpp2129 lpl2103 hlyD family secretion protein 1.5
lpg0011 resA lpp0011 lpl0011 thiol-disulfide oxidoreductase resA 1.5
lpg1743 fis3 lpp1707 lpl1707 similar to DNA-binding protein fis 1.5
lpg2613 murB lpp2666 lpl2536 UDP-N-acetylenolpyruvoylglucosamine reductase 1.5
lpg2423 - lpp2488 lpl2346 unknown 1.5
lpg1542 - lpp1499 lpl1484 conserved hypothetical protein  1.5
lpg2533 tehB lpp2599 lpl2455 similar to tellurite resistance protein TehB 1.5
lpg0738 dnaB lpp0803 lpl0774 replicative DNA helicase 1.5
lpg0695 legA8 lpp0750 lpl0732 ankyrin repeat protein 1.5
lpg1440 - lpp1395 lpl1601 similar to conserved hypothetical protein 1.5






Table 4.S2.  Genes repressed in PE phase as compared to E phase L. pneumophila 
Gene ID Name Paris ID Lens ID Description FC Ratio1
lpg2002 yajC lpp1983 lpl1978 similar to preprotein translocase  -14.5
lpg0063 aroH - - phospho-2-dehydro-3-deoxyheptonate aldolase -14.2
lpg0064 - - - unknown -11.2
lpg0479 rpmB lpp0544 lpl0520 50S ribosomal protein L28 -10.3
lpg2489 radC lpp2553 lpl2409 DNA repair protein RadC -7.0
lpg1997 - lpp1978 lpl1973 unknown -6.7
lpg0067 - - - YdeN-like -6.0
lpg2653 pth lpp2706 lpl2578 similar to peptidyl-tRNA hydrolase -5.9
lpg1862 tig lpp1830 lpl1826 peptidyl-prolyl cis-trans isomerase (trigger factor) -5.8
lpg2651 rplU lpp2704 lpl2576 50S ribosomal protein L21 -5.6
lpg0478 rpL33 lpp0543 lpl0519 50S ribosomal subunit protein L33 -5.5
lpg0260 - lpp0332 lpl0313 unknown -5.5
lpg0320 rplJ lpp0385 lpl0360 50S ribosomal subunit protein L1 unknown -5.3
lpg1592 rpsF lpp1550 lpl1433 30S ribosomal protein S6 -4.9
lpg2988 atpB lpp3059 lpl2916 highly similar to H+-transporting ATP synthase chain a -4.8
lpg1590 - lpp1548 lpl1435 similar to unknown protein -4.7
lpg2329 xseB lpp2277 lpl2249 similar to exodeoxyribonuclease VII- small subunit   -4.6
lpg0542 fis1 lpp0606 lpl0587 similar to DNA-binding proteins Fis -4.5
lpg2101 merA12 - - similar to merA1, mercuric reductase -4.4
lpg1591 rpsR lpp1549 lpl1434 30S ribosomal subunit protein S18 -4.3
lpg2213 - lpp2164 lpl2138 similar to hemin binding protein Hbp -4.3
lpg2636 rpsT lpp2689 lpl2561 30S ribosomal subunit protein S2 unknown -4.2
lpg1422 - lpp1377 lpl1373 similar to conserved hypothetical protein -4.2
lpg1832 - lpp1795 lpl1796 similar to unknown proteins -4.1
lpg0068 - - - transmembrane protein -4.1
lpg0172 - lpp0234 - unknown -4.1
lpg1520 - lpp1477 lpl1506 similar to hypothetical protein -4.0
lpg0342 rpsN lpp0407 lpl0382 30S ribosomal protein S14 -3.9
lpg2989 atpI lpp3060 lpl2917 similar to ATP synthase subunit i -3.9
lpg0042 - lpp0042 lpl0041 unknown -3.8
lpg3005 rpmH lpp3077 lpl2933 50S ribosomal protein L34 -3.8
lpg2650 rpmA lpp2703 lpl2575 50S ribosomal protein L27 -3.8
lpg0358 - lpp0423 lpl0399 similar to 3-oxoacyl-[acyl-carrier protein] reductase -3.8
lpg3003 - lpp3075 lpl2931 similar to conserved hypothetical protein -3.8
lpg0335 rpsC lpp0400 lpl0375 30S ribosomal protein S3 -3.7
lpg1982 - lpp1963 lpl1957 some similarity with eukaryotic proteins / Shorter in phila -3.7
lpg2694 legD1 lpp2748 lpl2621 similar to eukaryotic phytanoyl-CoA dioxygenase -3.7
lpg0408a - lpp0475 lpl0451 similar to putative transmembrane proteins -3.6
lpg0732 - lpp0798 lpl0769 weakly similar to outer membrane protein -3.6
lpg0922 etfB lpp0984 lpl0953 electron transfer flavoprotein beta-subunit (Beta-ETF) -3.6
lpg0339 rplN lpp0404 lpl0379 50S ribosomal protein L14 -3.6
lpg2707 rplM lpp2762 lpl2635 50S ribosomal subunit protein L13 -3.6
lpg0507 - lpp0570 lpl0546 similar to putative outer membrane proteins -3.5
lpg0353 rpsD lpp0418 lpl0394 30S ribosomal subunit protein S4 -3.5
lpg1546 - lpp1503 lpl1480 similar to fimbrial biogenesis and twitching motility protein (type 4) -3.4
lpg0287 efp lpp0365 lpl0340 similar to elongation factor P  -3.4
lpg1749 sppA lpp1713 lpl1713 similar to putative signal peptide peptidases -3.4
lpg1556 - lpp1513 lpl1470 similar to unknown protein /MutT/nudix family protein -3.4
lpg1776 - lpp1740 lpl1740 unknown -3.4
lpg0345 rplR lpp0410 lpl0385 50S ribosomal subunit protein L18 -3.4
lpg1921 - lpp1896 lpl1885 similar to conserved hypothetical protein -3.3






Gene ID Name Paris ID Lens ID Description FC Ratio1
lpg0601 ycf24 lpp0652 lpl0636 similar to ABC transporter- permease component -3.3
lpg2864 - lpp2922 lpl2776 similar to conserved hypothetical protein -3.3
lpg0600 - lpp0651 lpl0635 similar to conserved hypothetical protein -3.3
lpg2981 atpC lpp3052 lpl2909 highly similar to H+-transporting ATP synthase epsilon chain -3.3
lpg1396 acpP2 lpp1351 lpl1347 acyl carrier protein (ACP) -3.3
lpg0325 rps7 lpp0390 lpl0365 30S ribosomal protein S7 -3.2
lpg1519 ppt lpp1476 lpl1507 putative pyrimidine phosphoribosyl transferase -3.2
lpg1558 - lpp1515 lpp1468 similar to pyruvate dehydrogenase- (E1 alpha subunit) -3.2
lpg2912 - lpp2980 lpl2830 unknown -3.1
lpg2094 csrA lpp0845 lpl0820 global regulator CsrA -3.1
lpg2727 tgt2 lpp2784 lpl2653 similar to queuine tRNA-ribosyltransferase  -3.1
lpg0351 rpsM lpp0416 lpl0392 30S ribosomal protein S13 -3.1
lpg0474 pssA lpp0539 lpl0515 -3.1
lpg2765 hit lpp2813 lpl2682 similar to HIT (histidine triad nucleotide-binding protein) family protein -3.1
lpg2838 - lpp2897 lpl2750 similar to unknown protein -3.1
lpg0100 lpxD lpp0114 lpl0100 -3.1
lpg0650 rpmE lpp0704 lpl0686 50S ribosomal protein L31 -3.1
lpg2706 rpsI lpp2761 lpl2634 30S ribosomal subunit protein S9 -3.0
lpg0484 hflK lpp0548 lpl0524 protease subunit HflK -3.0
lpg2487 dut lpp2551 lpl2407 deoxyuridine 5 -triphosphate nucleotidohydrolase (dUTPase) -3.0
lpg2662 panC lpp2716 lpl2589 similar to pantothenate synthetases -3.0
lpg2714 thrS lpp2770 lpl2643 threonyl tRNA synthetase -3.0
lpg2712 rplT lpp2767 lpl2640 50S ribosomal protein L2 unknown -3.0
lpg2043 pal lpp2026 lpl2021 peptidoglycan-associated lipoprotein precursor (19 kDa surface antigen) (PPL) -2.9
lpg2308 secB lpp2256 lpl2227 similar to protein-export protein SecB -2.9
lpg2661 panB lpp2715 lpl2588 similar to 3-methyl-2-oxobutanoatehydroxymethyltransferase -2.9
lpg0328 rpsJ lpp0393 lpl0368 30S ribosomal subunit protein S1 unknown -2.9
lpg1803 - lpp1766 lpl1766 unknown -2.9
lpg0085 - lpp0099 lpl0084 putative secreted protein -2.9
lpg1167 - lpp1169 lpl1175 similar to conserved hypothetical protein -2.9
lpg0777 lag-1 lpp0841 lpl0816 O-acetyltransferase -2.9
lpg0372 smpA lpp0437 lpl0413 similar to other protein -2.9
lpg1162 - lpp1164 lpl1170 similar to other proteins -2.9
lpg0769 - lpp0834 lpl0810 unknown -2.8
lpg1689 - lpp1658 lpl1652 unknown -2.8
lpg0640 hslV lpp0694 lpl0677 peptidase component of the HslUV protease (heat shock protein) -2.8
lpg0602 - lpp0653 lpl0637 similar to ABC transporter ATP-binding protein -2.8
lpg0811 mreB lpp0873 lpl0844 rod shape-determining protein MreB -2.8
lpg2999 legP lpp3071 lpl2927 similar to eukaryotic zinc metalloproteinase -2.8
lpg0330 rplD lpp0395 lpl0370 50S ribosomal subunit protein L4 -2.8
lpg1840 glyQ lpp1804 lpl1805 glycyl-tRNA synthetase alpha chain -2.8
lpg0354 rpoA lpp0419 lpl0395 DNA-directed RNA polymerase alpha chain -2.7
lpg1658 - lpp1629 lpl1623 similar to amino acid transporter -2.7
lpg2956 dcd lpp3027 lpl2885 deoxycytidine triphosphate deaminase -2.7
lpg1005 lvrA lpp1076 lpl1038 lvrA -2.7
lpg2598 - lpp2651 lpl2521 similar to unknown protein -2.6
lpg2359 lporfX lpp2308 lpl2281 similar to conserved hypothetical protein -2.6
lpg1593 - lpp1551 lpl1432 similar to carbon storage regulator CsrA -2.6
lpg2577 - lpp2629 lpl2499 unknown -2.6
lpg0606 - lpp0657 lpl0641 similar to conserved hypothetical protein   -2.6
lpg2935 trxA lpp3003 lpl2864 highly similar to thioredoxin -2.6
lpg1535 - lpp1492 lpl1491 similar to rubredoxin protein    -2.6
lpg2713 infC lpp2769 lpl2642 translation initiation factor IF-3 -2.6
lpg0855 - lpp0917 lpl0886 similar to protease -2.6
lpg0370 - lpp0435 lpl0411 similar to conserved hypothetical proteins -2.5
lpg2840 - lpp2899 lpl2752 highly similar to bacterioferritin comigratory protein -2.5
similar to CDP-diacylglycerol-serine O-phosphatidyltransferase 
(phosphatidylserine synthase) 
similar to UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine N-
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lpg2462 - lpp2528 lpl2381 similar to hypothetical protein -2.5
lpg0296 - lpp0374 lpl0349 similar to conserved hypothetical protein -2.5
lpg0475 ptsH lpp0540 lpl0516 similar to sugar transport PTS phosphocarrier protein Hpr   -2.5
lpg1314 - lpp2055 - unknown -2.5
lpg0282 - lpp0358 lpl0334 some similarity with eukaryotic proteins -2.5
lpg1770 infA lpp1734 lpl1734 translation initiation factor IF-1 -2.5
lpg2116 - - - transposase -2.5
lpg2644 sclB lpp2697 lpl2569 similar to putative protein from Stx2 converting bacteriophage I -2.5
lpg2695a - lpp2750 lpl2623 similar to unknown proteins -2.5
lpg2339 - lpp2287 lpl2260 unknown -2.5
lpg0482 - lpp0546 lpl0522 similar to endo-1-4-beta-glucanase (hypothetical) -2.5
lpg0856 ccmA lpp0918 lpl0887 heme exporter protein CcmA -2.5
lpg3004 rnpA lpp3076 lpl2932 similar to ribonuclease P protein component (RNase P) -2.5
lpg0724 - lpp0790 lpl0761 similar to predicted periplasmic or secreted lipoprotein -2.5
lpg0485 hflC lpp0549 lpl0525 membrane protease subunit HflC -2.5
lpg1585 - lpp1543 lpl1440 unknown -2.5
lpg0486 purA lpp0550 lpl0526 adenylosuccinate synthetase (IMP-aspartate ligase) (AdSS) (AMPSase) -2.4
lpg2121 - lpp2041 lpl2039 similar to cold shock protein -2.4
lpg1966 - lpp1947 - unknown -2.4
lpg2827 - lpp2881 lpl2742 similar to conserved hypothetical protein -2.4
lpg2474 hypF lpp2539 lpl2394 hydrogenase maturation protein HypF -2.4
lpg0819 - lpp1851 lpp0038 similar to transposase (IS4 family) -2.4
lpg0149 - - - hypothetical protein -2.4
lpg2417 - - lpl2340 hypothetical protein -2.4
lpg2448 - - - transposase, ISSod6 -2.4
lpg0773 wzt lpp0838 lpl0814 ABC transporter of LPS O-antigen- Wzt -2.4
lpg1138 potD lpp1140 lpl1145 similar to spermidine/putrescine-binding periplasmic protein precursor potD -2.4
lpg0324 rpsL lpp0389 lpl0364 30S ribosomal protein S12 -2.4
lpg1383 rnhA lpp1338 lpl1334 similar to ribonuclease HI -2.4
lpg1999 - lpp1980 lpl1975 similar to pterin-4-alpha-carbinolamine dehydratase phhB -2.4
lpg2463 - lpp2530 lpl2383 similar to aspartyl/asparaginyl beta-hydroxylase -2.4
lpg2774 - lpp2822 lpl2691 similar to conserved hypothetical protein -2.4
lpg1163 - lpp1165 lpl1171 similar to permeases of the major facilitator superfamily (MFS) -2.4
lpg1395 fabG lpp1350 lpl1346 -2.4
lpg0329 rplC lpp0394 lpl0369 50S ribosomal subunit protein L3 -2.3
lpg2631 pepA lpp2684 lpl2556 similar to leucine aminopeptidase -2.3
lpg1920 lpxK lpp1895 lpl1884 similar to hypothetical protein -2.3
lpg2960 - lpp3031 lpl2889 similar to major outer membrane protein precursor -2.3
lpg1510 ala lpp1467 lpl1516 similar to D-alanine aminotransferase -2.3
lpg1142 - lpp1144 - hypothetical protein- similar to endonuclease -2.3
lpg1200 hisG lpp1202 lpl1208 ATP phosphoribosyltransferase -2.3
lpg2825 - lpp2878 lpl1057 similar to cold shock protein CspC -2.3
lpg2769 rpsO lpp2817 lpl2686 30S ribosomal protein S15 -2.3
lpg1333 rluD lpp1287 lpl1286 ribosomal large subunit pseudouridine synthase D (uracil hydrolyase) -2.3
lpg2026 grpE lpp2008 lpl2003 heat-shock protein GrpE (HSP-7 unknown cofactor) -2.3
lpg2568 - - - hypothetical protein -2.3
lpg0065 - - - unknown -2.3
lpg1529 prpD lpp1486 lpl1497 2-methylcitrate dehydratase -2.3
lpg1854 fabI lpp1821 lpl1820 similar to enoyl-[acyl-carrier-protein] reductase -2.3
lpg2548 - lpp2617 lpl2469 predicted transmembrane protein  -2.3
lpg1800 recX lpp1764 lpl1764 regulatory protein RecX -2.3
lpg1703 umuC lpp1668 lpl1662 similar to error-prone repair protein -2.2
lpg1410 - lpp1365 lpl1361 similar to unknown protein -2.2
lpg1919 kdsB lpp1894 lpl1883 3-deoxy-manno-octulosonate cytidylyltransferase -2.2
lpg2717 - lpp2773 lpl2645 unknown -2.2
lpg0815 - lpp0877 lpl0848 unknown -2.2
lpg0690 - lpp0745 lpl0726 similar to conserved hypothetical protein- predicted membrane protein -2.2
lpg1589 rplI lpp1547 lpl1436 50S ribosomal protein L9 -2.2
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lpg1923 - lpp1898 lpl1887 similar to ferredoxin -2.2
lpg1975 - - - unknown -2.2
lpg0133 proQm lpp0148 lpl0133 similar to N-terminus of ProQ- activator of ProP osmoprotectant transporter -2.2
lpg2860 - lpp2918 lpl2772 unknown -2.2
lpg1534 hemL lpp1491 lpl1492 similar to glutamate-1-semialdehyde-2-1-aminomutase -2.2
lpg0605 - lpp0656 lpl0640 NifU protein family- possibly involved in formation or repair of [Fe-S] clusters -2.2
lpg1101 - lpp1101 lpl1100 unknown -2.2
lpg1943 - lpp1924 lpl1913 similar to hypothetical protein -2.2
lpg0919 - lpp0980 lpl0950 unknown -2.1
lpg1649 iolE lpp1620 lpl1615 similar to myo-inositol catabolism protein iolE -2.1
lpg2284 - lpp2238 lpl2210 similar to ATP-binding component of ABC transporter -2.1
lpg0758 rmlB lpp0824 lpl0795 dTDP-D-glucose 4-6-dehydratase rhamnose biosynthesis -2.1
lpg1662 - lpp1633 lpl1627 similar to putative transport proteins- MFS family -2.1
lpg1418 serC lpp1373 lpl1369 similar to phosphoserine aminotransferase -2.1
lpg0755 yvfE lpp0821 lpl0792 similar to polysaccharide biosynthesis protein -2.1
lpg0858 ccmC lpp0920 lpl0889 heme exporter protein CcmC -2.1
lpg1392 plsX lpp1347 lpl1343 fatty acid/phospholipid synthesis protein -2.1
lpg1996 - lpp1977 lpl1972 unknown -2.1
lpg0973 - lpp1034 lpl1001 unknown -2.1
lpg2763 - lpp2811 lpl2680 similar to unknown protein -2.1
lpg1193 hisI lpp1195 lpl1201 -2.1
lpg0434 - lpp0501 lpl0477 unknown -2.1
lpg2695 - lpp2749 lpl2622 similar to glycosyltransferase -2.1
lpg2702 sspA lpp2757 lpl2630 similar to stringent starvation protein A -2.1
lpg0727 nusB lpp0793 lpl0764 similar to N utilization substance protein B homolog -2.1
lpg2949 wbm1 - - asparagine synthase -2.1
lpg1998 hisC2 lpp1979 lpl1974 similar to histidinol-phosphate aminotransferase -2.1
lpg2293 pgsA lpp2240 lpl2212 similar to CDP-diacylglycerol- glycerol-3-phosphate 3-phosphatidyltransferase -2.1
lpg0860 ccmE lpp0922 lpl0891 cytochrome c-type biogenesis protein CcmE -2.1
lpg0125 - lpp0139 lpl0124 similar to GTP-binding protein -2.0
lpg1384 dnaQ lpp1339 lpl1335 similar to DNA polymerase III- epsilon chain -2.0
lpg1476 - lpp1432 lpl1552 similar to conserved hypothetical protein -2.0
lpg2036 - lpp2019 lpl2014 similar to septum formation protein Maf -2.0
lpg0137 pgk lpp0152 lpl0137 phosphoglycerate kinase -2.0
lpg1281 - lpp1244 lpl1244 unknown -2.0
lpg2900 capM2 lpp2965 lpl2815 similar to glycosyltransferases -2.0
lpg0603 - lpp0654 lpl0638 similar ABC transporter- permease component -2.0
lpg2931a - lpp2999 lpl2860 unknown -2.0
lpg0396 trmD lpp0464 lpl0440 highly similar to tRNA (guanine-N1)-methyltransferase -2.0
lpg2022 metK lpp2004 lpl1999 S-adenosylmethionine synthetase -2.0
lpg2632 holC lpp2685 lpl2557 similar to DNA polymerase III- chi subunit -2.0
lpg2115 - - - hypothetical phage AbiD protein -2.0
lpg2158 pmtA lpp2097 lpl2086 similar to methyltransferase -2.0
lpg1198 hisC lpp1200 lpl1206 histidinol-phosphate aminotransferase (imidazole acetol-phosphate transaminase) -2.0
lpg0052 - lpp0054 lpl0052 similar to probable methylisocitrate lyase -2.0
lpg1860 clpX lpp1828 lpl1824 ATP-dependent Clp protease ATP-binding subunit ClpX -2.0
lpg1186 - lpp1188 lpl1194 similar to competence lipoprotein comL precursor -2.0
lpg2967 sodB lpp3039 lpl2897 superoxide dismutase-iron -2.0
lpg1119 map lpp1120 lpl1124 major acid phosphatase Map (histidine-acid phosphatase) -2.0
lpg1482 - lpp1438 lpl1546 unknown -2.0
lpg2882 metG_1 lpp2941 lpl2795 methionyl-tRNA synthetase -2.0
lpg1391 rpmF lpp1346 lpl1342 50S ribosomal subunit protein L32 -2.0
lpg1472 bioB lpp1428 lpl1556 biotin synthase -2.0
lpg2507 - lpp2575 lpl2429 unknown -2.0
lpg0604 - lpp0655 lpl0639 similar to cysteine desulfurase and to selenocysteine lyase -2.0
lpg2172 - lpp2110 - similar to adenosylhomocysteinase -1.9
lpg0568 tyrS lpp0628 lpl0611 tyrosyl-tRNA synthetase -1.9
lpg2710 pheT lpp2765 lpl2638 phenylalanyl-tRNA synthetase- beta subunit -1.9
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lpg1399 tmk lpp1354 lpl1350 similar to thymidylate kinase -1.9
lpg0008 - lpp0008 lpl0008 unknown -1.9
lpg0504 cdsA lpp0567 lpl0543 phosphatidate cytidylyltransferase -1.9
lpg2306 - lpp2254 lpl2225 similar to conserved hypothetical protein -1.9
lpg0868 - lpp0931 lpl0900 similar to acyl-CoA dehydrogenase -1.9
lpg1447 rluB lpp1402 lpl1594 similar to ribosomal large subunit pseudouridine synthase B -1.9
lpg2553 uhpC lpp2623 lpl2474 similar to hexose phosphate transport protein -1.9
lpg2881 - lpp2940 lpl2794 similar to electron transport complex protein rnfB -1.9
lpg0400 ffh lpp0467 lpl0443 similar to signal recognition particle protein Ffh -1.9
lpg2944 lpxD2 lpp3015 lpl2873 similar to UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase -1.9
lpg2791 secG lpp2837 lpl2706 protein export membrane protein secG (preprotein translocase subunit) -1.9
lpg0821 - lpp0883 lpl0852 similar to lipopolysaccharide biosynthesis glycosyltransferase -1.9
lpg1445 scpA lpp1400 lpl1596 similar to segregation and condensation protein A -1.9
lpg0510 fabZ lpp0572 lpl0548 (3R)-hydroxymyristoyl-[acyl carrier protein] dehydratase -1.9
lpg1841 com1 lpp1805 lpl1806 similar to outer membrane protein -1.9
lpg1831 mrp lpp1776 lpl1777 similar to unknown protein -1.9
lpg1471 bioA lpp1427 lpl1557 adenosylmethionine-8-amino-7-oxononanoate aminotransferase -1.9
lpg2021 ahcY lpp2003 lpl1998 adenosylhomocysteinase (S-adenosyl-L-homocysteinehydrolase) -1.9
lpg0541 - lpp0605 lpl0586 C-terminal part similar to unknown virulence protein -1.9
lpg0406 - lpp0472 lpl0448 similar to conserved hypothetical proteins -1.9
lpg0786 mesJ lpp0850 lpl0825 similar to cell cycle protein MesJ -1.9
lpg0946 pdxJ lpp1008 lpl0975 pyridoxal phosphate biosynthetic protein pdxJ -1.9
lpg2321 sdaC lpp2269 lpl2241 similar to serine transporter -1.9
lpg2047 - lpp2030 lpl2025 similar to ABC transporter permease protein -1.8
lpg0780 - lpp0844 lpl0819 similar to glyoxalase II -1.8
lpg1227 - lpp1235 lpl1235 unknown -1.8
lpg0799 nadA lpp0861 lpl0832 similar to quinolinate synthetase A -1.8
lpg1801 recA lpp1765 lpl1765 RecA protein -1.8
lpg2277 - lpp2231 lpl2203 similar to O-methyltransferase -1.8
lpg0424 - lpp0491 lpl0467 similar to hypothetical proteins -1.8
lpg0229 - lpp0288 lpl0282 unknown -1.8
lpg0098 - lpp0112 lpl0098 weakly similar to putative response regulator   -1.8
lpg0367a - lpp0432 lpl0408 putative lipopeptide -1.8
lpg0046 - lpp0047 lpl0045 unknown -1.8
lpg1103 - lpp1102 lpl1102b putative secreted protein -1.8
lpg0756 rmlC lpp0822 lpl0793 dTDP-4-dehydrorhamnose 3-5-epimerase -1.8
lpg2898 - lpp2963 lpl2821 similar to cytochrome c -1.8
lpg1661 - lpp1632 lpl1626 similar to conserved hypothetical proteins -1.8
lpg0789 - lpp0853 lpl0827 alginate O-acetyltransferase AlgI -1.8
lpg0731 - lpp0797 lpl0768 some similarity with outer surface protein -1.8
lpg1620 - lpp1590 lpl1403 similar to transcriptional regulator (MarR family) -1.8
lpg1657 - lpp1628 lpl1622 similar to dimethylarginine dimethylaminohydrolase -1.8
lpg2136 ceaC lpp2075 lpl2065 chemiosmotic efflux system protein C-like protein -1.8
lpg2004 queA lpp1985 lpl1980 S-adenosylmethionine: tRNA ribosyltransferase-isomerase -1.8
lpg0295 - lpp0373 lpl0348 similar to nucleotidyltransferase family protein -1.8
lpg1553 minC lpp1510 lpl1473 similar to cell division inhibitor MinC (septum placement) -1.8
lpg0651 - lpp0705 lpl0687 similar to NADP-dependent malic enzyme -1.8
lpg1548 ndk lpp1505 lpl1478 similar to nucleoside diphosphate kinase -1.8
lpg0748 - lpp0814 lpl0785 similar to LPS biosynthesis protein -1.8
lpg1319 lspE lpp1274 lpl1273 type II protein secretion ATPase LspE -1.8
lpg2322 legA5 lpp2270 lpl2242 ankyrin repeat protein -1.8
lpg0413 - lpp0480 lpl0456 similar to hypothetical proteins -1.8
lpg2558 - - - integrase of prophage CP-933C -1.8
lpg1507 - lpp1464 lpl1519 similar to sodium/hydrogen antiporter family protein -1.8
lpg0129a - lpp0144 lpl0129 weakly similar to conserved hypothetical protein -1.8
lpg0040 - lpp0041 lpl0040 similar to conserved hypothetical protein -1.8
lpg0251 - lpp0321 - similar to N-terminal part of eukaryotic RNA-binding protein precursor -1.8
lpg1764 - lpp1728 lpl1728 conserved hypothetical protein -1.8
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lpg0322 rpoB lpp0387 lpl0362 RNA polymerase B-subunit -1.8
lpg0691 parE lpp0746 lpl0727 DNA topoisomerase IV subunit B -1.8
lpg2701 sspB lpp2756 lpl2629 similar to stringent starvation protein B -1.8
lpg2580 gcdH lpp2632 lpl2502 similar to glutaryl-CoA dehydrogenase   -1.8
lpg1371 lpxB1 lpp1325 lpl1322 similar to lipid-A-disaccharide synthase -1.7
lpg0366 dapF lpp0431 lpl0407 diaminopimelate epimerase -1.7
lpg0832 - lpp0894 lpl0863 similar to oxidoreductases- short-chain dehydrogenase/reductase family -1.7
lpg1587 - lpp1545 lpl1438 similar to unknown protein -1.7
lpg1443 - lpp1398 lpl1598 similar to putative translation factor -1.7
lpg2522 - lpp2590 lpl2444 similar to other protein -1.7
lpg2003 tgt lpp1984 lpl1979 unknown -1.7
lpg2411 - lpp2480 lpl2335 unknown -1.7
lpg1015 yueD plpp0120 - conserved gene, perhaps benzil (sepiapterin, ketoacyl) reductase -1.7
lpg1477 - lpp1433 lpl1551 similar to conserved hypothetical protein -1.7
lpg267 - lpp2690 lpl2562 unknown -1.7
lpg2484 - lpp2548 lpl2404 similar to conserved hypothetical protein -1.7
lpg2337 hemK lpp2285 lpl2258 similar to methyltransferase hemK -1.7
lpg0613 - lpp0664 lpl0648 unknown -1.7
lpg0184 - - - unknown -1.7
lpg2278 hpd lpp2232 lpl2204 4-hydroxyphenylpyruvate dioxygenase (legiolysin) -1.7
lpg2361 rpoD lpp2310 lpl2283 RNA polymerase sigma factor rpoD (sigma-7 unknown) -1.7
lpg2356 - lpp2305 lpl2278 predicted membrane protein -1.7
lpg2963 pyrC lpp3035 lpl2893 similar to dihydroorotase- homodimeric type -1.7
lpg2913 - - - hypothetical protein -1.7
lpg2679 - lpp2733 lpl2606 similar to oxidoreductase -1.7
lpg0726 - lpp0792 lpl0763 similar to unknown proteins -1.7
lpg2898a - lpp2964 lpl2814 similar to ferredoxin component of dioxygenase -1.7
lpg0089 - lpp0103 lpl0088 conserved hypothetical protein -1.7
lpg0470 - lpp0535 lpl0511 similar to fructose-bisphosphate aldolase -1.7
lpg2420 - - lpl2343 hypothetical protein -1.7
lpg0618 tag lpp0672 lpl0656 similar to 3-methyladenine-DNA glycosylase I -1.7
lpg1872 lepA1 lpp1837 lpl1834 similar to GTP-binding elongation factor -1.7
lpg1826 - lpp1789 lpl1790 hypothetical gene -1.7
lpg2670 ftsY lpp2724 lpl2597 similar to C-terminal part of signal recognition particle GTPase- FtsY -1.7
lpg1586 - lpp1544 lpl1439 unknown- possibly truncated -1.7
lpg0858 ccmD lpp0921 lpl0890 heme exporter protein CcmD  -1.7
lpg1286 - lpp1249 lpl1249 similar to conserved hypothetical protein   -1.7
lpg1808 hemB lpp1771 lpl1772 similar to delta-aminolevulinic acid dehydratases (porphobilinogen synthase) -1.7
lpg2454 - lpp2520 lpl2373 similar to unknown protein -1.7
lpg2968 argD lpp3040 lpl2898 similar to ornithine/acetylornithine aminotransferase -1.7
lpg0481 - lpp0545 lpl0521 similar to S-adenosylmethionine-dependent methyltransferase -1.7
lpg0369 - lpp0434 lpl0410 similar to phospholipase/carboxylesterase -1.7
lpg0664 rpe lpp0721 lpl0701 ribulose-phosphate 3-epimerase -1.7
lpg2059 - - - hypothetical phage repressor -1.7
lpg2358 rpsU lpp2307 lpl2280 30S ribosomal protein S21 -1.7
lpg2902 - lpp2969 lpl2817 similar to conserved hypothetical protein -1.7
lpg2330 ispA lpp2278 lpl2250 similar to geranyltranstransferase; farnesyl-diphosphate synthase -1.6
lpg2657 feoB lpp2711 lpl2584 ferrous iron transporter B -1.6
lpg2567 - - - ISI400 transposase B -1.6
lpg0615 - lpp0666 - similar to polypeptide deformylase    -1.6
lpg2496 - lpp2563 lpl2417 similar to rRNA methylase -1.6
lpg1897 - lpp1866 lpl1861 similar to glutathione-regulated potassium-efflux system protein KefC -1.6
lpg2453 - lpp2519 lpl2372 unknown -1.6
lpg1704 umuD lpp1669 lpl1663 similar to error-prone repair: SOS-response transcriptional repressors -1.6
lpg2009a rpoZ lpp1991 lpl1986 RNA polymerase omega subunit -1.6
lpg1547 - lpp1504 lpl1479 similar to conserved hypothetical protein -1.6
lpg1486 - lpp1442 lpl1542 similar to transcriptional regulator (Lrp family) -1.6
lpg1991 - lpp1972 lpl1967 predicted membrane protein -1.6
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lpg0421 ywtG lpp0488 lpl0464 similar to sugar transport protein -1.6
lpg2085 traU - - TraU -1.6
lpg1844 dtD lpp1808 lpl1809 similar to D-tyrosyl-tRNA (Tyr) deacylase -1.6
lpg0778 - lpp0842 lpl0817 similar to glycosyltransferase -1.6
lpg2970 ubiE lpp2970 lpl2818 ubiquinone/menaquinone biosynthesis methyltransferase -1.6
lpg2770 truB lpp2818 lpl2687 tRNA pseudouridine synthase B -1.6
lpg1305 trpA lpp1269 lpl1268 tryptophan synthase- alpha subunit -1.6
lpg2754 dnaZX lpp2802 lpl2671 DNA polymerase III- gamma and tau subunits -1.6
lpg0513 serS lpp0575 lpl0551 seryl-tRNA synthetase -1.6
lpg1883 - lpp1847 lpl1844 putative membrane protein -1.6
lpg0077 pepP lpp0091 lpl0079 similar to proline aminopeptidase P II -1.6
lpg2839 smpB lpp2898 lpl2751 similar to SsrA-binding protein -1.6
lpg2285 - lpp2239 lpl2211 similar to ABC transporter- permease component -1.6
lpg2173 tnpA2 lpp1566 lpl0196 TnpA transposase (partial in Lens) -1.6
lpg0694 proS lpp0749 lpl0731 prolyl-tRNA synthetase (proline-tRNA ligase) (global RNA synthesis factor) -1.6
lpg0148 - - - hypothetical protein -1.6
lpg1544 hisS lpp1501 lpl1482 histidyl-tRNA synthetase -1.6
lpg1823 - lpp1786 lpl1787 similar to conserved hypothetical protein -1.6
lpg0633 - lpp0687 lpl0670 similar to peptidoglycan GlcNAc deacetylase proteins -1.6
lpg0593 - lpp0643 lpl0627 similar to 5-formyltetrahydrofolate cyclo-ligase -1.6
lpg2886 - lpp2945 lpl2799 highly similar to transcriptional regulator ExsB -1.6
lpg1545 - lpp1502 lpl1481 hypothetical protein -1.6
lpg1285 hmgA lpp1248 lpl1248 homogentisate 1-2-dioxygenase -1.6
lpg0404 - lpp0470 lpl0446 similar to amino acid antiporter -1.6
lpg2249 - lpp2203 lpl2175 similar to amidotransferase -1.6
lpg1304 trpB lpp1268 lpl1267 tryptophan synthase beta subunit -1.6
lpg2282 asnS lpp2236 lpl2208 asparagine tRNA synthetase -1.6
lpg2848 - lpp2906 lpl2760 similar to ribonuclease -1.6
lpg1873 - lpp1838 lpl1835 similar to membrane-bound lytic murein transglycosylase B precursor -1.6
lpg0298 surA lpp0376 lpl0351 similar to peptidyl-prolyl cis-trans isomerase SurA -1.6
lpg1922 - lpp1897 lpl1886 similar to ATP-dependent DNA helicase -1.6
lpg0533 sucB lpp0598 lpl0579 dihydrolipoamide succinyltransferase- E2 subunit -1.6
lpl1530 prpC lpp1487 lpl1496 2-methylcitrate synthase   -1.6
lpg0891 - lpp0881 - similar to transposase (IS4 family) -1.5
lpg0131 dapB lpp0146 lpl0131 similar to dihydrodipicolinate reductase proteins -1.5
lpg1855 ppiD lpp1825 lpl1821 similar to peptidyl-prolyl cis-trans isomerase D -1.5
lpg1871 lepB1 lpp1836 lpl1833 signal peptidase I -1.5
lpg2206 - lpp2157 lpl2131 unknown -1.5
lpg2184 - - - hypothetical protein -1.5
lpg1509 - lpp1466 lpl1517 -1.5
lpg0371 - lpp0436 lpl0412 similar to conserved hypothetical proteins -1.5
lpg1644 - lpp1614 lpl1382 similar to putative outer membrane proteins -1.5
lpg1303 trpF lpp1267 lpl1266 N-(5-phosphoribosyl) anthranilate isomerase -1.5
lpg2371 - - - hypothetical protein -1.5
lpg1197 hisB lpp1199 lpl1205 histidinol-phosphatase/imisazoleglycerol-phosphate dehydratase -1.5
lpg0323 rpoC lpp0388 lpl0363 RNA polymerase beta subunit -1.5
lpg2788 nuoB2 lpp2835 lpl2704 NADH dehydrogenase I chain B -1.5
lpg0800 nadB1 lpp0862 lpl0833 L-aspartate oxidase -1.5
lpg0120 - lpp0134 lpl0119 some similarity with L. pneumophila IcmL/DotI -1.5
lpg2936 - lpp3004 lpl2865 unknown -1.5
lpg0043 - lpp0043 lpl0042 similar to conserved hypothetical protein -1.5
lpg2951 cysK lpp3022 lpl2880 highly similar to cystathionine beta-synthase -1.5
lpg2286 - - - pirin -1.5
lpg2471 hypE lpp2536 lpl2391 hydrogenase expression/formation protein HypE -1.5
lpg2286 - - - pirin/signal transduction -1.5
lpg1448 - lpp1403 - similar to transcriptional regulator- LuxR family -1.5
lpg2604 - lpp2657 lpl2527 similar to unknown protein -1.5
lpg2542 - lpp2608 lpl2463 unknown -1.5






1 Fold Change (FC) 
Gene ID Name Paris ID Lens ID Description FC Ratio1
lpg1625 - lpp1595 lpl1398 unknown -1.5
lpg2184 - - - hypothetical protein -1.5
lpg2525 - - - hypothetical protein -1.5
lpg1504 aceE lpp1461 lpl1522 pyruvate dehydrogenase (decarboxylase component) E1p -1.5
lpg1347 - lpp1301 lpl1300 similar to rare lipoprotein B RlpB -1.5
lpg1429 - lpp1384 lpl1380 unknown -1.5
lpg1346 holA lpp1300 lpl1299 similar to DNA polymerase III- delta subunit HolA -1.5
lpg1748 suhB lpp1712 lpl1712 similar to inositol-1-monophosphatase -1.5
lpg2696 miaA lpp2751 lpl2624 similar to tRNA delta (2)-isopentenylpyrophosphate transferase -1.5
lpg1772 - lpp1736 lpl1736 similar to conserved hypothetical protein -1.5
lpg1716 - lpp1681 lpl1675 unknown -1.5
lpg1466 - lpp1422 lpl1562 similar to conserved hypothetical protein -1.5
lpg1141 potA lpp1143 lpl1148 similar to spermidine/putrescine transport system ATP-binding protein PotA -1.5
lpg1843 pip lpp1807 lpl1808 similar to proline iminopeptidase -1.5
lpg2184 - - - hypothetical protein -1.5
lpg0041 - - - -1.5
lpg0191 - lpp0251 - unknown -1.5
lpg1945 - lpp1926 lpl1916 similar to 3-5-cyclic-nucleotide phosphodiesterase precursor (CpdP)  -1.5
lpg1575 - lpp1533 lpl1450 hypothetical protein -1.5
lpg2451 - lpp2516 lpl2369 similar to N-hydroxyarylamine O-acetyltransferase -1.4
lpg0007 - lpp0007 lpl0007 putative carbon-nitrogen hydrolase family protein -1.4
lpg2834 - lpp2891 lpl2746 similar to transcriptional accessory protein -1.4
lpg2571 - - - hypothetical protein -1.4
lpg0078 ubiH lpp0092 lpl0080 similar to 2-octaprenyl-6-methoxyphenol hydroxylase -1.4
lpg1027 ceaC2 lpp2353 lpl2065 chemiosmotic efflux system C protein C -1.4
lpg1834 metI lpp1797 lpl1798 similar to ABC transporter permease protein -1.4









Gene ID Name Paris ID Lens ID Description FC1 FC1
lpg1340 flaA lpp1294 lpl1293 flagellin 104.5 144.1
lpg1160 - lpp1162 lpl1168 unknown 88.2 83.2
lpg2493 - lpp2559 lpl2414 similar to small heat shock protein 86.3 74.5
lpg2157 sdeA lpp2096 lpl2085 sdeA 75.0 70.1
lpg1339 - lpp1293 lpl1292 unknown 71.7 90.0
lpg1496 - lpp1453 lpl1530 some similarities with sidE protein 60.1 35.0
lpg2395 - lpp2461 lpl2318 unknown 55.5 15.2
lpg2222 - lpp2174 lpl2147 similar to unknown protein 47.9 45.9
lpg1206 - lpp1208 lpl1214 similar to unknown protein 43.4 36.7
lpg0901 - lpp0962 lpl0932 unknown 43.0 16.3
lpg0910 - lpp0972 lpl0942 to enhanced entry protein EnhA 40.8 56.0
lpg2246 - lpp2200 lpl2172 unknown 40.0 40.9
lpg0088 - lpp0102 lpl0087 similar to arginine-binding periplasmic protein 35.3 22.9
- - lpp0052 lpl0050 unknown 34.6 17.3
lpg1336 - lpp1290 lpl1289 similar to enhanced entry protein EnhA 33.3 12.3
lpg0672 - lpp0728 lpl0708 similar to acetoacetate decarboxylase 32.9 37.4
lpg2181 - lpp2133 lpl2108 similar to response regulator 27.7 31.8
lpg0499 - lpp0561 lpl0537 similar to carboxy-terminal protease family protein 27.5 14.6
lpg1669 - lpp1641 lpl1634 unknown 27.3 17.5
- sdeB - lpl2084 SdeB 27.3 25.1
lpg0644 - - - hypothetical protein 25.5 11.5
- - lpp2869 lpl2732 hypothetical gene 23.7 32.2
lpg0673 - lpp0729 lpl0709 similar to unknown protein 23.4 17.8
lpg0969 - lpp1031 lpl0998 unknown 23.3 9.5
lpg2268 - lpp2222 lpl2194 putative membrane protein 23.1 4.5
lpg1337 fliS lpp1291 lpl1290 similar to flagellar protein FliS 22.7 11.9
lpg2509 sdeD lpp2577 lpl2431 SdeD protein (substrate of the Dot/Icm system) 22.4 25.0
lpg0383 - lpp0450 lpl0426 unknown 22.3 5.8
lpg0902 - lpp0963 lpl0933 unknown 22.2 12.9
lpg2957 - lpp3028 lpl2886 similar to protease 22.1 17.5
lpg1960 - lpp1942 lpl1934 unknown 22.0 18.9
lpg1038 - lpp2343 - unknown 21.5 5.2
lpg2990 - lpp3061 lpl2918 unknown 21.4 23.6
lpg2153 sdeC lpp2092 lpl2081 SdeC protein- substrate of the Dot/Icm system 21.2 16.0
lpg0644 - - - hypothetical protein 21.0 15.3
lpg2529 - lpp2594 lpl2449 unknown 20.9 18.4
lpg1338 fliD lpp1292 lpl1291 similar to flagellar hook-associated protein 2 (flagellar capping protein) 20.9 13.4
lpg1793 - lpp1757 lpl1757 unknown 20.8 6.0
lpg1226 flgL lpp1234 lpl1234 flagellar hook-associated protein FlgL 20.6 11.8
- - lpp0364 lpl0339 signal peptide predicted 20.5 9.5
lpg0245 - lpp0315 lpl0299 similar to C-terminal part of conserved hypothetical protein 20.5 15.1
lpg0967 - lpp1029 lpl0996 unknown 20.4 7.2
lpg0644 - - - hypothetical protein 19.7 8.0
lpg2511 sidC lpp2579 lpl2433 SidC protein (substrate of the Dot/Icm system) 19.7 20.2
lpg1683 - - - hypothetical protein 19.6 14.3
lpg0878 - lpp0941 lpl0911 unknown 19.3 12.2
lpg1298 - lpp1262 lpl1261 unknown 19.1 2.4
lpg1485 - lpp1441 lpl1543 similar to unknown protein 19.1 4.3
lpg2049 - lpp2032 lpl2027 unknown 18.9 3.0
lpg1491 - lpp1447 lpl1537 some similarity with eukaryotic proteins 18.8 10.9
lpg2803 - lpp2849 lpl2718 similar to putative coproporphyrinogen oxidase A 18.8 8.5
lpg2334 - lpp2282 lpl2254 unknown 18.7 15.3







Gene ID Name Paris ID Lens ID Description FC1 FC1
lpg2666 - lpp2720 lpl2593 similar to unknown protein 17.9 7.5
lpg0644 - - - hypothetical protein 17.9 21.0
lpg1876 - lpp1841 lpl1838 similar to unknown protein 17.7 13.4
lpg1111 - lpp1112 lpl1115 unknown 17.7 11.9
- - lpp1110 lpl1113 hypothetical protein 17.6 11.4
- - lpp1260 lpl1259 unknown 17.6 9.1
lpg1895 - lpp1864 lpl1859 unknown 17.0 3.6
lpg0393 - lpp0460 lpl0436 unknown 16.6 6.3
lpg1290 - lpp1253 - unknown 16.2 3.3
lpg1115 - lpp1116 lpl1121 similar to other protein- ATP binding site 16.1 12.5
lpg1686 - - - hypothetical protein 15.6 15.9
lpg0671 - lpp0727 lpl0707 similar to NADH-ubiquinone oxidoreductase 15.6 10.4
- - - lpl1530 hypothetical protein 15.5 9.8
lpg2578 - lpp2630 lpl2500 unknown 15.3 2.9
- - - lpl2384 hypothetical protein 15.3 14.1
lpg0620 - lpp0674 lpl0657 unknown 15.2 6.3
- - - lpl2295 hypothetical protein 14.6 2.9
lpg2641 enhA lpp2694 lpl2566 enhanced entry protein EnhA 14.6 4.0
lpg2076 - - - hypothetical protein 14.4 10.5
lpg1782 fliA lpp1746 lpl1746 sigma factor 28 14.3 4.7
lpg2457 - lpp2523 lpl2376 similar to two-component response regulator 14.2 2.5
lpg2482 sdbB lpp2546 lpl2402 SdbB protein (putative substrate of the Dot/Icm system) 14.0 7.3
lpg0279 - lpp0354 lpl0331 similar to conserved hypothetical protein 13.7 5.8
lpg0741 - lpp0806 lpl0777 similar to conserved hypothetical protein 13.6 13.4
lpg1636 - lpp1606 lpl1390 similar to acetyltransferase- GNAT family 13.4 5.1
lpg1117 - lpp1118 lpl1123 similar to B. subtilis  PaiA transcriptional repressor of sporulation  13.3 8.5
lpg0037 - lpp0036 lpl0037 similar to arginine transport system periplasmic binding protein 13.2 11.6
lpg2971 - lpp3043 lpl2901 similar to NAD-linked malate dehydrogenase (malic enzyme) 13.1 14.5
lpg1135 - lpp1136 lpl1141 similar to transcriptional regulator- TetR family 12.7 5.2
- - lpp2567 lpl2421 unknown 12.4 3.9
lpg2149 - lpp2088 lpl2077 unknown 12.3 11.1
lpg1207 - lpp1209 lpl1215 similar to conserved hypothetical protein 12.3 10.2
lpg0968 - lpp1030 lpl0997 unknown 12.1 3.7
lpg1102 - - - hypothetical protein 12.0 2.0
lpg1495 - lpp1452 lpl1531 unknown 11.8 10.9
lpg1220 flgF lpp1228 lpl1228 flagellar biosynthesis protein FlgF 11.7 4.3
lpg2510 sdcA - - sdcA 11.7 12.2
lpg2105 - - - transmembrane protein 11.6 4.5
lpg2464 - - - hypothetical protein 11.6 6.7
lpg0244 - lpp0314 lpl0298 similar to oxydoreductase 11.6 8.7
lpg2527 - lpp2592 lpl2447 unknown 11.3 8.1
lpg1385 - lpp1340 lpl1336 unknown 11.3 7.3
lpg2258 - lpp2212 lpl2184 putative membrane protein 11.3 2.7
lpg0717 - lpp0783 lpl0754 unknown 11.2 4.0
lpg2106 - - - hypothetical protein 11.2 3.7
lpg2459 - lpp2525 lpl2378 similar to guanylate cyclase-related protein 11.2 2.2
- - - lpl1116 hypothetical protein 11.1 4.3
lpg1253 lvhB4 lpp0171 lpl0154 Legionella  vir homologue protein putative type IV secretion protein 11.0 8.3
lpg1225 flgK lpp1233 lpl1233 flagellar hook-associated protein 1 11.0 2.8
lpg0380 - lpp0447 lpl0423 unknown 10.9 4.6
lpg2510 sdcA lpp2578 lpl2432 SdcA protein- paralog of SidC (substrate of the Dot/Icm system) 10.8 7.5
- - lpp2998 lpl2859 similar to conserved hypothetical protein 10.8 3.9
lpg1950 ralF lpp1932 lpl1919 RalF protein- translocated into host cells by the Dot/Icm system 10.7 12.3
lpg2209 - lpp2160 lpl2134 similar to conserved hypothetical protein 10.6 3.7
lpg1055 - - - hypothetical protein 10.5 6.5
lpg1356 - lpp1310 lpl1307 similar to unknown protein 10.4 7.5
lpg2640 enhB lpp2693 lpl2565 enhanced entry protein EnhB 10.4 5.4
lpg0009 - lpp0009 lpl0009 similar to host factor-1 protein 10.3 7.7







Gene ID Name Paris ID Lens ID Description FC1 FC1
lpg0196 - lpp0253 lpl0252 unknown 10.0 8.0
lpg2147 - lpp2086 lpl2075 unknown 10.0 9.9
lpg1887 - lpp1854 lpl1849 Q-rich protein 10.0 12.4
lpg2759 - lpp2807 lpl2676 unknown 10.0 3.2
lpg1885 - lpp1849 lpl1846 unknown 9.9 3.4
- - lpp2976 lpl2824 unknown 9.9 4.1
lpg2393 - lpp2460 lpl2317 similar to bacterioferritin 9.8 3.7
lpg2958 - lpp3029 lpl2887 transmembrane protein- similar to membrane-bound serine protease 9.7 5.1
lpg0846 - lpp0908 lpl0877 similar to conserved hypothetical protein 9.7 5.2
lpg2465 sidD - - sidD 9.7 16.1
lpg2639 enhC lpp2692 lpl2564 enhanced entry protein EnhC 9.7 6.2
lpg1112 - - - hypothetical protein 9.6 3.2
lpg2862 legC8 - - coiled-coil containing protein 9.6 8.3
lpg0415 - lpp0482 lpl0458 similar to hypothetical proteins 9.5 8.7
lpg1925 - lpp1900 lpl1891 unknown 9.5 6.6
lpg2207 - lpp2158 lpl2132 similar to unknown protein 9.5 7.2
lpg2831 - lpp2888 - unknown 9.4 3.7
lpg0670 - lpp0726 lpl0706 similar to predicted esterae 9.3 8.6
lpg2520 - lpp2588 lpl2442 unknown 9.2 3.9
lpg0847 murA lpp0909 lpl0878 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 9.1 8.9
lpg1918 - lpp1893 lpl1884 weakly similar to endoglucanase 9.1 7.4
lpg0147 - - - transposase 9.1 4.6
lpg0737 - lpp0802 lpl0773 similar to conserved hypothetical protein 9.1 3.9
lpg0907 flgM lpp0969 lpl0939 similar to negative regulator of flagellin synthesis (Anti-sigma-28 factor)  9.1 4.1
lpg1039 - lpp2342 - similar to unknown protein 9.1 6.4
lpg2316 - lpp2264 lpl2236 similar to 3-hydroxybutyrate dehydrogenase 8.9 8.8
lpg2402 - lpp2467 lpl2325 similar to transcriptional regulator- LysR family 8.9 4.1
- - lpp1115 lpl1119 similar to other proteins 8.8 5.4
lpg2426 - lpp2493 - similar to malonate decarboxylase- alpha subunit   8.7 5.0
lpg1993 - lpp1974 lpl1969 similar to putative polysaccharide deacetylase-related protein 8.7 7.4
lpg1309 - lpp1273 lpl1272 unknown 8.6 4.1
lpg0674 - lpp0730 lpl0710 similar to adenylate cyclase 8.6 3.3
lpg1455 - lpp1411 lpl1573 similar to Legionella pneumophila  putative phospholipase C 8.5 7.4
lpg2017 - lpp1999 lpl1994 unknown 8.5 3.9
lpg1161 - lpp1163 lpl1169 similar to predicted phosphoribosyl transferase 8.5 2.9
lpg0527 - lpp0592 lpl0573 similar to conserved hypothetical protein 8.4 3.9
lpg1145 - lpp1147 lpl1151 unknown 8.3 6.4
lpg1058 - lpp2323 lpl1055 similar to polyhydroxyalkanoic-acid-synthase 8.2 5.0
lpg2187 - lpp2137 lpl2112 unknown 8.2 5.8
lpg2442 - lpp2509 lpl2362 unknown 8.1 5.0
lpg2075 dam - - DNA adenine methylase 8.1 5.2
lpg2820 - lpp2873 - similar to predicted oxidoreductase 8.1 8.3
lpg0632 - lpp0686 lpl0669 similar to type-4 fimbrial pilin related protein 8.0 2.4
lpg1796 - lpp1760 lpl1760 similar to transcriptional regulator (LysR family) 7.9 5.8
lpg1168 - lpp1170 lpl1176 regulatory protein (GGDEF and EAL domains) 7.9 5.3
lpg1223 flgI lpp1231 lpl1231 flagellar P-ring protein precursor FlgI 7.9 1.8
lpg2311 - lpp2259 lpl2230 unknown 7.8 6.4
lpg2257 - lpp2211 lpl2183 unknown 7.7 4.3
lpg1116 - lpp1117 lpl1122 similar to chitinase 7.7 7.0
lpg2323 - lpp2271 lpl2243 similar to type II secretion system protein-like protein and twitching mobility protein 7.7 4.7
- - lpp2368 - unknown 7.7 6.3
lpg2583 - lpp2635 lpl2505 similar to FlhB protein- part of export apparatus for flagellar proteins 7.6 2.7
lpg0277 - lpp0351 lpl0329 regulatory protein (EAL domain) 7.6 6.3
lpg0278 - lpp0353 lpl0330 similar to two-component sensor histidine kinase 7.6 4.1
lpg2138 - lpp2077 lpl2067 similar to transcriptional regulator- LysR family 7.6 2.6
lpg1083 - - - hypothetical protein 7.6 4.7
lpg0151 - - - hypothetical protein 7.6 5.0
- - lpp2958 lpl2807 unknown 7.4 1.6







Gene ID Name Paris ID Lens ID Description FC1 FC1
lpg1092 - lpp1093 lpl1096 similar to beta-phosphoglucomutase 7.4 5.2
- - - lpl2385 hypothetical protein 7.3 12.4
- - lpp0216 lpl0211 hypothetical protein 7.3 4.3
lpg2561 - - - hypothetical protein 7.2 3.2
lpg0669 - lpp0725 lpl0705 similar to hypothetical protein 7.1 8.9
- sidH' lpp2886 - substrates of the Legionella pneumophila  Dot/Icm system 7.1 8.4
lpg1944 - lpp1925 lpl1914 similar to conserved hypothetical protein 7.1 5.5
lpg2406 lidE lpp2472 lpl2329 lidE 7.1 4.0
- - lpp1177 lpl1183 unknown 7.1 4.0
lpg1123 - lpp1124 lpl1128 similar to amino acid ABC transporter (amino acid binding protein) 7.1 2.1
- - lpp0208 - some similarity with nucleoside hydrolase 7.1 3.9
lpg1046 - lpp2336 - unknown 7.0 3.8
lpg1110 - lpp1111 lpl1114 unknown 7.0 3.6
- - lpp2988 lpl2846 highly similar to putative lytic murein transglycosylase 7.0 5.4
lpg1032 - lpp2348 - unknown 7.0 4.7
lpg1639 - lpp1609 lpl1387 unknown 7.0 5.8
lpg1985 - lpp1966 lpl1960 similar to guanine deaminase 7.0 3.9
lpg1490 - lpp1446 lpl1538 similar to adenylate cyclase- family 3 6.9 5.2
lpg0817 - lpp0879 lpl0850 similar to ATP-dependent Clp protease adaptor protein ClpS 6.9 2.2
lpg1025 - lpp2355 - regulatory protein (GGDEF domain) 6.9 4.1
lpg2107 - - - hypothetical protein 6.9 3.4
lpg2721 - lpp2778 lpl2649 similar to unknown protein 6.8 4.4
lpg0165 - lpp0226 lpl0228 similar to conserved hypothetical protein 6.8 5.0
lpg0156 - lpp0219 lpl0220 regulatory protein (GGDEF domain) 6.7 10.8
lpg2719 - lpp2776 lpl2647 similar to conserved hypothetical protein 6.7 3.2
lpg2829 sidH lpp2883 - substrate of the Legionella pneumophila Dot/Icm system 6.7 2.3
lpg2154 - lpp2093 lpl2082 similar to L. pneumophila  SdeA protein 6.6 9.7
lpg2955 himD lpp3026 lpl2884 highly similar to integration host factor- beta subunit 6.6 2.9
lpg1454 - lpp1410 lpl1590 similar to probable multidrug efflux protein 6.6 6.3
lpg0854 - lpp0916 lpl0885 unknown 6.5 2.8
lpg0233 mdlC - - benzoylformate decarboxylase 6.5 3.9
lpg1903 - lpp1876 lpl1867 similar to hypothetical protein 6.4 5.9
lpg0818 clpA lpp0880 lpl0851 ATP-dependent Clp protease ATP-binding subunit ClpA 6.4 5.1
lpg0157 - lpp0220 lpl0221 regulatory protein (EAL domain) 6.4 4.4
lpg0074 - lpp0088 lpl0076 similar to other proteins 6.3 3.7
lpg2441 - lpp2508 - similar to hypothetical proteins 6.3 3.7
lpg2192 - - - small HspC2 heat shock protein 6.3 4.4
lpg1659 - lpp1630 lpl1624 similar to hypothetical proteins 6.2 3.7
lpg2191 gspA lpp2141 lpl2116 global stress protein GspA 6.2 3.5
lpg2830 - lpp2887 - conserved ubiquitin conjugation factor E4 family domain (U-box) 6.2 3.5
lpg1055 - lpp2327 - unknown 6.1 4.7
lpg1154 - lpp1156 lpl1161 unknown 6.1 4.8
lpg1125 - lpp1126 lpl1130 similar to amino acid ABC transporter 6.1 3.9
lpg0892 - lpp0953 lpl0923 similar to kynurenine 3-monooxygenase 6.0 3.5
lpg2761 - lpp2809 lpl2678 unknown 6.0 18.2
lpg2317 - lpp2265 lpl2237 similar to conserved hypothetical protein 6.0 5.4
lpg1224 flgJ lpp1232 lpl1232 flagellar biosynthesis protein FlgJ 5.9 2.6
lpg1095 - - - chemiosmotic efflux system B protein B 5.9 6.1
lpg1622 - lpp1592 lpl1401 unknown 5.9 2.0
lpg0906 - lpp0968 lpl0938 similar to unknown protein  5.9 2.9
lpg1915 - lpp1890 lpl1881 similar to type IV pilin PilA 5.9 5.0
lpg1670 - lpp1642 lpl1635 unknown 5.9 6.8
lpg2495 - lpp2562 lpl2416 similar to homospermidine synthase 5.8 5.6
lpg2028 hemE lpp2010 lpl2005 uroporphyrinogen decarboxylase 5.8 4.7
lpg1030 cecA1 lpp2350 - chemiosmotic efflux system C protein A 5.8 3.4
lpg0940 lidA lpp1002 lpl0971 LidA protein- substrate of the Dot/Icm system 5.8 5.0
lpg2161 - lpp2100 lpl2089 similar to conserved hypothetical protein 5.8 2.3
lpg2364 - - - hypothetical protein 5.8 2.8







Gene ID Name Paris ID Lens ID Description FC1 FC1
lpg1951 - lpp1933 lpl1920 weakly similar to sphingosine kinase 5.7 2.6
lpg1355 sidG lpp1309 - SidG protein- substrate of the Dot/Icm system 5.7 4.6
lpg2720 - lpp2777 lpl2648 putative cAMP/cGMP binding protein 5.7 2.0
lpg0586 - lpp0636 lpl0620 similar to conserved hypothetical protein 5.7 3.3
lpg2108 - - - hypothetical protein 5.7 3.3
lpg2327 - lpp2275 lpl2247 unknown 5.6 5.5
lpg1360 lspI lpp1314 lpl1311 type II secretory pathway protein LspI 5.6 5.6
- - lpp1640 - unknown 5.6 15.7
lpg2528 - lpp2593 lpl2448 weakly similar to alpha-glucosidase 5.6 4.6
lpg2642 - lpp2695 lpl2568 regulatory protein (GGDEF and EAL domains)   5.6 4.4
lpg1218 flgD lpp1226 lpl1226 flagellar basal-body rod modification protein FlgD 5.6 2.4
lpg1151 - lpp1153 lpl1157 unknown 5.5 3.0
lpg0631 - lpp0685 lpl0668 weakly similar with pre-pilin leader sequence 5.5 4.7
lpg1415 gltA lpp1370 lpl1366 citrate synthase 5.5 4.8
lpg3000 - lpp3072 lpl2928 unknown 5.5 3.1
lpg2132 - lpp2071 lpl2061 regulatory protein (GGDEF domain) 5.4 1.7
lpg1926 - lpp1901 lpl1892 similar to conserved hypothetical protein 5.4 4.6
lpg1155 - lpp1157 lpl1162 similar to eukaryotic pyruvate decarboxylase 5.4 4.2
lpg1024 copA1 lpp2356 - similar to copper efflux ATPase 5.4 5.3
lpg1635 - lpp1605 lpl1391 similar to hypothetical proteins  5.4 4.5
lpg2582 - lpp2634 lpl2504 similar to hypothetical proteins 5.3 1.8
lpg0227 - lpp0286 lpl0281 unknown 5.3 3.7
lpg2422 - lpp2487 lpl2345 some similarity with eukaryotic proteins 5.3 4.8
lpg1170 - lpp1172 lpl1178 similar to Pyruvate formate-lyase activating enzyme 5.3 1.5
lpg2248 - lpp2202 lpl2174 unknown 5.2 4.2
lpg2492 - lpp2558 lpl2413 similar to alcohol dehydrogenase 5.2 2.3
lpg2508 - lpp2576 lpl2430 unknown 5.2 3.9
lpg0267 - lpp0341 lpl0319 similar to magnesium and cobalt transport proteins 5.2 2.2
lpg1525 - lpp1482 lpl1501 putative cAMP/cGMP binding protein 5.1 2.7
lpg1098 - lpp1094 lpl1097 unknown 5.1 2.9
lpg2099 - - - methionine sulfoxide reductase B 5.1 3.7
lpg2976 - lpp3048 lpl2905 unknown 5.1 3.4
lpg1643 thrC lpp1613 lpl1383 similar to threonine synthase ThrC 5.1 2.2
- - lpp1762 lpl1762 unknown 5.0 3.3
lpg2111 - - - methionine sulfoxide reductase B 5.0 2.5
lpg2267 - lpp2221 lpl2193 similar to imidazolonepropionase and related amidohydrolases 5.0 3.5
lpg2148 - lpp2087 lpl2076 unknown 5.0 5.0
lpg2383 - lpp2445 lpl2301 similar to transcriptional regulator- LysR family 5.0 5.0
lpg2199 - lpp2149 lpl2123 unknown 5.0 6.1
lpg1040 - lpp2341 - predicted membrane protein- similar to hypothetical protein 5.0 4.2
lpg1105 - lpp1104 lpl1104 similar to Peptide methionine sulfoxide reductase msrB 5.0 2.2
lpg2318 motA2 lpp2266 lpl2238 5.0 2.3
lpg0666 - lpp0723 lpl0703 similar to conserved hypothetical protein 4.9 4.4
lpg2196 - lpp2146 lpl2121 similar to ketosteroid isomerase homolog 4.9 7.2
lpg2969 - lpp3041 lpl2899 similar to conserved hypothetical protein 4.9 2.2
lpg1540 - lpp1497 lpl1486 similar to universal stress protein A UspA 4.7 3.6
lpg0589 - lpp0639 lpl0623 unknown 4.7 2.5
lpg2228 - lpp2180 lpl2153 similar to 3-oxoacyl-[acyl-carrier-protein] synthase III 4.7 2.0
lpg2521 - lpp2589 lpl2443 unknown 4.6 3.7
lpg1783 fleN lpp1747 lpl1747 similar to flagellar synthesis regulator  4.6 2.3
lpg2396 - lpp2462 lpl2319 similar to conserved hypothetical protein 4.6 2.3
lpg0926 - lpp0988 lpl0957 unknown 4.6 6.6
lpg1948 legLC4 - - leucine-rich repeat and coiled coil-containing protein 4.6 4.0
lpg2229 - lpp2181 lpl2154 similar to acyl-CoA synthetase 4.5 3.0
lpg1522 pilB lpp1479 lpl1504 pilus assembly protein PilB 4.5 4.6
lpg0873 - lpp0936 lpl0906 unknown 4.5 1.7
lpg2526 - lpp2591 lpl2446 unknown 4.5 4.8
lpg2155 - lpp2094 lpl2083 unknown 4.5 5.2








Gene ID Name Paris ID Lens ID Description FC1 FC1
lpg2180 - lpp2132 - similar to two component sensor histidine kinase 4.5 1.9
lpg1949 - lpp1931 lpl1918 unknown 4.5 1.7
lpg1671 - lpp1643 lpl1636 unknown 4.5 2.9
lpg2409 - lpp2476 lpl2332 unknown 4.4 4.7
lpg2888 - lpp2947 lpl2801 unknown 4.4 4.7
lpg0073 - lpp0087 lpl0075 regulatory protein (GGDEF and EAL domains)  4.4 2.2
- - lpp0964 lpl0934 similar to hypothetical protein 4.4 3.1
lpg1984 - lpp1965 lpl1959 similar to hydantoin-racemase 4.3 2.3
lpg2428 - lpp2495 - similar to malonate decarboxylase- gamma subunit 4.3 4.2
- - lpp2316 - similar  to hydrolase 4.3 2.7
- - lpp2636 lpl2506 unknown 4.3 3.1
lpg2724 - lpp2781 lpl2650 some simillarity with eukaryotic proteins 4.3 5.0
lpg2524 - - - transcriptional regulator, LuxR family 4.3 3.8
lpg2073 - - - hypothetical protein 4.3 3.8
lpg0013 - lpp0013 lpl0013 similar to other protein 4.3 3.9
lpg1127 - lpp1128 lpl1133 similar to long-chain acyl-CoA synthetase 4.2 3.9
lpg2098 - - - MsrA3 - peptide methionine sulfoxide reductase 4.2 2.3
lpg1977 - lpp1960 lpl1954 similar to putative intracellular protease/amidase 4.2 1.7
lpg2074 - - - 4-diphosphocytidyl-2-methyl-D-erithritol synthase 4.2 4.1
lpg0625 - lpp0679 lpl0662 similar to unknown eukaryotic proteins 4.2 6.9
lpg1908 gst lpp1883 lpl1874 glutathione S-transferase 4.2 4.9
lpg1279 - lpp1242 lpl1242 unknown 4.2 3.5
- - lpp0564 lpl0540 unknown 4.2 3.3
lpg1451 - lpp1406 lpl1593 similar to unknown protein 4.1 2.5
lpg1898 - lpp1871 lpl1862 similar to MoxR-like ATPases- putative regulator 4.1 3.0
lpg2849 - lpp2907 lpl2761 similar to unknown proteins 4.1 2.9
lpg1515 lssB lpp1473 lpl1510 Legionella  secretion system protein B 4.1 1.9
lpg0010 - lpp0010 lpl0010 similar to GTP-binding protein HflX 4.1 3.6
lpg0585 - lpp0635 lpl0619 similar to hypothetical protein 4.1 1.7
lpg0903 - lpp0965 lpl0935 similar to protease 4.1 2.1
lpg1278 - lpp1241 lpl1241 similar to conserved hypothetical protein 4.1 1.8
lpg1687 - lpp1656 lpl1650 unknown 4.0 3.3
lpg2195 - lpp2145 lpl2120 similar to ornithine cyclodeaminase 4.0 4.6
lpg1386 - lpp1341 lpl1337 some similarity with EnhA protein 4.0 4.6
lpg1080 - - - deoxyguanosinetriphosphate triphosphohydrolase-like protein 4.0 2.8
lpg2301 - lpp2249 lpl2220 unknown 4.0 1.6
lpg0113 - lpp0126 lpl0111 Ankyrin repeat protein 4.0 3.0
lpg2200 - lpp2150 lpl2124 unknown 4.0 8.8
lpg1134 - lpp1135 lpl1140 similar to 2-nitropropane dioxygenase 4.0 3.0
lpg1174 pilR lpp1176 lpl1182 4.0 1.7
lpg2319 motB2 lpp2267 lpl2239 similar to flagellar motor protein 3.9 2.0
lpg2584 sidF lpp2637 lpl2507 substrate of the Dot/Icm system 3.9 1.8
lpg0893 - lpp0954 lpl0924 similar to unknown proteins 3.9 5.7
lpg2205 - lpp2156 lpl2130 predicted integral membrane protein 3.9 2.0
lpg2145 - lpp2083 lpl2073 similar to two-component response regulator 3.9 3.7
lpg2811 - lpp2857 lpl2726 similar to conserved hypothetical protein 3.9 2.0
- - lpp2293 lpl2266 unknown 3.9 2.5
lpg1688 - lpp1657 lpl1651 some similarity with flagellar hook-length control protein FliK  3.9 2.0
lpg1523 pilC lpp1480 lpl1503 pilus assembly protein PilC 3.8 2.9
lpg2018 - lpp2000 lpl1995 similar to conserved hypothetical protein 3.8 2.7
- - lpp0577 lpl0553 unknown 3.8 3.8
- - lpp1951 lpl1940 hypothetical gene 3.8 3.0
lpg2310 murI lpp2258 lpl2229 similar to glutamate racemase 3.8 4.9
lpg2087 traC - - TraC 3.8 3.9
lpg2917 - - - hypothetical protein 3.8 4.2
lpg1831 - lpp1794 lpl1795 similar to acetyl-coenzyme A synthetase 3.8 3.2
lpg0744 - lpp0809 lpl0780 regulatory protein (GGDEF domain)  3.8 2.4
lpg2709 himA lpp2764 lpl2637 similar to integration host factor- alpha subunit 3.8 1.6
similar to type 4 fimbriae expression regulatory protein PilR (two-component 







Gene ID Name Paris ID Lens ID Description FC1 FC1
lpg1779 - lpp1743 lpl1743 similar to hypothetical poteins 3.7 3.3
lpg2146 stuC lpp2084 lpl2074 sensor histidine kinase 3.7 2.4
lpg2532 - lpp2597 lpl2453 similar to chorismate mutase (C-terminal part) 3.7 1.6
lpg1555 - lpp1512 lpl1471 similar to arginine 3rd transport system periplasmic binding protein 3.7 4.0
lpg0525 lvgA lpp0590 lpl0571 unknown virulence protein 3.7 2.4
lpg1690 acnA lpp1659 lpl1653 aconitate hydratase 3.6 4.0
lpg2190 - lpp2140 lpl2115 present a domain similar to IcmL prtein 3.6 1.7
- - plpp0012 - similar to molybdenum cofactor synthesis protein 3 3.6 1.8
lpg2116 - - - transposase, IS4 family TnpA 3.6 2.0
lpg0845 - lpp0907 lpl0876 weakly similar to anti-anti-sigma factor  3.5 2.4
lpg2821 - lpp2874 - similar to unknown protein 3.5 3.2
lpg1518 lssE lpp1475 lpl1508 regulatory protein (GGDEF and EAL domains)  3.5 2.3
lpg0894 - lpp0955 lpl0925 similar to eukaryotic cytokinin oxidase 3.5 1.7
lpg0842 - lpp0904 lpl0873 similar to permease of ABC transporter 3.5 2.0
lpg0665 - lpp0722 lpl0702 predicted membrane protein 3.5 3.1
lpg0629 - lpp0683 lpl0666 similar to Tfp pilus assembly protein PilX 3.5 2.1
lpg2500 - lpp2569 lpl2423 similar to carbonic anhydrase 3.5 4.0
lpg0023 - lpp0023 lpl0024 putative membrane protein 3.5 5.4
lpg2810 - lpp2856 lpl2725 similar to conserved hypothetical protein 3.4 3.0
lpg2793 lepA lpp2839 lpl2708 effector protein A- substrate of the Dot/Icm secretion system 3.4 3.3
lpg2816 rep lpp2868 lpl2731 ATP-dependent DNA helicase Rep 3.4 2.1
- - - lpl2445 hypothetical protein 3.4 2.6
lpg0029 - lpp0029 lpl0030 regulatory protein (GGDEF and EAL domains) 3.4 2.1
- - - - structural toxin protein RtxA 3.3 4.4
lpg2112 - - - 24 kDa macrophage-induced major protein 3.3 6.2
lpg0723 - lpp0789 lpl0760 unknown 3.3 1.6
lpg1983 - lpp1964 lpl1958 unknown 3.3 2.2
lpg1551 - lpp1508 lpl1475 unknown 3.3 2.9
lpg0200 qxtA lpp0259 lpl0255 similar to cytochrome d ubiquinol oxidase subunit I 3.3 2.7
lpg1641 - lpp1611 lpl1385 similar to acylaminoacyl-peptidase proteins 3.2 2.7
lpg1158 - lpp1160 lpl1165 some similarity with eukaryotic proteins 3.2 3.9
lpg0473 - lpp0538 lpl0514 conserved hypothetical protein 3.2 3.5
lpg1097 phbC - - polyhydroxyalkanoic synthase 3.2 2.0
lpg2212 - lpp2163 lpl2137 unknown 3.2 1.7
lpg2399 - lpp2465 lpl2322 C-terminal part similar to Legionella unknown virulence protein 3.2 6.9
lpg0446 icmO/dotL lpp0512 lpl0488 icmO/dotL 3.2 2.0
lpg0790 sdhL lpp0854 lpl0828 similar to L-serine dehydratase 3.2 3.5
lpg0844 - lpp0906 lpl0875 similar to unknown protein 3.2 2.8
lpg1106 - lpp1105 lpl1105 unknown 3.1 3.0
lpg1987 - lpp1968 lpl1962 similar to phosphohistidine phosphatase SixA 3.1 2.0
lpg2812 - lpp2858 lpl2727 similar to unknown protein 3.1 2.4
lpg2126 - lpp2064 lpl2054 similar to potassium uptake protein            3.1 1.8
lpg1148 - lpp1150 lpl1154 putative coiled-coil protein 3.1 3.3
lpg1526 - lpp1483 lpl1500 unknown 3.1 2.8
lpg2152 - lpp2091 lpl2080 similar to multidrug resistance ABC transporter ATP-binding protein 3.1 2.5
lpg0628 - lpp0682 lpl0665 weakly similar to type 4 fimbrial biogenesis protein PilY1 3.1 1.9
lpg0825 - lpp0887 lpl0856 similar to peptidase proteins 3.1 2.3
lpg1672 purN lpp1644 lpl1637 phosphoribosylglycinamide formyltransferase 3.0 2.5
lpg0696 - lpp0751 lpl0733 unknown 3.0 2.0
lpg2429 - lpp2496 - similar to phosphoribosyl-dephospho-CoA transferase  3.0 2.9
lpg2143 - lpp2081 lpl2071 unknown 3.0 3.5
lpg1685 - - - hypothetical protein 3.0 2.8
lpg0136 sdhB1 lpp0150 lpl0135 SdhB protein- substrate of the Dot/Icm system 3.0 1.7
- 0 plpp0029 - weakly similar to TrbI protein 3.0 2.8
lpg1378 - lpp1333 lpl1329 similar to proton/peptide symporter family protein 3.0 1.8
- - lpp1652 lpl1645 unknown 3.0 2.2
lpg1043 - lpp2338 - similar to unknown protein 3.0 1.6
lpg0056 - lpp0058 lpl0056 unknown 3.0 3.0
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lpg0796 - lpp0859 - unknown 3.0 3.1
lpg2128 - lpp2068 lpl2058 unknown 2.9 3.4
lpg2264 - lpp2218 lpl2190 similar to unknown protein 2.9 2.9
lpg0269 - lpp0343 lpl0321 similar to conserved hypothetical protein 2.9 1.8
lpg0242 - lpp0312 lpl0296 similar to D-3 phosphoglycerate dehydrogenase SerA 2.9 3.3
lpg2300 - lpp2248 lpl2219 similar to ankyrin repeat domain protein 2.9 2.4
lpg0035 - lpp0034 lpl0035 unknown 2.9 2.1
lpg2689 icmX lpp2743 lpl2616 intracellular multiplication protein IcmX 2.9 2.9
lpg1292 - lpp1255 lpl1254 similar to two component response regulator 2.9 2.2
lpg0414 - lpp0481 lpl0457 similar to ribosomal protein S6 modification enzyme 2.9 2.5
lpg0192 - - - heat shock hsp20 2.8 2.6
- - lpp2560 - predicted membrane protein 2.8 4.2
lpg1684 - - - hypothetical protein 2.8 3.6
lpg0843 - lpp0905 lpl0874 similar to unknown protein  2.8 2.3
- - lpp2357 - unknown 2.8 2.4
lpg0386 - lpp0453 lpl0429 highly similar to C. burnetii heat shock protein HtpX 2.8 1.9
lpg0238 - lpp0308 lpl0292 similar to betaine aldehyde dehydrogenase BetB  2.8 1.8
lpg2458 shkA lpp2524 lpl2377 similar to two-component sensor histidine kinase  2.8 3.5
lpg2312 - lpp2260 lpl2231 unknown 2.8 1.7
lpg2440 - lpp2507 lpl2361 similar to conserved hypothetical protein 2.8 4.7
lpg0476 - lpp0541 lpl0517 similar to putative sigma-54 modulation protein  2.8 2.6
lpg2431 - lpp2498 - similar to malonyl-CoA acyl-carrier-protein transacylase 2.8 2.1
lpg2159 - lpp2098 lpl2087 similar to (hydroxyindole) O-methyltransferase 2.8 2.4
lpg0276 - lpp0350 lpl0328 unknown 2.7 2.3
lpg1961 - lpp1943 lpl1935 unknown 2.7 2.3
lpg2916 - lpp2985 lpl2844 unknown 2.7 1.9
lpg1726 - lpp1691 lpl1690 similar to acyl-CoA dehydrogenase 2.7 2.3
lpg1596 - lpp1554 lpl1429 2.7 2.5
lpg1836 - lpp1799 lpl1800 some similarity with eukaryotic protein 2.7 2.6
lpg2731 - lpp2787 lpl2656 similar to 2-amino-3-ketobutyrate coenzyme A ligase 2.7 1.7
lpg2216 - lpp2167 lpl2141 some similarity with eukaryotic protein 2.7 2.3
lpg2979 - lpp3050 lpl2907 hypothetical protein 2.7 2.5
- - - lpl2845 hypothetical protein 2.7 1.9
lpg0081 - lpp0095 - unknown 2.7 2.8
lpg1942 - lpp1923 lpl1912 similar to 3-hydroxybutyryl-CoA dehydrogenase 2.7 1.9
lpg1175 - lpp1178 lpl1184 similar to putative hydrolase 2.7 3.0
lpg1715 - lpp1680 lpl1674 16 kD immunogenic protein 2.7 2.8
lpg0619 - lpp0673 - unknown 2.7 5.9
lpg1875 - lpp1840 lpl1837 similar to putative general secretion pathway protein 2.7 3.0
lpg1468 - lpp1424 lpl1560 unknown 2.7 1.7
lpg2909 - lpp2978 - similar to hypothetical protein 2.6 4.3
lpg1021 - lpp2360 - similar to metallo-beta-lactamase superfamily proteins 2.6 1.7
lpg1851 - lpp1818 lpl1817 unknown 2.6 3.1
lpg0782 - lpp0846 lpl0821 similar to O-antigen acetylase 2.6 4.5
lpg2908 - lpp2977 lpl2825 highly similar to peptide methionine sulfoxide reductase 2.6 2.3
lpg2376 - lpp2441 - similar to transcriptional regulator- LysR family 2.6 1.9
lpg0241 - lpp0311 lpl0295 similar to glutaminase 2.5 2.0
lpg2110 - - - hypothetical protein 2.5 3.5
lpg2355 - lpp2304 lpl2277 similar to amidase 2.5 2.3
lpg0743 - lpp0808 lpl0779 similar to unknown proteins 2.5 2.2
lpg2519 - lpp2587 lpl2441 unknown 2.5 9.4
lpg2118 - - - transposase TnpA 2.5 2.7
lpg2189 - lpp2138 lpl2113 similar to putative transport proteins 2.5 2.1
lpg1780 motB lpp1744 lpl1744 similar to chemotaxis MotB protein 2.5 1.5
lpg0456 icmB/dotO lpp0522 lpl0498 icmB/dotO 2.5 1.6
lpg1114 - lpp1114 lpl1118 regulatory protein (GGDEF and EAL domains) 2.5 1.6
lpg2606 - lpp2659 lpl2529 similar to unknown protein 2.5 3.0
lpg0645 rtxA-1 lpp0699 lpl0681 structural toxin protein RtxA 2.5 3.1
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lpg1132 - lpp1134 lpl1139 unknown 2.4 1.8
lpg1042 - lpp2339 - similar to putative cytochrome c family protein 2.4 1.8
- - lpp2183 lpl2156 similar to acyl carrier protein (ACP) 2.4 2.9
lpg1583 - lpp1541 lpl1442 similar to aldehyde dehydrogenase 2.4 2.4
lpg1972 - lpp1955 lpl1950 unknown 2.4 3.0
lpg2467 - lpp2532 lpl2387 similar to coenzyme F42 unknown-reducing hydrogenase- ! subunit 2.4 1.7
lpg1973 - lpp1957 lpl1951 unknown 2.4 2.8
lpg0621 sidA lpp0675 lpl0658 SidA protein- substrate of the Dot/Icm transport system 2.4 2.0
lpg2156 sdeB lpp2095 lpl2084 substrates of the Legionella pneumophila  Dot/Icm system SdeB 2.4 2.3
lpg0275 sdbA lpp0349 lpl0327 SdbA protein- putative substrate of the Dot/Icm system 2.4 1.8
lpg1484 - lpp1440 lpl1544 weak similarity to myosin 2.4 2.2
lpg0153 - lpp0215 lpl0210 unknown 2.4 2.9
lpg1317 - - - hypothetical protein 2.4 2.3
lpg2741 - lpp2797 lpl2666 similar to oligoribonuclease 2.4 2.2
lpg1192 - lpp1194 lpl1200 similar to unknown proteins 2.4 2.1
lpg1718 - lpp1683 lpl1682 ankyrin repeat protein 2.3 2.4
lpg2039 - lpp2022 lpl2017 similar to mevalonate kinase 2.3 1.6
lpg2516 smlA lpp2584 lpl2438 major facilitator superfamily (MFS) transporter 2.3 2.2
lpg0294 - lpp0372 lpl0347 unknown 2.3 1.7
lpg1889 - lpp1856 lpl1851 similar to esterase/lipase 2.3 2.5
lpg0452 icmG/dotF lpp0518 lpl0494 icmG/dotF 2.3 1.5
lpg2262 ack lpp2216 lpl2188 acetate kinase 2.3 1.8
lpg2925 - lpp2991 lpl2851 conserved lipoprotein 2.3 1.6
lpg1126 - lpp1127 lpl1131 some similarity with eukaryotic proteins 2.3 1.8
lpg0402 - lpp0469 lpl0445 ankyrin repeat protein 2.3 2.3
lpg2256 - lpp2210 lpl2182 similar to metallo-beta-lactamase superfamily proteins 2.3 2.1
lpg2435 - lpp2502 lpl2356 unknown 2.3 1.5
lpg2460 - lpp2526 lpl2379 unknown 2.3 2.1
- - lpp0255 - similar to conserved hypothetical protein 2.3 2.2
lpg2742 cca lpp2798 lpl2667 tRNA nucleotidyltransferase 2.3 1.9
lpg1673 purD lpp1645 lpl1638 phosphoribosylamine-glycine ligase 2.3 2.1
lpg2794 msrA lpp2840 lpl2709 similar to phosphoglucomutase 2.3 2.0
lpg2261 pta lpp2215 lpl2187 similar to phosphotransacetylase 2.3 1.9
lpg0487 - lpp0551 lpl0527 similar to hypothetial proteins 2.3 2.0
lpg1041 - lpp2340 - predicted membrane protein 2.2 2.3
lpg2799 - lpp2845 lpl2714 similar to O-acetyltransferase 2.2 1.5
lpg1914 - lpp1889 lpl1880 similar to type IV pilin PilA 2.2 1.5
lpg1003 - lpp1074 lpl1036 similar to carbon storage regulator 2.2 2.9
lpg1597 - lpp1555 lpl1428 similar to "-subunit of fatty acid oxidation complex-3-keto-acyl-CoA-thiolase 2.2 2.8
lpg2129 - - - hypothetical protein 2.2 2.0
- - lpp0617 lpl0600 hypothetical protein 2.2 2.6
lpg2231 - lpp2184 lpl2157 similar to 3-oxoacyl-[acyl-carrier protein] reductase 2.2 2.5
lpg0540 - lpp0604 lpl0585 similar to putative transport proteins 2.2 2.0
lpg2550 - lpp2619 lpl2471 unknown 2.2 2.0
- - lpp0158 lpl0143 unknown 2.2 1.9
lpg1940 - lpp1921 lpl1910 similar to peptide antibiotic synthetase 2.2 1.7
lpg0642 - lpp0696 lpl0679 unknown 2.1 2.1
lpg2739 - lpp2795 lpl2664 similar to cation-efflux system membrane protein 2.1 1.8
lpg0014 - lpp0014 lpl0014 similar to conserved hypothetical protein 2.1 1.5
lpg1941 - lpp1922 lpl1911 similar to acyl-coA dehydrogenase  2.1 2.0
lpg2879 - lpp2938 lpl2792 unknown 2.1 2.1
lpg2498 - lpp2566 lpl2420 unknown 2.1 2.0
- - lpp2518 lpl2371 unknown 2.1 1.8
lpg1630 - lpp1600 - similar to 3-beta hydroxysteroid dehydrogenase/isomerase 2.1 1.8
- - lpp3009 - unknown 2.1 1.9
lpg1453 - lpp1409 lpl1591 unknown 2.1 4.3
lpg1029 cecA2 lpp2351 - chemiosmotic efflux system protein A-like protein 2.1 2.2
lpg2201 - lpp2151 lpl2125 similar to unknown proteins 2.1 1.9
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lpg0788 - lpp0852 lpl0826 unknown 2.0 2.4
lpg0214 - lpp0273 lpl0268 predicted membrane protein- similar to conserved hypothetical protein LrgA 2.0 4.1
lpg0385 - lpp0452 lpl0428 similar to LemA from Coxiella burnetii 2.0 3.6
lpg2227 - lpp2178 lpl2152 similar to propionyl-CoA carboxylase beta chain 2.0 1.7
lpg2050 - lpp2033 lpl2028 unknown 2.0 2.0
lpg1648 - lpp1619 lpl1614 putative secreted protein 2.0 1.8
lpg2466 - lpp2531 lpl2386 similar to hydrogenase 1 maturation protease 2.0 1.9
- - - plpl0026 conjugal pilus assembly protein TraF 2.0 2.0
lpg0428 - lpp0495 lpl0471 similar to hypothetical proteins 2.0 2.8
lpg1050 - lpp2332 - similar to ATP synthase C chain 2.0 1.8
lpg0070 - lpp0085 lpl0073 similar to aspartate aminotransferase  2.0 2.3
lpg0841 - lpp0903 lpl0872 similar to ABC transporter- ATP-binding protein 2.0 1.6
lpg1274 - lpp1237 lpl1237 similar to conserved hypothetical protein 1.9 3.4
lpg1037 - - - hypothetical protein 1.9 1.7
lpg2545 - lpp2612 lpl2467 unknown 1.9 1.8
lpg0930 pilP lpp0992 lpl0961 Tfp pilus assembly protein PilP 1.9 1.9
lpg0477 rpoN lpp0542 lpl0518 RNA polymerase sigma-54 factor (sigma-L) 1.9 1.6
lpg1318 - - - hypothetical protein 1.9 2.0
lpg0667 - lpp0724 lpl0704 similar to conserved hypothetical protein 1.9 2.8
lpg1031 - lpp2349 - unknown 1.9 1.7
lpg1501 - lpp1458 lpl1525 similar to acetyltransferase 1.9 2.0
lpg0401 - lpp0468 lpl0444 unknown 1.9 2.6
lpg1497 - lpp1454 lpl1529 similar to aminopeptidase N 1.9 2.1
lpg2607 - lpp2660 lpl2530 similar to peptidase 1.9 1.7
lpg1059 - lpp2322 lpl1056 similar to acetoacetyl-CoA reductase 1.9 1.6
lpg2455 - lpp2521 lpl2374 unknown 1.9 2.6
lpg2740 - lpp2796 lpl2665 similar to conserved hypothetical protein 1.9 2.2
lpg1959 - lpp1941 lpl1932 unknown 1.9 2.0
lpg1057 - lpp2324 lpl1054 regulatory protein (GGDEF and EAL domains)  1.9 2.6
- - - lpl0168 hypothetical protein 1.9 1.9
lpg2081 traF - - sex pilus assembly TraF, thiol-disulfide isomerase and thioredoxins 1.9 1.6
- - - - RNA polymerase sigma-32 factor 1.8 1.7
lpg0995 - lpp1066 lpl1028 unknown 1.8 1.9
lpg2352 mdh lpp2301 lpl2274 malate dehydrogenase 1.8 2.7
lpg1171 - lpp1173 lpl1179 unknown 1.8 3.3
- - lpp2147 - unknown 1.8 2.1
lpg0166 - lpp0227 lpl0229 similar to conserved hypothetical protein 1.8 4.5
lpg0566 - lpp0626 lpl0609 1.8 1.8
lpg0944 - lpp1006 - unknown 1.8 1.9
lpg1744 - lpp1708 lpl1708 similar to HesB/YadR/YfhF family proteins 1.8 1.5
lpg0050 - lpp0051 lpl0049 putative integral membrane protein 1.8 1.9
lpg2430 - lpp2497 - similar to 2-(5-triphosphoribosyl)-3-dephosphocoenzyme-A synthase 1.8 2.0
lpg1825 - lpp1788 lpl1789 similar to acetyl-CoA acetyltransferase  1.8 2.1
lpg2685 sbpA lpp2739 lpl2612 small basic protein SbpA  1.8 2.1
- - lpp2069 lpl2059 unknown 1.8 1.7
lpg2546 - lpp2615 - unknown 1.8 1.5
lpg2547 - lpp2616 lpl2468 similar to protein secretion chaperonin CsaA 1.7 1.5
- cadA1 lpp2369 - similar to cadmium-transporting ATPase (C-terminal part) 1.7 1.8
lpg1581 - lpp1539 lpl1444 weakly similar to NADP-specific glutamate dehydrogenase 1.7 1.6
lpg2537 - lpp2603 - similar to conserved hypothetical protein 1.7 1.9
lpg2503 - - - hypothetical protein 1.7 1.5
lpg1928 - lpp1903 lpl1895 similar to conserved hypothetical protein 1.7 2.0
lpg2230 - lpp2182 lpl2155 similar to acyl-CoA synthetase 1.7 1.7
lpg1882 - lpp1846 lpl1843 similar to lactoylglutathione lyase 1.7 1.8
lpg1091 - lpp1092 lpl1095 unknown 1.7 2.4
lpg1343 - lpp1297 lpl1296 similar to conserved hypothetical protein 1.7 1.9
lpg1933 - lpp1914 lpl1903 unknown 1.7 41.5
lpg2518 - lpp2586 lpl2440 unknown 1.7 3.9
similar to uncharacterized membrane protein- similar to Bacillus subtilis spore 





1 Fold Change (FC) 
PE NA
Gene ID Name Paris ID Lens ID Description FC1 FC1
lpg0532 sucA lpp0597 lpl0578 2-oxoglutarate dehydrogenase- E1 subunit 1.7 1.8
lpg2302 asd lpp2250 lpl2221 aspartate-semialdehyde dehydrogenase 1.7 2.1
lpg0898 - lpp0959 lpl0929 unknown 1.6 21.9
lpg0433 - lpp0500 lpl0476 putative transcriptional regulator 1.6 1.8
lpg2483 - lpp2547 lpl2403 similar to hypothetical protein 1.6 1.5
lpg2667 rpoH lpp2721 lpl2594 RNA polymerase sigma-32 factor 1.6 1.5
lpg1582 - lpp1540 lpl1443 similar to unknown proteins 1.6 1.6
lpg0556 - lpp0615 lpl0598 similar to hypothetical proteins 1.6 1.6
lpg1159 - lpp1161 lpl1167 similar to putative drug metabolite transport protein (DMT family)  1.6 1.8
lpg0630 - lpp0684 lpl0667 similar to Tfp pilus assembly protein PilW 1.6 7.4
lpg2680 - lpp2734 lpl2607 similar to D-alanine-D-alanine ligase (N-terminal part) 1.6 1.6
lpg2599 topA lpp2652 lpl2522 DNA topoisomerase I 1.6 1.6
lpg1564 - lpp1521 lpl1462 unknown 1.6 1.6
lpg0518 - lpp0581 lpl0557 unknown 1.5 3.5









Gene ID Name Paris ID Lens ID Description FC Ratio1 FC Ratio1
lpg0810 - lpp0872 lpl0843 similar to other proteins -45.0 -23.3
- - lpp2554 lpl2410 hypothetical gene -23.9 -3.1
lpg1713 tsf lpp1678 lpl1672 elongation factor Ts (EF-Ts) -8.7 -3.1
lpg2985 atpH lpp3056 lpl2913 highly similar to H+-transporting ATP synthase chain delta -7.1 -3.7
lpg2884 - lpp2943 lpl2797 unknown -6.6 -1.9
lpg2950 - - - hypothetical protein -6.4 -3.4
lpg0316 secE lpp0381 lpl0356 preprotein translocase secE subunit -6.2 -2.0
lpg2652 - lpp2705 lpl2578 similar to 50S ribosomal subunit protein L25- RplY -6.2 -1.9
lpg0319 rplA lpp0384 lpl0359 50S ribosomal protein L1 -6.0 -3.2
lpg0321 rplL lpp0386 lpl0361 50S ribosomal subunit protein L7/L12 -6.0 -2.8
lpg0397 rimM lpp0465 lpl0441 similar to 16S rRNA processing protein RimM -5.9 -3.0
lpg0419 glk lpp0486 lpl0462 similar to glucokinase -5.9 -3.5
lpg2986 atpF lpp3057 lpl2914 highly similar to H+-transporting ATP synthase chain b -5.9 -2.1
lpg2983 atpG lpp3054 lpl2911 highly similar to H+-transporting ATP synthase chain gamma -5.8 -3.5
lpg2987 atpE lpp3058 lpl2915 highly similar to H+-transporting ATP synthase chain c -5.7 -2.4
lpg0395 rplS lpp0463 lpl0439 50S ribosomal protein L19 -5.7 -1.9
lpg0318 rplK lpp0383 lpl0358 50S ribosomal protein L11 -5.4 -2.9
lpg2948 - - - hypothetical protein -5.2 -2.2
lpg0590 - lpp0640 lpl0624 similar to competence protein comM -5.1 -1.9
lpg2726 ppiB lpp2783 lpl2652 peptidyl-prolyl cis-trans isomerase B (cyclophilin-type PPIase family)  -5.1 -2.1
lpg2984 atpA lpp3055 lpl2912 highly similar to H+-transporting ATP synthase chain alpha -5.1 -3.1
lpg0399 rpsP lpp0466 lpl0442 highly similar to 30S ribosomal protein S16 -5.0 -1.8
lpg0416 zwf lpp0483 lpl0459 similar to Glucose-6-phosphate 1-dehydrogenase -4.9 -1.9
lpg0420 eda lpp0487 lpl0463 -4.8 -2.5
lpg0391 - lpp0458 lpl0434 similar to prolyl/lysyl hydroxylase -4.7 -1.9
lpg0349 secY lpp0414 lpl0389 preprotein translocase- SecY subunit -4.6 -3.0
lpg2982 atpD lpp3053 lpl2910 highly similar to H+-transporting ATP synthase beta chain -4.6 -3.0
lpg0317 nusG lpp0382 lpl0357 transcription antitermination protein NusG -4.5 -1.8
lpg0394 - lpp0462 lpl0438 similar to methylated-DNA-protein-cysteine S-methyltransferase -4.5 -1.7
lpg0462 accC lpp0528 lpl0504 biotin carboxylase (A subunit of acetyl-CoA carboxylase)  -4.5 -3.5
- rpmI lpp2768 lpl2641 50S ribosomal protein L35 -4.4 -2.3
lpg2773 nusA lpp2821 lpl2690 transcription elongation protein nusA -4.4 -2.5
lpg0340 rplX lpp0405 lpl0380 50S ribosomal protein L24 -4.2 -1.6
lpg0923 etfA lpp0985 lpl0954 electron transfer flavoprotein- alpha subunit -4.2 -2.2
lpg0418 edd lpp0485 lpl0461 similar to 6-phosphogluconate dehydratase -4.1 -2.5
lpg0594 - lpp0644 lpl0628 similar to unknown protein -4.1 -2.3
lpg0422 - lpp0489 lpl0465 similar to eukaryotic glucoamylase precursor -4.1 -2.6
lpg0508 lpxD2 lpp0571 lpl0547 UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase -4.1 -1.7
lpg0334 rplV lpp0399 lpl0374 50S ribosomal subunit protein L22 -4.1 -2.2
lpg1712 pyrH lpp1677 lpl1671 uridylate kinase (UK) (Uridine monophosphate kinase) -4.0 -2.6
lpg0595 - lpp0645 lpl0629 similar to aminodeoxychorismate lyase (PabC) -4.0 -2.1
lpg0338 rpsQ lpp0403 lpl0378 30S ribosomal protein S17 -3.9 -1.5
lpg0343 rpsH lpp0408 lpl0383 30S ribosomal protein S8 -3.9 -2.2
lpg0341 rplE lpp0406 lpl0381 50S ribosomal protein L5 -3.8 -1.7
lpg0747 iraA lpp0813 lpl0784 small-molecule methyltransferase IraA iron acquisition -3.8 -2.2
lpg3001 - lpp3073 lpl2929 similar to GTPase for tRNA modification trmE    -3.8 -1.7
lpg0388 - lpp0455 lpl0431 highly similar to ATP-binding component of ABC transporter -3.8 -2.8
lpg0753 neuC lpp0819 lpl0790 N-acylglucosamine 2-epimerase/LPS O-antigen biosynthesis -3.7 -2.0
lpg2000 secF lpp1981 lpl1976 similar to protein-export membrane protein SecF -3.7 -2.9
lpg0924 ald lpp0986 lpl0955 similar to alanine dehydrogenase -3.6 -2.4
lpg0333 rpsS lpp0398 lpl0373 30S ribosomal subunit protein S19 -3.6 -2.2
lpg0463 accB lpp0529 lpl0505 acetyl-CoA carboxylase biotin carboxyl carrier protein -3.6 -2.3
lpg1714 rpsB lpp1679 lpl1673 30S ribosomal protein S2 -3.6 -1.8
lpg1606 - lpp1571 lpl1419 similar to conserved hypothetical proteins -3.6 -1.9
lpg1853 udk lpp1820 lpl1819 uridine kinase -3.6 -1.5








Gene ID Name Paris ID Lens ID Description FC Ratio1 FC Ratio1
lpg2943 lpxA2 lpp3016 - -3.5 -2.3
lpg0171 - lpp0232 lpl0234 similar to hypothetical ABC transporter (permease) -3.5 -2.5
lpg0344 rplF lpp0409 lpl0384 50S ribosomal subunit protein L6 -3.5 -2.4
lpg0352 rpsK lpp0417 lpl0393 30S ribosomal protein S11 -3.5 -1.6
lpg0135 - lpp0149 lpl0134 similar to hypothetical protein -3.5 -2.5
lpg1971 - lpp1954 lpl1949 similar to organic hydroperoxide resistance protein -3.4 -1.5
lpg0336 rplP lpp0401 lpl0376 50S ribosomal protein L16 -3.4 -1.8
lpg0347 rpmD lpp0412 lpl0387 50S ribosomal subunit protein L3unknown -3.4 -1.9
lpg0417 pgl lpp0484 lpl0460 similar to 6-phosphogluconolactonase -3.4 -2.1
lpg1209 - lpp1211 lpl1217 similar to conserved hypothetical protein -3.3 -2.9
lpg0617 - lpp0671 lpl0655 similar to L. pneumophila  major outer membrane protein -3.3 -2.5
- tufA2 lpp0392 lpl0367 translation elongation factor Tu -3.3 -1.9
lpg0041 - - - hypothetical protein -3.3 -3.7
lpg1946 - lpp1927 lpl1917a similar to transcriptional regulator- LuxR family -3.3 -1.8
lpg0084 - lpp0098 lpl0083 similar to unknown proteins -3.2 -2.6
lpg2419 - - - hypothetical protein -3.2 -2.1
lpg0754 - lpp0820 lpl0791 similar to acetyl transferase -3.2 -2.6
lpg0812 mreC lpp0874 lpl0845 rod shape-determining protein MreC -3.2 -2.3
lpg0752 neuB lpp0818 lpl0789 N-acetylneuraminic acid condensing enzyme peptidoglycan biosynthesis -3.2 -1.6
lpg1393 fabH lpp1348 lpl1344 3-oxoacyl-[acyl-carrier-protein] synthase III -3.1 -2.3
lpg1559 - lpp1516 lpl1467 similar to pyruvate dehydrogenase E1 (beta subunit)  -3.1 -2.2
lpg1552 - lpp1509 lpl1474 similar to UDP-2-3-diacylglucosamine hydrolase -3.1 -2.0
lpg1433 deoC lpp1388 lpl1608 similar to 2-deoxyribose-5-phosphate aldolase -3.1 -2.5
lpg0461 prmA lpp0527 lpl0503 ribosomal protein L11 methyltransferase -3.1 -2.7
lpg2254 - lpp2208 lpl2180 similar to conserved hypothetical protein -3.1 -2.1
lpg0331 rplW lpp0396 lpl0371 50S ribosomal subunit protein L23 -3.1 -1.6
lpg0460 purH lpp0526 lpl0502 -3.1 -2.9
lpg0751 neuA lpp0817 lpl0788 CMP-N-acetlyneuraminic acid synthetase peptidoglycan biosynthesis -3.0 -2.1
lpg0099 polA lpp0113 lpl0099 DNA polymerase I -3.0 -2.6
lpg2934 ubiD lpp3001 lpl2862 highly similar to 3-polyprenyl-4-hydroxybenzoate decarboxylase -3.0 -1.8
lpg1350 - lpp1304 lpl1303 similar to dehydrogenase -3.0 -1.9
lpg0337 rpmC lpp0402 lpl0377 50S ribosomal subunit protein L29 -3.0 -1.6
- - - lpl2342 hypothetical protein -3.0 -2.1
lpg2595 def lpp2648 lpl2518 similar to polypeptide deformylase -2.9 -2.1
lpg2569 - - - hypothetical protein -2.9 -1.6
lpg0512 - lpp0574 lpl0550 similar to membrane protein involved in chromosome condensation -2.9 -2.4
lpg1140 potB lpp1142 lpl1147 similar to spermidine/putrescine transport system permease protein PotB -2.9 -2.0
lpg0346 rpsE lpp0411 lpl0386 30S ribosomal subunit protein S5 -2.9 -2.4
lpg1460 - lpp1416 lpl1568 similar to unknown protein -2.9 -2.5
lpg1215 hemF lpp1223 lpl1223 oxygen-dependent coproporphyrinogen III oxidase -2.8 -1.6
lpg0767 - lpp0832 lpl0808 unknown -2.8 -2.6
lpg2057 intD - - prophage dlp12 integrase -2.8 -1.5
lpg1351 - lpp1305 lpl1304 similar to aldehyde dehydrogenase -2.8 -2.1
lpg0332 rplB lpp0397 lpl0372 50S ribosomal subunit protein L2 -2.8 -2.0
lpg1421 rpsA lpp1376 lpl1372 30S ribosomal protein S1 -2.8 -1.9
lpg1560 - lpp1517 lpl1466 pyruvate dehydrogenase E2 (dihydrolipoamide acetyltransferase) -2.8 -2.2
- - lpp3017 - unknown -2.8 -1.7
lpg0187 - lpp0247 lpl0247 similar to conserved hypothetical protein -2.8 -2.1
lpg0348 rplO lpp0413 lpl0388 50S ribosomal subunit protein L15 -2.8 -1.9
lpg0787 - lpp0851 - unknown -2.7 -1.6
lpg0749 hisF1 lpp0815 lpl0786 similar to imidazole glycerol phosphate synthase subunit HisF  -2.7 -1.9
lpg1434 xapA lpp1389 lpl1607 similar to xanthosine phosphorylase -2.7 -1.8
- - lpp0240 - similar to hypothetical protein -2.7 -2.0
lpg2386 - lpp2451 lpl2310 unknown -2.7 -2.0
lpg0596 - lpp0646 lpl0630 similar to conserved hypothetical protein- predicted membrane protein -2.7 -2.0
lpg2643 - lpp2696 lpl2569 unknown -2.7 -1.7
lpg2711 pheS lpp2766 lpl2639 phenylalanyl-tRNA synthetase- alpha subunit -2.7 -1.7
similar to phosphoribosylaminoimidazolecarboxamide formyltransferase 
and IMP cyclohydrolase (bifunctionnal)








Gene ID Name Paris ID Lens ID Description FC Ratio1 FC Ratio1
lpg1719 - lpp1684 lpl1683 similar to methionine aminopeptidase- type I -2.7 -1.6
lpg0511 lpxA1 lpp0573 lpl0549 UDP-N-acetylglucosamine acyltransferase -2.7 -1.8
lpg0090 - lpp0104 lpl0089 unknown -2.6 -2.4
lpg0768 - lpp0833 lpl0809 similar to sialic acid synthase -2.6 -1.7
lpg2597 - lpp2650 lpl2520 similar to E. coli Smf protein -2.6 -1.8
lpg2659 - lpp2713 lpl2586 similar to predicted ATPase -2.6 -1.9
lpg2554 - lpp2624 lpl2475 similar to N-terminal part of rare lipoprotein A  -2.6 -1.6
lpg2674 dotD lpp2728 lpl2601 lipoprotein DotD -2.6 -2.0
lpg0423 - lpp0490 lpl0466 similar to transcriptional regulator (XRE-family) -2.6 -1.5
lpg2297 rne lpp2244 lpl2216 ribonuclease E -2.6 -2.6
lpg0327 tufB - - Elongation factor Tu -2.5 -2.0
lpg0060 - - - methylase -2.5 -2.0
lpg0548 - lpp0609 lpl0590 similar to phosphopantetheine adenylyltransferase -2.5 -2.9
lpg0700 - lpp0755 lpl0737 similar to L-isoaspartate carboxylmethyltransferase protein pcm  -2.5 -2.0
lpg1332 - lpp1286 lpl1285 similar to conserved hypothetical protein -2.5 -2.3
lpg2772 infB lpp2820 lpl2689 translation initiation factor IF-2 -2.5 -2.5
lpg1747 - lpp1711 lpl1711 similar to putative tRNA/rRNA methyltransferase -2.5 -2.4
lpg1578 - lpp1536 lpl1447 conserved hypothetical protein -2.5 -1.7
lpg1342 folC lpp1296 lpl1295 similar to dihydrofolate:folylpolyglutamate synthetase FolC -2.5 -2.0
lpg0506 - lpp0569 lpl0545 similar to protective surface antigen -2.5 -1.7
lpg2730 - lpp2786 lpl2655 similar to cytochrome c5 -2.4 -2.0
lpg0363 - lpp0428 lpl0404 similar to lipid A biosynthesis acyltransferase -2.4 -2.1
lpg0852 - lpp0914 lpl0883 unknown -2.4 -1.7
lpg2771 rbfA lpp2819 lpl2688 ribosome-binding factor A  -2.4 -2.5
lpg2929 ksgA lpp2995 lpl2855 similar to dimethyladenosine transferase (16S rRNA dimethylase)  -2.4 -2.0
lpg0292 - lpp0370 lpl0345 unknown -2.4 -2.2
lpg2994 - lpp3065 lpl2922 similar to conserved hypothetical protein -2.4 -2.5
lpg0654 dam lpp0708 lpl0690 DNA adenine methylase -2.4 -1.8
lpg1845 - lpp1809 lpl1810 conserved lipoprotein -2.4 -2.3
lpg2728 - lpp2785 lpl2654 similar to disulfide bond formation protein DsbB -2.4 -1.8
lpg1420 kcy lpp1375 lpl1371 cytidylate kinase -2.4 -1.5
lpg1195 hisA lpp1197 lpl1203 -2.3 -1.5
lpg1974 - lpp1958 lpl1952 major outer membrane protein -2.3 -1.5
- - lpp0214 lpl0209 similar to hypothetical protein -2.3 -1.7
lpg0728 thiL lpp0794 lpl0765 thiamine-monophosphate kinase -2.3 -1.5
lpg0355 rplQ lpp0420 lpl0396 50S ribosomal protein L17 -2.3 -1.9
lpg2880 nth lpp2939 lpl2793 endonuclease III -2.3 -1.9
lpg1380 hutH lpp1335 lpl1331 similar to histidine ammonia-lyase (Histidase) -2.3 -1.5
lpg0094 - lpp0108 lpl0093 highly similar to ribose 5-phosphate isomerase RpiA -2.3 -1.7
lpg2593 - lpp2646 lpl2516 similar to rRNA methylase (sun protein) -2.3 -2.2
lpg2476 hypA lpp2541 lpl2396 hydrogenase nickel incorporation protein HypA -2.3 -1.9
lpg1570 - lpp1528 lpl1455 some similarities to 3 -nucleotidase/nuclease -2.3 -1.9
lpg2176 - lpp2128 lpl2102 similar to eukaryotic sphingosine-1-phosphate lyase 1 -2.2 -2.0
lpg2601 - lpp2654 lpl2524 similar to conserved hypothetical protein -2.2 -1.9
lpg2801 - lpp2847 lpl2716 similar to phosphatidylglycerophosphate synthase -2.2 -2.1
lpg1379 hutU lpp1334 lpl1330 similar to urocanate hydratase (imidazolonepropionate hydrolase) -2.2 -1.9
lpg1196 hisH2 lpp1198 lpl1204 -2.2 -1.7
lpg0698 - lpp0753 lpl0735 similar to conserved hypothetical protein -2.2 -1.8
lpg1906 - lpp1881 lpl1872 similar to conserved hypothetical protein -2.2 -1.5
lpg0111 - lpp0124 lpl0110 similar to farnesyl-diphosphate farnesyltransferase (Squalene synthetase) -2.2 -1.6
lpg0297 - lpp0375 lpl0350 similar to organic solvent tolerance protein -2.2 -1.9
lpg1956 - lpp1938 lpl1925 similar to chloromuconate cycloisomerase -2.2 -1.8
lpg0636 tdk lpp0690 lpl0673 similar to thymidine kinase -2.2 -1.6
lpg1419 aroA lpp1374 lpl1370 3-phosphoshikimate 1-carboxyvinyltransferase -2.2 -1.9
lpg0195 katG lpp0252 lpl0251 catalase-peroxidase -2.2 -1.7
lpg0053 - lpp0055 lpl0053 similar to hypothetical protein -2.2 -2.6
lpg0360 - lpp0425 lpl0401 similar to hydroxymyristoyl-(acyl carrier protein) dehydratase -2.2 -2.0
imidazole glycerol phosphate synthase subunit HisH (IGP synthase 
glutamine amidotransferase subunit) 
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lpg2658 feoA lpp2712 lpl2585 ferrous iron transporter A -2.1 -1.9
lpg0864 - lpp0926 lpl0895 similar to cytochrome c-type biogenesis protein -2.1 -2.1
lpg1328 - lpp1283 lpl1282 some similarities with eukaryotic protein -2.1 -1.7
lpg0459 dotU lpp0525 lpl0501 dotU -2.1 -1.8
lpg1329 - lpp1284 lpl1283 unknown -2.1 -1.8
lpg2669 ftsE lpp2723 lpl2596 highly similar to cell division ABC transporter- ATP-binding protein FtsE -2.1 -1.9
- - - lpl2343 hypothetical protein -2.1 -1.8
lpg0054 - lpp0056 lpl0054 unknown -2.1 -2.3
lpg1962 - lpp1946 lpl1936 similar to peptidyl-prolyl cis-trans isomerase proteins -2.1 -1.8
lpg1818 lpxK lpp1781 lpl1782 similar to tetraacyldisaccharide 4-kinase -2.1 -2.1
lpg1861 clpP lpp1829 lpl1825 ATP-dependent Clp protease proteolytic subunit -2.1 -1.5
- - lpp0843 lpl0818 similar to glycosyl transferase -2.1 -1.6
lpg2208 - lpp2159 lpl2133 similar to oxidoreductase -2.1 -1.8
lpg0326 fusA lpp0391 lpl0366 translation elongation factor G -2.1 -2.3
lpg0101 - lpp0115 lpl0101 unknown -2.1 -1.8
lpg0608 - lpp0659 lpl0643 similar to methyltransferase -2.1 -1.8
lpg2757 - lpp2805 lpl2674 similar to hypothetical protein -2.1 -1.8
lpg2872 - lpp2931 lpl2785 similar to probable (di)nucleoside polyphosphate hydrolase NudH -2.1 -2.8
lpg3002 - lpp3074 lpl2930 putative inner membrane protein -2.1 -2.2
lpg1521 - lpp1478 lpl1505 similar to conserved hypothetical protein -2.1 -3.2
lpg1194 hisF2 lpp1196 lpl1202 imidazole glycerol phosphate synthase subunit HisF -2.1 -1.7
lpg1995 - lpp1976 lpl1971 unknown -2.1 -1.5
lpg2786 nuoD lpp2833 lpl2702 NADH dehydrogenase I chain D  -2.1 -1.8
lpg0139 gap lpp0153 lpl0138 glyceraldehyde 3-phosphate dehydrogenase -2.1 -1.7
lpg0145 ccrB - - site specific recombinase -2.0 -1.9
lpg1075 - - - hypothetical protein -2.0 -1.5
- - lpp2044 - unknown -2.0 -2.0
lpg0783 birA lpp0847 lpl0822 -2.0 -1.8
lpg1700 - lpp1665 lpl1659 similar to Uracil-DNA glycosylase -2.0 -1.9
lpg2211 - lpp2162 lpl2136 similar to conserved hypothetical protein -2.0 -1.8
lpg0759 gpi lpp0825 lpl0796 glucose-6-phosphate isomerase -2.0 -2.1
lpg0867 - lpp0930 lpl0899 similar to ATP-dependent DNA helicase RecQ -2.0 -1.8
lpg1852 - lpp1819 lpl1818 similar to putative alkaline phosphatase -2.0 -1.5
lpg0105 - lpp0119 lpl0105 similar to conserved hypothetical protein- predicted membrane protein -2.0 -1.8
lpg2768 pnp lpp2816 lpl2685 polynucleotide phosphorylase (PNPase) -2.0 -2.2
lpg2856 - lpp2914 lpl2768 similar to unknow protein -2.0 -2.3
lpg0003 recF lpp0003 lpl0003 RecF recombinational DNA repair ATPase -2.0 -1.8
lpg2705 petA lpp2760 lpl2633 similar to ubiquinol-cytochrome c reductase- iron-sulfur subunit -2.0 -1.9
lpg0110 - lpp0123 lpl0109 unknown -2.0 -1.5
lpg0005 - lpp0005 lpl0005 similar to peptidylarginine deiminase and related enzymes -2.0 -1.6
lpg1739 - lpp1704 lpl1703 similar to Adenylate cyclase 1 -2.0 -1.5
lpg0109 - lpp0122 lpl0108 unknown -2.0 -4.2
lpg2116 - - - transposase, IS4 family TnpA -2.0 -1.5
lpg0362 - lpp0427 lpl0403 similar to 3-oxoacyl-[acyl-carrier-protein] synthase beta chain -2.0 -1.8
lpg0137 - lpp0151 lpl0136 similar to pyruvate kinase II PykA- glucose stimulated -2.0 -1.9
lpg0598 - lpp0648 lpl0632 similar to unknown protein -2.0 -2.0
- - - lpl2341 hypothetical protein -2.0 -2.1
lpg0889 - lpp0950 lpl0920 similar to acetyltransferase -1.9 -2.0
lpg0547 - lpp0608 lpl0589 similar to putative outer membrane lipoproteins -1.9 -2.5
lpg2654 - lpp2707 lpl2580 similar to GTP-binding protein -1.9 -1.6
lpg1508 - lpp1465 lpl1518 similar to rare lipoprotein A RlpA -1.9 -1.6
lpg0514 - - - hypothetical protein -1.9 -1.6
lpg1711 rrf lpp1676 lpl1670 ribosome recycling factor -1.9 -1.8
lpg0083 - lpp0097 lpl0082 similar to unknown proteins -1.9 -2.0
lpg1296 - lpp1259 lpl1258 similar to conserved hypothetical protein -1.9 -1.7
lpg1699 ubiG lpp1664 lpl1658 3-demethylubiquinone-9 3-methyltransferase -1.9 -1.9
lpg1869 rnc lpp1834 lpl1831 similar to ribonuclease III -1.9 -1.7
lpg0838 - lpp0900 lpl0869 similar to conserved hypothetical protein -1.9 -1.9
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lpg2477 - lpp2542 lpl2397 weakly similar to high-affinity nickel-transport protein NixA -1.9 -1.7
lpg2660 - lpp2714 lpl2587 similar to unknown protein -1.9 -1.6
lpg1394 fabD lpp1349 lpl1345 malonyl CoA-acyl carrier protein transacylase -1.9 -1.5
lpg2506 - lpp2574 lpl2428 similar to sensor histidine kinase/response regulator -1.9 -1.8
lpg0051 - lpp0053 lpl0051 unknown -1.9 -2.2
lpg0170 - lpp0231 lpl0233 similar to C-terminal part of paraquat-inducible protein -1.9 -2.0
lpg0772 wzm lpp0837 lpl0813 ABC transporter of LPS O-antigen- Wzm -1.8 -1.8
lpg2785 nuoE lpp2832 lpl2701 NADH dehydrogenase I chain E -1.8 -1.7
lpg2594 fmt lpp2647 lpl2517 similar to methionyl-tRNA formyltransferase -1.8 -1.9
lpg0807 nadC lpp0869 lpl0840 nicotinate-nucleotide pyrophosphorylase -1.8 -2.0
lpg2784 nuoF lpp2831 lpl2700 NADH dehydrogenase I chain F -1.8 -1.8
lpg0863 ccmH lpp0925 lpl0894 cytochrome c-type biogenesis protein CcmH -1.8 -2.0
lpg1424 - lpp1379 lpl1375 similar to polysaccharide biosynthesis protein -1.8 -1.6
lpg0226 - lpp0285 lpl0280 similar to outer membrane component of multidrug efflux pump -1.8 -2.2
lpg1164 - lpp1166 lpl1172 similar to acetylornithine deacetylase -1.8 -1.6
lpg2865 - lpp2923 lpl2777 similar to unknown protein -1.8 -1.6
lpg1436 - lpp1391 lpl1605 unknown -1.8 -1.5
lpg1306 glnS lpp1270 lpl1269 glutamine tRNA synthetase -1.8 -2.1
lpg2165 - lpp2103 lpl2092 unknown -1.8 -2.5
lpg0412 - lpp0479 lpl0455 similar to Polyprenyltransferase (cytochrome oxidase assembly factor) -1.8 -1.7
lpg2314 dapA lpp2262 lpl2234 dihydrodipicolinate synthase -1.8 -2.2
lpg1538 pcnB lpp1495 lpl1488 poly(A) polymerase (PAP) (Plasmid copy number protein) -1.8 -2.1
lpg0361 - lpp0426 lpl0402 similar to 3-oxoacyl-[acyl-carrier-protein]synthase II -1.8 -1.9
lpg1149 - lpp1151 lpl1155 unknown -1.8 -2.0
lpg2933 - lpp3000 lpl2861 similar to C-terminal part of NAD(P)H-flavin reductase -1.8 -1.6
lpg1970 - lpp1953 lpl1948 similar to glutathione S-transferase -1.8 -1.6
lpg0167 - lpp0228 lpl0230 similar to conserved hypothetical protein -1.8 -1.6
lpg0125 - lpp0138 lpl0123 similar to cytochrome c4 -1.8 -1.8
lpg1463 secA lpp1419 lpl1565 preprotein translocase- secretion protein SecA subunit -1.7 -2.1
lpg0095 - lpp0109 lpl0094 similar to 5 -nucleotidase -1.7 -1.5
lpg2895 ctaG lpp2960 lpl2809 cytochrome c oxidase assembly protein -1.7 -2.1
lpg0830 - lpp0892 lpl0861 unknown -1.7 -1.5
lpg2795 folP lpp2841 lpl2710 dihydropteroate synthase -1.7 -1.6
lpg2787 nuoC lpp2834 lpl2703 NADH dehydrogenase I chain C -1.7 -1.8
lpg0140 tkt lpp0154 lpl0139 similar to transketolase -1.7 -1.6
lpg2867 - lpp2925 lpl2779 similar to unknown protein -1.7 -1.7
lpg1709 - lpp1674 lpl1668 similar to unknown proteins -1.7 -1.5
lpg0117 gcsA lpp0130 lpl0115 -1.7 -1.5
lpg1088 - lpp1089 - unknown -1.7 -1.6
lpg1536 - lpp1493 lpl1490 similar to conserved hypothetical protein -1.7 -1.8
lpg2993 - lpp3064 lpl2921 similar to phosphoheptose isomerase -1.7 -2.0
lpg1462 - lpp1418 lpl1566 similar to tRNA-dihydrouridine synthase A DusA -1.7 -1.6
lpg1989 - lpp1970 lpl1964 putative membrane protein -1.6 -1.6
lpg0491 - lpp0553 lpl0529 similar to putative glutamine-binding periplasmic protein precursor -1.6 -8.8
lpg0808 murG lpp0870 lpl0841 -1.6 -1.7
lpg0653 - lpp0707 lpl0689 similar to major facilitator family transporter -1.6 -1.7
lpg0185 - - - ABC sugar transporter, ATP binding protein -1.6 -1.6
lpg0760 rmlA lpp0826 lpl0797 glucose-1-phosphate thymidylyltransferase /rhamnose biosynthesis -1.6 -1.8
lpg2581 - lpp2633 lpl2503 -1.6 -1.8
lpg1814 - lpp1777 lpl1778 similar to conserved hypothetical protein -1.6 -1.6
lpg0784 - lpp0848 lpl0823 similar to phosphopantetheinyl transferase -1.6 -1.6
lpg2995 - lpp3066 lpl2923 conserved hypothetical protein- putative lipoprotein -1.6 -1.6
lpg0505 ecfE lpp0568 lpl0544 similar to putative membrane-associated Zn-dependent protease EcfE -1.6 -1.8
lpg0792 - lpp0856 lpl0830 similar to AmpG protein -1.6 -1.8
lpg0857 ccmB lpp0919 lpl0888 heme exporter protein CcmB -1.6 -1.6
lpg1543 - lpp1500 lpl1483 similar to conserved hypothetical protein -1.6 -1.7
similar to pyruvate/2-oxoglutarate dehydrogenase complex- 
dehydrogenase (E1) component- eukaryotic type- beta subunit
glycine dehydrogenase [decarboxylating] subunit 1 (glycine 








1 Fold Change (FC) 
PE NA
Gene ID Name Paris ID Lens ID Description FC Ratio1 FC Ratio1
lpg1815 oxyR lpp1778 lpl1779 hydrogen peroxide-inducible genes activator -1.6 -1.5
lpg1273 - lpp1236 lpl1236 unknown -1.6 -1.5
lpg2781 nuoI lpp2828 lpl2697 NADH-quinone oxidoreductase chain I -1.6 -1.5
lpg0006 speA lpp0006 lpl0006 similar to biosynthetic arginine decarboxylase -1.5 -1.8
lpg0861 ccmF lpp0923 lpl0892 cytochrome C-type biogenesis protein CcmF -1.5 -1.7
lpg0458 icmF lpp0524 lpl0500 icmF -1.5 -1.8
lpg1411 adk lpp1366 lpl1362 adenylate kinase -1.5 -1.5
lpg2450 - lpp2515 lpl2368 predicted integral membrane protein -1.5 -2.7
lpg2861 - lpp2919 lpl2773 similar to tRNA-dihydrouridine synthase B -1.5 -1.5
lpg2777 nuoM lpp2824 lpl2693 NADH-quinone oxidoreductase chain M -1.5 -1.6
lpg2635 - lpp2688 lpl2560 similar to integral membrane protein MviN -1.5 -1.7
lpg0806 - lpp0868 lpl0839 similar to Na(+)/H(+) antiporter -1.5 -2.2
lpg2475 hypB lpp2540 lpl2395 hydrogenase nickel incorporation protein HypB -1.5 -1.6
lpg2780 nuoJ lpp2827 lpl2696 NADH-quinone oxidoreductase chain J -1.5 -1.7
lpg0836 - lpp0898 lpl0867 similar to ABC transporter- ATP-binding protein -1.5 -1.5
lpg0257 - lpp0327 lpl0310 similar to multidrug resistance proteins -1.5 -2.3
lpg2897 coxB lpp2962 lpl2811 cytochrome c oxidase- subunit II -1.4 -1.8











Summary of work presented 
 To combat various metabolic and environmental stresses, many microbes alter 
their cellular physiology in a process known as differentiation.  Accordingly, when 
nutrients are abundant, L. pneumophila induces a cohort of genes that promote 
proliferation.  However, once nutrients are depleted, replication halts and L. pneumophila 
activates an arsenal of traits to facilitate host transmission and survival in the harsh 
environment.  My thesis work has examined both the regulatory proteins and the 
metabolic cues that regulate L. pneumophila phase differentiation.  Based on genetics in 
conjunction with phenotypic and transcriptional analysis, I postulate that the complexity 
of the LetA/LetS two-component system enables L. pneumophila to customize a panel of 
traits that are suitable for the local conditions.  Furthermore, I have uncovered several 
novel metabolites that govern the L. pneumophila developmental switch.  In particular, 
my data indicate that perturbations in fatty acid biosynthesis activate the stringent 
response pathway via an interaction between SpoT and ACP, which ultimately leads to L. 
pneumophila differentiation.  Finally, by comparing the transcriptional profiles of 
replicative and transmissive phase L. pneumophila to the genes that are regulated by 
nicotinic acid (NA), I have identified a set of genes that are unique to this phenotypic 
modulator.  Taken together, my data establish that L. pneumophila swiftly acclimates to 
environmental stresses by monitoring metabolic fluctuations and employing a regulatory 







Establishing whether LetA and LetS are partners within the same two-component system 
 The L. pneumophila LetA/LetS two-component system was originally identified 
by screening a library for mutants that were unable to activate flagellin expression 
(Hammer et al., 2002).  Surprisingly, genome analysis indicates that LetA and LetS do 
not reside within an operon or within the same region of the Legionella chromosome.  
Thus, it was an assumption that LetA and LetS are partners.  However, phenotypic 
analysis indicates that every PE trait regulated by LetA is similarly controlled by LetS, 
including: the ability to infect both macrophages and A. castellanii and to avoid 
phagosome-lysosome fusion, macrophage cytotoxicity, motility, sodium sensitivity, 
stress resistance and pigmentation (Bachman and Swanson, 2004a; Hammer et al., 2002; 
Lynch et al., 2003).  Moreover, microarray analysis of letA and letS mutants revealed that 
both regulate the same cohort of genes, apart from genes involved in arginine uptake and 
biosynthesis (lpg0553-lpg0555; Sahr et. al., unpublished).  Taken together, the 
phenotypic and transcriptional data indicate that LetA and LetS likely work together to 
regulate PE genes and traits.  To further bolster the argument that LetA and LetS are 
partners within a single two-component system, biochemical studies could analyze the 
transfer of phosphate from LetS to LetA.   
 
Determining the kinetics of the LetA/LetS phosphorelay 
 Work in Bordetella indicates that the BvgA/BvgS two-component system 
regulates at least four classes of genes based upon the consensus sequences located in the 
promoter region of Bvg-regulated genes, the rate that phosphate flows through the relay, 
and the intracellular concentrations of phosphorylated BvgA (Cotter and Jones, 2003).  
Slow rates of phospho-transfer leads to low levels of BvgA~P, which is only sufficient to 





High rates of phospho-transfer results in high levels of BvgA~P, a pool that is sufficient 
to bind promoters containing both high and low affinity binding sites (Cotter and Jones, 
2003).  It has been suggested that the expression of the intermediate class of Bvg-
regulated genes is dependent upon intermediate levels of phospho-transfer and 
intermediate concentrations of BvgA~P in the cell (Jones et al., 2005; Williams et al., 
2005).  Similarly, I predict that in Legionella, different flow rates in the phosphorelay 
affect the amount of phosphorylated LetA (LetA~P), which in turn impacts what targets 
LetA binds and which genes are transcribed.   
 At present, the biochemistry of the LetA/LetS phosphorelay has not been 
analyzed.  While my data predict that histidine 307 is the autophosphorylation site 
(Chapter 2), the other residues in LetA and LetS that are predicted to participate in the 
phosphorelay need to be tested.  Moreover, using purified LetA and LetS proteins, the 
contribution each signaling domain makes to the relay can be analyzed.  Finally, the 
kinetics of the wild-type phosphorelay can be established by reconstituting the LetA/LetS 
system in vitro.   
 As described in Chapter 2, I generated a mutation in LetS (designated as letST311M) 
that demonstrated that a hierarchy exists among the L. pneumophila LetA/LetS regulated 
genes and phenotypes.  I infer that the expression of the different transcriptional and 
phenotypic profiles is partially dependent on the rate that phosphate flows through the 
relay and the intracellular concentrations of LetA~P.  Although this prediction is in 
accordance with the BvgA/BvgS model, the kinetics of the phosphorelay in the letST311M 
mutant has not been examined.  Therefore, further biochemical analyses can test directly 
the prediction that LetA/LetS regulates expression through the concentration and flow of 








Identifying LetA and CsrA targets 
 Whereas the BvgA/BvgS system controls the various classes of genes through the 
binding affinities of BvgA~P to different consensus sequences located in Bvg-regulated 
promoters, a stringent genome-wide pattern search in L. pneumophila only identified the 
LetA consensus sequence TNAGAAATTTCTNA upstream of the small RNAs, RsmY 
and RsmZ (Kulkarni et al., 2006).  Although microarray data indicate that LetA regulates 
324 different genes, both bioinformatic and biochemical data suggest that the two 
regulatory RNAs are probably the only targets of LetA (Sahr et. al., unpublished).  
Additional studies are required to determine whether LetA can also bind genes with less 
stringent or entirely different consensus sequences.   
 Unlike Bordetella, the L. pneumophila regulatory cascade that governs 
differentiation includes both the LetA/LetS and the CsrA/RsmY/RsmZ systems (Fettes et 
al., 2001; Hammer et al., 2002; Lynch et al., 2003; Molofsky and Swanson, 2003).  By 
incorporating the Csr system into the rheostat model of regulation, I predict that when 
LetS receives an appropriate signal, it autophosphorylates, and then transfers the 
phosphoryl group along the relay to LetA.  Once LetA is phosphorylated, it binds 
upstream of RsmY and RsmZ and initiates their transcription.  The small RNAs then 
relieve CsrA repression on mRNAs by titrating the protein away from its respective 
targets.  RNA polymerase is then free to access and transcribe the mRNAs (Chapter 2).   
 Similar to the Bordetella system, I expect that the rate and efficiency of the 
LetA/LetS phosphorelay controls the level of LetA~P, and likewise, the amount of RsmY 
and RsmZ transcribed.  Since more than one CsrA molecule can bind target mRNAs, 
perhaps different classes of mRNAs have different amounts of CsrA bound.  Thus, some 
mRNAs would need high levels of RsmY and RsmZ to relieve CsrA repression, whereas 
mRNAs that have only one CsrA bound would need less RsmY and RsmZ transcribed.  It 
is also possible that CsrA has different affinities for particular mRNA sequences.  





would easily remove CsrA from its targets.  Conversely, other mRNAs would have CsrA 
more tightly bound and would require more RsmY and RsmZ to relieve CsrA repression.   
Therefore, the amount of RsmY and RsmZ transcribed would then affect the order in 
which mRNAs are relieved from CsrA repression.  This design is similar to Bordetella, 
but the L. pneumophila model contains an additional layer of regulation.  Since only one 
CsrA target has been identified to date, future studies will be required to uncover other 
CsrA targets, to determine whether the consensus sequences differ between the mRNAs, 
and if different amounts of RsmY and RsmZ affect the affinity of CsrA for particular 
mRNA sequences (C. Buchrieser, personal communication).   
 
Additional metabolites that cue L. pneumophila differentiation 
 In Chapter 3, I identified 22 novel triggers of L. pneumophila differentiation by 
screening hundreds of small molecules via phenotypic microarrays.  The short chain fatty 
acids (SCFAs) formic, acetic, propionic and butyric acid were among the compounds that 
elicited a positive response.  My data suggest that excess SCFAs perturb the balance in 
fatty acid biosynthesis, which ultimately triggers the stringent response pathway and L. 
pneumophila differentiation.   
 
Other fatty acids:  The Biolog screen identified eight additional carboxylic acids, and I 
postulate that these may similarly induce the phenotypic switch by altering fatty acid 
metabolism.  Indeed, preliminary data indicate that α-ketovaleric acid may impact 
branched chain fatty acid metabolism and alter the acetyl-CoA levels in the cell (Fonseca 
and Swanson, unpublished).  Moreover, several of the carboxylic acids could be degraded 
into SCFAs, which would then alter fatty acid biosynthesis similar to acetic and propionic 
acid (Chapter 3).  For example, caproic acid (hexanoic acid) was identified by the 
phenotypic microarrays and was subsequently shown to inhibit growth and induce 





CoA molecules.  As described in Chapter 3, acetyl-CoA can then be converted into 
malonyl-CoA, which can perturb the fatty acid biosynthetic pathway (Magnuson et al., 
1993).  Similarly, the 12-carbon carboxylic acid lauric acid triggered L. pneumophila 
differentiation, as determined by growth inhibition and activation of the flagellin 
promoter (data not shown).  However, the response of L. pneumophila to lauric acid was 
not as rapid or robust as the response induced by shorter chain fatty acids (data not 
shown).  This phenomenon might be attributed to the six rounds of β-oxidation that must 
occur for the release of the 6 acetyl-CoA molecules.  Whether additional long chain fatty 
acids also induce L. pneumophila differentiation has not been examined, since the 
phenotypic microarrays did not contain a panel of long chain fatty acids.  Therefore, 
directed studies will be required to deduce whether the other carboxylic acids cue 
differentiation via activation of the stringent response and amplification by the LetA/LetS 
two-component system.   
 
Tween detergents:  In addition to the carboxylic acids, two detergents, Tween 20 and 
Tween 80, also induced L. pneumophila differentiation.  It is possible that the detergents 
disrupt membrane integrity, which initiates a stress response and activates the regulatory 
pathways that govern phase differentiation.  However, it is important to note that both 
detergents contain carboxylic acid groups:  lauric and oleic acids, respectively.  Thus, 
Tween 20 and Tween 80 may act as carboxylic acids to trigger L. pneumophila 
differentiation.  However, the two related detergents Tween 40 and Tween 60 were 
present on the microarray plates, but neither inhibited growth or activated the flaA 
reporter construct.  Tween 40 and Tween 60 also contain carboxylic acid moieties, 
palmitic and stearic acid, respectively.  I did not test whether Tween 40 and Tween 60 
truly fail to trigger L. pneumophila differentiation or if the concentrations of these 





concentrations of the detergents can initiate the phenotypic switch, and whether palmitic 
and stearic acid alone can trigger differentiation.   
 
Nitrite:  An additional cue of L. pneumophila differentiation that was identified by the 
phenotypic microarrays was nitrite.  Nitrate, however, was unable to induce a response.  
Nitrite can be reduced to nitric oxide, a toxic compound that is released by macrophages 
to eliminate invading pathogens.  Data suggest that nitric oxide is sensed by obligate 
aerobes through H-NOX (Heme-Nitric Oxide and/or Oxygen binding) domains, which 
leads to activation or repression of nitric oxide-regulated genes (Boon and Marletta, 
2005).  Recently, L. pneumophila was found to encode two H-NOX proteins (lpg1056 
and lpg2459), and a double deletion renders the bacteria nonmotile (Boon and Marletta, 
2005).  Therefore, L. pneumophila may use its H-NOX proteins to regulate its 
differentiation and virulence traits when confronted by host defenses.   
 
Hydroxylamine:  Hydroxylamine is an extremely reactive intermediate in nitrification, 
the process by which ammonia is oxidized into nitrite (Richardson and Watmough, 
1999).  Thus, hydroxylamine may operate similar to nitrite as describe above.  
Alternatively, hydroxylamine also acts as an antioxidant for fatty acids (Drysdale and 
Lardy, 1953).  Since fatty acid degradation and biosynthesis are tightly coupled, the 
prevention of β-oxidation could shift the balance towards fatty acid biosynthesis, thereby 
disrupting flux in fatty acid metabolism (Chapter 3).   
 
Other metabolites identified by phenotype microarrays:  Perhaps the most enticing set of 
compounds to inhibit L. pneumophila growth and activate the flaA promoter are the six 
additional metabolites that have no obvious mechanism to elicit phase differentiation.  
These include:  dihydroxyacetone, parabanic acid, deoxyadenosine, deoxyribose, 2-





because dihydroxyacetone looks remarkable similar to a carboxylic acid, it may function 
similar to the aforementioned SCFAs.  Finally, of the 12 dipeptides screened, only the 
methionine-alanine dipeptide was identified as a potent inducer of L. pneumophila 
differentiation.  Importantly, single amino acids, including methionine and alanine, failed 
to generate a positive response (data not shown).  Subsequent studies will be necessary to 
discern whether other dipeptide combinations can activate L. pneumophila differentiation 
and the mechanisms by which they elicit a response.   
 
Nicotinic acid:  Studies in Bordetella have demonstrated that the concentration of NA 
modulates different classes of Bvg-regulated genes and phenotypes (Schneider and 
Parker, 1982).  Due to the similarities displayed between BvgA/BvgS and the LetA/LetS 
systems, I postulated that NA would also control the genotypic and phenotypic profiles of 
L. pneumophila.  As described in Chapter 4, when E phase L. pneumophila were 
supplemented with 5 mM NA the bacteria induced numerous transmissive phase 
phenotypes including: motility, cytotoxicity towards macrophages, lysosomal avoidance 
and sodium sensitivity.  Moreover, transcriptional analysis determined that the addition 
of NA regulated a panel of genes similar to PE L. pneumophila (Chapter 4).  Importantly, 
the addition of NA activated the expression of 114 genes and inhibited the expression of 
132 genes unique to NA supplementation (Chapter 4).  While the mode of action for NA 
modulation has yet to be determined, the most highly expressed genes 3 h after 
supplementation were lpg0272 and lpg0273 (Chapter 4).  These two genes lie within an 
operon, and transcriptional activation of lpg0272-3 has never been observed under a 
variety of other conditions (C. Buchrieser, personal communication).   
 While lpg0272 is predicted to encode a cysteine transferase, sequence analysis 
indicates that lpg0273 encodes a transporter within the Major Facilitator Superfamily 
(MFS).  One hypothesis is that lpg0273 may function as an importer of NA and other 





blind to NA modulation, and likewise, the strain would fail to induce PE genes and 
phenotypes following supplementation.  Alternatively, lpg0273 may serve as an exporter 
of NA or other toxic compounds.  According to this model, I anticipate that a deletion in 
lpg0273 would create a strain that is more sensitive to NA.  Therefore, the strain may 
respond to a lower concentration of NA or may lose viability when treated with the 
modulator.  Since attempts to construct a double deletion of lpg0272-3 have been 
unsuccessful, the operon may be essential.  To further study lpg0272-3, I recommend 
constructing a conditional null and analyzing the mutant for its sensitivity to NA.  In 
addition, whether lpg0272-3 is required for intracellular growth can be assessed by 
analyzing the conditional L. pneumophila mutant during macrophage infections.   
 
Potential sources of fatty acids during the L. pneumophila life cycle 
 Although the Biolog screen determined that SCFAs trigger the switch between the 
replicative and transmissive phases, it is unclear where L. pneumophila would encounter 
alterations in the fatty acids present in its environment.  One possibility is that SCFAs are 
generated by Legionella itself.  For example, when the TCA cycle does not operate 
completely, or when bacterial cells are overloaded with their preferred carbon source, 
they can excrete acetate and propionate into their extracellular milieu as a form of 
overflow metabolism (Wolfe, 2005).  To cope with abundant nutrients during the 
replicative phase of growth, L. pneumophila may excrete SCFAs into the vacuolar 
compartment, where they would accumulate over time.  Eventually, the high 
concentrations of SCFAs present in the vacuole could signal for differentiation, escape, 
and subsequent host transmission.  It has not been determined whether L. pneumophila 
secretes acetic and propionic acid during intracellular growth or in broth cultures.  Since 
SCFAs readily diffuse across membranes, isolating Legionella-containing vacuoles to 
monitor intracellular concentrations of the SCFAs would be nearly impossible, as 





spectrometry of broth cultures could determine the presence of the SCFAs at different 
times during the L. pneumophila growth curve.   
 Alternatively, L. pneumophila may monitor external sources of fatty acids that are 
derived from the host plasma or phagosomal membranes.  Consistent with this idea, L. 
pneumophila replicates within a lysosomal compartment, which is also the site for 
membrane degradation (Sturgill-Koszycki and Swanson, 2000).  While the lysosomes 
themselves contain lipases and phospholipases that aid membrane degradation, L. 
pneumophila also possesses lipolytic enzymes that may degrade host cell membranes into 
free fatty acids.  Furthermore, studies indicate that L. pneumophila secretes outer 
membrane vesicles during extra- and intracellular growth, and proteomic data suggest 
that the outer membrane vesicles contain several lipases including PlcB (lpg1455), PlaC 
(lpg2837), PlcA (lpg0502), PlaA (lpg2343) and Mip (Debroy et al., 2006; Fernandez-
Moreira et al., 2006; Galka et al., 2008).  Moreover, sequence data predict that L. 
pneumophila contains fadL (lpg1810) and fadD (lpg1554), which likely facilitate the 
transport of exogenous long chain fatty acids across the cell membrane.  I hypothesize 
that degradation of host membranes may release fatty acids into the lysosomal 
compartment, which accumulate over time, ultimately triggering L. pneumophila 
differentiation.   
 Conversely, when starved for essential nutrients, some bacteria will degrade 
phospholipids within their own cell membrane and use these internal stores for carbon 
and energy.  For example, during the adaptation phase of starvation, the environmental 
water-borne pathogen Mycobacterium avium undergoes cell wall rearrangements, 
activation of β-oxidation enzymes and a depletion of internal cellular lipids (Archuleta et 
al., 2005).  Likewise, upon starvation the aquatic pathogen Vibrio cholerae alters its cell 
wall, adopts a coccoid morphology and depletes 99.8% of total lipids in the cell (Hood et 
al., 1986).  In accordance with this model, when L. pneumophila transitions from the 





to a more coccobacillary shape as evident by phase-contrast microscopy (Bachman and 
Swanson, 2004a; Fettes et al., 2001; Hammer and Swanson, 1999; Molofsky and 
Swanson, 2003).  Although the precise phospholipid and fatty acid content in E and PE 
phase bacteria have not been analyzed, data indicate that the L. pneumophila surface is 
differentially regulated (Fernandez-Moreira et al., 2006).  Additionally, a previous report 
suggested that the fatty acid composition of L. pneumophila differs depending upon 
nutrient availability and during intracellular growth in Acanthamoeba polyphaga (Barker 
et al., 1993).  My data indicate that both an excess and a depletion in the SCFAs cue L. 
pneumophila differentiation (Chapter 3).  Thus, when nutrients become limiting L. 
pneumophila may modify its cellular membrane and convert its internal lipid stores to 
free fatty acids for energy, a process that could also stimulate its phenotypic switch.   
 
Acetyl- and propionyl-phosphate may regulate two-component systems other than 
LetA/LetS   
 Microbes can convert acetic and propionic acid to the high-energy intermediates, 
acetyl- and propionyl-phosphate, via the enzymes phosphotransacetylase (Pta) and acetyl 
kinase (AckA2) (McCleary et al., 1993; Wolfe, 2005).  Once generated, two-component 
systems can use these intermediates to phosphorylate the response regulator and activate 
transcription (Wolfe, 2005).  My data indicate that the ability of L. pneumophila to 
differentiate when confronted by excess SCFAs was dependent upon the LetA/LetS two-
component system (Chapter 3).  Accordingly, I tested whether acetic and propionic acid 
were being converted to acetyl- and propionyl-phosphate to active LetA/LetS, and 
likewise, initiate the switch between the replicative and transmissive phases.  By 
constructing a L. pneumophila mutant that lacks both the Pta and AckA2 enzymes, I 
determined that neither enzyme was required to induce differentiation in response to 





pneumophila differentiation by a mechanism other than generating acetyl- and propionyl-
phosphate intermediates.   
 Besides the LetA/LetS system, L. pneumophila is predictd to contain an additional 
12 histidine kinases and 13 response regulators (Cazalet et al., 2004; Chien et al., 2004).  
Thus, acetyl- and propionyl-phosphate may directly phosphorylate one of these two-
component systems to activate transcription and regulate response pathways.  Since the 
other L. pneumophila two-component systems and the genes they govern are not well 
understood, it will be difficult to ascertain whether acetyl- and propionyl-phosphate can 
induce other L. pneumophila genes and phenotypes when confronted by excess acetate or 
propionate.   
 
Determining the role of ACP in the L. pneumophila life cycle 
 Work in E. coli suggests that SpoT directly interacts with the functional form of 
ACP, as disruption of this interaction abrogates SpoT-dependent ppGpp accumulation 
when fatty acid biosynthesis is inhibited (Battesti and Bouveret, 2006).  Data presented in 
Chapter 3 indicate that perturbations in fatty acid biosynthesis alter the ACP profiles 
present in L. pneumophila and induce the stringent response pathway via SpoT.  
Moreover, a L. pneumophila mutant that contains a single amino acid substitution in 
SpoT that is predicted to prevent its association with ACP fails to induce PE traits when 
fatty acid biosynthesis is altered (Appendix A).   
 While E. coli encodes only one ACP, sequence data suggest that L. pneumophila 
contains three ACPs (lpg0359, lpg1396 and lpg2233) which all contain the serine residue 
that is modified by a 4'-phosphopantetheine moiety (Magnuson et al., 1993).  Using 
western analysis and mass spectrometry, attempts to identify which L. pneumophila 
ACPs are modified following perturbations in fatty acid biosynthesis have been 





whether these ACPs are functionally redundant, or whether the ACPs are specific for 
different environments or phases of the Legionella life cycle.   
 In addition to playing a key role in the synthesis of fatty acids, many organisms 
use an ACP protein to generate polyketides.  These secondary metabolites are produced 
using acetyl and propionyl subunits in a process that resembles fatty acid biosynthesis 
(Weissman, 2004).  Based on the known pathways for polyketide synthesis, L. 
pneumophila is not predicted to produce this particular class of metabolites.  However, 
due to the diversity that is displayed among the polyketides, a myriad of synthases and 
pathways are used for their generation, including many that have yet to be identified 
(Weissman, 2004).  Therefore, L. pneumophila may use one of its ACPs to produce 
polyketides via a novel set of genes and metabolic pathways.   
 
Identifying the precise fatty acid cue that triggers L. pneumophila differentiation 
 To monitor flux in fatty acid metabolism, it has been suggested that bacteria sense 
either an accumulation or a depletion of a key intermediate in the fatty acid biosynthetic 
pathway (Battesti and Bouveret, 2006; DiRusso and Nystrom, 1998).  Using inhibitors of 
fatty acid biosynthesis, my data indicate that L. pneumophila may assess malonyl-CoA 
levels in the cell to regulate its differentiation (Chapter 3).  For example, the cerulenin 
inhibitor causes malonyl-CoA levels to accumulate, while TOFA is predicted to deplete 
the levels of malonyl-CoA present in the cell (Cook et al., 1978; Heath and Rock, 1995; 
McCune and Harris, 1979).  When E phase L. pneumophila were treated with cerulenin, 
the bacteria immediately induced motility.  However, TOFA treatment failed to trigger 
this phenotypic switch (Chapter 3).  To deduce whether malonyl-CoA is the critical 
intermediate that governs L. pneumophila differentiation, the levels of the metabolite 
could be analyzed by HPLC during different phase of growth and when fatty acid 





 Alternatively, L. pneumophila may monitor the acyl chains attached to ACP to 
regulate its phenotypic switch.  In support of this model, western analysis determined that 
when E phase L. pneumophila were treated with excess SCFAs or cerulenin, the profiles 
of the acyl-ACPs in the cell changed significantly (Chapter 3).  By the proposed ACP-
SpoT interaction, L. pneumophila may recognize when acyl-ACPs levels are sparse or 
when the ratio is altered.  The design of this regulatory mechanism may enable the 
bacteria to swiftly synthesize ppGpp when perturbations in fatty acid biosynthesis occur.  
To analyze which L. pneumophila acyl-ACPs are depleted during different phases of 
growth and upon treatment with excess SCFAs and cerulenin, the acyl species could be 
separated by gel electrophoresis and then identified by mass spectrometry.   
 
Implications of thesis 
 Naturally found in aquatic environments as a parasite of fresh water protozoa, L. 
pneumophila can also exploit similar metabolic and regulatory pathways present in the 
alveolar macrophages to cause the acute respiratory illness, Legionnaires’ disease.  Due 
to the ubiquitous nature of Legionella and the various ecological niches within which this 
bacterium can persist, L. pneumophila must possess mechanisms that enable swift 
adaptations to various environmental stresses.  Through analysis of the LetA/LetS two-
component system, I have determined that the complex architecture of the regulon likely 
confers flexibility to the organism when confronted by disparate conditions.  Importantly, 
sequence data suggest that this phenomenon is not unique to L. pneumophila, but is 
probably applicable to other microbes.  Therefore, I predict that the multi-step design of 
tripartite two-component systems equip bacteria with a way to customize their traits to 
meet the demands of the local environment.  Moreover, my data challenges the model of 
most other two-component systems, which are thought to function as on/off switches to 
activate or repress their target genes.  This conceptual bias affects the design of 





of the cell is obtained at any given point in time.  The work I have presented 
demonstrates that, instead, many two-component systems may function as rheostats to 
fine-tune traits according to stresses incurred in the environment.   
 By screening hundreds of metabolites with phenotypic microarrays I have 
uncovered novel cues of L. pneumophila differentiation and virulence.  Specifically, L. 
pneumophila monitors the fatty acid biosynthetic pathway; when fluctuations occur, the 
bacteria activate the stringent response to induce a panel of traits that promote survival.  
To my knowledge, this data is the first to suggest that a pathogen can regulate its 
virulence traits by monitoring fatty acid metabolism via the stringent response.  Since 
many of the metabolic enzymes and pathways are conserved between microbes, I 
presume that other bacteria employ analogous strategies to coordinate an appropriate 
response.   
 Similar to work in Bordetella, I have determined that NA induces L. pneumophila 
PE genes and phenotypes.  However, even though NA modulation of the BvgA/BvgS 
system has been well documented, the mode of action has remained elusive.  By 
comparing the transcriptional profiles of both replicative and transmissive phase L. 
pneumophila to the genes that are controlled by NA, I have identified a cohort of genes 
that are specific for this phenotypic modulator.  In particular, my data suggest that a 
putative membrane protein may be involved in NA transport and regulation.  
Additionally, NA activates nearly 45 L. pneumophila genes that lack an assigned function 
in publicly available databases.  I expect that further analysis of the transcriptional data 
presented herein will unveil the mechanisms of NA regulation and the biological 
significance of NA modulation, both of which may be applicable to other bacterial 
pathogens.   
 In conclusion, my thesis work has exemplified how Legionella has evolved 
mechanisms to augment its versatility and fitness.  Specifically, L. pneumophila can 





stimuli into a coordinated response that ultimately promotes self-preservation.  Moreover, 
the elegant regulatory cascade that governs L. pneumophila differentiation enables the 
microbe to express a spectrum of traits that are ideal for its surroundings.  Finally, I 
speculate that the variability in the genotypic and phenotypic repertoires that are 
displayed by L. pneumophila may generate cellular diversity within the population, which 






















SPOT GOVERNS LEGIONELLA PNEUMOPHILA DIFFERENTIATION IN 
HOST MACROPHAGES  
 
Summary 
 To transit between host cells, Legionella pneumophila converts from a replicative 
to a transmissive state.  In broth, this transformation is coordinated by ppGpp.  To 
determine its role in the intracellular life cycle of L. pneumophila, the two ppGpp 
synthetases, RelA and SpoT, were disrupted.  Importantly, ppGpp synthesis was required 
for transmission, as relA spoT mutants were killed during the entry and exit periods of 
primary infections.  RelA senses amino acid starvation and is dispensable in 
macrophages, as relA mutants failed to activate transmissive gene expression following 
serine hydroxamate treatment, yet spread efficiently in macrophage cultures.  SpoT 
monitors fatty acid biosynthesis, since following cerulenin treatment, transmissive gene 
expression was normal in relA strains but abolished in relA spoT mutants.  As in E. coli, 
the SpoT response to perturbations in fatty acid biosynthesis required SpoT-acyl-carrier 
protein interaction, as judged by the failure of the spoTA413E allele to rescue transmissive 
trait expression of relA spoT bacteria.  SpoT, but not RelA, was essential for transmission 
between host cells, since only induction of spoT restored intracellular replication of relA 
spoT mutants.  More specifically, SpoT hydrolase activity is critical, as mutants lacking 
this function failed to convert from the transmissive to the replicative phase in 
macrophages.  Thus, L. pneumophila requires SpoT to monitor fatty acid biosynthesis 
through SpoT-ACP interaction and to alternate between replication and transmission in 






To cope with environmental fluctuations such as changes in temperature, 
osmolarity, and nutrient availability, bacteria modify their physiology.  Specific 
metabolic pathways become activated or deactivated, gene expression is altered, and 
distinct behaviors emerge.  To increase resilience and promote survival, some bacteria 
undergo morphological adaptations in response to deteriorating conditions.  Accordingly, 
differentiation is often essential to resilience and versatility of the organism.   
There are numerous examples of microbial differentiation in nature.  During 
starvation, the soil dwelling bacteria Myxococcus xanthus transitions from a swarming 
state to an aggregative state and develops multicellular fruiting bodies (Zusman et al., 
2007).  As a means to survive hostile environments, species of Bacillus and Clostridium 
form highly resilient endospores (Paredes et al., 2005).  The intracellular pathogen 
Coxiella burnetti, the causative agent of Q-fever, transitions between two distinct phases 
within macrophages: a highly stress-resistance small cell variant (SCV), and a replicative, 
more metabolically active, large cell variant (LCV) (Voth and Heinzen, 2007).  Likewise, 
within host cells, Chlamydia trachomatis alternates between an infectious and 
metabolically inert, elementary body (EB) and a non-infectious, replicative reticulate 
body (RB) (Abdelrahman and Belland, 2005).   
Similar to C. burnettii and C. trachomatis, the intracellular pathogen Legionella 
pneumophila also differentiates during its life cycle.  L. pneumophila is ubiquitous in 
aquatic environments where it resides either in biofilms or within freshwater protozoa 
(Swanson and Hammer, 2000).  Aerosolization of contaminated water can result in 
inhalation of the microbe by humans where it acts as an opportunistic pathogen of 
alveolar macrophages (Swanson and Hammer, 2000).  To efficiently transit between host 
cells, L. pneumophila transforms itself from a replicative state into a transmissive state 
suited for prolonged viability in the environment and evasion of host cell defenses 





transmissive L. pneumophila resist phagosome acidification and become sequestered 
within a protective, ER-derived vacuole (Joshi et al., 2001).  Favorable metabolic 
conditions within the vacuole prompt repression of transmissive genes and induction of 
genes required for protein synthesis and replication (Bruggemann et al., 2006; Molofsky 
and Swanson, 2003; Sauer et al., 2005).  Following multiple rounds of cell division that 
presumably exhaust host cell nutrients, the starved bacteria differentiate back to the 
transmissive form (Molofsky and Swanson, 2004; Swanson and Hammer, 2000).  Finally, 
transmissive bacteria escape the depleted host cell to invade a naive one, and the cycle is 
repeated (Molofsky and Swanson, 2004).   
Many of the factors required for transmission have been elucidated through 
phenotypic analysis of exponential (E) and post-exponential (PE) phase broth-grown 
bacteria.  PE phase, or transmissive, L. pneumophila are more infectious toward 
macrophages and amoeba than bacteria in the replicative, or E phase (Byrne and 
Swanson, 1998).  Increased infectivity of transmissive bacteria has been attributed both to 
activation of Type IV secretion and to modifications of the bacterial surface that together 
inhibit phagosome-lysosome fusion (Fernandez-Moreira et al., 2006).  Flagellar 
expression and motility also promote infection by transmissive L. pneumophila, likely by 
enabling the bacterium more efficient access to host cells (Molofsky et al., 2005).   
As in broth, L. pneumophila cycles between replicative and transmissive phases in 
host cells.  Microscopic examination of flaA expression and flagella revealed biphasic 
regulation in macrophages (Hammer and Swanson, 1999).  Cytotoxicity and sodium 
sensitivity measurements of bacteria harvested from macrophages indicate intracellular L. 
pneumophila differentiate during infection (Byrne and Swanson, 1998).  Recently, in vivo 
transcriptional profiling demonstrated that, as in broth, L. pneumophila exhibits biphasic 
gene expression patterns in amoebae, with later time points of primary infections 
matching the transmissive phase gene expression observed in vitro (Bruggemann et al., 





partially mimics exit from the replicative phase and entry into the transmissive phase in 
host cells.   
In broth cultures, the L. pneumophila E to PE phase transition is concomitant with 
accumulation of guanosine tetraphosphate, or ppGpp (Hammer and Swanson, 1999; 
Zusman et al., 2002).  The alarmone ppGpp acts as a general signal of bacterial starvation 
and stress (Magnusson et al., 2005; Srivatsan and Wang, 2008).  In many gram-negative 
species, ppGpp, in cooperation with the transcription factor DksA, interacts with 
secondary channel near the active site of RNA polymerase (RNAP) to control gene 
expression by altering RNAP affinity for specific promoters (Magnusson et al., 2005; 
Srivatsan and Wang, 2008).  The global transcriptional changes that ppGpp and DksA 
instruct are collectively referred to as the stringent response (Magnusson et al., 2005; 
Srivatsan and Wang, 2008).  During the stringent response, transcriptional deactivation of 
ribosomal RNA operons by ppGpp and DksA increases the availability of RNAP for 
ppGpp- and DksA-mediated activation of amino acid biosynthetic operons and genes 
required for stabilization of alternative sigma factors (Bougdour and Gottesman, 2007; 
Paul et al., 2004; Paul et al., 2005).  Global transcriptional profiling of the stringent 
response in Escherichia coli has revealed that, in addition to direct regulation of 
ribosomal and amino acid biosynthetic operons, flagellar and chemotaxis related genes 
are also under stringent control, as are key enzymes involved in fatty acid biosynthesis 
(Durfee et al., 2008; Traxler et al., 2008).  Thus, by modulating ppGpp levels, a variety 
of bacteria balance nutrient availability with their protein synthetic capacity and 
expression of metabolic pathways essential for stress survival.   
Several pathogenic bacteria also exploit ppGpp for virulence gene expression and 
survival in host cells.  For L. pneumophila, a rise in intracellular ppGpp levels 
coordinates a switch from a bacillus-shape to a more coccoid morphology, and the cells 
become motile, resistant to osmotic and heat stresses, and are more infectious (Hammer 





colonize the urinary tract, requires ppGpp for expression of FimB, a site-specific 
recombinase controlling type I fimbriae expression (Aberg et al., 2006).  Salmonella, a 
pathogen that cycles between extracellular and intracellular virulence gene programs, 
require ppGpp for invasion of intestinal epithelial cells, survival in murine macrophages 
in vitro, and colonization of BALB/c mice in vivo (Pizarro-Cerda and Tedin, 2004; Song 
et al., 2004; Tompson et al., 2006).  Other pathogens, including Mycobacterium 
tuberculosis, Listeria moncytogenes, Pseudomonas aeruginosa, and Campylocbacter 
jejuni, also require ppGpp to regulate particular virulence mechanisms (Erickson et al., 
2004; Gaynor et al., 2005; Primm et al., 2000; Taylor et al., 2002).   
In gram-negative bacteria such as E. coli and Salmonella spp., the levels of ppGpp 
in the cell are regulated by the ppGpp synthetase RelA and the bifunctional 
synthetase/hydrolase SpoT (Magnusson et al., 2005; Srivatsan and Wang, 2008).  During 
amino acid starvation, uncharged tRNAs accumulate at the ribosome, triggering rapid 
accumulation of ppGpp by ribosome-bound RelA and, consequently, activation of the 
stringent response (Magnusson et al., 2005; Srivatsan and Wang, 2008).  SpoT 
hydrolyzes ppGpp during exponential growth, an activity that might be regulated through 
a direct interaction with the ribosome-associated bacterial G-protein CgtA (Jiang et al., 
2007; Raskin et al., 2007).  In this model, in the absence of metabolic stress, CgtA 
activation of SpoT hydrolase activity maintains a steady state level of ppGpp, thereby 
repressing the stringent response when metabolic conditions are favorable (Jiang et al., 
2007; Raskin et al., 2007).  Since SpoT hydrolase activity is required to prevent RelA-
dependent ppGpp from accumulating unabatedly, spoT is an essential gene in the 
numerous bacteria that encode relA.  However, since relA mutants are defective for 
RelA-dependent ppGpp production, spoT is not essential when the RelA synthetase has 
been disrupted; within this genetic context, SpoT function can be analyzed (Magnusson 





SpoT can also synthesize ppGpp.  In particular, the enzyme elicits accumulation 
of the alarmone in response to a variety of stresses, including carbon source deprivation, 
phosphate starvation, iron starvation, and fatty acid biosynthesis inhibition (Magnusson et 
al., 2005; Srivatsan and Wang, 2008).  In E. coli, SpoT interacts with acyl-carrier protein 
(ACP), an enzyme critical for fatty acid biosynthesis (Battesti and Bouveret, 2006).  
Moreover, to respond to fatty acid biosynthesis inhibition, the SpoT-ACP interaction is 
required (Battesti and Bouveret, 2006).  Site directed point mutations within the C-
terminal TGS domain of SpoT not only disrupts interaction with ACP, but also alters the 
enzymatic balance of the enzyme such that synthesis is favored over hydrolysis (Battesti 
and Bouveret, 2006).  Phosphate starvation also results in SpoT-dependent ppGpp 
accumulation that requires SpoT hydrolase activity, not synthetase activity (Bougdour 
and Gottesman, 2007; Spira and Yagil, 1998).  It remains to be determined if all 
starvation conditions that elicit ppGpp accumulation alter the association of SpoT with 
ACP, or result from either an inhibition of ppGpp hydrolysis or an increase in synthesis.   
The role of ppGpp in L. pneumophila pathogenesis was discovered when 
experimental induction of alarmone accumulation triggered exponentially growing 
bacteria to rapidly transition into the transmissive state (Hammer and Swanson, 1999).  A 
rise in intracellular ppGpp levels caused cells to become motile, sodium sensitive, and 
more infectious and cytotoxic toward macrophages.  Subsequent genetic studies 
demonstrated that L. pneumophila requires RelA both for ppGpp accumulation upon 
entry into stationary phase and for maximal expression of the primary flagellar subunit 
flaA (Zusman et al., 2002).  However, RelA was dispensable for L. pneumophila growth 
in Acanthamobae castellanii or HL-60-human derived macrophages (Abu-Zant et al., 
2006; Zusman et al., 2002).  Legionella also encode a SpoT homolog with putative 
ppGpp hydrolase and synthetase domains.  Attempts to disrupt the spoT locus in both 
wild-type (WT) and relA mutant backgrounds were unsuccessful, leading to the 





 For the present study, we undertook a comprehensive analysis of the contributions 
of RelA and SpoT to the L. pneumophila life cycle.  We found distinct metabolic cues 
trigger SpoT and RelA activity and that, during the L. pneumophila life cycle in host 
macrophages, SpoT is critical for both the replicative to the transmissive phase transition 




Bacterial strains, culture conditions and reagents.  L. pneumophila strain Lp02 (thyA 
hsdR rpsL; MB110), a virulent thymine auxotroph derived from Philadelphia 1, was the 
parental strain for all the strains analyzed.  L. pneumophila was cultured at 37°C in 5 ml 
aliquots of N- (2-acetamido)-2-aminoethanesulfonic acid (ACES; Sigma)-buffered yeast 
extract (AYE) broth with agitation or on ACES-buffered charcoal yeast extract (CYE), 
both supplemented with 100 µg/ml thymidine (AYET, CYET) when necessary.  Bacteria 
obtained from colonies <5 days old were cultured in broth overnight, than subcultured 
into fresh AYET prior to experimentation.  For all experiments, exponential (E) cultures 
were defined as having an optical density at 600 nm (OD600) of 0.3 to 2.0 and post-
exponential (PE) cultures as having an OD600 of 3.0 to 4.5.  Where indicated, ampicillan 
(amp; Fisher) was added to a final concentration of 100 µg/ml, kanamycin (kan; Roche) 
to 10 µg/ml, gentamycin (gent; Fisher) to 10 µg/ml, chloramphenicol (cam; Roche) to 5 
µg/ml, cerulenin (Cer; Sigma) to 0.5 µg/ml, serine hydroxamate (Sigma) to 1 mM, 
propionic acid to 10 mM, acetic acid to 10 mM, and isopropyl-beta-D-
thiogalactopyranoside (IPTG) to the concentrations specified.  To determine colony-
forming units (CFU), serial dilutions of L. pneumophila were plated on CYET and 






relA and relA spoT mutant strain construction.  To construct a relA insertion mutant, we 
generated pGEM-relA by amplifying the relA locus (lpg1457) plus flanking sequence 
from Lp02 genomic DNA using the primers relA1 and relA2.  The kanamycin resistance 
gene cassette from pUC4K and the gentamycin cassette from PUCGent were obtained 
from their respective plasmids by EcoRI digestion, and pGEM-relA was digested with 
SnaBI.  The fragments containing the resistance cassettes were blunted with Klenow, gel 
extracted, and ligated into the blunted pGEM-relA plasmid, creating pGEM-relA::kan and 
pGEM-relA::gent.  After verification by PCR and restriction enzyme digest, the insertion 
alleles were used to transform Lp02 by natural competence, and the resulting 
transformants were selected using the appropriate antibiotic (Stone and Kwaik, 1999). 
Recombination of the desired relA insertion alleles onto the Lp02 chromosome was 
confirmed by PCR, and the resulting relA::kan and relA::gent mutant L. pneumophila 
were designated MBXXX and MBXXX, respectively.   
To construct the relA spoT double mutant, we generated pGEM-spoT by 
amplifying the spoT locus (lpg2009) plus flanking sequence from Lp02 genomic DNA 
using the primers spoT1 and spoT2.  pGEM-spoT was digested with HindIII, which cuts 
at sites ~100-bp and ~590-bp 3' to the transcriptional start, releasing a ~490-bp fragment 
encoding a significant portion of the predicted hydrolase and synthetase coding regions at 
the N-terminus of SpoT.  The linear fragment containing the spoT deletion was blunted, 
and a kanamycin cassette was ligated to the blunted fragment, generating pGEM-
spoT::kan.  After verification by PCR and restriction enzyme digest, the 
deletion/insertion alleles were used to transform relA::gent mutant L. pneumophila 
MBXXX by natural competence, and transformants were selected using the appropriate 
antibiotic (Stone and Kwaik, 1999).  Recombination of the desired spoT 
deletion/insertion allele into the relA::gent mutant chromosome was confirmed by PCR.  
The resulting relA::gent spoT::kan double mutant L. pneumophila was designated 





a selectable marker and a transcriptional fusion of the flaA promoter to gfp (Hammer and 
Swanson, 1999; Hammer et al., 2002).  MBXXX and MBXXX were transformed with 
the pflaAgfp reporter plasmid to create MBXXX and MBXXX, respectively.   
 
Inducible relA and spoT expression.  To generate strains in which expression of either 
relA or spoT could be induced, we cloned promoterless fragments of relA and spoT into 
pMMB206-Δmob, a plasmid containing a PtaclacUV5 IPTG inducible promoter and a 
chloramphenicol resistance cassette.  To construct pGEM-relAi, the relA locus was 
amplified from Lp02 genomic DNA using the primers relAi1 and relAi2, each containing 
a SalI restriction site.  The fragment was excised from pGEM-relAi using SalI and ligated 
into pMMB206-Δmob at the SalI site within the MCS immediately 3' of the PtaclacUV5 
promoter, generating prelAi.  Insertion and orientation were confirmed by both PCR and 
restriction enzyme digest.  prelAi was used to transform MBXXX, and transformants 
were selected on chloramphenicol, creating MBXXX for inducible relA expression.  To 
construct pGEM-spoTi, the spoT locus was amplified from Lp02 genomic DNA using the 
primers spoTi1, which contains a SalI restriction site, and spoTi2, which contains a 
HindIII site.  pGEM-spoTi and pMMB206-Δmob were each digested with SalI and 
HindIII and then ligated, generating pspoTi.  Insertion and orientation of spoT in the 
MCS of pMMB206-Δmob was confirmed by PCR and restriction enzyme digest.  pspoTi 
was used to transform MBXXX, generating MBXXX for inducible spoT expression.   
 
Construction of spoTA413E and spoTE319Q inducible constructs.  pGEM-spoT was used as a 
template for spoTA413E and spoTE319Q mutant allele construction.  To generate site-directed 
mutations in spoT, Stratagene’s QuickChange® II XL Site-Directed Mutagenesis Kit was 
used.  To synthesize spoTA413E, pGEM-spoT plasmid DNA was amplified with PfuUltra 
HF DNA polymerase (Stratagene) and the complementary primers spoTA413E1 and 





selected on ampicillin. To verify the GCC to GAA codon change, candidate plasmids 
were sequenced and then designated pGEM-spoTA413E.  pGEM-spoTA413E was digested 
with SalI and HindIII, and the locus cloned into pMMB206-Δmob, as described for the 
WT spoT allele, generating pspoTA413E.  MBXXX was transformed with pspoTA413E, and 
transformants were selected on chloramphenicol, generating MBXXX for inducible 
spoTA413E expression.  Except for primer variations, construction of pspoTE328Q was 
carried out identically to pspoTA413E.  In this case, the primers spoTE328Q1 and 
spoTE328Q2 were used to generate pGEM-spoTE328Q. The desired GAG to CAG codon 
change was verified by sequencing, and the spoTE328Q allele was then cloned into 
pMMB206-Δmob as described for spoTA413E, generating p206-spoTE328Q.  MBXXX was 
transformed with pspoTE328Q, and transformants were selected on chloramphenicol to 
generate MBXXX for inducible spoTE328Q expression.   
 
Detection of ppGpp.  Accumulation of the ppGpp in the PE phase and in response to 
amino acid starvation and fatty acid biosynthesis inhibition was detected by thin-layer 
chromatography (TLC) as described (Cashel, 1969, 1994; Hammer and Swanson, 1999).  
Briefly, to detect PE phase ppGpp production in WT and mutant L. pneumophila, 100 
µCi/ml carrier-free [32P]-phosphoric acid was added in late-E phase, and bacteria were 
cultured at 37°C on a roller drum to the PE phase, or approximately 6 h.  To detect 
ppGpp accumulation following amino acid starvation and fatty acid biosynthesis 
inhibition, E phase cultures were diluted to an OD600 = 0.25 and labeled with 
approximately 100 µCi/ml of carrier-free [32P]-phosphoric acid (ICN Pharmaceuticals) 
for 6 h, or two generation times, at 37°C on a roller drum.  After incorporation of the 
radioactive label, cultures were supplemented with a carrier control, 1 mM serine 
hydroxamate, or 0.5 µg/ml cerulenin.  Cultures were incubated for an additional 1.5 h at 
37°C.  To extract the nucleotides, 50 µl aliquots were removed from each culture, added 





two freeze-thaw cycles and stored at -80°C until chromatographed.  Formic acid extracts 
(35 µL in the case of the treated cultures and 25 µL in the case of the PE samples) were 
applied to a PEI-cellulose TLC plates (20 × 20; Sorbent) and developed with 1.5 M 
KH2PO4, pH 3.4 as described (Cashel, 1969, 1994; Hammer and Swanson, 1999).  TLC 
plates were exposed to Kodak BioMax MR Film (18 × 24 cm) for 72 hours before 
development.  To monitor growth in these experiments, OD600 were determined for non-
radioactive cultures grown under identical conditions.   
  
Fluorometry.  To monitor expression of the flagellin promoter in WT and mutant 
cultures, L. pneumophila containing the reporter plasmid pflaAgfp were cultured in AYE 
media.  Overnight cultures in mid-E phase OD600 = 1.0-1.75 were back diluted to early-E 
phase OD600 = 0.50-0.85 (T = 0).  At the times indicated, the cell density of each culture 
was measured as OD600.  To analyze similar bacterial concentrations, aliquots were 
collected by centrifugation, and the cells were normalized to OD600 = 0.01 in 1 × PBS.  
An aliquot of each sample (200 µL) was transferred to black 96-well plates (Costar), and 
the relative fluorescence intensity was measured using a Synergy™ HT microplate reader 
and 485 nm excitation, 530 nm emission, sensitivity of 50.  A similar protocol was used 
to monitor flaA promoter activity in cultures supplemented with 1 mM serine 
hydroxamate and 0.5 µg/ml cerulenin.  Overnight cultures in mid-E phase OD600 of 1.0-
1.75 were back diluted to early-E phase OD600 of 0.50-0.85 (T = 0), at which time WT 
and mutant bacteria were treated with either serine hydroxamate or cerulenin.  L. 
pneumophila cultures supplemented with water or DMSO served as negative and vehicle 
controls, respectively.  Optical density and relative fluorescence were measured as 
described above.   
 
Sodium sensitivity.  To calculate the percentage of L. pneumophila that were sensitive to 





NaCl.  After a 6-day incubation at 37°C, CFUs were enumerated, and the percentage of 
sodium sensitive microbes calculated as described (Byrne and Swanson, 1998).   
 
Macrophage cultures.  Macrophages were isolated from femurs of female A/J mice 
(Jackson Laboratory) and cultured in RPMI-1640 containing 10% heat-inactivated fetal 
bovine serum (RPMI/FBS; Gibco BRL) as described previously (Swanson and Isberg, 
1995).  Following a 7-day incubation in L-cell supernatant-conditioned media, 
macrophages were plated at either 5 × 104 per well for cytotoxicity, or 2.5 × 105 per well 
for degradation assays, infectivity assays and intracellular growth curves.   
 
Lysosomal degradation.  The percentage of intracellular L. pneumophila that remain 
intact after a 2 h macrophage infection was quantified by fluorescence microscopy 
(Bachman and Swanson, 2001; Molofsky and Swanson, 2003).  Briefly, macrophages 
were plated at 2.5 × 105 onto coverslips in 24 well plates.  Then, E or PE phase microbes 
were added to macrophage monolayers at an MOI ~ 1.  The cells were centrifuged at 400 
× g for 10 min at 4°C and then incubated for 2 h at 37°C.  Extracellular bacteria were 
removed by washing the monolayers three times with RPMI/FBS, and the macrophages 
were fixed, permeabilized and stained for L. pneumophila as described (Molofsky et al., 
2005).   
 
Infectivity and intracellular growth.  Infectivity is a gauge of the ability of L. 
pneumophila to bind, enter, and survive inside macrophages during a 2 h incubation, as 
previously described (Byrne and Swanson, 1998; Molofsky and Swanson, 2003). In brief, 
macrophages were infected with strains at an MOI of ~1, with centrifugation at 400 x g 
for 10 min.  Cells were incubated for 2 h at 37°C, washed three times with fresh RPMI, 
and lysed in a 1:1 solution of RPMI and saponin, then intracellular CFU were 





from lysed macrophages at 2 h post-infection.  To gauge intracellular growth, the pooled 
macrophage supernatant and lysate were plated for CFU at various times post-infection, 
as described elsewhere (Molofsky and Swanson, 2003).  Results for intracellular growth 
are expressed as either total CFU recovered or relative CFU.  In the latter, CFU recovered 
at 24, 48 and 72 h are divided by the number of CFU at 2 h.  Culturing conditions for WT 
and mutant L. pneumophila varied depending upon the experimental question addressed.  
For experiments assaying infectivity and intracellular survival of WT, relA and relA spoT 
bacteria lacking expression vectors, cultures were grown to E or PE phase prior to 
infection.  To test the contribution of relA and spoT to the replicative to transmissive 
phase transition in broth, overnight cultures in mid-E phase OD600 = 1.0-1.75 were 
diluted to early-E phase OD600 = 0.50-0.85.  Cultures were incubated for approximately 3 
h at 37°C to an OD600 = 1.0-1.75; then, 200 µM IPTG was added and maintained until PE 
phase.  To assess the role of relA and spoT in the transmissive to replicative phase 
transition within host cells, bacteria were cultured in broth with 200 µM IPTG to PE 
phase, and 200 µM IPTG was maintained throughout macrophage infection.  A similar 
protocol was used to test the transmissive to replicative transition in bacteriological 
medium by plating bacteria that had been induced with 200 µM IPTG and cultured into 
PE phase onto CYET with 200 µM IPTG.   
 
Cytotoxicity.  To determine contact-dependent cytotoxicity of L. pneumophila following 
macrophage infection, bacteria were added to macrophage monolayers at the indicated 
MOI.  After centrifugation at 400 × g for 10 min at 4°C (Molofsky et al., 2005), the cells 
were incubated for 1 h at 37°C.  For quantification of macrophage viability, RPMI/FBS 
containing 10% alamarBlue™ (Trek Diagnostic Systems) was added to the monolayers 
for 6-12 h, and the reduction of the colorimetric dye was measured spectrophoretically as 
described (Molofsky et al., 2005).  Protocols for culturing WT and mutant microbes 





induction on cytotoxicity of relA spoT mutant bacteria, microbes were cultured with 200 
µM IPTG to PE phase in broth as described above.  To determine if expression of WT 
and mutant spoT was sufficient to rescue the cytotoxicity defect of relA spoT mutant 
bacteria in which fatty acid biosynthesis had been perturbed, overnight cultures in mid-E 
phase OD600 = 1.0-1.75 were back diluted to early-E phase OD600 = 0.45-0.60 and treated 
with either 25 or 50 µM IPTG for 1 h.  After a 1 h incubation on a roller at 37°C, mutant 
cultures were split and either mock-treated or treated with propionic acid, acetic acid, or 
cerulenin.  Cultures were incubated at 37°C for an additional 3 h prior to assaying 




In the absence of relA, spoT is not essential in L. pneumophila 
To rigorously test the hypothesis that the stringent response controls L. 
pneumophila virulence expression, we created relA and relA spoT double mutant strains.  
In the stationary phase, L. pneumophila secretes pyomelanin, a molecule important for 
iron metabolism, in a relA-dependent manner (Chatfield and Cianciotto, 2007; Zusman et 
al., 2002).  Therefore, to verify that relA was disrupted, we assayed extracellular pigment 
production by stationary phase cultures.  As expected, our relA insertional null mutant 
was completely defective for pigment production (data not shown).   
As observed for other gram-negative bacteria, we and others were unable to 
generate single spoT null mutant strains of L. pneumophila, and attempts to construct a 
conditional spoT mutant were also unsuccessful (Zusman et al., 2002).  Therefore, to 
analyze the contribution of SpoT to the L. pneumophila life cycle, we constructed a relA 
spoT double mutant in which a significant portion of the putative, overlapping synthetase 
and hydrolase domains of SpoT were deleted and replaced by a gentamycin resistance 





morphology (data not shown) reminiscent of that described for relA spoT mutants of E. 
coli (Traxler et al., 2008; Xiao et al., 1991).  Therefore, in the absence of relA, spoT is 
not essential for L. pneumophila replication on rich bacteriological medium.   
 
RelA and SpoT contribute to ppGpp accumulation and motility in the stationary phase 
 To assess the contribution of SpoT to L. pneumophila PE phase biology, we tested 
the ability of relA and relA spoT mutants to accumulate ppGpp in stationary phase.  After 
radiolabeling the L. pneumophila guanosine nucleotide pools for 6 h (two doubling 
times), ppGpp levels were analyzed by thin-layer chromatography.  WT L. pneumophila 
cultured to the PE phase accumulated a pool of ppGpp, much of which was dependent 
upon relA (Fig. A.1A).  The relA mutants also accumulated a small but appreciable pool 
of ppGpp that was not observed in the relA spoT double mutant (Fig. A.1A).  Thus, when 
L. pneumophila are cultured in rich broth, RelA synthetase activity accounts for the 
majority of ppGpp in the PE phase, whereas SpoT synthetase activity contributes 
modestly (Fig A.1A).  L. pneumophila obtains carbon and energy from amino acids, not 
sugars (Tesh and Miller, 1981; Tesh et al., 1983).  Therefore, it is not surprising that, 
upon starvation in a rich medium composed of yeast extract, much of the ppGpp that 
accumulates is dependent upon RelA activity (Hammer and Swanson, 1999; Zusman et 
al., 2002).   
 To test the biological consequence of the small amount of spoT-dependent ppGpp 
accumulating in PE phase and determine its contribution to L. pneumophila 
differentiation, we assayed flaA expression and motility, two hallmarks of stationary 
phase cells.  The relA and relA spoT mutants were transformed with a plasmid containing 
a flaAgfp transcriptional fusion that enables promoter activity of flaA, the primary 
flagellar subunit of L. pneumophila to be analyzed by fluorometry (Fig. A.1B) (Hammer 
and Swanson, 1999).  As expected, the flaA promoter was inactive during exponential (E) 





into the PE phase, both WT and relA mutant L. pneumophila activated the flaA promoter; 
however, in relA mutant cultures the flaA promoter activity was decreased relative to 
WT, consistent with a previous report (Zusman et al., 2002).  In contrast, relA spoT 
mutant cultures failed to activate flaA expression upon entry into PE, indicating that the 
residual flaA promoter activity observed in relA mutants is dependent upon SpoT (Fig. 
A.1B).  Consistent with their flaA expression, the relA mutants also exhibited a 30-50% 
decrease in the fraction of motile bacteria per field relative to WT cultures, while relA 
spoT mutants failed to express motility at all PE phase time points analyzed (data not 
shown).  Therefore, both RelA and SpoT contribute to flaA expression by PE L. 
pneumophila, and the small spoT-dependent ppGpp pool that accumulates in PE phase 
(Fig. A.1A) is nevertheless sufficient to activate flaA expression and motility by L. 
pneumophila.   
 
The stringent response is required for PE phase survival 
Upon entry into PE phase, L. pneumophila not only builds a flagellum and 
becomes motile, but the cells also change shape and surface properties, increase stores of 
energy rich polymers, and become resistant to environmental stresses (Fernandez-
Moreira et al., 2006; Molofsky and Swanson, 2004).  To investigate the importance of the 
stringent response to survival in the the PE phase, we assessed the OD600 and CFU of 
WT, relA and relA spoT cultures over time (Fig. A.1C).  Both parameters were similar for 
all strains between 2 and 30 h; however, by 44 h, or ~20 h after entry into stationary 
phase, relA spoT yielded higher OD600 values (~0.75-1.0 units) than WT and relA.  When 
analyzed by microscopy at 44 h, the relA spoT cells appeared hyperfilamentous relative 
to WT and relA, which had adopted the more coccoid-like morphology that is 
characteristic of PE phase L. pneumophila (data not shown) (Molofsky and Swanson, 
2004).  In addition, by 44 h relA spoT cultures began to exhibit a loss in CFU relative to 





pronounced after 66 h.  Therefore, as reported for other bacteria, including C. jejuni and 
Helicobacter pylori (Gaynor et al., 2005; Mouery et al., 2006), L. pneumophila requires 
the stringent response for differentiation and survival in stationary phase.   
 
RelA-dependent ppGpp synthesis is required for flaA expression following amino acid 
starvation 
 To verify that, like E. coli, L. pneumophila relies on RelA to initiate the stringent 
response following amino acid starvation, we subjected WT and mutant cultures to 
treatment with serine hydroxamate.  Since serine hydroxamate, an analog of the amino 
acid serine, inhibits the attachment of serine to transfer RNA, it has been used extensively 
in E. coli to characterize the mechanism by which RelA senses accumulation of 
uncharged tRNAs at the ribosome (Magnusson et al., 2005; Tosa and Pizer, 1971).  
Unlike mock-treated cultures, WT cells subjected to serine hydroxamate treatment 
accumulated an appreciable pool of ppGpp (Fig. A.2A).  In contrast, neither relA nor relA 
spoT mutant L. pneumophila responded to serine hydroxamate treatment.  Thus, like E. 
coli, L. pneumophila relies on RelA to synthesize ppGpp following amino acid starvation. 
 To determine the physiological relevance of the ppGpp pool observed, we asked 
if the relA-dependent ppGpp that accumulated after serine hydroxamate treatment was 
sufficient to activate flaA expression.  Indeed, the pattern of flaA expression in serine 
hydroxamate-treated cultures (Fig. A.2B, top panel) mimicked that observed for ppGpp 
production (Fig. A.2A).  Whereas WT cultures activated flaA as early as 3 h post 
treatment, neither relA nor relA spoT treated with serine hydroxamate activated flaA 
throughout the time course analyzed (Fig. A.2B, top panel).  Mock-treated cultures 
exhibited patterns of flaA activation similar to those observed upon entry into PE phase 
(Fig. A.1B).  Serine hydroxamate treatment did lead to partial growth inhibition of all 
strains relative to mock-treated control samples (Fig. A.2B, bottom panel), an effect that 





observations verify that in response to amino acid starvation, RelA synthesizes adequate 
ppGpp to activate flaA in L. pneumophila.   
 
SpoT-dependent ppGpp accumulation leads to flaA activation following inhibition of fatty 
acid biosynthesis 
 For E. coli, it is known that RelA and SpoT respond to distinct starvation stimuli 
to trigger ppGpp accumulation.  Whereas RelA responds to amino acid starvation, SpoT 
responds to carbon source deprivation, fatty acid biosynthesis inhibition, phosphate 
starvation, and iron starvation (Magnusson et al., 2005).  Therefore, we tested the 
hypothesis that L. pneumophila RelA and SpoT also respond to distinct metabolic cues.  
For this purpose we used the antibiotic cerulenin, a specific inhibitor of fatty acid 
biosynthesis in bacteria that acts on the 3-ketoacyl-[acyl carrier-protein (ACP)] synthases 
I and II, FabB and FabF (Seyfzadeh et al., 1993).  Appreciable amounts of ppGpp were 
detected in WT and relA cultures treated with cerulenin, whereas relA spoT mutant L. 
pneumophila failed to accumulate ppGpp under these conditions (Fig. A.2C).  The 
response was specific to the antibiotic, since cultures receiving the DMSO vehicle did not 
generate detectable ppGpp.   
 To investigate the phenotypic consequences of the SpoT-dependent ppGpp pool, 
we assayed the ability of WT and mutant cultures to activate flaA following cerulenin 
treatment.  As observed after the serine hydroxamate treatment, the pattern of flaA 
expression reflected the size of the ppGpp pool in each strain (Fig. A.2D, top panel).  
Cerulenin-treated WT and relA mutant L. pneumophila activated flaA, but relA spoT cells 
did not (Fig. A.2D, top panel).  As observed for cultures treated with serine hydroxamate, 
cerulenin treatment also inhibited growth independently of ppGpp accumulation in the 
strain (Fig. A.2D, bottom panel).  Cultures treated with DMSO were not inhibited for 
growth and activated fluorescence only upon entry into PE phase. Thus, with RelA and 





signals, including amino acid starvation via RelA, and inhibition fatty acid biosynthesis 
using SpoT.   
 
Amino acid substitution in SpoT renders the enzyme insensitive to fatty acids 
 In addition to responding to fatty acid biosynthesis inhibition (Fig. A.2), L. 
pneumophila that are exposed to excess short chain fatty acids (SCFA) also activate 
transmissive phenotypes in a SpoT-dependent manner (Chapter 3).  Like cerulenin 
treatment, addition of either 10 mM acetic or propionic acid to E phase L. pneumophila 
triggers expression of several transmission traits, including lysosome evasion, motility, 
and cytotoxicity (Chapter 3).  In E. coli, SpoT monitors and responds to perturbations in 
fatty acid metabolism through a specific interaction with ACP (Battesti and Bouveret, 
2006).  Accordingly, we tested the hypothesis that a SpoT-ACP interaction is essential 
for L. pneumophila to activate transmissive phenotypes in response to SCFA.  To do so, 
we designed plasmids for the inducible expression of either WT spoT or spoTA413E, an 
allele encoding an enzyme predicted to be defective for ACP interaction (Battesti and 
Bouveret, 2006).  We then asked whether expression of either plasmid-borne spoT or 
spoTA413E was sufficient to restore cytotoxicity to relA spoT bacteria (Fig. A.3A) exposed 
to SCFA.   
 WT or mutant spoT expression was first induced for 1 h with 25 µM IPTG before 
the cells were cultured for 3 h with 10 mM SCFA and 25 mM IPTG.  When exposed to 
propionic acid, WT spoT restored relA spoT mutant cytotoxicity toward macrophages, 
but spoTA413E did not (Fig. A.3A).  Likewise, only WT spoT rescued relA spoT 
cytotoxicity after acetic acid or cerulenin addition (data not shown).  The plasmid-
encoded spoTA413E allele was functional:  When the IPTG concentration was doubled to 
50 µM, relA spoT mutants carrying the spoTA413E plasmid were even more cytotoxic than 
those harboring either WT spoT or the empty vector (Fig. A.3B).  Furthermore, the 





renders the enzyme insensitive to perturbations in fatty acid metabolism and also leads to 
increased ppGpp pools, presumably by disrupting the balance between ppGpp synthesis 
and hydrolysis.   
 
The stringent response activates transmissive traits 
 L. pneumophila coordinates entry into stationary phase with expression of not 
only motility but also virulence-associated phenotypes like sodium sensitivity, 
cytotoxicity, and lysosome avoidance (Byrne and Swanson, 1998).  Accordingly, to 
assess the contributions of RelA and SpoT to virulence trait expression in PE L. 
pneumophila, we assayed WT and mutant bacteria for sodium sensitivity and lysosome 
evasion.  As predicted, relA spoT mutants remained sodium resistant even when cultured 
into PE phase (Fig. A.4A).  PE phase relA mutant L. pneumophila, which accumulate low 
amounts of ppGpp, activate flaA and become motile (Fig. A.1), also become sensitive to 
sodium.  Likewise, whereas PE WT and relA resisted phagosome-lysosome fusion and 
remained intact following macrophage phagocytosis, E phase WT and PE phase relA 
spoT were degraded (Fig. A.4B).  Therefore, even the modest SpoT-dependent pool of 
ppGpp is sufficient to induce sodium-sensitivity and protect L. pneumophila from 
lysosomal degradation.   
 
Induction either ppGpp synthetase is sufficient rescue relA spoT mutants in broth 
 Since L. pneumophila requires ppGpp for flaA expression, motility, sodium 
sensitivity and lysosome avoidance (Fig. A.1, and A.4) we predicted that, during PE 
phase starvation, induction of either synthetase would equip replicative relA spoT 
mutants to enter the transmissive phase.  Indeed, IPTG induction of plasmid-borne relA, 
spoT, or spoTA413E suppressed both the flagellar and the cell-remodeling defect of relA 
spoT mutant bacteria, as judged by the motility of cocciod bacteria.  In contrast, relA 





When relA, spoT or spoTA413E was induced, relA spoT L. pneumophila killed more 
macrophages than either relA spoT mutant bacteria carrying vector alone or E phase WT 
(Fig. A.5A).  Induction of relA, spoT and spoTA413E also increased the infectivity of relA 
spoT bacteria:  When cultured with IPTG to the PE phase, relA spoT mutants harboring 
plasmids encoding either ppGpp synthetase were 10-25% more infectious than relA spoT 
mutants with empty vector (Fig. A.5B).  Thus, expression of relA, spoT or spoTA413E was 
sufficient to trigger replicative phase relA spoT mutants to enter the transmissive phase.  
These results not only verify that the phenotypic defects of relA spoT mutants were not 
due to secondary site mutations or polar effects, but also indicate that, regardless of its 
source, ppGpp coordinates the replicative to transmissive phase transition in broth.   
 
The stringent response is essential during macrophage infection 
 As in broth, L. pneumophila cycles between replicative and transmissive phases in 
host cells (Bruggemann et al., 2006; Byrne and Swanson, 1998; Hammer and Swanson, 
1999).  Since ppGpp is essential for activation of the transmission phenotype in vitro 
(Fig. A.1A), we postulated that RelA and SpoT are also required for transmission 
between host cells.   
As observed previously, relA was dispensable for L. pneumophila growth and 
survival in macrophages (Fig. A.6A) (Abu-Zant et al., 2006; Zusman et al., 2002).  In 
contrast, relA spoT mutants infected with a decreased efficiency relative to PE phase WT, 
a phenotype similar to WT in the E phase (Fig. A.6A; 2 h time point).  Those relA spoT 
and E phase WT bacteria that survived the initial attack moved on to replicate efficiently 
between 2 and 24 h.  However, after 24 h, when E phase WT CFU had increased to 
values equivalent to PE phase WT, relA spoT mutants exhibited no further increase in 
CFU over the remainder of the period analyzed (Fig. A.4A).   
Since 24 h corresponds to the period of flagellar expression and initiation of 





were defective for either escape from an exhausted host or entry into a naive one.  To 
distinguish between these two hypotheses, we performed immunofluorescence 
microscopy.  At 16 and 24 h, both WT and relA spoT bacteria occupied replication 
vacuoles (data not shown); however, between 24 and 36 h, a unique class of infected 
macrophages emerged in relA spoT cultures.  Intact bacteria were no longer observed 
(data not shown); instead, degraded L. pneumophila particles were dispersed throughout 
the macrophage.  In addition, there was scant evidence of secondary infection at time 
points between 24 and 48 h (data not shown).  Thus, the majority of bacteria were 
apparently destroyed following the replicative growth period, prior to escape.  In the rare 
macrophage that contained one or two bacteria at time points beyond 24 h, the relA spoT 
mutants were also degraded, likely due to their inability to avoid phagosome-lysosome 
fusion (data not shown).  Therefore, the stringent response is required for L. pneumophila 
transmission between macrophages, and SpoT is a critical component of its 
developmental switch.   
   
SpoT, not RelA is essential for transmission in macrophages 
 Based on the degradation of intracellular relA spoT mutants that we observed after 
24 h (Fig. A.6A), we postulated that ppGpp must accumulate to equip L. pneumophila to 
escape from an exhausted host cell.  To investigate the contributions of RelA and SpoT to 
transmission in macrophages, we tested whether induction of either relA or spoT was 
sufficient to rescue the intracellular relA spoT mutants.   
 The relA spoT mutant L. pneumophila were cultured in the absence of IPTG to the 
early PE phase and then added to macrophages.  After ~16 h, IPTG was added to the 
cultures and maintained for the remainder of the infection.  Like relA spoT harboring 
empty vector, double mutants in which relA had been induced exhibited an ~20 fold 
increase in CFU between 2 and 24 h, but no appreciable increase beyond 24 h (Fig. 





beyond 24 h, and by 72 h, their yield was nearly equivalent to that of WT (Fig. A.7A).  
Thus, SpoT activity, but not RelA, was critical for L. pneumophila transmission in 
macrophages.   
 
SpoT is required for the transmissive to replicative phase transition in host cells 
Since induction of plasmid borne relA in the relA spoT mutant likely results in 
unrestrained ppGpp accumulation due to lack of SpoT hydrolase activity in this strain, 
cells cultured in the presence of IPTG are predicted be locked in the transmissive phase 
and so incapable of re-entering the replicative phase.  Therefore, to address whether SpoT 
synthetase and/or hydrolase activity is critical for the life cycle of L. pneumophila, we 
tested whether induction of relA, spoT or spoTA413E equipped transmissive bacteria to 
differentiate into the replicative phase in both macrophages and on solid medium.   
Broth grown cultures of relA spoT bacteria carrying relA, spoT, or spoTA413E were 
induced with IPTG into PE phase to active transmission traits.  Transmissive bacteria 
were either used to infect macrophages in the presence of IPTG (Fig. A.8A), or plated 
onto rich medium with or without IPTG (Fig. A.8B).  During macrophage infection with 
the relA spoT strains, induction of WT spoT resulted in a pattern of intracellular growth 
identical to that of PE phase WT bacteria (Fig. A.8A).  Interestingly, neither induction of 
relA nor spoTA413E equipped relA spoT L. pneumophila to replicate intracellularly (Fig. 
A.8A).  Similar patterns were observed when transmissive bacteria were plated onto 
bacteriological medium with or without IPTG.  Mutant L. pneumophila that expressed 
WT spoT and relA spoT bacteria carrying vector alone readily formed colonies on 
medium containing IPTG (Fig. A.8B, left panel).  In contrast, consistent with their 
intracellular phenotype, relA spoT mutants harboring either relA or spoTA413E failed to 
replicate when IPTG was present in the medium (Fig. A.8B, left panel).  Together, these 
results suggest that SpoT hydrolase activity is required for transmissive cells to re-enter 





data also indicate that the spoTA413E allele encodes an enzyme defective for ppGpp 
hydrolysis.   
 
Discussion 
 To endure starvation and other stresses, many bacteria rely on the stringent 
response pathway to alter their transcriptional profiles and enhance their fitness.  When 
nutrients become scarce, L. pneumophila generates ppGpp to coordinate the transition 
from a replicative to a transmissive form (Hammer and Swanson, 1999; Zusman et al., 
2002).  Although L. pneumophila requires RelA to produce ppGpp upon entry into the PE 
phase in yeast extract broth, this enzyme is dispensable for replication in either amoeba 
or human macrophages (Figs. A.1A and A.7) (Abu-Zant et al., 2006; Zusman et al., 
2002).  Like several other microbes, L. pneumophila also encodes the bifunctional and 
essential enzyme SpoT, which either synthesizes or hydrolyzes ppGpp depending on the 
nutrient supply.  We report here that the RelA and SpoT enzymes equip L. pneumophila 
to respond to distinct metabolic stresses, and that SpoT in particular is a critical regulator 
of the pathogen’s life cycle in both broth and macrophages. 
 When L. pneumophila is cultured in broth, a large proportion of its ppGpp pool is 
generated by RelA (Fig. A.1A).  The more minor contribution by SpoT can be observed 
as the residual ppGpp detected in relA mutants (Fig. A.1A), since only two ppGpp 
synthetases are apparent in the L. pneumophila genome, and no alarmone is detectable in 
relA spoT double mutant cells (Fig. A.1A).  Like E. coli SpoT, the L. pneumophila 
enzyme may be a weak synthetase (Seyfzadeh et al., 1993).  Alternatively, the low levels 
of SpoT-dependent ppGpp observed may be a consequence of experimental conditions:  
Because its fastidious character precludes use of low-phosphate medium, L. pneumophila 
was cultured in a rich media that contains amino acids as the sole energy source, which 
not only reduces the efficiency of radiolabeling the nucleotide pools but also favors 





SpoT is sufficient to induce not only the flaA promoter, but also motility, sodium 
sensitivity, and evasion of lysosomes (relA mutant; Figs. A.1B, A.4 and data not shown).  
Taken together, our phenotypic and biochemical analysis of WT, relA, and relA spoT 
bacteria establish that the stringent response alarmone ppGpp coordinates differentiation 
of replicating L. pneumophila to the transmissive form. 
In addition to triggering its panel of transmission traits, ppGpp is also critical for 
L. pneumophila to survive the PE phase in broth cultures (Fig. A.1B and A.C).  In E. coli, 
ppGpp-dependent control of fatty acid and phospholipid metabolism allows the bacterium 
to selectively modify its membranes during stress.  For example, ppGpp inhibits fatty 
acid and phospholipid biosynthesis through repression of plsB (sn-glycerol-3-phosphate 
acyltransferase), resulting in accumulation of long-chain acyl-ACPs and cell shortening 
(Heath et al., 1994).  Indeed, the E. coli stringent response both activates and represses 
several genes in the fatty acid and phospholipid biosynthetic pathways, as judged by 
transcriptional profile analysis (Durfee et al., 2008).  Accordingly, we predict that the 
stringent response pathway induces synthesis of specific membrane constituents that are 
critical for L. pneumophila to survive prolonged periods of starvation. 
 As described previously (Abu-Zant et al., 2006; Zusman et al., 2002), the RelA 
enzyme itself is dispensable for L. pneumophila to survive phagocytosis by macrophages 
and also for the intracellular bacteria to replicate (Fig. A.6).  On the other hand, the 
alarmone ppGpp is critical to induce the virulence factors that equip L. pneumophila to 
establish its protected intracellular niche, since mutants that lack both relA and spoT 
survive poorly within macrophages (Fig. A.6).  The source of ppGpp is inconsequential, 
since expression of either RelA or SpoT largely bypasses the transmissive trait defects of 
relA spoT double mutant bacteria (Fig. A.5A).  Once replication ensues, ppGpp is no 
longer required, since the few relA spoT mutant bacteria that do survive the initial 
infection replicate efficiently during the subsequent 24 h primary infection period (Fig. 





Many species of bacteria initiate the stringent response when their nutrient supply 
wanes.  In E. coli, RelA responds to amino acid limitation, whereas SpoT activates the 
stringent response pathway during all other types of stresses and starvation (Magnusson 
et al., 2005).  Similarly, amino acid depletion stimulates L. pneumophila to produce 
ppGpp and induce differentiation by a RelA-dependent pathway (Fig. A.2A and A.B).  
On the other hand, to respond to perturbations in fatty acid biosynthesis, L. pneumophila 
relies on SpoT (Fig. A.2C and A.D).  Since this environmental microbe and opportunistic 
pathogen thrives within a variety of ecological niches, we predict that its dual stringent 
response enzymes equips L. pneumophila to coordinately induce transmission traits when 
confronted with one of a variety of stresses.   
 To activate the stringent response pathway following fatty acid starvation, E. coli 
depends on a regulatory interaction between SpoT and ACP, a component of the fatty 
acid biosynthesis pathway (Battesti and Bouveret, 2006).  In particular, Battesti and 
Bouveret identified a single amino acid substitution in SpoT that abrogates a physical 
interaction with ACP and renders the mutant bacteria blind to fatty acid starvation 
(Battesti and Bouveret, 2006).  L. pneumophila also utilizes an interaction between SpoT 
and ACP to respond to alterations in fatty acid biosynthesis, since the analogous spoT 
A404E mutant bacteria fail to trigger cytotoxicity in response to excess short chain fatty 
acids (Fig. A.3A).  By some mechanism, ACP appears to regulate SpoT enzyme activity 
to reduce ppGpp pools, as judged by three phenotypic assays.  L. pneumophila treated to 
express the spoT A413E allele strongly apparently contain excessive ppGpp, as the cells are 
more cytotoxic than WT PE bacteria (Fig. A.3B), and they survive yet fail to replicate 
when cultured either in macrophages or on rich medium (Fig. A.8 and data not shown).  
Based on the capacity of the analogous E. coli spoTA404E mutant to adapt to histidine 
starvation, Battesti and Bouveret also deduced that excess ppGpp accumulates when the 
SpoT-ACP interaction is disrupted (Battesti and Bouveret, 2006).  Accordingly, our 





interact with SpoT, promoting its hydrolase activity.  Thus, to transition to the replicative 
phase, transmissive L. pneumophila require that acyl-ACP stimulate SpoT to degrade the 
ppGpp alarmone.  When fatty acid biosyntheses is perturbed, free ACP activates the 
SpoT synthetase to generate ppGpp.  Biochemical studies can now test the prediction that 
the SpoTA413E protein is a weak synthetase whose activity cannot be stimulated by the 
non-acylated forms of ACP. 
During the replication period in A/J mouse macrophages, WT L. pneumophila 
reside within an acidic lysosomal compartment (Sturgill-Koszycki and Swanson, 2000). 
Like WT L. pneumophila, relA spoT mutant bacteria slowly traffic to the lysosomal 
compartment (data not shown).  However, at the end of the intracellular replication cycle, 
L. pneumophila that cannot produce ppGpp become degraded and scattered throughout 
the macrophage cytosol, as judged both by microscopy and a decline in CFU (Fig. A.6, 
data not shown).  Therefore, the ppGpp produced by SpoT is essential for L. pneumophila 
to escape from the harsh lysosomal environment and to move to another phagocyte.   
  In contrast to the critical role of the ppGpp alarmone, a number of positive 
activator proteins of transmission traits that are critical during culture in amino acid-rich 
broth are nevertheless dispensable for L. pneumophila to spread from one macrophage to 
another.  These regulatory proteins include the LetA/S two-component regulatory system, 
the LetE enhancer of transmission traits, and the FliA flagellar sigma factor (Bachman 
and Swanson, 2004a; Hammer et al., 2002).  Apparently, the ppGpp-dependent regulators 
that operate in macrophage vacuoles are either redundant or distinct from those identified 
as critical for inducing transmission traits during the PE phase in yeast extract broth.  One 
hypothesis is that L. pneumophila requires ppGpp for transcriptional activation of its six 
alternative sigma factors (Cazalet et al., 2004; Chien et al., 2004).  Alternatively, the 
sigma factor competition model holds that stress-induced sigma factor proteins require 
ppGpp to displace RpoD from RNA polymerase to activate their specific cohort of targets 





RpoN, or FliA, do not confer an intracellular defect (Jacobi et al., 2004).  One exception 
is RpoS, which exhibits replication defects in amoebae and in macrophages (Bachman 
and Swanson, 2001; Hales and Shuman, 1999).  Therefore, unless the regulators are 
redundant, some other ppGpp-dependent positive activators must induce the transmission 
phenotype of intracellular L. pneumophila.   
The precise stimuli that cue L. pneumophila differentiation in vivo also remain to 
be determined.  Several intracellular pathogens, including Agrobacterium tumefacians, 
Brucella abortus and Mycobaterium tuberculosis, sense host membrane lipids and initiate 
defense mechanisms when deemed appropriate.  Also, L. pneumophila requires 
phosphotidylcholine for both survival in host cells and cytotoxicity (Conover et al., 
2008).  Accordingly, we postulate that the ability of SpoT to sense variations in fatty acid 
metabolism in broth also equips L. pneumophila to respond to fluctuations in lipids 








Figure A.1.  RelA and SpoT contribute to ppGpp accumulation, motility and 
survival in PE phase. 
(A)  To evaluate ppGpp accumulation in the PE phase, mid-E phase AYET broth cultures 
of WT, relA, and relA spoT bacteria were incubated for 6 h with 32P phosphoric acid 
(~two generation times), a period sufficient for the cells to enter the PE phase.  At this 
time, cell extracts were prepared and nucleotides were separated by PEI-TLC.  The 
autoradiogram shown represents one of two separate experiments.  (B)  To monitor flaA 
expression, WT (triangles), relA (squares) and relA spoT (circles) strains transformed 
with pflaAgfp were cultured in broth.  At the times indicated, bacterial density was 
quantified by measuring OD600 (closed symbols, dashed lines), and GFP accumulation 
was quantified by fluorometry (open symbols, solid lines).  Shown is a growth curve 
beginning in early-E phase that is representative of multiple cultures in >5 independent 
experiments.  (C)  To evaluate survival of PE phase stress, early-E phase cultures of WT 
(triangles), relA (squares), and relA spoT (circles) bacteria were diluted to an OD600 of 
0.1. Then, bacterial density was quantified by measuring OD600 (closed symbols, dashed 
lines), and viability was assessed by enumerating CFU/ml on CYET (open symbols, solid 
lines).  Shown are mean CFU ± SE from duplicate samples, and the data represent one of 
















Figure A.2.  L. pneumophila requires RelA and SpoT for ppGpp accumulation and 
flaA expression in response to distinct metabolic cues. 
(A)  To analyze ppGpp accumulation in response to amino acid starvation, early-E phase 
AYET broth cultures were labeled with 32P phosphoric acid for two generations before 
addition of either 1 mM serine hydroxamate (+), or water (-).  After an additional 1.5 h 
incubation period, cell extracts were prepared, and nucleotides were separated by PEI-
TLC.  The autoradiogram represents one of two independent experiments.  (B)  To 
quantify flaA expression in response to amino acid starvation, mid-E phase AYET 
cultures of WT (triangles), relA (squares), relA spoT (circles) strains harboring pflaAgfp 
were diluted to early-E phase before the addition of either 1 mM serine hydroxamate 
(open symbols, solid lines), or water (closed symbols, dashed lines).  Then, cultures were 
sampled at 3 h intervals until WT and relA reference samples entered PE phase (OD600, 
bottom panel) and exhibited flaA promoter activity fluorescence (9 h; top panel). These 
data represent one of three independent experiments.  (C)  To analyze ppGpp 
accumulation in response to inhibition of fatty acid biosynthesis, mid-E phase AYET 
cultures of WT (triangles), relA (squares), relA spoT (circles) were incubated for 1 h with 
cerulenin at 0.5 µg/ml  (+) or DMSO (-).  Then, cell extracts were prepared and analyzed 
by PEI-TLC.  Shown is one autoradiogram representing one of three independent 
experiments.  (D)  To quantify flaA expression in response to fatty acid biosynthesis 
inhibition, mid-E phase cultures of WT (triangles), relA (squares), or relA spoT (circles) 
bacteria were treated with cerulenin (open symbols, solid lines) or DMSO (closed 
symbols, dashed lines).  Samples were collected at 3 h intervals to measure bacterial 
density (bottom panel) and fluorescence (top panel) until WT and relA reference cultures 
entered PE phase and exhibited fluorescence (12 h).  The data depicted represent one of 

















Figure A.3.  SpoT mutation abrogates transmission gene expression following 
perturbations in fatty acid metabolism.   
(A)  E phase cells normalized to an OD600 of 0.5-0.6 were incubated with 25 µM IPTG 
for 1 h.  Then, cultures were split and 10 mM propionic acid was added to one half, while 
the other half was mock-treated.  After 3 h of incubation, triplicate wells of macrophages 
were infected at various multiplicities of infection (MOI) with treated or mock treated 
relA spoT mutant bacteria harboring vector backbone, pspoT, or pspoTA413E.  After 1 h 
incubation with the macrophages, cytotoxicity was measured as the ability of viable 
macrophages to reduce the calorimetric dye alamarBlue™.  (B)  As described in A, 
macrophages were infected with propionic acid-, or mock-treated relA spoT mutant 
bacteria harboring the plasmids shown.  To induce high levels of protein, bacteria were 
incubated with 50 µM IPTG for 2 h, twice the amount and time used for A.  Then, 
cultures were split and either treated with propionic acid or mock-treated.  After 3 h of 
treatment, macrophages were infected in triplicate, and cytotoxicity was measured.  The 
values plotted represent the mean ± standard error for triplicate samples determined in 










Figure A.4.  The stringent response governs L. pneumophila transmission traits in 
broth. 
(A)  To quantify sodium resistance, E or PE phase cultures of the strains shown were 
plated on medium with or without 100 mM NaCl, then efficiency of colony formation 
was calculated as [(CFU on CYET + 100 mM NaCl)/(CFU on CYET)] x 100.  Shown are 
mean percentages ± SE from duplicate samples, and the data represent one of three 
independent experiments.  (B)  The ability of bacteria to bind, enter, and survive 
ingestion by macrophages was quantified by fluorescence microscopy by scoring the 
percent of bacteria that were intact 2 h after infection.  Infected macrophages were 
double-labeled with the DNA stain DAPI to visualize macrophage nuclei and intact 
bacteria and with L. pneumophila-specific antibody to visualize both intact and degraded 
L. pneumophila.  Shown are mean percentages ± SE from duplicate samples, and the data 









Figure A.5.  Induction of either ppGpp synthetase rescues transmission trait 
expression of relA spoT mutants. 
(A)  To determine the contribution of RelA and SpoT to L. pneumophila cytotoxicity, 
relA spoT mutants transformed with vector (circles), prelA (squares), pspoT (diamonds), 
or pspoTA413E (open circles) were cultured from mid-E phase to PE phase with 200 µM 
IPTG.  Bacteria were added to triplicate wells of macrophages at the MOI shown.  WT 
cells carrying vector and cultured to either E phase (triangles), or PE phase (dashed line, 
triangles) were added as controls.  After 1 h incubation, cytotoxicity was measured.  The 
values plotted represent the mean ± standard error for triplicate samples determined in 
one of three similar experiments.  (B)  Macrophages were infected at an MOI of ~1.0 for 
2 h with either E or PE phase WT carrying vector, relA spoT mutants transformed with 
vector, prelA, pspoT, or pspoTA413E cultured from mid-E phase to PE phase with 200 µM 
IPTG, as described above.  Shown are mean percent of cell-associated CFU ± SE from 








Figure A.6.  The stringent response is essential for L. pneumophila transmission in 
macrophages. 
Macrophages were infected at an MOI of ~1 with E phase WT (triangles, dashed line), 
PE phase WT (triangles, solid line), PE phase relA (squares) or PE phase relA spoT 
mutants (circles) for the periods shown, and then the number of viable bacteria per well 
was determined.  Shown are mean CFU ± SE from duplicate samples in one of five 






Figure A.7.  SpoT, not RelA, is essential for L. pneumophila transmission in 
macrophages.   
Macrophages were infected at an MOI ~ 1.0 with E phase WT (triangles, dashed line) 
and PE phase relA spoT harboring: vector (circles), prelA (squares) or pspoT (diamonds).  
At 16 h post infection, 200 µM IPTG was added to the wells and maintained throughout 
the remainder of experiment.  Relative CFU was calculated by dividing the CFU values 
obtained at 24, 48 and 72 h by the 2 h value.  Shown are mean fold increase in CFU ± SE 









Figure A.8.  Transmissive L. pneumophila require SpoT to enter the replicative 
phase. 
(A)  To determine if SpoT hydrolase activity contributes to the transmissive to replicative 
phase transition within host cells, relA spoT mutant L. pneumophila carrying either prelA 
(squares), pspoT (diamonds) or pspoTA413E (circles) were induced with 200 µM IPTG in 
mid-E phase, cultured into PE phase (4-5 h), and then used to infect macrophages at an 
MOI of ~1.  During the 72 h infection, 200 µM IPTG was maintained.  WT carrying 
empty vector cultured into PE phase (dashed line, open triangles) served as a positive 
control in this assay.  Relative CFU was calculated as described above.  Shown are mean 
fold increase in CFU ± SE from duplicate wells in one of three independent experiments.  
(B)  As in A, relA spoT mutant derivatives of L. pneumophila were cultured in mid-E 
phase to PE phase (4-5 h) in the presence of 200 µM IPTG.  Then, to mimic the induction 
conditions used in the macrophage experiment, bacteria were plated onto CYET with or 
without 200 µM IPTG.  Shown are images of CYET agar plates of one of three 












EFFECT OF DECREASING COLUMN INNER DIAMETER AND THE USE OF 
OFF-LINE TWO-DIMENSIONAL CHROMATOGRAPHY ON METABOLIC 




 Capillary liquid chromatography coupled with electrospray ionization to a 
quadropole ion trap mass spectrometer was explored as a method for the analysis of polar 
anionic compounds in complex metabolome mixtures.  A ternary mobile phase gradient, 
consisting of aqueous acidic, aqueous neutral and organic phases in combination with an 
aqueous compatible reversed-phase stationary phase allowed metabolites with a wide 
range of polarities to be resolved and detected.  Detection limits in the full scan mode for 
glycolysis and tricarboxylic acid cycle intermediates were from 0.9 to 36 fmol.  Using 
this system, 111 ± 9 (n = 3) metabolites were detected in Escherichia coli lysate samples.  
Reducing column I.D. from 50 µm to 25 µm increased the number of metabolites 
detected to 156 ± 17 (n = 3).  The improvement in number of metabolites detected was 
attributed to an increase in separation efficiency, an increase in sensitivity, and a decrease 
in adduct formation.  Implementation of a second separation mode, strong anion 
exchange, to fractionate the sample prior to capillary RPLC increased the number of 
metabolites detected to 244 ± 21 (n = 3).  This improvement was attributed to the 
increased peak capacity which decreased co-elution of molecules enabling more sensitive 
detection by mass spectrometry.  This system was also applied to islets of Langerhans 
where more significant improvements in metabolite detection were observed.  In islets, 





results demonstrate that column miniaturization and use of two-dimensional separations 
can yield a significant improvement in the coverage of the metabolome.   
 
Introduction 
Analysis of small molecule pools present in cells holds the promise of elucidating 
novel biochemical pathways, functions of genes, drug effects and mechanisms of 
pathophysiological states.  Coupling of separation methods such as capillary 
electrophoresis (CE) (Edwards et al., 2006; Soga et al., 2002; Soga et al., 2003), gas 
chromatography (GC) (Fiehn et al., 2000; Jonsson et al., 2004), reversed-phase liquid 
chromatography (RPLC) (Lu et al., 2006; Tolstikov et al., 2003), strong anion-exchange 
chromatography (SAX) (Mashego et al., 2004) and hydrophilic interaction liquid 
chromatography (HILIC) (Lafaye et al., 2005) with mass spectrometry (MS) has proven 
effective for detecting large numbers of metabolites in complex mixtures.  Despite the 
resolving power of these methods, they generally only detect a fraction of the metabolites 
that are present.  Several factors contribute to the difficulty of detecting all metabolites in 
a given sample.  The many components demand high peak capacity of the separation to 
detect the complete metabolome.  The huge variation of metabolite concentrations 
requires wide dynamic range of the measurement.  Finally, the chemical heterogeneity of 
metabolites in terms of polarity, size, and charge suggest that not all components will be 
compatible with a single extraction and separation protocol.  In this work, we examine 
how column miniaturization and use of two-dimensional (2D) separations impacts the 
coverage of the metabolome in complex mixtures by increasing peak capacity and 
sensitivity.   
One approach to improving peak capacity is to improve efficiency by using smaller 
particles, as in ultra-high-pressure liquid chromatography (UHPLC).  Application of 
UHPLC to metabolomic analysis has yielded impressive resolution of complex mixtures 





also improve peak capacity.  While dual column GC-MS is becoming prevalent for 
analysis of some classes of metabolites (Mohler et al., 2006; Welthagen et al., 2005), 2D 
condensed-phase separations for metabolites has received less attention.  In one example, 
a combination of conventional RPLC with a fast 2nd dimension of carbon-coated zirconia 
RPLC was used to analyze plant extracts and allowed detection of 100 small molecules in 
25 min (Stoll et al., 2006).  An offline combination of LC with CE has been used to 
separate and detect 63 metabolite standards (Jia et al., 2005).  The use of absorbance 
detection likely limited both detection and identification of more metabolites in these 
cases.  The relative lack of multi-dimensional analysis for metabolites is in contrast to 
proteomics where multi-dimensional separations have been widely developed and 
characterized (Opiteck et al., 1997; Washburn et al., 2001).   
In this work, we examined the effect that 2D separations would have on the 
numbers of metabolites detected in complex mixtures from extracts of both prokaryotes 
and eukaryotes.  Polar anions were selected as a group of compounds to target because 
they include energy metabolites, central to any organism, and their related products.  
Therefore, a combination of SAX and RPLC for the two-dimensions of separation was 
used.   
In addition to exploring the effect of 2D separations, we also examined the utility 
of decreasing column inner diameter (I.D.) for improving the number of metabolites 
detected in a complex mixture.  Column miniaturization improves separation efficiency 
(Kennedy and Jorgenson, 1989) and electrospray ionization efficiency (Schmidt et al., 
2003).  Both of these effects are expected to aid in detection of more metabolites in a 
complex mixture.  For these reasons, and because of the reduced sample consumption, 
capillary LC is commonly used in proteomics.  In contrast, capillary LC has been 
relatively unexplored for metabolomic analysis (although, CE has seen some use for this 
application).  This lack of application of capillary LC may be because most metabolomic 





microbes, and bodily fluids, thus negating the need to analyze small quantities.  
Nevertheless, miniaturization may be expected to improve sensitivity, and therefore the 
number of compounds detected.  Furthermore, use of miniaturized columns should also 
enable analysis of more limited samples including specific mammalian tissues (Harwood 
et al., 2006; Kennedy et al., 1989; Wolters et al., 2005; Woods et al., 2005) such as 
embryos, neurons, and islets of Langerhans, which are too small to analyze with currently 





Reagents and materials.  All chemicals were purchased from Sigma-Aldrich (St Louis, 
MO USA) unless otherwise noted.  All solvents were purchased from Burdick and 
Jackson (Muskegon, MI USA).  Fused silica capillary was purchased from Polymicro 
Technologies (Phoenix, AZ USA).  Reversed phase chromatographic stationary phase 
was purchased from Waters (Milford, MA USA).  SAX chromatographic stationary 
phase was donated by Dionex (Sunnyvale, CA USA).  Eppendorf Safelock Biopur tubes 
were purchased from Fisher Scientific (Fairland, NJ).   
 
Capillary column fabrication.  Capillary columns were prepared as previously described 
(Haskins et al., 2001).  Briefly, macroporous photopolymerized frits were placed 5 cm 
from the end of 50 cm long by 50 µm or 25 µm I.D. capillaries.  Using a P-2000 laser 
puller, tips were pulled 1 cm downstream of the frit, then etched for 30 seconds in 49% 
HF (v/v) and rinsed to create a ~3 µm opening at the outlet of the column unless stated 
otherwise.  Capillaries were packed with 3 µm Atlantis C18 aqueous reversed phase 





1989).  All columns had 30 cm packed bed length and were subsequently cut to 35 cm 
total length.   
For the SAX capillary columns, frits were formed by tapping 10 µm diameter 
borosilicate particles (Duke Scientific Palo Alto, CA USA) into the orifice of a 50 cm 
long by 250 µm I.D. capillary to a distance < 2 mm.  The glass particles were then 
sintered in place with a flame (Kennedy and Jorgenson, 1989).  SAX particles (CarboPac 
PA-100, 8.5 µm diameter) were slurry-packed at 2,000 psi, using 1 M NaCl as the 
solvent, to a bed length of 40 cm.   
 
Chromatography conditions.  The RPLC system utilized two flow-splitters, one before 
the injection valve and one after the injection valve, to reduce flow into the system and 
control flow during injection (Fig. B.1).  To avoid extra-column band broadening from 
the use of a conventional six port injection valve onto capillary columns, samples were 
loaded off-line.  In the injection procedure, flow was diverted from the column to splitter 
1 using the injection valve.  The column was uncoupled from the system and sample (9 
nL for 50 µm I.D. and 2.5 nL for 25 µm I.D.) pumped onto the column using gas pressure 
applied to a sample reservoir.  The column was then reconnected to the splitting tee and 
the injection valve actuated to initiate flow through the column.  With this procedure, the 
HPLC pump (Model 626, Waters) was able to maintain a constant pressure and initiated 
flow immediately after the valve actuation.  Despite multiple re-connections, no air 
bubbles were observed during the course of these experiments.  Three mobile phases 
were used to form the reversed phase gradient.  Mobile phase A was 20 mM formic acid 
pH 2.7, mobile phase B was 20 mM ammonium acetate pH 6.5, and mobile phase C was 
acetonitrile.  All gradient transitions were linear, with the following profile (time: %A, 
%B, %C); initial time 0 min: 100%, 0%, 0%; hold 5 min.; 10 min: 0%, 100%, 0%; 18 
min: 0%, 80%, 20%; 23 min: 0%, 65% 35%; 60 min: 0%, 25%, 75%; 65 min: 100%, 0%, 





completion.  Extended gradient consisted of 0 min: 100%, 0%, 0%; hold 5 min.; 10 min: 
0%, 100%, 0%; 23 min: 0%, 80%, 20%; 34 min: 0%, 65% 35%; 60 min: 0%, 25%, 75%; 
65 min: 100%, 0%, 0%.   
The SAX chromatography system was operated in a conventional 6 port injection 
valve format.  After injection of 10 µL of sample, a step gradient was used to elute 
anionic metabolites off the column.  All gradient steps were 10 min in duration with 
mobile phase A: 5 mM ammonium formate pH 6.5 and mobile phase B: 700 mM 
ammonium formate (NH4HCO2) pH 6.5.  Buffer was adjusted using ammonium 
hydroxide and formic acid as needed to reach the desired pH.  The gradient profile was as 
follows (time: %A, %B): 0 min: 100%, 0%; 10 min: 86%, 14%; 20 min: 72%, 28%; 30 
min: 58%, 42%; 40 min: 44%, 56%; 50 min: 30%, 70%; 60 min: 0%, 100%.  Six 
fractions were collected from the capillary outlet in 10 min intervals.  Fractions were then 
evaporated to dryness using a vacuum centrifuge and reconstituted to 10 µL with 10 mM 
formic acid for further analysis using RPLC-MS.   
 
Mass spectrometry.  Detection was accomplished using a LCQ Deca XP Plus quadrupole 
ion trap mass spectrometer (Thermo-Electron, San Jose, CA USA) operated in negative 
mode (spray voltage: -1.0 kV).  Spectra were obtained in centroid mode with the mass 
spectrometer tuned for nucleotides (GTP) and the capillary temperature set to 150°C.  
Experiments were performed in full scan mode with the maximum injection time of 25 
ms and the scan range between 50-1500 m/z.  The capillary column was interfaced to the 
mass spectrometer using a nanospray interface (Thermo-Electron).   
 
Sample preparation: E. coli.  For cells cultured in minimal media, E. coli N99 was first 
grown in LB media on an orbital shaker overnight.  The following morning, 25 µL of 
culture was added to 50 mL of minimal media (48 mM Na2HPO4, 22 mM KH2PO4, 8.6 





shaker at 37°C until OD600 = 1.5 (~20 h) when 15 mL of cultured E. coli was added to 35 
mL of water at 4°C.  Afterwards, the sample was spun and rinsed with cold water.   
After a second rinse-resuspension, the E. coli suspension was centrifuged, 
supernatant decanted and replaced with -20°C 500 µL of 50:50 methanol-water (v/v).  
Cells were lysed using a sonic dismembrator (Fischer Scientific, model 60) set to power 
of 9 W for 10 s.  The lysate was then mixed 50:50 (v/v) with chloroform and set to 
equilibrate on ice for 10 min.  The final solvent composition was 25:25:50 (v/v/v) 
methanol: water: chloroform.  The aqueous portion was then removed and centrifuged at 
4°C, 1200 g for 10 min.  Supernatant was collected and vacuum centrifuged to near 
dryness (< 5 µL), then reconstituted with mobile phase A to 100 µL for analysis.  
Samples were stored at -80°C until use (< 1 week).   
 
Sample preparation: Islets of Langerhans.  Islets of Langerhans were isolated from CD-1 
mice (20-30 g) as previously described (Edwards and Kennedy, 2005) with slight 
modifications.  Briefly, collagenase XI (0.5 mg/mL) was infused through the pancreatic 
duct.  Pancreas was then removed and incubated in 5 mL of collagenase XI (0.5 mg/mL) 
at 37 ºC for 7 min.  Islets were isolated by passing digested pancreas through a 100 µm 
pore diameter nylon cell strainer (Fisher Scientific) with 10 mL of Krebs ringer buffer.  
This procedure collected islets that were greater than 100 µm in diameter.  Islets were 
transferred to a Petri dish by inverting the filter, which was rinsed with 5 mL of buffer.  
Islets were manually selected using a pipette and transferred to a Petri dish containing 
cell culture media (10 mM glucose RPMI media 1640 with L-glutamine) supplemented 
with 10% fetal bovine serum and 100 units/mL of penicillin and 100 µg/mL of 
streptomycin.  Islets were incubated in this media at 37ºC, 5% CO2 for 2 to 7 days before 
use.   
A total of 50 islets were transferred from media to a rinse solution of 10 mM 





Biopure tube and tapped down to deposit islets at the bottom of the tube.  Rinse solution 
was then removed to ~ 5 µL and 10 µL of 50:50 MeOH-H2O (v/v) at -20ºC was added.  
Islets were triturated using a pipette until they appeared shredded as imaged through an 
inverted microscope.  The process between rinse and ending trituration took ~45 sec.  
After islets were lysed, 15 µL of chloroform was added to the lysate and allowed to 
equilibrate on ice for 10 min.  Sample was then treated as E. coli samples, with a post 
evaporation reconstitution volume of 15 µL.   
 
Data processing.  Peaks were discriminated from noise using MS Processor version 8.0 
from Advanced Chemistry Development (Toronto, Canada).  Detection of peaks, using a 
reconstructed ion chromatogram format, was performed using the following parameters: 
MCQ threshold = 0.85; smoothing window width = 3 scans; minimum full width at half 
maximum height = 3 scans; signal-to-noise = 5.  Peaks were matched between runs when 
tr < 3% RSD and Δm/z < 0.5.  Statistical comparison was performed using a two-tailed 
student’s t-test.   
 
Results and discussion 
 
Chromatography of metabolite standards   
Our initial experiments focused on developing a capillary RPLC system for 
separation of polar metabolites.  In order to ensure separation of a wide scope of small 
molecules, 24 metabolites from glycolysis and the tricarboxylic acid (TCA) cycle were 
targeted for separation and detection (see Table B.1 for compounds used).  These 
analytes were chosen because they cover a broad range of charges and polarities, from 
polar glucose-6-phosphate to nonpolar FAD.  A silica-based reversed-phase particle 
designed to be compatible with 100% aqueous mobile phases (Atlantis) was used to 





Work with this stationary phase revealed that manipulation of mobile phase pH 
was critical in allowing separation of the different types of analytes present in glycolysis 
and the TCA cycle.  With aqueous mobile phases at pH < 3.0, polar organic acids were 
well-retained and resolved but, phosphorylated nucleotides yielded poor peak shape and 
peak height (See supporting information Fig. B.S1 and B.S2).  When the aqueous 
component of the mobile phase had pH > 6.5, the phosphorylated nucleotides were well 
resolved but, polar organic acids co-eluted near the column dead volume.  Intermediate 
pH mobile phases (pH = 4.5) yielded poor resolution and peak shape for all classes of 
metabolite standards (data not shown).  These data indicated that low pH mobile phase 
was necessary for separation of small organic acids while higher pH was required for 
separation of phosphorylated nucleotides.  To resolve this problem, a gradient of formic 
acid pH 2.7 to ammonium formate pH 6.5 was used for the initial part of the separation 
followed by an increase in acetonitrile content to elute the less polar analytes.  As seen in 
Fig. B.2, these conditions allowed separation of 23 of the 24 metabolite standards and 
were used for all further RPLC experiments.   
For detection, negative mode ESI was used.  Preliminary experiments revealed 
that negative mode ESI substantially decreased adduct formation and increased S/N when 
compared to positive mode ESI for these metabolites (data not shown).  The use of 
capillary columns allowed for good sensitivity with lower detection limits of 0.3-12 fmol 
for glycolytic and TCA metabolite standards (see Table B.1).  These detection limits are a 
two to three order of magnitude improvement over previous reports even though the prior 
work used SRM for detection instead of full-scan mode (Bajad et al., 2006; Mashego et 
al., 2004).  For these measurements, only 9 nL of sample were consumed for the 
injection.  Although the mass detection limit was considerably improved over previous 
results, the concentration detection limit was generally not improved over prior results.  
The use of full scan mode was chosen to facilitate an untargeted metabolomics approach, 





modes.  The good mass detection limits suggest that this method may have utility for 
sample limited metabolomic analysis; although that application was not explored in this 
work.   
 
E. coli metabolite detection   
 When this method was applied to extracts of E. coli, 157 features were detected in 
the LC-MS data.  We were interested in determining the number of actual endogenous 
small molecules detected; therefore, data were analyzed to eliminate false peaks and 
multiple peaks for single compounds.  Peaks due to Na+ and formate adducts (as 
indicated by + 22 and + 46 m/z respectively and identical retention time to the base 
analyte), multiple charge states, and water loss, were eliminated from analyte count.  
Using the above criteria, a total of 111 ± 9 (n = 3) compounds were detected in the E. coli 
samples that were not present in background.   
Using the average peak width for the compounds detected and the retention time 
window, a peak capacity of 110, based on unity resolution, was calculated for this 
separation.  In calculating peak capacity, we determined the peak capacity separately for 
the two different gradients (a pH gradient and the organic phase gradient), because the 
peaks had different widths in these gradients, and added them together.  Detection of 
more small molecules than indicated by the calculated peak capacity is due to the use of 
the mass spectrometer as the detector, which substantially increases the peak capacity.   
To evaluate the effect of column dimension on detection of metabolites in E. coli, 
the capillary column I.D. was reduced from 50 µm to 25 µm.  For these experiments, the 
gradient conditions and mobile phase velocity were kept the same but the volume 
injected was decreased by 4 in proportion to the column volume.  The ESI tip I.D. was 
decreased from 3.0 to 1.5 µm and the volumetric flow rate from 104 to 25 nL/min.  
Decreasing the column I.D. is expected to improve separation efficiency primarily by 





Furthermore, the lower flow rate and smaller emitter tips may be expected to improve 
ionization efficiency and therefore sensitivity (Andren and Caprioli, 1995; Korner et al., 
1996).  Both of these effects are seen in the comparison of the reconstructed ion 
chromatograms for m/z 662, chosen as a typical analyte, shown in Fig. B.3.  On average, 
peak width decreased by 25 ± 14% (n = 4) while the signal increased by 88 ± 21% (n = 4) 
for decreasing the column I.D. by 2-fold.  The signal increased even though 4-fold less 
sample was injected.  The improvement in signal intensity cannot be solely attributed to 
improved peak shape as peak area was also increased (23% greater) in the 25 µm column.   
An added benefit of the decrease in column I.D. was a decrease in adduct 
formation.  As shown in Fig. B.3B and C, peaks 698 m/z and 720 m/z, adducts to 662 
were reduced from ~40% of base height to ~20%.  The increase in signal intensity 
discussed above can be in large part attributed to the reduced adduct formation and 
increased ionization efficiency (Schmidt et al., 2003).   
As summarized in Fig. B.4, the decrease in peak width associated with decreasing 
the column bore increased peak capacity from 114 to 168.  The actual number of peaks 
detected in E. coli extracts increased in proportion to the peak capacity from 111 ± 9 to 
156 ± 17 (n = 3).  These results illustrate a multi-faceted improvement in decreasing 
column I.D. for complex metabolite detection.  We also examined the effect of extending 
the gradient time from 11 to 24 min.  This manipulation had a modest, but not statistically 
significant, improvement in peak capacity and number of metabolites detected (Fig. B.4).   
 
Two-dimensional capillary chromatography   
 After establishing the peak capacity and number of components detected on the 
reversed phase column, the effect of pre-fractionation using a SAX column was 
evaluated.  For this investigation, six fractions resulting from step gradients of 100 mM 
increments of ammonium formate were collected from the SAX column off-line and 





method was applied to extracts of E. coli lysate.  Fig. B.5B-G shows the base peak 
chromatogram of six SAX fractions injected onto a capillary RPLC column.  The use of a 
2D separation resulted in detection of 244 ± 21 compounds compared to 170 ± 14 (n = 3) 
for the single dimension RPLC with the same RPLC gradient.  As the SAX eluent was 
dried and then reconstituted to the same volume as initially injected (Fig. B.5B-G), 
dilution effects of the first dimension should not be present.  The peak capacity of the 
separation is estimated as 970 (6 SAX fractions × 161 peaks for RPLC).   
Carryover, defined as detection of a given compound in more than 1 SAX 
fraction, was found for approximately 14% of the small molecules detected.  The 
majority of the carryover was present between the first two fractions.  This indicated that 
those compounds which were weakly retained on the SAX column were overloaded, 
whereas those compounds of higher affinity were well retained and preconcentrated in 
the 1st dimension.   
In principle, the MS adds a significant resolving component making it 
unnecessary to use extremely high peak capacity separations; however, the above results 
illustrate that the improved separation resolution increased the coverage of the 
metabolome.  At least part of this effect is due to signal enhancement associated with 
reducing the number of co-eluting components.  Signal enhancement was quantified by 
comparing signal intensity from co-eluting compounds in the 1-D RPLC with those same 
compounds which were separated into different fractions by SAX and analyzed by 
RPLC.  Seven sets of peaks were found to co-elute in the 1D analysis, which were 
resolved into different fractions by SAX.  These peaks increased signal intensity on 
average by 47% (± 29%).  Presumably this improvement is due to reduction of competing 








Islet analysis   
The majority of metabolomic analyses have involved plants and prokaryotes; 
however, metabolomic analysis of specific tissues is mammalian systems is emerging as 
an important application (Haskins et al., 2001; Jensen et al., 2006).  We therefore also 
evaluated the effectiveness of these methods on islets of Langerhans.  Islets are 
microorgans dispersed throughout the pancreas, which contain about 3000 cells each.  
Islets secrete insulin in a process driven by glucose metabolism.  Metabolic disturbances 
of islets are a possible root cause of type 2 diabetes, therefore considerable benefit may 
emerge from metabolomic analysis of these cells.  Only ~70 islets can be isolated from a 
single mouse and the smallest reasonable sample volume for extracting this amount of 
tissue is ~ 20 µL; therefore, minimizing the sample volume required for analysis is of 
interest.  The use of capillary columns is well-suited for analysis of such samples.   
Fig. B.6A shows the base peak chromatogram from a capillary RPLC-MS 
analysis of lysate from 50 islets in 15 µL.  Average peak width for these samples (n = 3) 
was 8 s, which is ~ 2 s less than those found with E. coli samples.  The decrease in 
average peak width was due to detecting a larger number of hydrophobic compounds, 
which tend to elute as narrower zones in this gradient.  As a result of the decrease in peak 
width, the peak capacity calculated for the separation was increased to 240 from 161 for 
the E. coli sample (Fig. B.4).  Using the criteria described above for the E. coli analysis 
for distinguishing peaks from compounds, an average of 191 ± 14 (n = 3) compounds 
were detected in the islet samples.   
As with the E. coli samples, use of the 2D separation significantly increased the 
coverage of the metabolome (Fig. B.4 and B.6B-G).  Whereas the single dimension 
RPLC yielded on average 191 small molecules, 2D-LC allowed for detection of 391 ± 33 
peaks with a peak capacity of 1200.  Fig. B.6 illustrates that the number of peaks detected 





fractions.  The limited number of compounds found in the last three steps suggests that 
metabolites with a high degree of charge are relatively rare in islets.   
Interestingly, islets yielded significantly more metabolites than the E. coli (Fig. 
B.4) even though the islet samples were about 1% as concentrated on a per gram of tissue 
basis.  Many of these metabolites were fairly large (m/z > 600) and non-polar (i.e., eluted 
during the organic phase of the gradient).  The greater complexity of the metabolome is 
likely due to in part to the media in which the cells are cultured.  Islets were incubated in 
media containing glucose, amino acids, vitamins and fetal bovine serum, which would 
allow for synthesis and uptake of more metabolites than the media containing only 
glucose as a fuel as was the case for E. coli.  The differences in metabolites detected may 
also reflect inherent differences in the complexity of the metabolomes of the different 
tissue types.  Because of the greater complexity of the islet metabolome, the use of 2D 
separation was even more important for increasing the number of detected metabolites in 
these samples than for the E. coli samples (compare increase in detected metabolites in 
Fig. B.4).   
Our experiments have addressed the potential impact of column dimensions and 
multi-dimensionality on metabolite separations.  Many other factors are important in 
determining the quality of metabolomic data including sample extraction, quantification, 
and peak identification.  Recent data has suggested for example that the use of water 
rinses on bacteria samples, such as those used here, prior to extraction may result in 
disturbance of metabolite levels (Saghatelian et al., 2004).  Therefore, development of 
metabolomic methods for quantification will require consideration of those variables as 
well.   
 
Conclusion 
 The work presented here demonstrates the utility of an aqueous-compatible 





with a wide range of polarities and charge, including those in glycolysis and the TCA 
cycle.  Reduction of column I.D. led to superior peak shape, reduction of adducts, and 
higher signal intensity.  The use of multiple dimensions improved peak capacity as 
expected.  Combined, these effects more than doubled the number of metabolites detected 
from a complex metabolomic samples as summarized in Fig. B.4.  A comparison of the 
number of metabolites in the E. coli and islet samples reveals detection of approximately 
60% more in the islets.  Furthermore, the islet samples had more high molecular weight 
molecules.  These differences may reflect either an inherently more complex metabolome 
or effects of incubation media or both.  Regardless, these results illustrate the potential 
for high sensitivity and high resolution for metabolomic analysis by multi-dimensional 









Figure B.1.  Block diagram of capillary LC system illustrating splitters and voltage 
application.   
For sample loading, the 6 port valve is set in “load” position (flow path represented by 
dashed line), the column is removed from the tee, sample loaded onto column using gas 
pressure sample reservoir (500 psi) and then reconnected to tee.  The valve is actuated to 
inject position (solid lines) and gradient initiated.  With this configuration, the pump is 










Figure B.2.  Reconstructed ion chromatogram illustrating resolution of 23 of 24 
metabolite standards using ternary gradient of formic acid, ammonium formate and 
acetonitrile.   
Standards were mixed together before analysis.  The LC column used was 30 cm long × 
50 µm I.D. packed with Atlantis dC-18 3 µm particles and equipped with an integrated 
nanospray tip with 3 µm diameter.  Gradient is given in the experimental section.  Flow 
velocity was 100 nl/min.  * indicate peak for the analyte when multiple peaks are 









Figure B.3.  Effect of decreasing column I.D. on peak signal and mass spectrum.   
(A)  Reconstructed ion chromatogram of 662 m/z from 50 µm I.D. and 25 µm I.D. 
column.  (B)  Average mass spectrum over width of 662 m/z peak from 50 µm I.D. 
column.  (C)  Average mass spectrum over width of 662 m/z peak from 25 µm I.D. 
column.  Comparison of B and C illustrates fewer adducts to the 662 m/z peak and a 73% 









Figure B.4.  Effect of chromatographic changes on the peak capacity and number of 
small molecules detected in complex mixtures.   
Error bars represent 1 standard deviation.  Statistical significance between samples is as 












Figure B.5.  Base peak chromatograms from 1D and 2D separation of small 
molecules from E. coli.   
RPLC was performed using 30 cm × 25 µm I.D. column.  2D was performed by off-line 
fraction collection in 10 min step intervals from SAX capillary column.  [Brackets] 
indicate the average number of small molecules detected.  (A)  1-D RPLC-MS [170].  (B-
G)  2-D SAX-RPLC.  (B)  5 mM NH4HCO2 fraction [79].  (C)  100 mM NH4HCO2 
fraction [46].  (D)  200 mM NH4HCO2 fraction [45].  (E)  300 mM NH4HCO2 fraction 








Figure B.6.  Base peak chromatograms from 1D and 2D separation of small 
molecules from 50 islets of Langerhans.   
Experiment performed as in Figure B.5.  [Brackets] indicate the average number of small 
molecules detected.  (A)  1-D RPLC-MS [191].  (B-G)  2-D SAX-RPLC.  (B)  5 mM 
NH4HCO2 fraction [155].  (C)  100 mM NH4HCO2 fraction [70].  (D)  200 mM 
NH4HCO2 fraction [73].  (E)  300 mM NH4HCO2 fraction [41].  (F)  400 mM NH4HCO2 








Metabolite % RSD LLOD (fmol) LLOD (µM) 
G6P/F6P 24 4 0.5 
F1,6P 18 6 0.6 
Glyceraldehyde-3-
Phosphate 16 30 4 
2/3 Phospho-glycerate 26 30 4 
Bis-phospho-glycerate 17 7 0.8 
Phosphoenol Pyruvate 11 20 3 
Pyruvate 33 20 2 
Acetyl CoA 25 2 0.2 
Citrate 31 10 1 
Isocitrate 30 7 0.8 
α−Ketoglutarate 18 10 1 
Succinyl CoA 30 4 0.4 
Succinate 10 9 1 
Fumarate 27 10 2 
Malate 19 3 0.3 
Oxaloacetate 24 20 2 
ATP 6 5 0.6 
ADP 10 4 0.4 
NAD 17 1 0.1 
GTP 19 5 0.6 
GDP 34 4 0.4 
FAD 32 2 0.2 
 
 
Table B.1.  Figures of merit for metabolite standards.   
% RSDs were analyzed based on peak height for 5 µM n = 3.  Lower limits of detection 
were calculated as the concentration that would give a S/N of 3 based on the average S/N 
ratio of peaks at sample concentrations of 5 µM, n = 3.  Detection limits were determined 












Figure B.S1.  Separation of metabolite standards under acidic (pH 2.7) conditions 
with ACN.   











Figure B.S2.  Separation of metabolite standards under neutral (pH 6.5) conditions 
with ACN gradient.   
Gradient was 0-20% ACN over 20 min.  Top 5 traces are reconstructed ion 
chromatograms (RIC) for mass of each compound indicated.  Bottom trace is total ion 
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